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Delirium occurs in 20% of inpatients, and at higher rates in older patients. It 
independently leads to adverse outcomes, but remains poorly recognised clinically, 
particularly hypoactive forms. This is partially due to poor consensus about delirium 
screening tools, as well as under-appreciation of the importance of hypoactivity. 
Although early identification and intervention may improve prognosis, delirium 
prevention programmes have had the most impact on outcomes to date. The 
delirium prodrome concept has been considered in the literature for decades, but 
remains poorly characterised. Greater understanding of this prodromal phase would 
facilitate identification of delirium-prone patients prior to delirium onset, potentially 
leading to improved strategies for delirium prevention and management.  
Methods 
Medical inpatients of ≥70 years in two hospitals in Cork city were initially screened 
for prevalent delirium using the Revised Delirium Rating Scale (DRS-R98) and also 
assessed using a series of cognitive tests which were then tested for diagnostic 
accuracy in delirium detection. Participants without prevalent delirium on initial 
screening were assessed on a daily basis for delirium development, prodromal 
features and motor subtype. Baseline predictors of incident delirium were identified 
using multivariable logistic regression. Survival analysis models identified which 
prodromal features predicted the emergence of incident delirium in the cohort in 
the first week of admission. The Delirium Motor Subtype Scale-4 (DMSS-4) was used 
 
 2 
ascertain motor subtype in those with full syndromal (FSD) and sub-syndromal 
delirium (SSD), and the longitudinal course and stability of subtypes were examined. 
A small cross-sectional study was also conducted to assess the clinical utility of the 
NICE guidelines (2010) screening recommendations. A questionnaire based on the 
guidance was developed and administered to nursing staff by trained researchers 
blinded to the delirium assessments, and diagnostic accuracy was then calculated. 
Results 
Of 555 patients approached, 470 had full delirium assessments performed and 184 
(33.2%) had prevalent delirium. Of six cognitive screening tests, the 6-CIT was most 
robust in detecting delirium (AUC 0.88), 95% CI 0.84-0.91). The most efficient cut-off 
for use as a screening tool was found to be 8 / 9 with a sensitivity of 89.9% (95% CI 
83.8-93.9) and specificity 62.7% (95% CI 56.6-68.5). A total of 191 patients were 
included in the prospective study of incident delirium. The median age was 80 (IQR 
10), 101 (52.9%) were male and 32 (16.9%) had premorbid dementia. Sixty-one 
patients developed incident delirium within the first week of admission. 
Independent baseline predictors of delirium development were premorbid 
dementia; functional impairment; and higher comorbidity. Controlling for these 
factors, several prodromal features predicted the emergence of delirium in the 
cohort. Using a novel Prodromal Checklist based on the existing literature, seven 
predictive behavioural features were identified: increasing confusion or ‘fogginess’ 
(HR 2.28, 95% CI 1.4-3.72); being easily distractible or going ‘off-track’ (HR 1.89, 95% 
CI 1.11-3.21); needing prompting for usual tasks (HR 1.86, 95% CI 1.1-3.14); seeming 
tired in the morning (HR 1.77, 95% CI 1.12-2.81); drowsiness during the day (HR 1.74, 
 
 3 
95%CI 1.12-2.71); being ‘fidgety’, restless or wandering (HR 1.72, 95%CI 1.08-2.75); 
and irritability (HR 1.72, 95% CI 1.06-2.78). Using serial cognitive tests, prodromal 
impairments in orientation, attention, short-term memory and visuospatial function 
were also found, independent of premorbid dementia and other confounders. 
Additionally, using the DRS-R98 daily, multiple core delirium features were detected 
in the prodrome, including disturbances in sleep-wake cycle, perception, attention, 
and short-term memory, as well as lability of affect and symptom fluctuation. 
Examining longitudinal motor subtypes in those with delirium, subtypes were found 
to be predominantly stable over time, the most prevalent being hypoactive subtype 
(62.3%). Furthermore, hypoactive subtype was almost twice as common in SSD and 
FSD events than in ‘no delirium’ (p<0.001), whereas ‘no delirium’ periods most 
commonly presented with no subtype. Finally, regarding the clinical utility of an 
operationalised version of the NICE guidelines screening recommendations, where 
any positive response was considered a positive screen, the sensitivity of the 
instrument was too low (at 64.3%-66.7%), to be a useful screening tool for delirium.  
Discussion 
This thesis explored multiple aspects of delirium in older medical inpatients, and 
includes an in-depth characterisation of the delirium prodrome; evaluation of the 
baseline predictors of incident delirium; detailed examination of the motor 
subtyping of FSD and SSD with respect to course, stability, and relationship to other 
factors; as well as investigation of the efficacy of several methods for delirium 
screening. The findings of this thesis should help to inform future delirium 





Delirium is a serious neuropsychiatric syndrome which occurs in the setting of acute 
illness, injury, or toxicity. It is extremely common, occurring in approximately 20% of 
hospital inpatients (1), and at higher rates in older patients (2). Delirium is 
independently associated with adverse outcomes, such as mortality, and cognitive 
and functional decline (3), yet it remains under-detected with up to 72% of older 
medical inpatients being missed or misdiagnosed (4). Because delirium is challenging 
to diagnose without training and experience, it is now generally accepted that a two-
phase approach should be employed such that a sensitive, simple test should first be 
used to screen for possible delirium cases, followed by formal diagnosis in those who 
screen positive (5). Unfortunately, although multiple screening methods have been 
proposed, there remains no consensus as to which approach is best. Moreover, the 
concept of subsyndromal delirium (SSD), in which a patient presents with certain 
delirium features without reaching full diagnostic thresholds, further obfuscates the 
issue. 
 
Although early intervention may improve prognosis (6), studies over the past few 
decades have demonstrated that in order to meaningfully impact on the long-term 
burden of delirium, prevention is the key (7). However, and unsurprisingly given the 
multifactorial aetiology of delirium, successful delirium prevention strategies involve 
a systematic and widespread multifaceted approach, which requires that delirium is 
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considered a serious healthcare concern by clinical leaders, senior health 
management and practicing healthcare professionals alike (8). Unfortunately, with 
the ever-increasing workload on busy clinical staff, delirium prevention and 
intervention strategies are commonly neglected. To date, the development of 
strategies for the prevention and early intervention of delirium has been informed 
by numerous studies of delirium risk factors in various study populations. A vast 
array of risk factors have been identified, the most consistent being advancing age 
and premorbid cognitive impairment (9). Our ageing population means that the 
prevalence and associated adverse sequelae of delirium is set to rise significantly, 
hence our preventative efforts are likely to be spread even more thinly. It is thus 
important that we aim to direct these efforts towards the most delirium-prone. 
 
One potential way to reduce the occurrence of full-syndromal delirium is to identify 
patients with impending delirium and focus intensive prevention efforts on this 
group. Although one of the key diagnostic features of delirium is its acute onset, over 
the last number of years the concept of a delirium prodrome has emerged, referring 
to a variety of symptoms which may occur in the days prior to delirium development. 
Although this concept has appeared in the literature for decades, it remains poorly 
characterised, the few studies conducted differing greatly in methodology, 
populations studied and assessments used (10). A further understanding of this 
prodromal period may facilitate early detection, intervention and possibly 





The overall aim of this study is to characterise delirium and its prodrome in older 




The primary objective of this thesis was to characterise the delirium prodrome in 
older people admitted medically to the acute hospital. This prodrome was studied in 
detail by evaluating patients for the emergence of (i) behavioural features (somatic; 
emotional; and non-specific); (ii) cognitive features; and (iii) delirium 
phenomenological features in a prospective fashion, while simultaneously assessing 
for incident delirium development.  
 
Secondary objectives were: 
 To determine the prevalence of delirium in older medical inpatients on 
admission and identify which screening tools are most efficacious in 
detecting prevalent delirium in this cohort - objective (iv). 
 To determine the incidence of delirium in older medical inpatients and 
identify predictors of incident delirium in this group - objective (v). 
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 To examine the clinical utility of the NICE guidelines’ screening 
recommendations (using a novel operationalised tool) in detecting incident 
delirium - objective (vi). 
 To assess the prevalence and stability of different motor subtypes of incident 
delirium in older medical inpatients - objective (vii). 
 To characterise the phenomenology and motor profile of subsyndromal 
delirium in older medical inpatients - objective (viii).  
 
1.4. RESEARCH SETTING 
This project studied older people admitted to acute hospitals who were at high risk 
of developing delirium. The cohort were followed closely on a longitudinal basis to 
detect incident delirium during the hospitalisation. Patients were assessed for the 
presence of a range of delirium risk factors, in order to ascertain which factors 
predicted the development of incident delirium in this cohort. The delirium was 
carefully characterised, in relation to phenomenology and motor activity profile, and 
evidence of potential prodromal symptoms was also sought on a daily basis, by 
interviewing both the patient and the relevant nursing staff. A novel prodromal 
checklist was devised to detect behavioural features and patients were assessed for 
cognitive decline and for other prodromal delirium features daily. Patients were also 
evaluated daily for motor subtype expression using the DMSS-4 and longitudinal 
subtypes were applied to patients with both full-syndromal delirium (FSD) and 
subsyndromal delirium (SSD) using criteria from earlier similar studies (11).  
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This thesis also tested the validity of the ‘indicators of delirium’ that have been 
proposed by the National Institute for Health and Clinical Excellence (NICE) 
guidelines for the detection, prevention and management of delirium (5). An 
operationalised version of these recommendations was developed and tested for 
diagnostic accuracy. Additionally, a series of other potential delirium screening tests 
were also assessed for utility in detecting delirium in older medical inpatients on 
admission.  
 
1.5. THESIS OUTLINE 
This thesis is comprised of eight papers (as yet unsubmitted) which explore the 
phenomenology of the delirium prodrome; the motor profile of both FSD and SSD; 
predictors of incident delirium; and the diagnostic accuracy of multiple screening 
methods. The thesis aims, objectives and associated papers are outlined in figure 1. 
Chapter 2 provides an introduction to delirium with particular emphasis on early 
detection and the existing evidence on the delirium prodrome. This thesis also 
includes a detailed methodology chapter (Chapter 3).  
In the results chapters (Chapters 4 to 11), for ease of reading, I will report the 
findings in order of the chronology of data collection and analysis, rather than the 
order of the objectives (figure 1 shows the link between each chapter and objective). 
Prevalent delirium: Older medical inpatients were assessed within 36 hours of 
admission for prevalent delirium. They were also assessed using a series of cognitive 
tests, which have potential as delirium screening tests, including the 6-CIT (Six-item 
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Cognitive Impairment Test). Chapter 4 examines the diagnostic accuracy of these 
cognitive tests in screening for prevalent delirium on admission. 
Predictors of Incident Delirium: Those who did not have prevalent delirium nor any 
other exclusion criterion were then included in a prospective study of incident 
delirium and underwent daily assessment. Data pertaining to a variety of baseline 
risk factors was collected, for example demographics, functional impairment, pre-
morbid dementia and comorbidity burden. Chapter 5 outlines the baseline features 
which independently predicted delirium development in this cohort. 
NICE Delirium Indicators: The NICE (National Institute for Health and Clinical 
Excellence) Guidelines on Delirium: Diagnosis, Prevention and Management were 
published in 2010, (5) shortly before this PhD was commenced. In these guidelines, it 
is recommended that patients at risk of delirium are screened daily for ‘indicators of 
delirium’ (see Chapters 3 and 6 for detail), however this method of screening has not 
been validated in the clinical setting. Chapter 6 investigates the clinical utility of 
these screening recommendations.  
Delirium Prodrome: The characteristics of the delirium prodrome are explored in 
Chapters 7 to 9. Chapter 7 outlines evidence for the presence of behavioural 
features in the prodromal period. Chapter 8 investigates if cognitive decline occurs in 
the delirium prodrome and which cognitive domains are affected during this period. 
Chapter 9 examines which delirium phenomenological features occur in the 
prodromal period before full delirium development. 
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Motor Subtypes: Chapter 10 describes the prevalence, course and stability of motor 
subtypes in older medical inpatients with delirium and explores factors related to 
subtype stability, such as demographics, functional ability, presence of pre-morbid 
dementia and comorbidity. Chapter 10 also investigates if motor subtype relate to 
cognitive performance in this population.  
Subsyndromal delirium: Chapter 11 examines the motor profile and phenomenology 
of SSD, and investigates the phenomenological differences between SSD and full-
syndromal delirium (FSD), and particularly between SSD and normal controls. 
An overall discussion of the main study findings, strengths and limitations, clinical 
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This chapter provides a brief overview of delirium and its prodrome, with particular 
focus on the importance of early detection and current and potential diagnostic 
approaches. The clinical features of full-syndromal and subsyndromal delirium are 
outlined, and motor subtypes are described. The concept of the delirium prodrome 
is introduced and the existing literature on this area is summarised.  
 
2.1. DELIRIUM: EPIDEMIOLOGY AND SIGNIFICANCE 
Delirium is a complex neuropsychiatric syndrome characterised by acutely declined 
cognitive function and can be precipitated by a variety of factors including acute 
illness or injury, substance toxicity or withdrawal. It is one of few conditions to 
permeate across all treatment settings, occurring in one-fifth of all hospital 
inpatients (1) , in up to half of the hospitalised elderly (2) and at higher rates in the 
critically ill and other vulnerable groups (12, 13). Although delirium is a serious 
condition which independently leads to increased mortality (14); increased length of 
hospital stay (15) and readmission rates (16); and increased cognitive (17) and 
functional decline (16), it is often viewed as simply a marker of underlying pathology 
and is commonly overlooked. Studies have highlighted that the adverse outcomes 
linked to delirium can be modified by prompt detection and early intervention (6, 7), 
but are further intensified by late or misdiagnosis (18, 19). Despite this, delirium 
remains missed or mistaken for other conditions, particularly in older patients (2), 
those with pre-existing dementia (20) and those with hypoactive features (21, 22). 
Studies in the emergency department (ED) have found that delirium is missed by ED 
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physicians in 65% to 75% of cases (23, 24). Collins and colleagues reported detection 
rates to be as low as 28% in older medical inpatients (4) and Kishi and co-workers 
found in a study of general hospital referrals to liaison psychiatry, that 46% of 
delirium diagnoses were missed by the referring team (25).  
 
2.2. DELIRIUM PATHOPHYSIOLOGY AND THE ROLE OF BIOLOGICAL MARKERS  
Although multiple hypotheses have been suggested as to the underlying 
pathophysiology of delirium, the exact process is not yet fully understood. Theories 
include disturbances in the neurotransmitter system; altered central responses to 
peripheral inflammation; hypothalamic pituitary adrenal axis dysregulation; and 
direct cerebral insults such as hypoxia and trauma (26). Given the wide differential of 
aetiological contributors to delirium, it is probable that each of these hypotheses 
play a role in delirium development and that the initial insult and resultant triggering 
mechanism ultimately leads to a final common pathway of reduced cholinergic and 
GABAergic activity and increased dopamine, glutamate and noradrenaline release 
(27). Irrespective of the theories underpinning delirium pathogenesis, it is important 
to recognise that delirium occurs particularly frequently in those with a vulnerable 
brain (e.g. dementia, learning disability, stroke), where an exaggerated central 
physiological reaction occurs as a consequence of an aberrant stress response in the 




Hypotheses concerning delirium pathogenesis have prompted multiple studies of 
biomarkers and genetic polymorphisms which indicate relationships with delirium 
incidence, course and severity (26, 29). Studies of peripheral inflammatory 
mediators, for example IL-8 (interleukin-8), cortisol and CRP (C-reactive protein), 
have shown some promise in relation to signalling imminent delirium, however 
results are somewhat conflicting (30-34), particularly in relation to CRP. Low levels of 
the cytoprotectant peptide insulin-like growth factor 1 (IGF-1) are associated with a 
greater delirium risk (35, 36), but are not predictive of delirium emergence (37). 
Further studies of the neurobiological processes underlying delirium and the role of 
biological markers in delirium detection are required, before we can assess whether 
biomarkers can be utilised as a diagnostic approach for delirium. 
 
2.3. CLINICAL PRESENTATION AND MOTOR SUBTYPES 
Delirium has been recognised as a clinical syndrome since ancient times, however it 
was not until the publication of DSM III (Diagnostic and Statistical Manual of Mental 
Disorders, 3rd edition) in 1980 that its definition became standardised. Prior to this, 
acute and subacute cognitive disturbances were labelled by a wide variety of terms 
based on differences in aetiology and clinical settings, which hampered meaningful 
progress in delirium research and clinical care. However, considering delirium as a 
unitary syndrome has helped to foster a greater awareness of its significance and its 
ubiquitous nature, and has facilitated research across treatment settings over the 




Delirium presents in a myriad of ways, its constellation of symptoms representing 
widespread cortical dysfunction. The features vary greatly not only from patient to 
patient but also within the same patient as they fluctuate in severity and nature over 
the course of the day, partly explaining why achieving consensus as to its definition 
was a slow process. Certain delirium features are central to diagnosis, for example 
inattention and acuity of onset, and hence form the basis for gold-standard 
diagnostic systems such as DSM, which is now in its fifth edition (Diagnostic and 
Statistical Manual of Mental Disorders - 5th edition (39)). Some delirium features 
occur frequently but not universally (such as psychomotor disturbance), and others 
present more sporadically (for instance, affective lability, perceptual abnormalities 
and delusions) (40), the result being a protean condition which is difficult to 
diagnose unless trained and experienced. Factor analysis has been used to examine 
the inter-relationship of these features (41), and has identified a three-factor 
structure to delirium, comprising (i) attention / other cognitive; (ii) circadian 
(psychomotor and sleep-wake cycle disturbances); and (iii) higher level thinking 
(disorders of language, thought process and executive function) (42, 43). This 
construct facilitates improved understanding of the inter-play between delirium 
features and future work should focus on efforts to illuminate the relationship 
between these factors and delirium neuro-pathogenesis, amongst other areas (41).  
 
Identification of clinical sub-categories of delirium may facilitate delirium detection 
and promote more targeted approaches in research and in the clinical setting. 
Attempts to categorise delirium have included classifications based on severity, 
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aetiology, comorbidity status, evidence of psychosis, actigraphic profile and motor 
activity profile (38). To date, the most successful approaches have defined subtypes 
based on psychomotor change. Because motor disturbance occurs with such 
frequency in delirium, it is considered a core element of delirium phenomenology. 
Although some motor features, particularly hypoactive aspects, are subtle to the 
untrained eye, motor activity disturbance is readily observable when it is actively 
sought out. Describing delirium based on motor profile is not a modern concept, 
with references dating back as far as the ancient Greeks who used the terms 
‘lethargicus’ and ‘phrenitus’ to label reduced and increased activity profiles 
respectively (38). More recently, Lipowski (44) suggested the words ‘hyperactive’ 
and ‘hypoactive’ to categorise these individual subtypes, before adding a third 
‘mixed’ subtype to include patients who present with elements of both hypo- and 
hyperactivity within short time periods.  
 
Early endeavours to define these motor subtypes resulted in multiple methods, 
including an array of both motor and non-motor features. The wide disparity 
between these tools was highlighted when concordance between the four most 
commonly used tools was found to be only 34% (45). Hence, in order to improve 
consistency, thirty of the elements from antecedent methods were combined to 
form the Delirium Motor Checklist (DMC), which was then employed to ascertain the 
frequency of different motor features in delirious patients and non-delirious controls 
(45, 46). Using principal components analysis and replication analysis, thirteen of the 
original thirty DMC items significantly distinguished between motor subtypes and 
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also correlated with independent measures of motor activity on the Delirium Rating 
Scale-Revised ’98 (DRS-R98), and a new 13-item scale called the Delirium Motor 
Subtype Scale (DMSS) (46, 47) was the result. Unlike earlier approaches, the DMSS 
has undergone meticulous validation and correlates highly with objective measures 
of motion using accelerometry (48). Furthermore, the DMSS is relatively delirium-
specific, and has predictive validity with respect to outcomes (47). Recently it has 
been further reduced to the four-item DMSS-4, by latent class analysis, allowing for 
quicker assessment without compromising on subtyping accuracy (49). A recent 
study in older medical inpatients found that the DMSS-4 has high concordance with 
the DMSS and good inter-rater reliability (50). 
 
The epidemiology and prognosis of the individual delirium subtypes have varied 
widely across studies, due to inconsistent methodologies and referral bias within 
study samples (38). Additionally, most studies have been cross-sectional in 
methodology, which gives misleading results, given the dynamic and fluctuating 
nature of delirium. Longitudinal work in the palliative care setting has found that 
subtypes are most commonly stable across time, with the most prevalent subtype 
being hypoactive (11, 51). Conversely, in a longitudinal study of hip fracture patients, 
approximately 87% of patients had a variable motor profile throughout the delirium 
episode (52). It is possible that hip fracture patients follow a different course to 
other patient cohorts. For example, it is now generally accepted that in most settings 
hypoactive delirium carries the worst prognosis, whereas Marcantonio and 
colleagues found that amongst hip fracture patients with delirium, it was those with 
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hypoactive motor profile (albeit using categories based on the Memorial Delirium 
Assessment Scale, MDAS) who achieved the best outcomes, independent of delirium 
severity and other confounders (53). 
 
Longitudinal studies in palliative care patients have found that motor subtype is 
more closely related to delirium phenomenology than to medication exposure or 
aetiology (54). The subtypes can differ with respect to the non-cognitive features of 
delirium, but they do not differ in relation to the spectrum and severity of cognitive 
impairment (38, 54), except that in patients without a motor subtype, cognitive 
impairment is less pronounced than in those presenting with a subtype. This former 
group have also been shown to experience a less phenomenologically intense 
delirium than the other subtypes and often have rating scores in the subsyndromal 
range on the DRS-R98 (54). Although there are few studies investigating how motor 
subtypes relate to various risk factors for delirium, some work suggests that 
increasing age and premorbid cognitive impairment may be more common in those 
with hypoactive presentation (55, 56).  
 
To date, studies in older medical inpatients with delirium have all been cross-
sectional in nature and results have been widely conflicting. In 1992, Liptzin and 
Levkoff found that 52% of 125 older medical inpatients with incident delirium had a 
mixed profile, whereas only 19% were hypoactive, and that motor subtype did not 
relate to sex, age, place of residence or presence of comorbid dementia (57). 
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O’Keeffe and Lavan found that mixed subtype predominated in 94 acute geriatric 
medicine patients with delirium, but that those with hypoactive profile had higher 
illness severity and longer length of stay (58). A more recent cross-sectional study of 
older medical inpatients primarily designed to identify MMSE (Mini-Mental State 
Examination) items on admission that predict the occurrence of incident delirium, 
used DRS-R98 motor items to apply motor profile and found that the most common 
subtype in patients with incident delirium was hypoactive (13 / 34, 38%) (59). 
Furthermore, a study investigating the occurrence of delirium in older patients in the 
emergency department found that 92% of cases were hypoactive, based on the 
Richmond Agitation Sedation Scale, and worryingly over three quarters of cases were 
missed by emergency physicians (23). Drawing meaningful conclusions from these 
discordant results is limited by the cross-sectional nature of these studies and also 
because each study differed in relation to the subtyping methods employed. 
Longitudinal data, using a validated instrument, is needed to accurately examine the 
motor profile expression in this patient group. Hence, in this thesis, I aim to 
investigate the course and stability of motor subtypes in older medical inpatients, 
and to examine the relationship between these subtypes and both baseline risk 
factors (such as demographics, functional ability, presence of pre-morbid dementia 
and comorbidity), as well as cognitive performance. 
 
2.4. SUBSYNDROMAL DELIRIUM 
In addition to full-syndromal delirium (FSD), in which patients meet criteria for 
delirium using diagnostic systems such as DSM, a clinical spectrum exists such that 
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subsyndromal delirium (SSD) describes the clinical presentation of certain delirium 
features without fully meeting FSD diagnostic thresholds. SSD definitions and 
prevalence rates have varied across research groups, with both categorical and 
dimensional methods being used and therefore lack of clarity still exists in relation to 
accurate SSD definition and diagnosis. Categorical methods for SSD definition are 
based on the presence or absence of key diagnostic features (60-66) whereas 
dimensional approaches incorporate symptom severity scores on a spectrum from 
absence of delirium to presence of the full-syndromal state (67-73). Our 
understanding of SSD is further complicated by the fact that that outside the 
delirium spectrum, some delirium symptoms can occur in isolation as components of 
illness behaviour (for example drowsiness, hypoactivity) or in clusters as part of 
other non-delirium diagnoses (for example hypomania, acute psychosis). Hence 
defining features which differentiates SSD from non-delirium presentations is 
important, particularly given the clinical relevance of SSD. Multiple studies have 
found that SSD has prognostic significance with SSD patients experiencing adverse 
outcomes intermediate between those with delirium and normal controls (53, 62, 
65, 69, 74). The context in which SSD develops is not fully understood, but it has 
been suggested that SSD can exist either in isolation, without ever crossing full 
syndromal thresholds (75), or occur as a transitional state either preceding delirium 
as a prodrome, or following delirium in the post-dromal or recovery period. One 
study found that antipsychotic prophylaxis during SSD in post-cardiotomy patients 
reduced progression to FSD in the post-operative period (73), indicating that SSD 
may present an opportunity for delirium prevention strategies, however further 
work is needed in other populations. 
 
 22 
Recently, analysis of pooled multicultural data has found that SSD is phenotypically 
closer to delirium than non-delirium and that core delirium features occur in SSD, 
albeit with milder intensity than in FSD (75), providing evidence for a dimensional 
spectrum of delirium presentation. Furthermore, results from our research group 
indicate that certain core diagnostic features (including deficits in higher order 
thinking and cognition, particularly attention) were the key features to differentiate 
between SSD and FSD, and SSD and no delirium (76). In this cross-sectional study, 
SSD patients with inattention had higher DRS-R98 severity and total scores than 
those without, and also scored higher on items related to cognition (including 
attention); higher order thinking; motor agitation; and on diagnostic items such as 
acuity of onset and severity of fluctuations. This more anchored definition of SSD 
recognises that although other delirium features can vary between patients with SSD 
(as they do in FSD), certain features are core and mandatory to SSD diagnosis, 
namely impaired attention span; and an acute or subacute onset of symptoms. 
These important features are crucial to the diagnosis and philosophy of full-
syndromal delirium and so their significance in defining a milder delirium spectrum 
disorder is unsurprising (76).  
 
Hence, SSD and FSD are conceptually similar, the former presenting with milder 
manifestations of core delirium features that do not reach FSD diagnostic criteria. 
Although studies as cited above have investigated the phenomenology of SSD, and 
notwithstanding the significance of abnormal motor behaviour in FSD, the relevance 
of motor subtypes in SSD has yet to be explored. Understanding the prevalence and 
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presentation of motor subtypes in SSD may improve approaches towards detecting 
SSD in the clinical setting, as motor presentations are the most clinically observable 
features of delirium phenomenology. Thus, one of the aims of this thesis was to 
measure the prevalence and stability of motor subtypes in SSD using validated motor 
subtyping methods in older medical inpatients.  
 
2.5. DELIRIUM DETECTION 
2.5.1. IMPORTANCE OF EARLY DIAGNOSIS  
Research has highlighted the importance of early and more optimal intervention in 
delirium, particularly in mitigating short term-outcomes such as delirium severity 
and duration, however even early detection and intervention has limits in addressing 
the long-term burden of delirium sequelae (6). Studies have also shown that 
identifying delirium-prone patients and incorporating delirium prevention strategies 
are crucial in order to impact significantly on long-term outcomes, such as mortality, 
cognitive and functional decline (7), however success in achieving this requires 
systematic and widespread implementation of multifaceted delirium prevention 
programmes such that delirium is targeted as a serious healthcare issue by clinical 
leaders, senior hospital management, and healthcare professionals alike.  
 
The under-recognition of delirium is one of the most serious challenges facing 
delirium care today for many reasons. Firstly, non-detection is associated with 
particularly poor prognosis, including mortality. Kakuma and colleagues (19) found 
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that 6-month mortality was significantly increased in older patients discharged from 
the ED with undetected delirium, compared to those in whom the diagnosis of 
delirium had been made (19). Secondly, delirium duration is directly related to poor 
outcomes, such that the longer a patient goes undiagnosed, the greater their risk of 
adverse sequelae. Gonzalez and co-workers reported an 11% increase in mortality in 
acute older inpatients for every additional 48 hours of delirium (18) and Kiely and 
colleagues found that patients with persistent delirium were almost three times 
more likely to die within one year than those in whom delirium resolved early, 
independent of other confounders (77). Furthermore, non-detection not only leads 
to inadequate management of delirium symptoms, but also compounds the distress 
experienced by relatives and carers who struggle to comprehend the sudden 
changes in their affected loved one without appropriate explanation from clinical 
staff (78, 79). 
 
2.5.2. BARRIERS TO DETECTION 
The reasons for under-diagnosis are myriad, not least the complex and fluctuating 
clinical presentation of delirium, with clinicians potentially being deceived by 
symptoms that not only vary from patient to patient but also wax and wane 
characteristically within the same patient over the course of the day. Moreover, the 
more common and prognostically serious hypoactive form is more subtle to staff 
than the stereotypical but less prevalent hyperactive agitated form, and hence is 
commonly mistaken for depression. Another barrier to improved detection is that 
delirium is often not considered in itself a medical emergency leading to serious 
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healthcare, economic and personal burden, instead being viewed simply as an 
expression of underlying illness by medical and nursing staff. Additionally, the 
conventional misperception that ‘confusion’ is a natural phenomenon in the ill older 
adult, or even an element of the normal ageing process, undermines the importance 
of delirium as a diagnosis and hinders identification across disciplines. Lastly, another 
obstacle to improving delirium detection rates relates to the lack of robust and 
systematically applied procedures, even in those at high risk.  
 
2.5.3. APPROACHES TO IMPROVING DETECTION 
2.5.3.1. Identifying the vulnerable patient 
The development of strategies for the prevention and early management of delirium 
has been guided by many studies of factors which increase delirium risk, so that 
efforts are targeted at those most vulnerable to delirium development. Despite the 
uncertainty in relation to the exact mechanism driving delirium pathogenesis, 
multiple predisposing and precipitating factors for delirium in a range of treatment 
settings and patient groups have been identified (80, 81). The most consistent 
predisposing factors independent of the underlying cause, are older age and pre-
existing cognitive impairment (9). Modifying these risk factors using proactive 
multifaceted systematic interventions can halve delirium incidence (7), but these 
strategies are often spread too thinly in our under-resourced health service, as the 
proportion of inpatients over the age of seventy years rises in tandem with our 




In 2010, the United Kingdom’s National Institute for Health and Clinical Excellence 
(NICE) published a guidance document on the diagnosis, prevention and 
management of delirium (5), its main focus being to improve delirium care by 
promoting a “THINK DELIRIUM” approach for use by all healthcare professionals in 
their daily work. The guidelines were informed by comprehensive review of the 
existing literature by delirium experts and advises that all high risk patients should 
be monitored daily for delirium development, in order to improve detection rates. 
This includes all those who have any of the following risk factors: being of 65 years 
and over; having cognitive impairment or dementia; having a current hip fracture; or 
being severely unwell at risk of decompensation. Unfortunately, this classifies the 
vast majority of hospital inpatients as being at risk, reflective of the ubiquitous 
nature of delirium, but making prevention strategies difficult to incorporate in 
clinical practice. Efforts to refine our ability to identify patients particularly at risk 
could, therefore, facilitate more focused and efficient approaches towards delirium 
prevention and detection. 
 
2.5.3.2. Screening and Diagnostic Approaches 
Definitive delirium diagnosis is challenging due to its nuanced and commonly 
complex presentation. Two standard diagnostic systems are used for the diagnosis of 
delirium, the Diagnostic and Statistical Manual of Mental Disorders criteria (39) and 
the International Classification of Diseases (ICD)-10 (82). The former is the most 
commonly used system, both clinically and in the research sphere, as it most 
accurately reflects the disturbances found in delirium, however neither are easily 
 
 27 
applicable in daily practice, requiring specific training and expertise in their use. In 
order to enhance the feasibility of delirium identification in a practical setting, a two-
phase approach to diagnosis is now recommended by experts and advocated by the 
NICE guidelines (5). The first stage should entail screening for core delirium features 
in high-risk patients using a short, simple, sensitive instrument, and the second step 
should incorporate formal assessment by a trained expert of those who screen 
positive. Although numerous delirium screening tools have been developed, 
consensus is lacking as to which screening method is best. The NICE guidelines 
propose a screening approach based on daily monitoring for specific delirium 
indicators, however this method has not yet been operationalised nor validated for 
routine clinical use. Identifying an appropriate screening approach depends on many 
factors, including the clinical setting, but a paramount characteristic is that it should 
be highly sensitive in order to reduce the possibility of missing delirium cases. 
Additionally it should require minimal training, and be brief so as to avoid 
significantly increasing the burdensome workload of ward staff. Below, I have 
outlined the benefits and disadvantages of many of the existing screening and 
diagnostic instruments, as well as potential screening approaches which have been 
studied further in this thesis. 
 
2.5.3.2.1. Confusion Assessment Method (CAM) 
The most widely used screening test is the Confusion Assessment Method (CAM, see 
appendix A) (83, 84), which has been translated into several languages and validated 
in a wide range of settings, for example, intensive care (85), ED (23, 86) and long-
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term care settings (62). This tool is based on DSM-IIIR (Diagnostic and Statistical 
Manual of Mental Disorders, 3rd edition) criteria and was originally designed as a 
diagnostic instrument for non-psychiatrists. It tests for the presence or absence of 
key delirium features: acuity of onset, fluctuating course, inattention, disorganised 
thinking and altered level of consciousness, incorporating semi-structured patient 
interview and collateral history. Taking at least five minutes to administer, it lacks 
the brevity required for routine ward screening. Even more importantly, its 
diagnostic accuracy depends on the training level of assessors, such that half of cases 
are missed by minimally trained users (87). A systematic review of its accuracy in 
research studies reported high specificity (99%, 95% CI 87-100%) but only moderate 
to high sensitivity (82%, 95% CI 69-91%), cautioning against use of the CAM above 
best clinical judgement. Recently, an operationalised brief version of the CAM 
(bCAM), has shown promise as a screening approach in the ED (88), however this 
version needs further study. 
 
2.5.3.2.2. The Revised Delirium Rating Scale (DRS-R98) 
The DRS-R98, see appendix A, is a widely used comprehensive assessment tool which 
is designed for delirium diagnosis by psychiatrists. With appropriate training, it can 
be used successfully by other physicians, nurses and psychologists. It is a 16-item 
clinician-rated scale with 13 severity items and 3 diagnostic items which is used to 
rate symptoms over the previous 48-hour period, with higher scores indicating a 
greater severity of delirium. It has high interrater reliability, validity, sensitivity and 
specificity for distinguishing delirium from mixed neuropsychiatric populations 
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including dementia, depression, and schizophrenia (89, 90). Scores are applied using 
all available sources of information, including assessment of the patient and 
discussion with nursing staff and family or caregivers, and hence this instrument is 
far too time-consuming to be used as a screening tool.  
 
2.5.3.2.3. The 4-AT (The 4 ‘A’s Test) 
The 4 ‘A’s Test (4AT) was developed recently for routine use in clinical practice (91). 
This multidimensional instrument assesses (i) level of alertness; (ii) cognition using 
the AMT4 (Abbreviated Mental Test-4); (iii) attention using months of the year 
backwards (MOTYB); and (iv) acuity of onset and / or presence of fluctuations. It has 
gained traction particularly in the UK where is widely used in the acute setting. It is 
quick, simple to administer, requires very little training in its use, and has been found 
to have a sensitivity of 89.7% and specificity of 84.1% in older acute and 
rehabilitation patients. One disadvantage to its use as a screening test is that 
collateral history is required to accurately complete the test and although obtaining 
collateral history is central to delirium diagnosis, reliance on this information as part 
of a screening step is likely to hinder success in the routine setting. 
 
2.5.3.2.4. The Nu-DESC (The Nursing Delirium Screening Scale) 
A number of instruments have been developed for use by nursing staff in an attempt 
to capitalise on their proximity to patients over a 24-hour period, as well as to 
address issues with patient fatigability and potential learning effect. These tools tend 
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to focus on observation for changes synonymous with impending delirium. One such 
instrument is the Nu-DESC (The Nursing Delirium Screening Scale), an observational 
five-item scale which (92) measures symptoms of disorientation, inappropriate 
behaviour and communication, perceptual abnormalities and psychomotor 
retardation. It has been translated into several languages (93-96) and has been 
validated in several settings, including medical (92) and surgical units (97), the 
recovery room (98), and the intensive care unit (99), with high sensitivities and 
specificities calculated at 83 to 98% and 79 to 92% respectively (using DSM-IV 
criteria as the reference standard).  Another strength is its recognition of the 
importance of hypoactivity, which can be difficult to detect and associated with 
poorer outcomes (38). One problem with the Nu-DESC is that it does not include a 
measurement of attention, nor consideration of the context of symptoms, such as 
temporal onset, and both of these features are central to delirium diagnosis (100).  
 
2.5.3.2.5. The NEECHAM 
The NEECHAM is another nursing based tool used mainly in post-operative patients 
(101). It incorporates the measurement of physiological markers of illness severity as 
well as assessment for delirium features. It takes approximately ten minutes to 





2.5.3.2.6. RADAR (Recognizing Acute Delirium As part of your Routine) 
The RADAR is a recently-developed tool which was devised specifically to improve 
feasibility in clinical settings and acceptability with nursing staff (102). This tool, 
which is designed for use during the medication round, contains three simple 
observation-based items that are intended to detect features which may indicate the 
presence of delirium (evidence of drowsiness; impaired ability to follow instructions; 
slow movements). There is no formal patient assessment, which helps to address 
issues such as patient acceptability, fatigability and learning effect. There is also no 
requirement for collateral history which ensures the test can be conducted promptly 
and consistently. Results from early validation studies are relatively promising given 
the simplicity of the instrument (sensitivity 73%; specificity 67%), although higher 
sensitivity would be optimum for use as a screening test.  
 
2.5.3.3. Other Potential Screening Approaches 
2.5.3.3.1. Attention Testing 
Short common bedside cognitive instruments have been considered as potential 
delirium screening tools, for example the MMSE (Mini-Mental State Examination 
(103)). However, most generic cognitive screening instruments lack specificity for 
delirium (9) and cannot differentiate it from other cognitive disorders such as 
dementia and mild cognitive impairment. Although attention is affected in many 
disorders, including dementia, depression, and developmental conditions such as 
attention deficit hyperactivity disorder, it is disproportionately affected in delirium, 
with deficits being more global and severe. Additionally, given that inattention is a 
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cardinal and mandatory feature of delirium, it occurs with much greater frequency 
than other cognitive deficits (42). Hence, theoretically, tests of attention should have 
utility in ruling out those without delirium at an early stage. Objective measures of 
attention such as The Edinburgh Delirium Test Box have shown excellent accuracy 
for differentiating delirium from both dementia and cognitively intact controls (104), 
however devices such as this are too cumbersome for use as a screening test in a 
busy clinical setting. Bedside tests of attention are more observer dependent and 
given that attention is a basic component of cognitive function, performance on 
attention tests may be influenced by deficits in other domains, for example visual or 
auditory processing speed and motor execution. Nonetheless, bedside attention 
tests are simple, brief and generally require little training in their use which 
enhances their feasibility in busy clinical settings. Furthermore, results from recent 
studies indicate that they may be useful as a first step in screening for delirium (105-
108). Two of the most well-recognised tests are ‘WORLD backwards’ and ‘serial 7’s’ 
from Folstein’s MMSE (103), however these are known to be particularly sensitive to 
educational level (109), and have not specifically been tested as delirium screening 
tests. Other tests such as the Months of the Year Backwards (MOTYB); Digit Span 
Test, the Spatial Span Forwards (SSF); the Vigilance ‘A’ Test, and the Digit 
Cancellation Test have all been found to facilitate delirium detection (105-107, 110). 
The visual SSF is a pattern recognition test derived from the digit span forwards 
(111), and may differentiate inattention due to delirium from that caused by 
dementia (110). The MOTYB, also known as the Months Reverse Test, is a very 
simple attention test which is widely used for bedside assessment. A recent study by 
our research group found that the Months of the Year Backwards (MOTYB), a test in 
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which the subject is asked to recite the months of the year in reverse order starting 
with December, had a sensitivity of 83.3% and a specificity of 90.8% in detecting full 
syndromal delirium in general hospital patients (112).  
 
2.5.3.3.2. The Six-item Cognitive Impairment Test (6-CIT) 
The 6-CIT, originally called the Six-item Orientation-Memory-Concentration Test (see 
appendix A), was developed by Katzman et al (113) by shortening Blessed’s Mental 
Status Test (114) as a screening test for dementia. It is also known as the Short 
Orientation-Memory-Concentration Test and the Short Blessed Test. It involves three 
tests of temporal orientation (year; month; time of day), two tests of attention 
(counting backwards from twenty to one; reciting the months of the year in reverse 
order) and short-term memory (remember a 5-item address). It is scored out of 
twenty-eight with higher scores indicating more impaired cognition. It has a broad 
spectrum of use, having been used to screen for dementia in primary care (115); for 
cognitive screening in the acute setting (116); in research on Alzheimer’s disease 
(AD) (117, 118); and in large epidemiological studies (119). It is quick to perform, 
requires minimal training, and with its focus on three major cognitive domains 
affected by delirium, in theory it could have utility as a delirium screening test. 
 
It correlates highly with the MMSE (r2=- 0.82to -0.926)(115, 116, 120-123), however 
is much shorter in duration (approximately 2-3 minutes), is less affected by 
educational attainment (122) and is less culturally biased (124). Other advantages 
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include that it doesn’t require any equipment and it has less potential for 
interpretive error than other tests such as interlocking pentagons and clock-drawing 
(122). Because it is completely verbal, it can be also be used in the visually impaired 
(125), and those with upper limb issues. A study in nursing students showed that 
scoring accuracy is higher than for the MMSE (126) and another study using the 6-
CIT to screen for delirium in the acute setting showed high acceptability by nursing 
staff (127). A small study by the same group showed that it can be reliably used over 
the telephone without modification (128) and is also easily translatable into other 
languages (122). Additionally, of importance where serial testing is required, no 
significant learning effect has been demonstrated (123). A patient’s score on 6-CIT is, 
however, influenced by increasing age (123), as is seen with other cognitive tests, for 
example the MMSE (129). 
 
One limitation of the test is that there is no consensus as to the most appropriate 
cut-off for dementia or cognitive impairment and cut-offs have hence varied from 
study to study. The most common cut-off proposed for the detection of dementia is 
10 / 11 with sensitivities ranging from 82.5% to 90% and specificities from 86.8% to 
96%  (116, 121-123), however this score was chosen as optimal in these studies by 
favouring a high specificity over high sensitivity, so as to avoid false-positive 
dementia diagnoses. This cut-off is in keeping with results from Katzman’s original 
validation study (113), where scores of more than 10 were consistent with dementia, 
whereas 90% of normal controls had scores of 6 or less. Brooke and Bullock (115) 
found the best psychometrics using a cut-off of 7 / 8 in a primary care sample of 287 
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patients (sensitivity 78.6%, specificity 100%) and particularly found it more sensitive 
than the MMSE in the detection of mild dementia. Other studies have used 8 (128) 
and 6 (130) respectively as cut-offs for cognitive impairment, and it is generally 
considered that using lower cut-offs improve sensitivity in detecting milder 
impairments. The most recent study published assessing the suitability of the 6-CIT 
as a dementia screening test was performed in primary care patients (131) and 
interestingly, the results are inconsistent with the other evidence to date. The study 
involved 72 general practitioners and 3,908 patients and using either a 6-CIT cut-off 
of 7 / 8 or 10 / 11, sensitivity in detecting dementia was extremely poor at 49% and 
32% respectively (specificity was >90% at each cut-off). Despite the large sample, 
this study was limited by the fact that there was no clinical reference standard for 
dementia and instead diagnosis was obtained from health insurance records. 
Additionally, the time of diagnosis was unknown so it was not discernible as to 
whether the patient had dementia at time of testing with 6-CIT or not. Although, it is 
therefore difficult to appropriate significance to the authors’ findings, these results 
illustrate that further research is required to assess the utility of the 6-CIT as a 
screening test for dementia and for other causes of cognitive impairment. Given its 
theoretical potential for detecting the cognitive deficits of delirium, I was interested 
to assess if the 6-CIT could be used to characterise the cognitive features of the 
delirium prodrome (Chapter 8) and also to ascertain if the instrument could be 





2.5.3.3.3. The Clock-Drawing Test (CDT) 
Bedside tests of visuospatial function are another proposed method of delirium 
screening, particularly the Clock-Drawing Test (CDT, see appendix A) which is widely 
used in screening for cognitive impairment and dementia (132). The CDT can be 
dated back as far as the early 1900’s as a test of constructional apraxia, however it is 
now recognised that performance is associated with ability in other 
neuropsychological domains, including visuospatial function and also perception; 
executive function; and verbal and semantic memory (133). There are conflicting 
reports as to the utility of the CDT in the detection of delirium. Some authors found 
it reliable for this purpose (134, 135), and others found it unsuitable for delirium 
screening (133, 136-139). Its advantages include that it is largely unbiased by 
educational level, ethnicity, language and socio-economic status and it is quick and 
widely accepted by physicians and patients alike (140, 141). Although multiple 
scoring methods exist, all of them correlate well with other tests of global cognition 
(136).  
 
2.5.3.3.4. Interlocking Pentagons test (IPT) 
The Interlocking Pentagons Test (IPT, see appendix A), also known as the intersecting 
pentagons, overlapping pentagons or pentagon copying test, is another well-known 
visuospatial test which requires the subject to copy a representation of two 
interlocking pentagons with a quadrilateral figure formed by their overlapping 
corners. It initially gained popularity as one of a set of nine figures in the Bender-
Gestalt test used to assess for specific developmental problems in children (142). 
 
 37 
Since then it has been incorporated into other cognitive tests including the MMSE 
(Mini-Mental State Examination) in which it is scored in a binary fashion (143), and 
its modified version (Modified Mini-Mental State or 3MS) in which the scoring of the 
pentagons was altered to a ten-point scale (144). The most commonly applied 
scoring system remains the binary method. In a study of geometric copying and 
handwriting tasks in a community-dwelling population of 668 older patients, the IPT 
was one of the most sensitive tests in detecting small changes in cognition (145). 
Impairments on the IPT can differentiate between patients with Dementia with Lewy 
Bodies (DLB) and Alzheimer’s Dementia (146-149) and can predict cognitive decline 
in Parkinson’s disease patients with normal cognition and with mild cognitive 
impairment (150-153). Given the phenomenological similarities between DLB and 
delirium, it is possible that this test may have utility in detecting delirium, however 
to our knowledge, no studies have yet examined this.   
 
2.6. DELIRIUM PRODROME (10) 
One of the central features of delirium, using any of the available diagnostic criteria, 
is that it is acute in onset, with symptoms typically appearing over hours to days. 
However, the concept of a delirium prodrome has been emerging in the literature 
over the past number of years. The term “prodrome” is defined by the Oxford 
English Dictionary as “an early symptom indicating the onset of an illness” and is 
well-recognised in other medical conditions such as migraine, epilepsy, and syncope. 
In delirium, this phase is thought to represent the emergence of a range of features 
before the patient meets criteria for a diagnosis of full-syndromal delirium. To date, 
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there have been very few studies focusing on the delirium prodrome, most designed 
primarily for other purposes. Other authors have given anecdotal descriptions based 
on clinical experience. Hence a true understanding of the context and characteristics 
of the delirium prodrome is limited. One of the first references to this prodromal 
phase was made by Lipowski in his seminal work “Delirium: Acute Confusional 
States” published in 1990 (154), in which he suggested that the delirium prodrome 
was characterised by disturbances in concentration and perception; fatigue and 
sleep-wake cycle disruption; restlessness; irritability; malaise; as well as 
hypersensitivity to light and sound (154). Subsequent studies of the prodrome 
describe a varied range of features, which can broadly be considered in four major 
categories: cognitive features, non-cognitive neuropsychiatric features, somatic or 
physical features, and affective or emotional features. The latter two categories can 
be considered as one category of behavioural features. Some prodromal features are 
recognised as part of the delirium cluster, however they can occur in the absence of 
full delirium diagnostic criteria and may be considered elements of a subsyndromal 
delirium presentation (see below), depending on their nature and severity. Other 
suggested prodromal symptoms are less related to delirium phenomenology and are 
more somatic or emotional in nature. Hence, the features of the prodromal phase 
could be considered even more heterogeneous than the delirium itself, increasing 
the challenge of detection.  
 
Another aspect of the delirium prodrome which requires clarification is its duration 
in relation to the onset of delirium. Lipowski suggested that a longer prodrome 
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preceded delirium secondary to systemic illness or metabolic abnormalities, and that 
delirium secondary to mechanical or surgical aetiology was likely to be more acute in 
onset (154). Conversely, studies in hip surgery populations have found that many 
patients present with prodromal features three to four days before delirium (155, 
156). A similar duration has been reported in bone marrow transplant (BMT) 
patients (157, 158), whereas in general hospital patients, duration ranged from one 
to nineteen days (159), with a mean of 2.7 days. Prodromal duration is reported as 
longer in long-term care patients (160), however in this study, patients were only 
assessed weekly and hence accurate assertions as to the duration of the prodromal 
phase cannot be made. A consistent observation is that prodromal features tend to 
increase in number and severity as delirium proximity increases, best illustrated by 
the findings of Fann and colleagues (157), which shows a precipitous rise in all 
prodromal features from four days prior to delirium diagnosis. In a study in hip 
fracture patients by Duppils and co-workers, behavioural changes were different and 
more repeatedly observed in those with emerging delirium compared to those who 
remained delirium-free (161). Additionally, the frequency and intensity of 
behavioural changes increased as delirium approached.  
 
Improved understanding of the characteristics and duration of this prodromal period 
may facilitate strategies that promote even earlier detection of delirium. It is also 
possible that intervention in this prodromal period may prevent delirium occurrence, 
however this hypothesis needs study. Below, I have outlined the various potential 
aspects of the delirium prodrome, based on the existing literature, considering them 
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as elements of the four major domains mentioned above. Additionally, 
characteristics and findings from the existing studies of the delirium prodrome have 
been outlined in table 1, and the suggestions from case studies and case series are 
summarised in table 2.  
 
2.6.1. COGNITIVE SYMPTOMS 
2.6.1.1. Inattention / clouding of consciousness 
Considering the importance of impaired attention span in relation to delirium 
diagnosis, it is unsurprising that inattention (either distinctly or as an element of the 
concept known as ‘clouding of consciousness’) is the most commonly referenced 
feature of the delirium prodrome. In his 1990 textbook, Lipowski describes how 
delirium came to be viewed as a disorder of consciousness in the late nineteenth 
century, highlighting how the term ‘clouding of consciousness’ evolved to describe  
disruption in concentration and attention associated with abnormal level of 
alertness (154). His clinical report of the prodromal state referred to a wide variety 
of features including poor concentration. Likewise, a subjective experience of the 
delirious state, written by Crammer, a retired emminent psychiatrist, describes a 
‘declining awareness of the environment’ as delirium emerged (162) and 
Mermelstein reports a prodrome consisting of ‘difficulty focusing’ in one patient in a 




Studies of hip fracture patients have found that inattention occurs with variable 
frequency in the prodromal period before delirium development. De Jonghe and 
colleagues, using the digit span and the Delirium Rating Scale, found that inattention 
occurred in over half of pre-delirious patients two days before diagnosis, rising to 
over 80% of cases on the day before delirium onset (155). Similarly, Lee and 
colleagues found using the Korean version of the Revised Delirium Rating Scale (K-
DRS-R98), that inattention occurred as early as four days prior to delirium diagnosis 
in a Korean cohort of post-operative hip surgery patients (156). Duppils & Wikblad 
used a patient observation protocol to assess hip fracture patients for the 
development of behavioural changes in the post-operative period and reported that 
although clouding of consciousness did not feature prominently in older hip surgery 
patients, when it did occur it was only in those with emerging delirium (161).  
 
Inattention has also been reported as a frequent prodromal feature in other 
populations, for example older medical and surgical inpatients and in Bone Marrow 
Transplant (BMT) patients. Levkoff and coworkers used the Delirium Symptom 
Interview (DSI) to examine the onset and characteristics of delirium and its 
prodrome in older hospitalised patients and reported prodromal inattention in 
15.9% of 91 cases of delirium in the prodromal phase (159). Fann and colleagues 
used detailed assessments of mood (Profile of Mood States), pain (numerical pain 
score ranging from one to ten), and delirium features (DRS and Memorial Delirium 
Assessment Scale, MDAS) to characterise prodromal features in a population of 90 
BMT patients, half of whom went on to have a delirium episode (157). Prodromal 
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decline in attention span and cognition was observed in the delirium group as 
delirium approached. Beglinger and co-workers used a comprehensive battery of 
neuropsychological tests to prospectively examine the cognitive performance of 19 
delirious BMT patients compared to 35 non-delirious BMT patients and 10 healthy 
controls (158). Tests administered at baseline pre-transplantation included Modified 
Mini Mental State Examination (3MS); Trail-making tests (TMT) A and B; The 
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS); The 
Wechsler Abbreviated Scale of Intelligence (WASI); and a visual analogue scale of 
thinking clarity. The groups were comparable for age, education level and WASI IQ at 
baseline. Subsequently, participants were assessed twice weekly for up to four 
weeks following transplantation, using an abridged version of the baseline 
assessment (TMT; 3MS; RBANS List Learning, Coding, Fluency, List Recall and List 
Recognition subsets). Those who developed delirium demonstrated a steady decline 
in scores on all measures throughout the post-transplant period, and particularly 
scores on TMT B, list recall and coding dropped significantly in these patients from 
the second-last visit to the visit just before delirium was diagnosed. This suggests 
that a prodromal period consisting of acquired impairments in attention (especially 
divided attention, complex scanning and visual tracking), psychomotor speed, 
learning and memory before delirium onset in BMT patients.  
 
2.6.1.2. Disorientation 
Disorientation is another frequently observed cognitive feature of emerging 
delirium, being one of the key prodromal features reported by Levkoff et al in a 
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prospective study of 325 older general medical and surgical patients (159). Of 91 
cases of delirium, 69.2% experienced a prodrome and almost half of these patients 
experienced disorientation in the prodromal phase, measured using the DSI. 
Disorientation has been a consistent feature of the delirium prodrome in hip surgery 
patients. Duppils and Wikblad found that disorientation occurred with significantly 
higher frequency in patients with imminent delirium in the 48 hours prior to 
diagnosis, compared to their non-delirious counterparts. Furthermore, disorientation 
was a prominent feature in these prodromal patients (161). De Jonghe and co-
workers found that disorientation preceded delirium development by as early as 
four days in post-operative hip fracture patients and became increasingly prevalent 
as delirium approached (155), a finding which was replicated in a similar Korean 
cohort (156). In addition to these prospective prodromal studies, a 1996 report 
written by Eden and Foreman described prodromal disorientation in a 69-year old 
elective renal endarterectomy patient with emerging delirium in the intensive care 
unit (ICU) (164).  
 
2.6.1.3. Registration and Memory impairment 
Deficits in registration and memory have also been described in the delirium 
prodrome in some of the aforementioned studies. Both short- and long-term 
memory impairments occurred frequently in the prodrome to delirium in de Jonghe 
and colleagues’ hip fracture cohort (155). Lee and co-workers found that long-term 
memory deficits appeared first and persisted throughout the prodromal phase, while 
short-term memory deficits appeared just prior to delirium onset (156). Significant 
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decreases in immediate recall and long-term memory were recorded during the last 
assessment prior to delirium diagnosis in BMT patients (158), and in a recent study 
of long-term care patients, declining performance in registration (measured by 
requesting immediate recall of three words) was significantly associated with 
imminent delirium (160). Furthermore, Crammer’s report of his subjective 
experience of delirium describes the onset of retrograde amnesia and impaired 
registration prior to delirium emergence (162). 
 
2.6.1.4. Visuospatial deficits 
Visuospatial impairments seem to be less prevalent and less prominent than other 
features in the delirium prodrome, however most reports do not give details on how 
this domain was tested. In the comprehensive neuropsychological study conducted 
by Beglinger and colleagues, a decline in TMT B in prodromal BMT patients was 
noted but this may reflect other cognitive domains including poor visuomotor 
processing speed, attention and working memory, and not necessarily just 
visuospatial impairment (158). Mild prodromal decline in visuospatial function has 
been reported in hip surgery patients however the deficit observed was of less 
magnitude than that in other cognitive domains (156). 
 
2.6.2. NON-COGNITIVE NEUROPSYCHIATRIC FEATURES 
This domain includes features which occur as part of the delirium phenomenological 
spectrum. Almost all recognised non-cognitive neuropsychiatric symptoms have 
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been reported to varying degrees in the prodromal phase. Perceptual disturbances; 
psychomotor abnormalities; and sleep-wake cycle disruption are the most prevalent 
of these features, whereas delusions; affective lability; disorders of speech and 
thought; and evidence of fluctuations have been reported less frequently. 
 
2.6.2.1. Motor changes 
Psychomotor disturbance has long been recognised as central to delirium 
presentation (40, 42), and hence it is intuitive that motor change would be observed 
in the prodromal phase. Some studies have described a prodrome characterised by 
hypoactivity, however, restlessness or hyperactivity has predominated in the 
prodromal literature. This may be because hypoactivity is more subtle to the 
untrained eye, does not present the same practical management problems for ward 
staff that motor agitation causes and hence may be under-reported in some studies.  
 
Levkoff and colleagues reported prodromal psychomotor changes in 54% of older 
hospitalised patients who went on to develop delirium, (159) and hyperactive 
features (particularly restlessness), were slightly more prevalent than hypoactive 
features. Restlessness has featured prominently in case studies or accounts of the 
prodromal phase, and again this may be because it is more commonly noticed than 
hypoactivity. Lipowski refers to restlessness in his anecdotal characterisation of the 
delirium prodrome (154). In Eden and Foreman’s ICU case study, it was one of initial 
harbingers of impending delirium, magnifying in severity as delirium approached 
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(164). Hip fracture patients have also demonstrated prodromal increases in 
psychomotor agitation occurring twice as frequently than in non-delirious controls 
(156, 161). In a study of 20 coronary care unit patients, almost all in the delirium 
group (n=10) had evidence of hyperactivity during the prodromal phase (165), 
however the small numbers in this study are limiting. Elective cardiac surgery 
patients with imminent or early delirium were found to have significantly higher 
levels of hypoactivity (using wrist actigraphy) in the first 24 hours post-operatively, 
when compared to those who did not develop delirium, however it was unclear from 
the report whether the changes were recorded in the early stages of full-syndromal 
delirium or in the prodromal phase (166).  
 
2.6.2.2. Sleep-wake cycle disturbance 
Disruptions in the sleep-wake cycle have also been described in the delirium 
prodrome, though generally with less consistency. One study of hip surgery patients 
found that sleep-wake cycle disturbances occurred significantly more frequently in 
the delirium group, four days prior to delirium onset (156), whereas a similar study 
found that the meaningful differences between pre-delirious and non-delirious 
patients only occurred on the day before delirium development (155). A third study 
in hip fracture patients did not find significant prodromal abnormalities in sleep-
wake cycle, although this study differed greatly from the other two with respect to 
methodology and rather than using formal delirium tools to characterise delirium 
and its prodrome, employed only observational techniques to assess for prodromal 
features (161). In a small study of cardiology patients there was a significant 
 
 47 
difference between non-delirious and prodromal patients in relation to sleep 
disturbance (165), and in general hospital patients, Levkoff and colleagues reported 
that 25.4% of prodromal patients experienced sleep-wake cycle problems, especially 
in relation to getting to sleep and staying asleep during the night (159). Nocturnal 
insomnia has also been described in anecdotal reports of the delirium prodrome 
(154, 164). 
 
2.6.2.3. Perceptual abnormalities 
Although other cognitive and non-cognitive features occur with more frequency in 
the prodromal phase, perceptual disturbance is the most common psychotic feature 
of the delirium prodrome, and the presence of these abnormalities in this period 
presents the most convincing evidence for a prodromal phase which is pathological 
and not simply the manifestation of illness behaviour. Prodromal perceptual 
disturbances have been reported to varying degrees in studies of older general 
hospital patients (159); hip surgery patients (156, 161); BMT patients (157); and 
long-term care patients (160). Lipowski maintained that a spectrum of perceptual 
abnormalities may occur in the prodromal phase, from mild disorders of perception 
such as vivid dreams; nightmares; and difficulty differentiating between dreaming 
and waking imagery to more severe disturbance such as fleeting illusions and 
disturbing hallucinations. Furthermore, he hypothesised that these latter 
experiences may contribute to a deterioration in the patient’s sense of control over 




2.6.2.4. Other non-cognitive symptoms 
Other delirium symptoms have been reported in the prodromal phase but with less 
consistency. In one case of clarithromycin-induced delirium, ‘confused speech’ was 
reported in the prodromal period (163). Incoherent speech and tangentiality 
occurred respectively in 49.2% and 22% of prodromal hospitalised older patients 
(159) and incoherence occurred up to four days before delirium onset in one study 
of hip fracture patients (155). However, in Duppils & Wikblad’s study, incoherent 
speech occurred with practically equal frequency in prodromal and non-delirious hip 
surgery patients alike (161). Furthermore, speech disturbance was not a significant 
prodromal feature in the Korean cohort of hip surgery patients. Instead this research 
group found that that disorganised thinking, delusions and lability of affect occurred 
in the prodromal phase (156). New-onset disorganised thinking occurred in the 
prodrome in the long-term care cohort studied by Voyer and co-workers (160), 
whereas Fann and colleagues reported evidence of fluctuations in BMT patients 
(157).  
 
2.6.3. SOMATIC OR PHYSICAL FEATURES 
A wide spectrum of somatic features have been reported as occurring in the delirium 
prodrome, however their nature and frequency vary disparately from study to study. 
Pain or discomfort is reported with the most consistency. In an early study of 100 
consecutive cases of delirium referred to liaison psychiatry, Sirois observed 
retrospectively that unexplained headaches heralded delirium onset in a number of 
patients (167). Back pain and discomfort at catheter sites has been reported in 
 
 49 
prodromal coronary care patients (165). The most robust assessment of prodromal 
pain was conducted in BMT patients by Fann and colleagues who found that pain 
(measured using a ten-point Likert Scale) preceded delirium by approximately three 
days, increasing in intensity as delirium emerged (157). Other somatic prodromal 
features have been described anecdotally by Lipowski, such as fatigue, malaise and 
hypersensitivity to light and sound (154), however these features have not been 
examined in a prospective fashion. 
 
2.6.4. AFFECTIVE OR EMOTIONAL SYMPTOMS 
One of the reasons that the delirium prodrome has not yet been fully characterised, 
despite being mooted as a concept for decades, is that there are elements that 
challenging to define and quantify. Anecdotally many clinicians, and indeed family 
members, have noted retrospectively that a patient may have seemed ‘not quite him 
/ herself’ or ‘not quite right’ in the days before delirium onset. These observations 
are usually made with the benefit of hindsight as the signs and symptoms considered 
are often vague, non-specific and even nebulous, such that detecting or pinpointing 
them prospectively is difficult. Studying the existing literature, the vast majority of 
suggested non-specific features include an element of emotional or affective change. 
These reported emotional changes include irritability (154, 168), anxiety (164, 165), 
fear (168), and dysphoria (169). Anxiety is the most prevalent, documented in 
cardiology patients (165), in Eden and Foreman’s case study of an ICU patient (164), 
and prominently in one study of hip surgery patients (161), in which it manifested as 
‘urgent calls for attention’ in the prodromal period. Furthermore, Sirois reported 
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that complaints of ‘general uneasiness’ preceded delirium in many cases (167), 
whereas apathy, dysphoria and withdrawal were noted in the delirium prodrome in 
children and adolescents in an urban sub-Saharan setting (169). The most 
comprehensive study of prodromal mood and emotional change was conducted in 
BMT patients by Fann and colleagues (157), using the Profile of Mood States, a valid 
and reliable measure of distress and mood disturbance. It has six subscales (Tension-
Anxiety; Depression-Dejection; Anger-Hostility; Vigor-Activity; Fatigue-Inertia; 
Confusion-Bewilderment), from which composite scores of affective distress (the 
sum of Tension-Anxiety; Depression-Dejection; Anger-Hostility) and fatigue less vigor 
(Fatigue-Inertia minus Vigor-Activity) can be calculated. In this study, an increase in 
all negative emotional states, as well as the two composite scores, were observed in 
the five days before delirium onset and continued to rise for a further number of 
days into the delirium episode before abating. These results indicate that delirium is 
preceded by a marked rise in distress and fatigue levels in the prodromal period in 
BMT patients (157). Further study in this area is required in other clinical 
populations. 
 
2.6.5. PRODROME OVERVIEW 
In summary, the delirium prodrome is suggested to consist of a multitude of features 
which vary from study to study, hampering efforts to develop a definition. Some 
features appear consistently across the literature (e.g. inattention), whereas others 
are observed in only one study (e.g. headaches). Figure 2 is a schematic 
representation of the proposed prodromal features based on the literature to date. 
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Given that SSD can occur in the prodromal period as a transitional state towards FSD, 
some may argue that the delirium prodrome is simply a subsyndromal transitional 
state, however the prevalence of non-delirium features in the prodromal phase 
supports the view that the prodrome is a conceptually distinct entity which may 
include subsyndromal features as part of its presentation. Furthermore, although 
many of the described somatic and emotional features could be influenced by other 
patient factors such as illness behaviour, understandable anxiety in relation to 
prognosis, and low mood caused by reduced function, some studies have found that 
these features occur more frequently and with more intensity in patients with 
emerging delirium than those with no delirium. Nonetheless, further work in this 
area is required to define and characterise the delirium prodrome, particularly in the 
most vulnerable groups, such as older hospitalised patients. 
 
2.7. SUMMARY 
Delirium is a serious, highly prevalent condition which impacts significantly on 
medical, social and personal outcomes, as well as on increasingly strained health 
budgets. Our ageing population is manifest across all medical settings, and generates 
higher case complexity and increased rates of all age-related conditions, especially 
the ‘Geriatric Giants’ such as delirium. Delirium shares risk factors with other such 
frailty syndromes such as falls, and hence, enhanced delirium care is a key factor in 
delivering better quality healthcare to this growing proportion of older patients. 
Early identification of those particularly at risk would be helpful in streamlining 
preventative efforts towards those who need it most, however some risk 
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stratification methods are over-inclusive for busy clinical workloads and require 
refining for practical implementation. Delirium prognosis is linked to delirium 
duration, emphasising the importance of early detection and intervention, yet we 
are still hindered by poor awareness and understanding of delirium on the ground. 
Delirium diagnosis requires training and experience, however delirium screening, 
using simple yet sensitive screening methods, is now recognised as the most 
efficacious way to improve detection rates. Although a number of diagnostic 
approaches have been suggested, it is still undecided as to which approach is best.  
 
Even more so than early detection and intervention, strategies to prevent delirium 
have potential to yield great long-term benefits for patients and healthcare systems 
but such strategies must be multifactorial, system-wide and imbedded in the 
philosophy of our institutions in order to be effective. Understanding early indicators 
of delirium, specifically the prodromal features, may promote the development of 
targeted approaches to identify those in the early stages of delirium. Although, the 
existing work in this area has described the landscape, further research is required to 
definitively characterise this prodromal period, especially in older medical inpatients, 
a particularly vulnerable group. Once we fully comprehend the clinical nature of the 
delirium prodrome, we can then move our research focus towards investigating if 
intervention during this prodromal phase can impact on prognosis. Thus, prospective 
studies of incident delirium with particular focus on characterising the delirium 






Table 1: Summary of studies of the delirium prodrome (10)  
3MS: Modified MMSE; APACHE II: Acute Physiology and Chronic Health Evaluation II; BI: Modified Barthel Index; BC(s): Behavioural change(s); BMT: Bone Marrow Transplant; CAM: Confusion 
Assessment Method; CAM-ICU: Confusion Assessment Method for the Intensive Care Unit; CCU: Coronary Care Unit; DSI: Delirium Symptom Interview; DRS: Delirium Rating Scale; DRS-R98: 
Revised Delirium Rating Scale; DSM-III: Diagnostic and Statistical Manual for Mental Disorders (3
rd
 Edition); DSM-IIIR: Diagnostic and Statistical Manual for Mental Disorders (3
rd
 Edition)- Revised; 
DSM-IV: Diagnostic and Statistical Manual for Mental Disorders (4
th
 Edition); EEG: Electroencephalogram; HDS: Hierarchic Dementia Scale; K-DRS-R98: Korean version of the Revised Delirium 
Rating Scale; LTM: Long-term memory; MDAS: Memorial Delirium Assessment Scale; MMSE: Mini Mental State Examination; MMSE-K: Korean version of the MMSE; ns: not significant; POMS: 
Profile of Mood States; RBANS: Repeatable Battery for the Assessment of Neuropsychological Status; SD: Standard Deviation; STM: Short-term memory; TMT A and B: Trail Making Tests A and B; 
WAIS: The Wechsler Abbreviated Intelligence Scale 
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Table 2: Case studies describing an apparent prodromal period (10) 




Prodromal features Prodromal 
duration 
Eden et al, 1996 (164) Case study Intensive Care Unit 1 Patient was described as having 
restlessness, anxiety, nocturnal 
insomnia, and intermittent 








3 One patient had a apparent prodrome 




Crammer, 2002 (162) Case report Intensive Care Unit 
(subjective 
experience) 
1 This retired psychiatrist described 
experiencing retrograde amnesia, a 
declining awareness of the 
environment and impaired 
registration before the onset of 
delirium. 
 
At least 24 
hours 










23 22% (n=5) patients presented with an 
apparent prodrome. Features included 
apathy, dysphoria and withdrawal. 
A few days to 









Figure 2: A schematic representation of the prodromal features of delirium, based on prominence in the existing literature (10) 






This study was a prospective observational cohort study and was conducted in two 
acute teaching hospitals in Cork city (Cork University Hospital and Mercy University 
Hospital). I spent nine months recruiting patients from the Mercy University Hospital 
(MUH) (Oct 2011- April 2012 and June- July 2012) and 12 months recruiting in Cork 
University Hospital (CUH) (Aug 2012 – Aug 2013). Recruiting commenced in MUH 
because, it being the smaller hospital with a fewer number of daily medical 
admissions, there was more time for me to manage the patient load while refining 
study processes. 
 
3.2. SELECTION OF THE STUDY POPULATION 
3.2.1. INCLUSION AND EXCLUSION CRITERIA 
I performed formal delirium assessment on assenting patients admitted under the 
medical services aged 70 years and older, within 36 hours of admission. This 
assessment included semi-structured interview with the patient, followed by 
collateral history from both a nearest relative or caregiver and a member of nursing 
staff responsible for the care of the patient in question. Patients were excluded from 
initial assessment if they refused assessment, were admitted electively with a 
planned length of stay of less than 48 hours, or if their death was considered 
imminent. All other patients were eligible for initial assessment. In some cases initial 
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assessment took place but formal delirium assessment was impossible due to severe 
communication difficulties (e.g. severe dysphasia, severe non-communicative 
dementia) or coma. These patients were excluded from further assessment, 
although demographic data was collected from all excluded patients for my records. 
Patients who were eligible for inclusion were then invited to participate in the study 
and informed consent was sought. 
 
3.2.2. STUDY SAMPLE 
The study sample consisted of non-consecutive patients recruited from Monday to 
Friday during the recruitment period, however patients were not recruited on every 
weekday during the study period. Because of the longitudinal nature of the study 
and the fact that I was working alone, I was only able to assess a certain number of 
participants at any given time. At points during study recruitment, I would be unable 
to recruit more patients until current participants either were discharged, withdrew, 
or completed the study protocol. Hence, recruitment days varied greatly depending 
on the number of admissions and the proportion excluded following initial 
assessment.  
 
3.3. STUDY PROCEDURES 
3.3.1 RECRUITMENT PROCESSES 
Recruitment processes were slightly different in both hospitals. When recruiting in 
MUH, on a recruitment morning I obtained a list of patients admitted through the 
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Emergency Department (ED) from the ED administrative staff. This list was manually 
prepared using patient labels and listed patient details, admitting consultant and 
current ward. In addition to this list, I also checked for admissions to the Geriatric 
Medicine ward, as in MUH some emergency patients are admitted directly there. In 
CUH, the electronic admissions system was more accessible and on recruitment 
mornings, I accessed the hospital admissions system to ascertain a list of medical 
patients over the age of 70 years admitted within the previous 36 hours. This list 
incorporated both emergency and elective admissions. I then approached the 
patients to invite them to participate in the study. 
 
3.3.2. SCREENING ASSESSMENT 
Patients eligible for inclusion were assessed for delirium within 36 hours of 
admission to detect prevalent delirium on admission. This screening assessment 
consisted of a semi-structured interview with the patient, using the Confusion 
Assessment Method (CAM) (83) and the Revised Delirium Rating Scale (DRS-R98) 
(90) and collateral history from a caregiver or nearest relative, and from nursing 
staff. Other tests included the Six-item Cognitive Impairment Test (6-CIT); the Spatial 
Span Forwards (SSF); and tests of visuospatial function including the Clock-Drawing 
test (CDT); interlocking pentagons (IPT), from the Standardised Mini Mental State 
Examination (SMMSE) (170); and a set of questions developed to assess visuospatial 
function verbally (see below). The motor activity profile was defined using the four-
item Delirium Motor Subtype Scale-4 (DMSS-4). Potential prodromal symptoms were 
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ascertained using a novel Prodromal Checklist, the development of which will be 
described later.  
 
3.3.2.1. Confusion Assessment Method 
This tool (see appendix A) has been described in Chapter 2 (Section 2.5.3.2.1). 
Formal training is required for accurate usage. I had already undergone expert-led 
CAM training based on the CAM training manual (171) and had conducted two 
studies using this instrument as an assessment tool, prior to commencement of this 
study (1, 172). For details on how I scored the individual items in the CAM, please 
see appendix B.  
 
3.3.2.2. Delirium Rating Scale Revised-98 
This instrument (see appendix A) has been introduced in Chapter 2 (Section 
2.5.3.2.2.). The DRS-R98 is a widely-used 16-item clinician-rated scale with 13 
severity items and 3 diagnostic items. The 13-item severity section can be scored 
separately from the 3-item diagnostic section; their sum constitutes the severity 
scale score (0-39). It rates symptoms over the previous 48-hour period and higher 
scores indicate a greater severity of delirium. The three diagnostic items are used to 
contextualise the symptoms identified. The score from these three items are then 
added to the severity scale score to give the DRS-R98 total score. Severity scores of 
≥15 and / or total scores ≥18 have been shown to be consistent with a diagnosis of 
delirium (90). All available sources of information, including assessment of the 
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patient and discussion with nursing staff and family or caregivers is considered in 
rating each item. Patient assessment takes approximately 15 minutes. The DRS-R98 
is designed to be used by psychiatrists, however with appropriate training in 
evaluating psychiatric phenomenology in medically ill patients; other physicians, 
nurses and psychologists can become competent in using it. It has high interrater 
reliability, validity, sensitivity and specificity for distinguishing delirium from mixed 
neuropsychiatric populations including dementia, depression, and schizophrenia 
(110). In July and August 2011, I underwent specific training in this tool with Prof. 
David Meagher in Limerick, based on the DRS-R98 administration manual written by 
Prof. Paula Trzepacz, the instrument’s creator (173) and learned how to elicit 
evidence of abnormalities when present. Please see appendix B for details on how I 
scored each item throughout the study.  
 
3.3.2.3. Delirium Motor Subtype Scale-4 (DMSS-4) 
The Delirium Motor Subtype Scale-4 (DMSS-4, see appendix A) is a four-item data-
derived scale developed by Prof. David Meagher (38). Further detail on its 
development is available in Chapter 2 (Section 2.3). It is used to classify whether a 
patient meets criteria for one of the delirium motor subtypes, which are categorised 
as hypoactive, hyperactive, mixed or no subtype. A patient is considered to fit the 
hypoactive subtype if they have at least one hypoactive feature present and no 
hyperactive features. Conversely, to fit the hyperactive subtype, the patient must 
have at least one hyperactive feature and no hypoactive features. If a patient 
presents with one or more features from each group, they have a mixed profile and 
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if they have no feature from either group, they are considered not to have a motor 
subtype. In this study, the DMSS-4 was scored by questioning the nursing staff, 
allowing for observations made during patient interview. The DMSS-4 was used to 
assess all patients on a daily basis irrespective of their delirium status. 
 
3.3.2.4. The Six-item Cognitive Impairment Test (6-CIT)  
The 6-CIT is discussed in detail in Chapter 2 (Section 2.5.3.3.2.) (113). It involves 
three tests of temporal orientation (year; month; time of day), two tests of attention 
(counting backwards from twenty to one; reciting the months of the year in reverse 
order) and short-term memory (remember a 5-point address), see appendix A.  
 
3.3.2.5. Spatial Span Forwards 
The visual Spatial Span Forwards (SSF) is a pattern recognition test based on the digit 
span forwards (111), and has recently shown utility in identifying inattention in 
patients with delirium versus those with dementia (110). The SSF is performed using 
an A5-sized piece of white card with eight red squares (each measuring 1.5cm2) 
evenly spaced over three rows (configuration three, two, three; landscape; see 
appendix A). Predetermined sequences are tapped out for the patients to replicate. 
The test begins with a sequence of two squares and the sequence increases in 
number with each correct iteration, up to a maximum sequence of seven. Two 
attempts are allowed at each level using different predetermined sequences. In 
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general, patients who are unable to correctly repeat a sequence of five are 
considered to have failed the test. 
 
3.3.2.6. Clock-Drawing Test 
The Clock-Drawing Test (CDT, see appendix A) has also been described in Chapter 2 
(Section 2.5.3.3.3.). There are multiple methods for scoring the CDT. In this study, we 
used a 15-point scoring method from the QMCI (Quick Mild Cognitive Impairment 
screen), a tool developed to differentiate between mild cognitive impairment and 
normal controls (174). Using this method, the subject is given a pre-drawn circle and 
is requested to draw in the numbers and set the time at ‘ten past eleven’. A 
transparent template, designed to facilitate inter-rater reliability, is used to guide 
scoring of the placement of the numbers and hands (175), see appendix A. The score 
ranges from 0 to 15 with lower scores indicating greater degree of impairment.  
 
3.3.2.7. Interlocking Pentagons Test (IPT) 
The Interlocking Pentagons Test (IPT, see appendix A), described in Chapter 2 
(Section 2.5.3.3.4) can be scored either in a binary fashion, as in the MMSE (143) or 
on a ten-point scale (144), utilised in the Modified Mini Mental State. The most 
commonly applied scoring system remains the binary method, in which the patient 
must draw two pentagons intersecting to form a four-sided figure in order to pass 




3.3.2.8. Environmental Visuospatial Questions Test (EVSQ) 
Visuospatial ability is commonly impaired in delirium (75) and is one of five cognitive 
domains assessed using the DRS-R98. Many visuospatial tests are unsuitable for 
those with fine motor or visual impairment as they require that the subject 
reproduce a figure using pen and paper. We developed a series of questions (EVSQ 
or the Environmental Visuospatial Questions Test, see appendix A) relating to the 
patient’s surroundings. We hypothesised that these questions would at least partly 
assess their visuospatial function. Each patient was asked five questions daily, from a 
pool of eight possible questions and questions were rotated to minimise learning 
effect. One mark was given for each correct answer and the test was scored out of 
five.  
 
3.3.3. IDENTIFYING PREVALENT DELIRIUM  
Prevalent delirium was defined by a DRS-R98 severity score of ≥ 15 and / or total 
score of ≥ 18, based on assessment and symptoms described over the previous 48 
hours. Patients with prevalent delirium were excluded from the longitudinal study, 
because in these patients, a prospective assessment of prodromal features (the main 
study objective) would not be possible. Hence, patients with prevalent delirium on 
admission underwent limited assessment only and demographic data was collected, 
as with all excluded patients. Occasionally, some patients with prevalent delirium 
were followed daily which was unplanned. This occurred when collateral history 
from a family member (suggesting prevalent delirium) was not available until later in 
the admission. Data pertaining to patients with late-identified prevalent delirium on 
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admission who consented or assented (see ethical procedures) to study 
participation, was included in the analysis for Chapter 4 which relates to the efficacy 
of screening methods for prevalent delirium.  
 
3.3.4. BASELINE ASSESSMENT 
In the first few weeks of the study, full baseline assessment was performed on 
consenting patients on the first assessment day, however, this proved to be very 
time inefficient as many soon-to-be excluded patients were being assessed in full, for 
example, those with prevalent delirium and those who would be discharged the 
following day. Hence from approximately week 4 onwards, baseline assessment was 
completed on day 2 of the study. 
 
Baseline assessment included the following (see Appendix A for samples of the 
instruments used and appendix C for a copy of the baseline data collection file): 
 Demographic information including age, sex, time from ED arrival to ward 
admission. 
 Social History: Marital status, place of residence, social support, highest level 
of education, alcohol history (units per week) and smoking history (pack year 
history). 
 Screening for visual and hearing impairment: Simple bedside assessment of 
hearing and vision was used. A person was considered hearing impaired 
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either if they used one / two hearing aids; if they answered no to the 
question ‘Can you hear me?’; if they stated they had hearing problems; if 
hearing impairment was documented in their chart; or if there was evidence 
of hearing impairment during the interview. A person was considered visually 
impaired if they were unable to identify either a pen or a watch or read a 
sentence (font 28) while wearing appropriate spectacles if required. Literacy 
was taken into account for this assessment.  
 Standardised Mini Mental State Examination (SMMSE) (170) 
 Modified Barthel Index (BI) (176) 
 Mini-Nutritional Assesssment - Short Form (MNA-SF) (177) 
 ABCDS Depression Score (178) [+/- 15-item Geriatric Depression Scale (GDS) 
(179)] 
 Medical history, including medication history was recorded from the medical 
notes and the Modified Cumulative Illness Rating Scale (M-CIRS) was 
calculated. 
 
3.3.4.1. SMMSE (Standardised Mini-Mental State Examination) 
The SMMSE (see appendix A) is based on the original Mini-Mental State Examination 
(MMSE) published in 1975 by Folstein (143). The MMSE was developed as a short 
screening test to detect cognitive impairment, and was primarily indicated for 
clinical use, however, evolved to become a commonly used screening test to 
evaluate patients’ suitability for inclusion / exclusion in clinical trials, and additionally 
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as an outcome measure in such studies. It measures several cognitive domains, 
including orientation to time and place; registration; short-term memory; attention; 
language; constructional and visuospatial ability; and ability to follow commands.  
The original test had few instructions for scoring which led to wide variability in 
scoring methods between raters and hence reduced test reliability. This led to 
efforts to improve inter- and intra-rater reliability by standardising the scoring 
system. The SMMSE, published in 1991 (170) was developed and tested in order to 
decrease variability and improve the reliability of the MMSE, by providing clear and 
well-defined scoring and administration instructions (180). When reliability was 
compared with the original MMSE, intra-rater variance was improved by 86% and 
inter-rater variance by 76% when SMMSE was used. Intra-class correlation for the 
SMMSE was 0.90, and for the MMSE 0.69. Additionally the duration of the test was 
shortened when using the SMMSE (mean duration 10.47 minutes v. 13.39 minutes 
for the unstandardised version) (180). In this study, if a patient was unable to 
complete certain items due to, for example severe vision impairment or dominant 
hand paresis, an adjusted SMMSE score was calculated by dividing the patient’s 
score by their total possible score and multiplying the numerator by 30, as in other 
similar studies (181). Additionally, scores were adjusted for advanced age and low 
level of educational attainment as recommended by Prof. Will Molloy (the developer 
of the SMMSE) and by other research groups (109, 182). In patients of 80 years and 
older, one point was added to their final SMMSE score and in those whose education 
did not go beyond primary school, one point was also added to their final score. 
During the baseline assessment in which the SMMSE was performed, items common 
to the SMMSE and the 6-CIT were only asked once. 
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3.3.4.2. Modified Barthel Index 
The Modified Barthel Index (BI, see appendix A) was originally developed in 1965 as 
an instrument to assess level of disability in inpatients with neuromuscular and 
musculoskeletal conditions (183). It scores ten variables out of a total score of 20, 
with lower scores indicating greater levels of functional dependence. It has been 
recommended by the Royal College of Physicians for the routine assessment of 
functional ability in older adults (184).  
 
3.3.4.3. Short-form Mini-Nutritional Assesssment (MNA-SF) (177) 
The Mini Nutritional Assessment (MNA) was developed in the early 1990’s as a 
nutrition screening tool in the elderly (177). Since then it has become the most 
established and most widely used tool for this purpose and has been translated into 
multiple languages. In order to shorten the duration of the assessment, an abridged 
version (MNA-SF) was developed. This was based on item correlation with total MNA 
score and with clinical nutritional status, as well as internal consistency; reliability; 
completeness; and ease of administration of each item (185). This shortened version 
correlated very well with the full version (r=.945) and has now superseded its 
predecessor due to its improved feasibility. The test is scored out of 14, with lower 
scores indicating worse nutritional status. Scores of 12 to 14 indicate normal 
nutritional status, whereas scores of 8-11 signal patients at risk of malnutrition, and 




3.3.4.4. Screening for depression  
3.3.4.4.1. The AB Clinician Depression Screen ABCDS (178)  
The ABCDS (see appendix A) is a short screening tool for depression, which takes less 
than two minutes to complete. It was developed by correlation of items from the 30-
point Geriatric Depression Score (GDS-30) with diagnosis of depression (defined as 
GDS-30 of 14 or more). Sensitivities, specificities, positive predicted values (PPV) and 
negative predicted values (NPV) were calculated and receiver operating 
characteristic (ROC) curve analysis was performed. The resulting top five correlates 
were developed into a two-step screening process, with the best correlate used as a 
single question in step one (“Do you often feel downhearted or blue?”, NPV 96%). A 
negative response to question 1, hence negates the need for further questioning, as 
it rules out depression with 96% certainty. In the setting of a positive response, the 
four other highly correlated questions are asked and an overall score out of five is 
calculated. Scores of one or two indicate low risk of depression, whereas scores of 
four or five suggest current depression. A score of three is inconclusive and requires 
further testing with the Geriatric Depression Scale.  
 
3.3.4.4.2. The 15-item Geriatric Depression Scale (GDS-15)(179) 
In this study, if the ABCDS was scored as three (inconclusive), the patient underwent 
further testing for depression using the GDS-15, see appendix A. This is a fifteen item 
scale developed from the long form of the Geriatric Depression Scale (GDS-30)(186) 
by item correlation with diagnosis of depression. This shorter form has been shown 
to correlate well with the original GDS (179), however is more feasible in the 
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physically ill and in those with mild dementia, as their attention spans may be short 
and / or they may fatigue easily. In general, GDS-15 scores of 0-4 are considered 
normal, whereas 5-8 suggest mild depression and 9-15 indicating more severe 
depression.   
 
3.3.4.5. The Modified Cumulative Illness Rating Scale (M-CIRS) 
The Cumulative Illness Rating Scale (CIRS) was initially developed in 1968 by Linn and 
colleagues in order to quantify comorbidity in older patients, such that meaningful 
comparisons could be drawn between patients in relation to medical burden (187). 
In the intervening years, it has been modified and updated to improve feasibility, as 
well as to have additional applicability in older patients with complex medical 
histories, and to allow successful inclusion of acute medical conditions. The most 
current version is the Modified CIRS (M-CIRS) (188), which scores each of thirteen 
categories (based on organ systems) from 0 to 4 (higher scores indicating greater 
levels of morbidity). The individual scores are then added to give a cumulative score.  
 
3.3.4.6. Frailty 
Frailty is a concept which is difficult to fully define however it is commonly thought 
of as an increased vulnerability to stressors, which usually occurs as a person ages, 
due to impairments in multiple inter-related systems. Collecting data pertaining to 
frailty was also considered, given the population under study, however ultimately 
this element was excluded for two reasons. Firstly, a number of different frailty 
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instruments have been validated over the years, including rules-based definitions, 
the summation of deficits, and clinical judgement scores, however all these tools 
have been validated in community-based samples because frailty is considered to 
pertain to a person’s baseline state rather than how a person presents in the setting 
of acute illness. Only one instrument, the Reported Edmonton Frail Scale, has been 
used in hospital inpatients (189). This tool which is based on the Edmonton Frail 
Scale (190), using self-reports rather than objective measures, has only been 
validated in one small Australian study of acute older hospitalised inpatients. This 
study compared the Reported Edmonton Frail Scale to a reference standard of 
experienced clinican impression only, without any data collected pertaining to 
outcomes (189). Given the expected cognitive vulnerability of the population in our 
study, we felt that using a self-reported quesionnaire would be unreliable, especially 
given that it had not yet been definitively validated. We also felt that the other frailty 
instruments, having not been designed nor validated for use in the acute setting, 
would not be appropriate for use in this study. Furthermore, we had decided to use 
the MNA-SF to ascertain nutritional status (see above and appendix A), which has 
been validated for use in the acute setting. This instrument comprises many 
elements considered central to the measurement of frailty (cognition, weight loss, 
appetite, psychological stress, mobility) and hence we felt that to also measure 






3.3.5. COLLATERAL HISTORY 
Obtaining accurate collateral history from a close relative or next-of-kin (NOK), or 
others, for example nursing home staff, is a cornerstone of delirium assessment. If 
there are obvious symptoms present, it is important to ascertain the acuity of onset 
of these features, temporal relationship to illness or other potential precipitants, and 
presence of fluctuations. If there are mild or no obvious symptoms present, it is still 
important to speak with a relative to investigate if there were any recent delirium 
features that have resolved since arrival to hospital or that are still fluctuating in 
severity. Furthermore, speaking to a relative or NOK is also key to ascertaining pre-
morbid cognitive status (see later) as cognitive assessments in the acute setting 
cannot be relied upon, especially in the setting of delirium. Additionally, collateral 
informants were questioned in relation to the presence or absence of potential 
prodromal features using a novel prodromal checklist (see below). Hence, the 
collateral history included questions relating to delirium phenomenology; the 
Prodromal Checklist (see later); and the IQCODE-SF (Informant Questionnaire for 
Cognitive Decline in the Elderly-Short Form, see below) (191).  
  
3.3.5.1. Identifying premorbid dementia 
Identifying premorbid dementia is highly relevant in the assessment of patients for 
delirium, given that it is one of the strongest independent risk factors for delirium. 
Moreover, many features of the two conditions can overlap and confound diagnosis 
and, as a result, delirium is often mistaken for dementia. Ascertaining premorbid 
cognition can be very challenging, especially in patients with acute illness, delirium, 
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poor cooperation, communication problems and additionally in those with limited 
education. Particularly in the acute setting, patients may underperform on cognitive 
assessment tools for a number of possible reasons. They may have delirium or more 
subtle subsyndromal delirium or may be too ill to participate. Hence, I investigated 
for pre-existing dementia by examining the medical notes and used an informant 
questionnaire called the IQCODE-SF (Informant Questionnaire for Cognitive Decline 
in the Elderly-Short Form) (191) to ascertain pre-admission cognitive status (see 
below). Sometimes collateral history was not available and in these cases, if the 
corrected SMMSE (see above for SMMSE scoring) was 27/30 or above, these 
patients were considered not to have pre-existing cognitive impairment, in keeping 
with similar studies (181, 192). If the SMMSE was lower than 27/30, allowing for 
poor education and advanced age, it was unclear whether the lower score was due 
to an acute, subacute or chronic problem and hence premorbid cognitive status 
could not be applied. Patients with scores that were borderline or who had 
discordant SMMSE and IQCODE-SF were discussed with my supervisors and a 
consensus decision on pre-morbid cognitive status was made. 
 
3.3.5.1.1. Informant Questionnaire for Cognitive Decline in the Elderly - Short Form 
(IQCODE-SF) 
The IQCODE or Informant Questionnaire for Cognitive Decline in the Elderly was 
developed in order to facilitate assessment of pre-morbid cognitive function by using 
informant reports comparing current cognitive function to that of approximately ten 
years previously. The initial instrument consisted of 39 items. This was then 
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consolidated to the 16-item short form which correlated 0.98 with the full form and 
had comparative validity with respect to clinical diagnosis. This short form is now the 
most commonly used form and has been translated into many languages (193). The 
informant is asked to grade the patient’s current cognitive status as ‘much 
improved’; ‘a bit improved’; ‘not much change’; ‘a bit worse’; or ‘much worse’, 
compared to ten year’s previously (see appendix A). The answers for each item are 
assigned scores of 1 to 5, from ‘much improved’ to ‘much worse’. In an older cohort 
of patients, the majority of scores lie between 3 and 5 for each item, as 
improvement is unusual in these circumstances. The scores for each item are then 
added together and divided by 16 to calculate the final mean score. There is no 
unanimous IQCODE-SF cut-off used for dementia screening, and in general, cut-offs 
have been lower in dementia screening in the community than in hospital samples. 
In a review of its use (193), a table of studies summarise the IQCODE-SF cut-off 
scores used in a variety of studies and the review authors recommend that those 
intending to utilise the tool for study purposes should choose a cut-off from a study 
closest in composition to the population in their own study. Hence, in this study a 
cut-off of 3.5 or above was used to indicate premorbid dementia, reflecting the cut-
offs used in other older medical inpatient cohorts (194-196). There are some 
limitations to the IQCODE-SF. Firstly, in patients with anxiety or depression, 
occasionally the test may be falsely positive. This may be due to an effect of 
depression on cognitive function or an inability on the informant’s part to distinguish 
anxiety and depression from cognitive decline. Secondly, the IQCODE-SF score can 
be influenced by informant characteristics such carer anxiety and / or depression as 
well as the quality of the relationship between the patient and the informant (193). 
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Hence, where IQCODE-SF scores were incongruous with the rest of the assessment, 
consensus decision on pre-morbid dementia was made with my supervisors, based 
on all available information. 
  
3.3.6. LONGITUDINAL ASSESSMENTS 
Patients who were eligible for inclusion in the longitudinal study of delirium 
prodrome and who gave informed consent (see ethical procedures), were reviewed 
daily for the first seven days of admission and then weekly thereafter until discharge. 
Patients whose admissions were shorter than one week were assessed daily until 
discharge. These longitudinal assessments included both patient and staff interview. 
Daily patient assessment included CAM; DRS-R98; 6-CIT; MOTYB; SSF; CDT; IPT; 
EVSQ. Daily interview with nursing staff included questions relating to CAM and DRS-
R98 items; the Prodromal Checklist and the DMSS-4. Those who were discharged 
within three days without delirium were excluded from the study, as we could not 
confidently outrule delirium development within the week after admission in these 
patients. Patients who were assessed for at least four consecutive days post-
admission and who remained delirium-free were considered controls and were 
reviewed weekly until discharge. Patients who developed delirium during the first 
week were considered cases and were reviewed daily as tolerated until delirium 
resolved or the patient was discharged. In patients in whom delirium resolved, 
assessments continued on a weekly basis until discharge. Delirium resolution was 
defined as three consecutive days with DRS-R98 scores in the subsyndromal or 
normal range, taking into account the patients’ pre-delirium scores. 
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3.3.7. THE DELIRIUM ETIOLOGY CHECKLIST (DEC) 
The Delirium Etiology Checklist (DEC) (27) was completed for all patients who 
developed delirium (see appendix A). This is a commonly used research tool which is 
used to attribute etiology to the delirium episode. It includes twelve categories: drug 
intoxication; drug withdrawal; metabolic / endocrine disturbance; traumatic brain 
injury; seizures; intracranial infection; systemic infection; intracranial neoplasm; 
systemic neoplasm; cerebrovascular; organ insufficiency; other central nervous 
system problems; and other systemic problems. The presence and suspected role of 
multiple potential contributors are rated according to the degree of attribution to 
the delirium episode, ranging from 0 (ruled out / not present / not relevant) to 4 
(definite cause).  
 
3.3.8. DEVELOPING THE PRODROMAL CHECKLIST 
Because it is not yet known exactly what symptoms comprise the prodrome to 
delirium, there has been no instrument developed to detect it. Hence, in order to 
investigate for prodromal symptoms in this study, it was necessary to develop a tool 
designed to identify prodromal symptoms. In the first instance, in order to identify 
potential prodromal symptoms, I performed a preliminary literature search on 
PubMed, PsycInfo, CINAHL, Science Direct and Web of Knowledge using the search 
terms “delirium” or “confusion” (title / abstract) and “prodrom*” or “early indicat*” 
(all fields). Following review of abstracts and subsequently of potentially relevant 
articles, eight studies of the delirium prodrome (155, 157-159, 161, 165-167) and 
five publications of case studies / case series referring to the prodromal phase (162-
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164, 168, 169) were considered relevant (of note, when this search was updated in 
2013, two further studies were discovered (156, 160), see tables 1 and 2 in Chapter 
2). These articles were reviewed for methods used in the investigation of prodromal 
features and also for the symptoms measured. Additionally, we sought opinions 
from two experts in this field (Dr. Dimitrios Adamis and Dr. Jos de Jonghe) as to other 
potential features. 
 
In consultation with my supervisors, we decided to devise a checklist of symptoms, 
known as the Prodromal Checklist, for use during interview with relevant nursing 
staff. The questionnaire had to encompass all potential prodromal symptom 
domains, however had to be relatively short in duration and acceptable to busy 
nursing staff. It was clear that assessment for prodromal features would be required 
on a regular basis, and because of staff changeover twice in a 24-hour period on 
hospital wards, ideally these assessments would take place during each shift. 
However, for feasibility purposes, as I was the sole researcher, my supervisors and I 
decided that the assessments would take place daily, including weekends. The 
assessments would involve using the Prodromal Checklist to ascertain from relevant 
staff nurses if there was any evidence of emerging symptomatology over the 
previous 24 hours. Rather than scoring the features on the checklist in a binary way 
(present / absent), we deemed it more appropriate initially to score each item as 0 
(not present), 1 (possibly present / somewhat present) or 2 (definitely present). This 
was because the checklist is very subjective and some features are difficult to define, 
hence we wished to ensure sensitivity in detecting all potential prodromal features. 
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The checklist, following a few iterations based on suggestions from my supervisors, 
was additionally reviewed for face validity by Prof. Paula Trzepacz, an international 
delirium expert and creator of the DRS-R98. Some minor modifications were 
subsequently made and the final checklist can be found in appendix A. To ascertain 
any prodromal features at admission, the patients’ caregivers / nearest relative was 
interviewed using the prodromal checklist and presence of features over the 
previous week were sought. On subsequent assessments, the relevant nursing staff 
were questioned and in this situation the presence of features over the previous 24 
hours were sought.  
 
3.4 OUTCOMES 
In addition to recording the course of the delirium during the hospital stay, the in-
hospital patient outcomes were examined using the hospital electronic system, 
including mortality, length of stay and discharge destination. I also gathered data 
pertaining to outcomes at six-months using the hospital electronic system. Patients 
were also invited to come for re-assessment at a dedicated research clinic held in the 
Assessment and Treatment Centre (ATC) in St. Finbarr’s Hospital (SFH). Although 
multiple parameters were measured at this research clinic (including cognitive and 
functional status; depression; and nutrition), these results will be reported 
elsewhere as they are beyond the scope of this thesis. Six-month outcomes reported 
in this thesis include a composite adverse outcome of mortality and 
institutionalisation. If I was unable to reach individual participants at six months, I 
contacted their General Practitioners to ascertain these outcomes. Composite 
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adverse outcomes at discharge and at six months were compared between those 
who developed incident delirium and those who did not using both univariate and 
multivariable logistic regression (Chapter 10).  
 
3.5. SAMPLE SIZE ESTIMATION 
As aforementioned, the primary objective of this study was to characterise the 
delirium prodrome, particularly the behavioural features. Hence, we attempted to 
power the study to meet this objective, but because this was an exploratory study 
using a novel instrument, accurate power calculations were challenging. Given that 
there were 31 major behavioural features separated into 6 different domains, it was 
anticipated that we would identify approximately 8 to 12 unique prodromal features, 
using factor analysis. Hence, for this analysis it was considered that between 80 and 
120 cases of incident delirium would be required. It was also expected that we 
would use regression analysis to identify which symptoms were most predictive of 
delirium development. In this analysis, for an effect size of 0.35, alpha 0.05, and 
power 0.95, and 12 predictor variables, a sample size of 86 is considered sufficient. 
Hence to ensure good power for both analyses, a sample size of 85 to 120 would be 
recommended. The prevalence of delirium in older medical inpatients is known to be 
approximately 42% and the in-hospital incidence in this population between 8 and 
12% (197). If we assume an incidence of 10%, this means that between 850 and 1200 
patients would need to be screened in order to detect enough cases of incident 
delirium, which would not be feasible in the given time-frame for a solo researcher. 
Thus, because the study was exploratory, and that often power estimations are not 
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reliable, in consultation with my supervisors (DM, ST) and another expert in the field, 
Dr. Dimitrios Adamis, we agreed that sixty incident cases of delirium would be 
sufficient for this study.  
  
3.6. DATA COLLECTION AND DATA MANAGEMENT 
Data collection commenced in October 2011 using individual paper data collection 
files which covered the baseline and longitudinal assessments for each participant. 
Basic demographic data was also collected for excluded patients. Each recruited 
patient was assigned a study number which was used to pseudo-anonymise the 
data. The patient identifiers were kept in separate folder and locked away. Hence, 
the names and / or medical record numbers of participants did not feature on any 
document concerning the research and all research documents were kept securely in 
a locked office. In April 2012, electronic data collection was commenced using the 
filemaker pro programme (version 11) on iPad. This made data collection much more 
efficient and easier to manage electronically. The file that was used for data 
collection was again pseudo-anonymised and did not include any patient identifiers. 
All databases used to analyse the data excluded patient identifiers and all electronic 





3.7. STATISTICAL ANALYSIS 
The majority of the analyses were conducted using SPSS version 20, however for 
recurrent event survival analyses Stata version 11 was used. Delirium was defined as 
a DRS-R98 severity score of ≥15 and / or a total score of ≥18 for all analyses. In 
Chapter 5, in which the utility of the NICE-based questionnaire in detecting delirium 
is investigated, we conducted an additional analysis, considering CAM as the 
reference standard for delirium diagnosis: CAM positive indicating presence of 
delirium and CAM negative indicating its absence. For all analyses, except that 
conducted in Chapter 8 on subsyndromal delirium (SSD), normal controls were 
considered to have a DRS-R98 severity score of <15 and a total score of <18. In 
Chapter 8, patients were considered to have SSD if they had a DRS-R98 total score ≥6 
and <18 with scores of at least 1 for each of items 10 (attention) and 14 (temporal 
onset of symptoms) on the DRS-R98, see Chapter 8 for further detail. Hence in this 
analysis only, normal controls were those who had DRS-R98 total scores <6, or those 
with total scores ≥6 and <18 who scored 0 on either / both of the above items.  
 
Demographic data were expressed as means ± standard deviation (SD) or medians 
and interquartile ranges (IQR), depending on the distribution of the data. 
Comparisons of groups were made using a χ2 or Fisher Exact test for differences in 
proportions, a t-test or ANOVA (Analysis of Variance) for differences in means or 
Mann Whitney U non-parametric tests for differences in mean ranks. In Chapter 5, 
univariate logistic regression was used to assess if various baseline predictor 
variables were associated with incident delirium. Subsequently, multivariable logistic 
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regression (including variables with p<0.05 on univariate analysis) was used to 
identify which screening tests predicted the occurrence of prevalent delirium. Final 
multivariable regression models were assessed using -2 log likelihood and goodness 
of fit was examined using the Hosmer-Lemeshow (CHL) test.  
 
In the analysis of screening tests in the detection of prevalent delirium (Chapter 4), 
Receiver Operating Characteristic (ROC) analysis was conducted and the Area Under 
the Curve (AUC) was calculated for tests rated on a continuous scale, whereas 2 x 2 
tables were used to calculate sensitivities, specificities and positive and negative 
predictive values with 95% confidence intervals for tests with binary outcomes. 
Stepwise discriminant analysis was utilised to investigate how the screening tests 
distinguish delirium, dementia and normal controls using all the screening tests as 
independent variables. In Chapter 6, outlining the efficacy of the NICE-based 
questionnaire in the detection of delirium, stepwise discriminant analysis was also 
used to identify the elements of the questionnaire which discriminate delirium from 
no delirium. In this chapter, as aforementioned, separate analyses were conducted 
using the DRS-R98 and CAM respectively as the reference standard for delirium 
diagnosis. To evaluate the correlations between the elements of the NICE-based 
questionnaire and the individual items of the CAM and DRS-R98, Spearman’s Rho 




In chapters 7, 8, and 9, recurrent event survival analysis was used to examine the 
association between various prodromal features and the development of delirium. 
Cox proportional hazards models adjusted for age, sex, comorbidity, functional 
status and cognitive status were utilised and the proportional hazards assumptions 
were checked using extended Cox models with time-dependent covariates (see 
chapters 7, 8, and 9 for more detail on the selection of confounding variables). If any 
of the variables varied across time, extended proportional hazards models were used 
for the analysis. Log likelihood and the AIC (Akaike Information Criterion) were used 
to assess model fit. Hazard ratios with confidence intervals of 95% are reported in 
the results. 
 
The Generalised Estimating Equation (GEE) method was utilised to analyse 
longitudinal data for the relationship over time between motor subtypes and 
independent variables in Chapter 10. The GEE method allows for the fact that within 
subject observations are correlated and estimates the population average across 
time (expressed as coefficients). The estimated coefficients depict the relationship 
between the independent predictors and motor subtype status at each time point, 
rather than comparing motor profile groups based on longitudinal course. This 
allowed each available score for every included patient to be incorporated in the 





3.8. ETHICAL CONSIDERATIONS AND PROCEDURES 
3.8.1. INFORMED CONSENT  
People with delirium and / or dementia are potentially vulnerable and hence the 
most rigorous ethical principles apply to any research involving such patients.  By the 
very nature of the condition, many patients with delirium lack capacity to give 
informed consent to participation in studies. Currently, in Ireland, there is no legal 
provision for another adult to give consent on behalf of an incapacitated adult. If all 
patients who lack capacity were excluded, however, a very significant sample bias 
would occur (198). Hence, as with previous studies, informed consent was requested 
from those who had the capacity to give it and assent to participation was sought 
from patients who were incompetent to consent, as well as approval from a ‘nearest 
relative’. Participants were informed both verbally and in writing about the nature 
and purpose of the research. In addition, patients and relatives were informed that 
participation in the research was voluntary and that should they choose not to 
participate, no negative penalty would apply. A patient information leaflet was 
supplied, outlining the purpose and procedures of the study, and that all 
participation was voluntary. A copy of the consent form and patient information 
leaflet is supplied in appendix D. If at any point during assessment, questioning 
distressed the patient, the interview was discontinued immediately and nursing staff 
were made aware of the patient’s condition. A facility was provided by Dr. Suzanne 
Timmons (PI) for follow-up of patients / carers to discuss any issues that arose during 
the study, however this facility was never requested. The study involved the 
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collection of routine clinical data and no additional phlebotomy or investigations 
were performed.  
 
3.8.2. CONFIDENTIALITY 
This study involved assessing patients across multiple domains on several occasions 
as well as gaining access to confidential information such as demographic data and 
medical history. All data collected was kept in a password-encrypted database and 
only the lead researcher and research staff had access (see ‘data collection and 
management’ above). 
 
3.8.3. PATIENT CARE 
If I detected that a patient had delirium, I informed the responsible nurse verbally 
and I put a note in the chart outlining the subtype of delirium and any aetiological 
and precipitating factor I considered contributory. I also left my phone number in the 
notes, should one of the medical team wish to contact me to discuss. The decision as 
to what course of action was appropriate was made by the medical team looking 
after the patient just as they would do if a relative or nurse noticed a patient had 
possible delirium outside of the study.  A copy of the standard note for medical 
charts is supplied in Appendix D, however in most cases I wrote extra information 




3.8.4. ETHICAL APPROVAL 
Formal ethical approval was granted by the Cork Research Ethics Committee (CREC). 
A copy of the letter of approval from CREC is available in appendix D. 
 
3.9. DELIVERING OBJECTIVES 
In the following section, methodology specific to the individual objectives of this 
thesis are summarised. More detail is available in the respective results chapters. 
 
3.9.1. CHAPTER 4: THE SIX-ITEM COGNITIVE IMPAIRMENT TEST AS A SCREENING TEST 
FOR DELIRIUM.  
Objective (iv) To identify the prevalence of delirium on admission and establish 
the diagnostic accuracy of screening tests in delirium detection. 
This was one of the secondary aims of the study. Medical inpatients were identified 
through the processes described above. Patients were approached and assessed for 
study eligibility unless they were terminally ill. Those approached who refused 
participation, or in whom assessment was impossible (e.g.  coma, stupor) were 
excluded, as were those in whom full formal assessment was attempted but 
impossible due to communication problems (e.g. muteness or severe dysphasia). All 
other patients who consented or assented according to our protocol were included 
in this element of the study. This study was cross-sectional in nature. I used the DRS-
R98 to formally assess for presence of prevalent delirium within 36 hours of 
admission (and usually within 24 hours). Patients were considered to have delirium if 
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the DRS-R98 severity score was ≥15 and / or the total score was ≥18. Patients also 
underwent a series of cognitive tests (also conducted by me) at the same time as the 
delirium assessment. These tests included the 6-CIT; CDT; IPT; MOTYB; SSF; and 
EVSQ (see above). The IQCODE-SF was used to ascertain if premorbid dementia was 
present in a subgroup of patients. We assessed the psychometrics of the screening 
tests in detecting the presence of prevalent delirium as described in the statistics 
section above. Given the challenges in differentiating delirium from dementia in the 
acute setting, we also used discriminant analysis to assess if any of the tests had 
utility in discriminating these two conditions in this cohort.  
 
3.9.2. CHAPTER 5: MAKING NICE NICER- A SUGGESTED APPROACH TOWARDS 
TARGETING THE MOST VULNERABLE.  
Objective (v): To determine the incidence of delirium in older medical 
inpatients and identify predictors of incident delirium in this group. 
The recent NICE guidelines propose that all patients who meet one of the following 
criteria should be assessed daily for delirium: age 65 years or older; cognitive 
impairment; current hip fracture; or severe illness at risk of decompensation. In the 
introduction, I have outlined how this risk stratification method may be difficult to 
implement in clinical practice, so in this chapter I attempted to identify other 
features which may help to further risk stratify older medical patients, so that 
screening approaches can be targeted towards the most vulnerable. As described 
above, patients were assessed within 36 hours of admission, using the DRS-R98 for 
evidence of prevalent delirium. Those who were non-delirious and who consented to 
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inclusion, were then assessed daily for the development of incident delirium. 
Incident delirium was diagnosed if a patient reached a severity score of ≥15 and / or 
a total score of ≥18 on the DRS-R98. Risk factors for delirium were assessed using 
logistic regression and included age; alcohol history; premorbid dementia; poor 
functional status; comorbidity burden; history of depression; current depression; 
hearing and visual impairment; polypharmacy; and use of deliriogenic medications 
pre-admission, see Chapter 5 for detail. Other potential risk factors were also 
assessed including sex; place of residence; social support; level of education; 
smoking; and poor nutritional status on admission.  
 
3.9.3. CHAPTER 6: THE NICE SCREENING RECOMMENDATIONS: CLINICAL EFFICACY AND 
RELATIONSHIP TO DELIRIUM PHENOMENOLOGY  
Objective (vi): To examine the clinical utility of the screening recommendations 
made by the NICE guidelines in detecting incident delirium. 
The recent NICE guidelines (5) propose ‘indicators of delirium’ which should be 
checked daily in all high-risk hospitalised groups (see above). These indicators focus 
on changes or fluctuations in usual behaviour in the following domains: cognitive 
function: “for example, worsened concentration, slow responses, confusion”; 
perception: “for example, visual or auditory hallucinations”; physical function: “for 
example, reduced mobility, reduced movement, restlessness, agitation, changes in 
appetite, sleep”; and disturbance of social behaviour: “for example, poor 
cooperation, withdrawal, or alterations in communication, mood and/or attitude”. 
This screening tool has been developed by expert consensus opinion, however its 
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clinical utility had not previously been formally assessed. I designed a questionnaire 
for interviewing nursing staff based on the NICE guidance (see appendix A). The 
exact phraseology of the guidelines was used when possible, in order to ensure that 
the questionnaire was as close as possible to being an operationalised version of the 
guidance document. The questions used were reviewed by my supervisors to ensure 
that proximity to the original guidance was optimised. Researchers (Dr. Maeve Davis, 
Dr. Mary Buckley, Dr. Annmarie Hannon, Dr. Theva Jayaraman) were trained to ask 
these questions in a standardised way and used the questionnaire to then 
independently survey the relevant nursing staff about the presence or absence of 
these ‘indicators of delirium’. I was not made aware of the results of the 
questionnaire and the researchers were blinded to the delirium status of the 
patients assessed throughout the study. The accuracy of these nurse-observed 
delirium indicators in predicting presence of delirium was then assessed. We also 
investigated which elements of the questionnaire correlated with formally assessed 
elements of delirium phenomenology, in order to identify to which features of 





3.9.4. CHAPTERS 7, 8 AND 9: DELIRIUM IS PRECEDED BY A BEHAVIOURAL PRODROME IN 
OLDER MEDICAL INPATIENTS; COGNITIVE IMPAIRMENT HERALDS DELIRIUM ONSET 
INDEPENDENT OF DEMENTIA; DELIRIUM FEATURES OCCUR IN THE DELIRIUM PRODROME  
Objectives (i), (ii), and (iii): Characterising the Prodromal Features of Incident 
Delirium in Older Medical Inpatients: Behavioural Features; Cognitive Features; 
and Delirium Features. 
This was the primary aim of the study and hence three chapters have been devoted 
to this important aspect. These three chapters outline the prodromal features, 
respectively the behavioural features; cognitive features; and features of delirium 
phenomenology, found to predict delirium onset in this cohort of older medical 
inpatients. To date, the studies in this area have varied considerably in methodology, 
assessments used and treatment setting. We aimed to use all available information 
from the existing literature on delirium prodrome to define the prodromal period in 
older medical inpatients. Patients underwent a series of assessments on a daily basis 
to investigate for prodromal features, including cognitive assessment, delirium 
assessment and observation for behavioural features. Relevant nursing staff were 
interviewed using the novel Prodromal Checklist (see above and appendix A) to 
assess for objective evidence of any behavioural features in the previous 24-hours. 
Additionally, any prodromal behaviour noticed by me during daily interview with the 
patient that was missed by the nursing staff, was marked as present appropriately. 
The family member / next-of-kin / carer who provided collateral history for the 
delirium assessment was also questioned using the Prodromal Checklist, to assess 
for evidence of prodromal features in the week prior to admission (only new 
symptoms / exacerbation of previous symptoms in the previous week were eligible 
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for inclusion). This information was then pooled with the nursing responses on the 
screening day so that all available information on potential prodromal features in the 
lead-up to admission was utilised on day 1. Cognitive tests employed were the 6-CIT 
(incorporating MOTYB, 20-1, temporal orientation and short-term memory); tests of 
visuospatial function (including the CDT; IPT; and EVSQ); and tests of attention 
(including the SSF and MOTYB). Patients underwent these tests on a daily basis and 
hence we were able to use longitudinal analysis to assess if impairments on these 
tests predicted development of incident delirium, independent of pre-morbid 
dementia. We used the DRS-R98 daily to assess the delirium status of our 
participants and similar to the study in Korean hip fracture patients published by Lee 
et al (199), we used longitudinal analysis to identify which delirium 
phenomenological features predicted the emergence of delirium.  
 
3.9.5. CHAPTER 10: MOTOR PROFILE OF INCIDENT DELIRIUM IN OLDER MEDICAL 
INPATIENTS: FREQUENCY; STABILITY; AND PREDICTORS 
Objective (vii): To assess the prevalence and stability of motor subtypes of 
incident delirium in older medical inpatients. 
Patients were assessed daily for delirium and additionally for objective evidence of 
motor features. Motor subtyping is not only the most common and most objective 
way to classify delirium, but it also has the most evidence for meaningful differences 
between subgroups based on aetiology, pathophysiology and prognosis (38).  The 
Delirium Motor Subtype Scale - 4 (DMSS-4) was used to ascertain the motor profile 
for each patient in the initial stages and throughout the course of the delirium (see 
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above and appendix A). This scale allows for categorisation of the delirium as either 
hyperactive, hypoactive, mixed subtype or no subtype. As patients were assessed in 
a longitudinal fashion, we were able to apply longitudinal motor subtypes to each 
patient with delirium, based on the subtypes expressed during a delirium episode, 
similar to studies in palliative care patients (11, 54). Five longitudinal categories were 
possible, four stable and one variable: hypoactive subtype throughout; hyperactive 
subtype throughout; mixed subtype thoughout; no subtype throughout; and variable 
profile (see Chapter 10 for detail). From these data, we were able to examine the 
frequency and stability of motor subtypes in this population.  
 
3.9.6. CHAPTER 11: MOTOR PROFILING CAN DIFFERENTIATE OLDER MEDICAL PATIENTS 
WITH SUBSYNDROMAL DELIRIUM FROM THOSE WITH NO DELIRIUM  
Objective (viii): To characterise the phenomenology and motor profile of 
subsyndromal delirium in older medical inpatients. 
Subsyndromal delirium is a state in which a patient presents with certain delirium 
features, however does not meet criteria for full delirium diagnosis. It is important 
clinically because it leads to adverse outcomes at rates intermediate between 
patients with delirium and those with no delirium spectrum disorder. However, 
many patients without any delirium spectrum disorder, particularly in the acute 
hospital setting, present with individual delirium features, for example sleep-wake 
cycle abnormalities. Although recent studies have shown that subsyndromal delirium 
is phenomenologically more similar to delirium than no delirium, it can be 
challenging to discern what specifically distinguishes patients with no delirium from 
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those with the more prognostically significant subsyndromal delirium. Additionally, 
we do not understand if motor subtypes have any role in subclassifying 
subsyndromal delirium. In this study, patients were assessed daily for delirium and 
additionally for objective evidence of motor features. The DRS-R98 and DMSS-4 were 
used to provide in-depth characterisation of the phenomenology and motor profile 
of both full- and subsyndromal delirium (FSD, SSD) and longitudinal motor subtypes 
were applied. Frequency and stability of subtypes was evaluated. In relation to 
phenomenology, mean scores of each item on the DRS-R98 were compared between 
normal controls, patients with SSD and those with FSD and certain features were 
found to differentiate between the groups.  
 
 96 
4. THE SIX-ITEM COGNITIVE IMPAIRMENT TEST AS A SCREENING 
TEST FOR DELIRIUM 
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Delirium is a complex neuropsychiatric condition which occurs in the setting of acute 
illness. It is highly prevalent across clinical settings (1), and is independently 
associated with adverse outcomes including increased mortality and accelerated 
cognitive and functional decline (3, 17). Although studies indicate that early 
recognition and intervention can impact positively on prognosis (18, 19, 200, 201), 
delirium remains largely unrecognised across settings (1, 23, 202), particularly in 
older patients (2) and those with pre-existing dementia (20). Understanding delirium 
is challenging to the untrained eye. The variable and fluctuating symptom profile 
with periods of lucidity can often be misleading, and the more common and 
prognostically serious hypoactive form is less visible to staff than the stereotypical 
but less prevalent hyperactive agitated form. Furthermore, the conventional 
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misperception that ‘confusion’ is a natural occurrence in the setting of acute illness 
in the older adult, or even an element of the normal ageing process undermines the 
significance of delirium as a diagnosis and impedes identification across disciplines. 
 
In view of its seriousness and scale, all at-risk patients should be regularly assessed 
for delirium development. However, this poses a significant challenge given that 
formal diagnosis requires thorough and often time-consuming assessment by a 
trained and experienced clinician. The most feasible approach, advocated by the 
NICE guidelines (5), incorporates two steps: firstly, screening for core delirium 
features using a simple, short test, followed by formal assessment in those who 
screen positive. Identifying an appropriate initial assessment depends on the clinical 
setting amongst other factors, but in general, a useful delirium screening tool should 
be highly sensitive, require minimal training, and be brief so that it does not add 
much to the existing burdensome workload of ward staff. There are numerous 
screening tools available but there remains no consensus as to which should be 
used. 
 
The most widely used delirium instrument is the Confusion Assessment Method 
(CAM) (83, 84), based on DSM-IIIR (Diagnostic and Statistical Manual of Mental 
Disorders, 3rd edition) criteria. It tests for the presence or absence of key delirium 
features: acuity of onset, fluctuating course, inattention, disorganised thinking and 
altered level of consciousness, and includes semi-structured patient interview as well 
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as informant history. Although it is considered the most robust short bedside test 
(203), has been validated in several languages and adapted for multiple settings (85), 
its potential as a routine screening test is hampered by its administration time of 
approximately five minutes and low sensitivity in untrained hands (87). However, an 
operationalised brief version of the CAM (bCAM), has shown promise as a successful 
screening approach in the Emergency Department (88). A more recently developed 
multidimensional tool, the 4 ‘A’s Test (4-AT), was designed for routine use in clinical 
practice (91). It incorporates assessment of (i) level of alertness; (ii) cognition using 
the AMT4 (Abbreviated Mental Test-4); (iii) attention using Months of the Year 
Backwards (MOTYB); and (iv) acuity of onset and / or presence of fluctuations. It is 
widely used clinically, brief and simple to administer, and a study of diagnostic 
accuracy conducted in acute and rehabilitation geriatric medicine units in an 
independent centre found a sensitivity of 89.7% and specificity of 84.1%. Like the 
CAM and bCAM, collateral history is required to complete the test with accuracy, 
and although obtaining accurate collateral history is central to formal delirium 
diagnosis, this often time-consuming, and sometimes impossible, step may hinder 
the success of a screening test in practice. Other screening instruments based purely 
on patient observation do not require informant reports nor cognitive testing, are 
acceptable to nursing staff and initial studies of their use are encouraging, yet 
further studies are required to validate results (92, 102).  
 
Common bedside cognitive tests have also been suggested for screening, however 
these tools tend to lack specificity for delirium (9) unless they focus upon deficits in 
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cognitive domains (e.g. attention) which are disproportionately affected in delirium 
when compared to normal ageing and dementia (105-108). Attention tests such as 
the MOTYB and Spatial Span Forwards (SSF), amongst others, have been found to be 
delirium sensitive (105-107). The SSF is a visual pattern recognition test based on the 
digit span forwards (111), and may discriminate the inattention of delirium from that 
caused by dementia (110). The MOTYB is a simple test of attention which is widely 
used for bedside assessment. It is sensitive in detecting delirium in acute hospital 
inpatients, particularly in older patients (105). The Six-item Cognitive Impairment 
Test (6-CIT) is a cognitive screening test which incorporates tests of attention with 
evaluation of temporal orientation and short-term memory (113), three of the main 
cognitive domains affected in delirium. It hence has potential as delirium screening 
test. Because it is a completely verbal test, it can be also be used in the visually 
impaired (125) and those with upper limb issues. It requires minimal training and has 
high acceptability among nursing staff (127). Additionally, of importance where serial 
testing is required, no significant learning effect has been demonstrated (123). Its 
applicability as a delirium screening test has not yet been studied and thus there are 
no suggestions as to an appropriate cut-off in this setting. Bedside tests of 
visuospatial function are another proposed method of delirium screening, 
particularly the Clock-Drawing Test (CDT), which is widely used in screening for 
cognitive impairment and dementia (132). As well as visuospatial function, it 
assesses constructional praxis, executive function; and verbal and semantic memory 
(133). There are conflicting reports as to the utility of the CDT in the detection of 
delirium. Some authors found it reliable for this purpose (134, 135), and others 
found it unsuitable for delirium screening (133, 136-139). Its advantages include that 
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it is largely unbiased by educational level, ethnicity, language and socio-economic 
status and it is quick and widely accepted by physicians and patients alike (140, 141). 
Another well-known visuospatial test is the Interlocking Pentagons test (IPT), which 
initially gained popularity as one of a set of nine figures in the Bender-Gestalt test 
used to assess for developmental problems in children (142). Since then it has been 
incorporated into other cognitive tests including the MMSE (Mini-Mental State 
Examination) (143). Impairments on the IPT can differentiate between patients with 
Dementia with Lewy Bodies (DLB) and Alzheimer’s Dementia (146-149) and can 
predict cognitive decline in Parkinson’s disease patients (150-153). Given the 
phenomenological similarities between DLB and delirium, it is possible that this test 
may have utility in detecting delirium, however to our knowledge, no studies have 
yet examined this. Thus, the aim of this study was to assess the utility of several 
simple bedside assessments in the detection of prevalent delirium in older medical 
patients on admission. The tests we assessed were the 6-CIT; MOTYB; SSF; CDT; IPT 
and a set of verbal visuospatial questions (see below).  
 
4.2. METHODS 
This cross-sectional study was part of a larger longitudinal study of delirium 
conducted in two hospitals in Cork city, Ireland (Cork University Hospital and the 
Mercy University Hospital) between October 2011 and August 2013. Patients of 70 
years and older who were admitted medically were eligible for inclusion. Patients 
were excluded for many reasons: refusal to participate; being terminally unwell or 
comatose; or due to severe communication issues (e.g., advanced non-
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communicative dementia; severe dysphasia). Patients were assessed for prevalent 
delirium within 36 hours of presentation to the emergency department using the 
Delirium Rating Scale Revised ’98 (DRS-R98). They also concurrently underwent 
testing with six other cognitive screening methods as described below and in figure 
3.  
 
4.2.1. ASSESSMENTS  
4.2.1.1. Delirium Rating Scale-Revised ’98 (DRS-R98) 
This is a 16-item scale incorporating 13 severity items (rated from 0 to 3) and 3 
diagnostic items (rated from 0 to 2 or 3), with a total possible score range of 0 to 46. 
It is used both as a diagnostic tool and additionally to evaluate phenomenology and 
symptom severity over the previous 24-hour period. It has high inter-rater reliability, 
validity, sensitivity and specificity for distinguishing delirium from other 
neuropsychiatric disorders including dementia and depression (90, 204, 205). In 
keeping with guidelines for its use (173), in this cross-sectional study DRS-R98 
defined delirium was denoted by a severity score ≥15 or total score  ≥18.  
 
4.2.1.2. Six-item Cognitive Impairment Test 
The Six-item Cognitive Impairment Test (6-CIT), originally called the Six-item 
Orientation-Memory-Concentration Test was developed by Katzman et al (113) as a 
screening test for dementia. It involves three temporal orientation questions; two 
tests of attention; and a test of short-term logical memory (see figure 3). It is scored 
out of twenty-eight with higher scores indicating greater degree of impairment.  
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4.2.1.3. Spatial Span Forwards 
The Spatial Span Forwards (SSF) is performed using an A5 card with eight red squares 
(each measuring 1.5cm2) evenly spaced over three rows (formation three, two, 
three; landscape) on a white background, see appendix A. Predetermined sequences 
are tapped out for the patient to repeat, beginning with a sequence of two and up to 
a maximum of seven. Two attempts are allowed at each level and subjects unable to 
correctly repeat a sequence of five are generally considered to have failed the test. 
Because it is non-verbal, it can be used in those cannot speak (e.g. intubated patients 
/ tracheostomy patients), or have expressive aphasia (e.g. stroke patients).  
 
4.2.1.4. Months of the Year Backwards 
The Months of the Year Backwards (MOTYB), can be scored using several methods, 
either dichotomised into a positive or negative result in a variety of different ways, 
or using a scale of accuracy performance based on the number of errors (206). In this 
study, as in previous studies from our research group (1, 105, 181), subjects were 
first invited to say the months of the year forward from January to December and 
subsequently asked to recite the months backwards from December to January. 
Those who reached July without error were considered to have passed the test.  
 
4.2.1.5. Environmental Visuospatial Questions Test 
Visuospatial ability is commonly impaired in delirium (75) and is one of five cognitive 
domains assessed using the DRS-R98. Many visuospatial tests require that the 
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subject reproduce a figure and are unsuited to those with fine motor or visual 
impairments. We devised a series of questions (EVSQ or Environmental Visuospatial 
Questions Test) relating to the patient’s environment which we hypothesised would 
at least in part reflect their visuospatial function. From a pool of eight questions, five 
were asked daily of each patient (see figure 3). The questions were rotated in order 
to minimise learning effect. A mark was given for each correct answer and the test 
was scored out of five. 
 
4.2.1.6. Interlocking pentagons test 
The Interlocking Pentagons Test (IPT) requires the subject to copy a representation 
of two intersecting pentagons with a quadrilateral figure formed by their overlapping 
corners, see figure 3. It can be scored either in a binary fashion as in the MMSE 
(Mini-Mental State Examination) (143) or as a ten-point scale (144). The most 
commonly applied scoring system remains the binary method, which was applied in 
this study.  
 
4.2.1.7. Clock-Drawing Test 
The Clock-Drawing Test (CDT) can be scored by a variety of different methods, all of 
which correlate well with other tests of global cognition (136). In this study we used 
a 15-point scoring method from the QMCI (Quick Mild Cognitive Impairment screen), 
a tool developed to differentiate between mild cognitive impairment and normal 
controls (174). Using this method, the subject is given a pre-drawn circle and is 
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requested to draw in the numbers and set the time at ‘ten past eleven’. A 
transparent template is used to guide scoring of the placement of the numbers and 
hands, see appendix A.  
 
4.2.2. ASSESSMENT OF PREVIOUS COGNITIVE STATUS 
Medical charts were examined for an indication of a previous diagnosis of dementia 
by an appropriately trained physician. The Informant Questionnaire on Cognitive 
Decline in the Elderly Short-Form (IQCODE-SF) was also used to ascertain a prior 
dementia history (mean cut-off ≥3.5) through a standardised interview of carers / 
next-of-kin (193). In borderline cases, diagnosis was reached by consensus opinion of 
experts (ST, DM). In those with no known diagnosis or available informants, a score 
of ≥27 /30 on the SMMSE (Standardised Mini Mental State Examination) was 
considered normal, in keeping with other studies (181). In subjects with lower 
SMMSE scores and with no available collateral history, premorbid cognition was 
considered “unknown”.  
 
4.2.3. ETHICAL PROCEDURES 
This study was approved by the Clinical Research Ethics Committee of the Cork 
Teaching Hospitals. The nature and purpose of the study was discussed with 
participants and informed consent was obtained. Because of the nature of the study, 
it was anticipated that many participants would not have capacity to give informed 
consent and so, consistent with similar studies and in accordance with the Helsinki 
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Guidelines for Medical Research involving human subjects (207), ethical approval 
was granted to augment patient assent in those lacking capacity with approval from 
a nearest relative or next-of-kin.   
 
4.2.4. STATISTICAL ANALYSIS 
Statistical analyses were conducted using SPSS version 20. Demographic data were 
expressed as means ± SD or medians and IQR, depending on the distribution of the 
data. Delirium was defined as a DRS-R98 severity score of ≥15 and / or a total score 
of ≥18. Comparisons of categorical variables were made using a χ2 test and for 
continuous variables parametric or non-parametric tests were used dependent on 
their distribution. Also Receiver Operating Characteristic (ROC) analysis, and the 
Area Under the Curve (AUC) were calculated for the tests which were rated on a 
continuous scale. Subgroup analysis evaluating test performance in patients with 
and without dementia was also performed. Spearman’s Rho was used to investigate 
the relationship between the six screening tests. Multivariable logistic regression, 
using a backwards stepwise method, was used to identify which screening tests 
significantly predicted occurrence of prevalent delirium. Model fit was assessed 
using -2 Log likelihood and goodness of fit using the Hosmer-Lemeshow (CHL) test. 
Stepwise discriminant analysis was utilised to investigate how the screening tests 
distinguish delirium, dementia and normal controls using all the screening tests as 





Of 555 patients approached, 470 had full delirium assessments performed and 184 
(33.2% of those approached) met criteria for delirium. The median age of the cohort 
was 81 years (range 70-99; IQR 10) and 50.4% (n=237) were female, see table 3. 
Comorbid dementia status was known in 320 patients (68% of those included), and 
79 patients had premorbid dementia. Patients with delirium were slightly older and 
were more likely to have pre-existing dementia than those without. The correlations 
between performance on the six screening tests were assessed using Spearman's rho 
coefficients (see table 4). Correlations between 6-CIT and the other scales are all 
negative (- sign), as higher scores on the 6-CIT indicate more impaired cognition, 
whereas the opposite is the case for the other scales. The binary tests (MOTYB and 
IPT) were coded 0 for fail and 1 for pass, hence these also have negative correlation 
with the 6-CIT.   
 
Tables 5 and 6 show the performance of the six tests in detecting delirium. The AUC 
for continuous variables is shown in table 5, as is the best cut-off with sensitivity, 
specificity, NPV (Negative Predictive Value), PPV (Positive Predictive Value) and 95% 
confidence intervals for each scale using DRS-R98 diagnosis as the reference 
standard. These values have been calculated for the overall group and also for those 
with and without pre-morbid dementia. Figures 4 to 7 show the respective ROC 
curves for each test. Table 6 shows sensitivity, specificity, NPV and PPV with 95% 
confidence intervals (95% CI) for each binary test, also divided into subgroups. 
Caution must be used when interpreting these results, particularly the NPV and PPV, 
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given that the sample was not consecutive and hence the prevalence rate may not 
be completely accurate. In the diagnosis of prevalent delirium, the most robust test 
was the 6-CIT with an AUC of 0.88 (95% CI 0.84-0.91). For the whole group, a cut-off 
point of 11 / 12, was found to have the best match between sensitivity and 
specificity at 83.5% (95% CI 76.6-88.8) and 76.0% (95% CI 70.3-81), respectively 
(p<0.001). However when screening for a serious condition with high prevalence, 
favouring sensitivity and NPV over specificity and PPV is advised, in order to reduce 
the risk of missed cases. With this in mind, the accuracy of other cut-offs were 
explored and using a cut-off of 8 / 9 for the whole group, sensitivity was 89.9% (95% 
CI 83.8-93.9) and NPV was 91.2% (95% CI 85.8-94.7), whereas specificity was 62.7% 
(56.5-68.5) and PPV was 59.2% (95% CI 52.6-65.4). This optimal cut-off did vary 
depending on dementia status, see table 5. 
 
Logistic regression analysis was conducted to assess which tests most accurately 
predicted delirium occurrence. All six screening tests were entered into the initial 
model, with dementia and age as covariates, and forced entry method was used to 
arrive at the best model, as shown in table 7. This model correctly classified 82.7% of 
participants, 60.8% with delirium and 92% without. In order to identify which test 
specifically distinguished delirium from dementia and from normal controls, we 
performed a stepwise discriminant function analysis with the categorical variable 
(delirium / dementia / no neurocognitive disorder) as the dependent variable and all 
six screening tests as independent variables. We found that only the 6-CIT 
significantly predicted correct classification, with 78.1% of the original grouped cases 
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correctly classified (Wilks' Lambda=0.748, F=62.15, df1:1, df2:1, df3:184, p<0.001). 
Using statistically more rigorous cross-validation, in which each case was re-classified 
by the functions derived from all other cases, results were similar. We then 
compared the mean scores on the 6-CIT between the different neurocognitive 
groups, using Kruskall-Wallis test, and found that they differed significantly from 
each other (see table 8). Controls scored significantly lower (i.e. performed 
significantly better) than those with either dementia or delirium, with a median 
score of 6 (IQR 7, range 0-22). Patients with dementia only were more impaired, with 
a median score of 14 (IQR, range 2-28), but delirium patients scored significantly 
much higher, their median score being 19 (IQR 11, range 0-28), p<0.001. Figure 8 
illustrates median 6-CIT scores for the three groups.  
 
4.4. DISCUSSION  
We found that the 6-CIT is a robust method of screening for prevalent delirium on 
admission in older medical inpatients, with high overall sensitivity and NPV, and an 
optimum cut-off for delirium screening of 8 / 9. We also found that the 6-CIT can 
distinguish patients with delirium from those with dementia (and no delirium) and 
also from those with neither diagnosis. Being the first time this test has been 
investigated for utility as a delirium screening test, our suggested cut-off of 8 / 9 for 
delirium screening is the first such proposed cut-off. In previous studies of its use in 
screening for dementia, several cut-off scores have been suggested, the most 
common one being 10 / 11 with sensitivities ranging from 82.5% to 90% and 
specificities from 86.8% to 96%  (116, 121-123). In these studies, a high specificity 
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was emphasised over high sensitivity, so as to minimise false-positive dementia 
diagnoses. Other studies have used 7 / 8 (128) and 5 / 6 (130) respectively as cut-offs 
for the non-specific term ‘cognitive impairment’, and it is generally considered that 
using lower cut-offs improves sensitivity in detecting milder impairments.  
 
The individual tests of attention, MOTYB and SSF, were also sensitive to the presence 
of delirium, but specificity was low for both these tests particularly in patients with 
dementia. A previous study conducted by our research group found that MOTYB had 
high sensitivity and specificity in detecting delirium, and was particularly useful in 
older patients (≥69 years) with a sensitivity of 83.8% and a specificity of 89.6% (105). 
In this more recent study, sensitivity was similar (84.6%), but specificity was lower at 
58.4%. The reasons for this are unclear however, it may relate to differences in study 
methodology. The former study was part of a large point prevalence study of 
delirium in all adult inpatients (aged 17 to 95 years) in a general hospital, whereas 
this latter study concentrated only on medical inpatients of 70 years and older at the 
point of admission. There were, thus, more patients with pre-morbid dementia in 
the current study which may have contributed to the difference in findings. The 6-
CIT incorporates a version of the MOTYB as one of its measures of attention, and it 
may be that its accuracy improves with the addition of tests of other core cognitive 
domains affected in delirium.   
 
This was the first study to examine the performance of IPT in detecting delirium, and 
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although it missed very few cases, it seemed to detect a more generalised 
impairment in cognition, rather than that specifically due to delirium. The CDT 
performed well in the overall analysis and in the non-dementia group, however the 
results in the dementia group were poor and not statistically significant. This test 
was also associated with delirium occurrence on multivariable logistic regression but 
was unable to distinguish between delirium and dementia on discriminant analysis 
which is in keeping with more recent studies of its use (133, 136-139). Our 
environmental questions (EVSQ) designed to identify visuospatial deficits in those 
who could not use a pen, were not useful in delirium detection. Although the 
correlations between EVSQ and the CDT and IPT respectively were statistically 
significant, the correlation coefficients were low. Thus, it is likely that the EVSQ also 
detects impairments in cognition other than in visuospatial function. Interestingly 
the 6-CIT correlated highly with all the other tests. 
 
The tests which independently predicted the diagnosis of delirium were 6-CIT, SSF 
and CDT. However on stepwise discriminant analysis only the 6-CIT differentiated 
between delirium, dementia (without delirium) and normal controls, an important 
finding given that delirium is commonly mistaken for dementia and attempting to 
distinguish between the two in an acute setting is challenging. A systematic review 
conducted by Morandi and colleagues in 2012 indicated that the CAM and CAM-ICU 
were most useful for detecting delirium superimposed on dementia but studies 
using these tools were not designed specifically to distinguish between patients with 
delirium and those with dementia only (208). Other studies identify that sustained 
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visual attention (104); bedside measures of attention (110, 209) and deficits in visual 
perception (210) can differentiate the two conditions. Previous work by Meagher 
and co-workers has highlighted that the SSF can distinguish between delirium and 
dementia as well as between comorbid delirium-dementia and dementia but did not 
discriminate between both delirium groups (110). Our results do not replicate this 
finding, and the differing results may be due to a variety of reasons. Firstly, the 
previous study by Meagher et al involved palliative care patients with a younger age 
range, whereas our cohort were older medical patients. Furthermore, unlike 
previous work, we did not separate the delirium cases into those with dementia and 
those without, as we did not have dementia diagnosis available in all of the delirium 
cases. Lastly, we did not discern dementia severity in our cohort which may have 
impacted on results. Importantly, although our results show that patients with 
delirium score significantly higher on the 6-CIT than those with dementia only (who 
in turn score higher than normal controls), figure 8 demonstrates that the boxplots 
overlap, hence we cannot discern an accurate cut-off to distinguish the two from our 
data.  
 
The strengths of this study include that delirium was diagnosed by a trained 
experienced rater using a well-validated sensitive instrument. There were a high 
number of delirium cases included (n=184) and six bedside cognitive tests were 
assessed, although one limitation is the potential for bias given that the same 
investigator conducted the delirium assessments and the cognitive testing. A study 
strength is that dementia status was determined using the IQCODE-SF, which is a 
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well-recognised and validated tool for studies such as this. On the other hand, 
IQCODE-SF scores were not available for all those included. The issue of identifying 
pre-morbid dementia at the point of admission is commonly challenging in day-to-
day practice, when collateral history can often be difficult to obtain, and dementia is 
also vastly under-recognised in the community and in the hospital sector. In a study 
of dementia prevalence in the acute hospital setting, one-quarter of patients had 
dementia, yet only approximately one-third of these had a prior diagnosis (181). In 
the acute setting, in order to expedite delirium diagnosis and hence facilitate 
appropriate intervention strategies, a simple quick method to screen for delirium is 
crucial and although collateral history, supported by appropriate diagnostic 
instruments, remains the first line in attempting to identify if a patient with a 
cognitive deficit is acutely compromised with delirium or chronically impaired with 
dementia, it should not be a rate-limiting step in the screening process. This study 
suggests that early in admission, the 6-CIT is a useful screening tool to detect 
prevalent delirium and our results also indicate that it may distinguish between 
patients with delirium and those with dementia only. Further studies in larger 
populations with more defined neurocognitive groups are needed to verify these 
results. Of particular importance for future work in this area is the identification of 
an accurate method to differentiate delirium from dementia using the 6-CIT. The 
question as to whether or not the 6-CIT can differentiate between patients with 
delirium superimposed on dementia from those with delirium alone, is less clinically 




Figure 3: Description of screening tests included in the study 
*QMCI = Quick Mild Cognitive Impairment Screen. It includes a template for scoring the clock-drawing test. 
A. The Six-item Cognitive Impairment Test 
(6-CIT) 
Scoring 
 1. What year is it? Score 4 if incorrect 
 2. What month is it? Score 3 if incorrect 
 Repeat after me:  
“John / Smith / 42 / High Street / Bedford.” 
I want you to try to remember that name and 
address. I will ask you about it later. 
(not scored) 
 3. About what time is it? Score 3 if more than 1 hour wrong 
 4. Count backwards from 20 down to 1 Score 2 if one error 
Score 4 if two or more errors 
 5. Say the months of the year in reverse order, 
starting with December 
Score 2 if one error 
Score 4 if two or more errors 
 6. What was that name and address you 
repeated after me earlier? 
Score 2 for each error  
Maximum score 10 for 5 errors 
 Total score = ____/ 28 
B. Spatial Span Forwards (SSF) 
 
Subject must repeat sequences of 
squares of increasing difficulty 
tapped out by the examiner. 
Correctly repeating a sequence of 5 
squares is generally considered the 
criteria to pass the test.  
 
C. The Months of the Year Backwards  
(MOTYB) 
Subject must get back as far as July 
without error in order to pass the 
test. 
 
D. Environmental Visuospatial Questions 
(EVSQ) 
 
 1. Where is the toilet? 
2. Where is the nurses’ station? 
3. Where is the way out? 
4. Which is bigger, ……* or …….*? 
5. Which is closer to you, the window or the 
door? 
6. Which of my hands is closer to you? 
7. Which is taller, ….. *or ……*? 
8. Which is closer to you, ……* or …….*? 
Five of these questions were asked 
daily and the subject was given a 
mark for each correct answer. The 
test was scored out of five. 
 
 
*Objects in room or on bedside table 
are used here 
 
E. Interlocking pentagons (IPT)  
 
 
Score 1 if entirely correct 
Score 0 if any mistake 
 
F. Clock-Drawing Test (CDT) The patient is given a pre-drawn 
circle. They are instructed to fill in 
the numbers to make it look like a 
clock, and to draw the hands at ‘ten 
past eleven’. The test is scored 
according to the QMCI*, out of 15 
with lower scores indicating a 















Age (years), median (IQR) 81 (10) 82 (15.25) 80 (9) <0.001 
Sex (% female) 50.4 50 50.7 0.882
 
Dementia status (n=320) 










Table 4: Correlations between different approaches to screening for delirium 
6-CIT= Six-item Cognitive Impairment Test; SSF = Spatial Span Forwards; EVSQ = Environmental Visuospatial Questions; MOTYB = Months of the Year 
Backwards; IPT = Interlocking Pentagons Test; CDT = Clock Drawing Test. All correlations are significant at the level <0.001, except for those marked , which are 
significant at the level <0.01 
  6-CIT SSF EVSQ MOTYB IPT CDT 
6-CIT Correlation  coefficient 1.000 -0.569 -0.446 -0.548 -0.419 -0.576 
SSF Correlation  coefficient -0.569 1.000 0.385 0.345 0.378 0.422 
EVSQ Correlation  coefficient -0.446 0.385 1.000 0.245 0.136 0.298 
MOTYB Correlation  coefficient -0.548 0.345 0.245 1.000 0.227 0.346 
IPT Correlation  coefficient -0.419 0.378 0.136 0.227 1.000 0.414 








Table 5: AUC with 95% confidence intervals for each continuous screening test. 
This is shown for the whole group and then divided into those with and without dementia. The most efficient cut-off score for each scale based 
on the coordinates of the curve is also shown. *Cut-off score that optimises sensitivity and Negative Predictive Value 
6-CIT= Six-item Cognitive Impairment Test; SSF = Spatial Span Forwards; EVSQ = Environmental Visuospatial Questions; CDT = Clock Drawing Test; NPV = Negative Predictive 
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Table 6: Performance of binary screening tests in the detection of delirium 
MOTYB = Months of the Year Backwards; IPT =Interlocking Pentagons Test; CI = Confidence Interval; NPV = Negative Predictive Value; PPV = Positive 
Predictive Value 
























































Table 7: Multivariable logistic regression model of screening tests which were significantly predictive of prevalent delirium status 
-2 log likelihood 258.27; Hosmer-Lemeshow test p=0.288, β= coefficient, OR = odds ratio, CI = confidence interval 
82.7% cases correctly classified (60.8% of delirium cases, 92% of no delirium cases) 
 β OR 95% CI for OR sig. 
6-CIT score (per unit increase) 0.145 1.157 (1.09-1.22) <0.001 
CDT score (per unit increase) -0.111 0.895 (0.83-0.96) 0.002 
SSF score (per unit increase) -0.324 0.731 (0.55-0.97) 0.028 
constant -0.564 0.569   
 
Table 8: Comparison of 6-CIT scores for each neurocognitive group 
6-CIT = Six-item Cognitive Impairment Test; IQR = interquartile range 
*Kruskall-Wallis Test was used as distribution was non-parametric 
 Controls 
(n=132) 





6-CIT score  


















Figure 4: Receiver Operating Characteristic Curves for 6-CIT: a) overall group; b) 
patients without dementia; c)patients with dementia 
 
 
Figure 5: Receiver Operating Characteristic Curves for SSF: a) overall group; b) 
















Figure 6: Receiver Operating Characteristic Curves for EVSQ: a) overall group; b) 




Figure 7: Receiver Operating Characteristic Curves for CDT: a) overall group; b) 
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5.1. INTRODUCTION 
Delirium is a complex neuropsychiatric syndrome caused by underlying illness or 
injury which presents with an acute change in cognition and attention (3). It is highly 
prevalent, occurring in approximately 20% of hospital inpatients (1) and up to 60% in 
frail hospitalised older adults (211). It is a serious condition which leads to increased 
mortality (14); more prolonged hospital stays (15) with higher readmission rates 
(16); and increased cognitive (17) and functional decline (16). Early identification and 
management is key to minimising these adverse outcomes (212), yet delirium 
remains seriously underdetected across clinical settings (20, 23, 213).  
 
The pathophysiology of delirium remains unclear and although it is often caused by 
direct brain insults such as trauma, hypoxia, metabolic abnormalities, stroke and 
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drug effects, it can also be the result of an aberrant stress response where there is 
an exaggerated physiological reaction to apparently mild peripheral illness or injury, 
particularly in those with a vulnerable brain (28). Despite the uncertainty in relation 
to the precise mechanisms of delirium pathogenesis, multiple predisposing and 
precipitating factors have been identified (80, 81). Modifying  these risk factors 
through proactive multifaceted systematic interventions has been shown to halve 
delirium incidence (7).  
 
In 2010, the United Kingdom’s National Institute for Health and Clinical Excellence 
(NICE) published guidance on the diagnosis, prevention and management of delirium 
(5) based on comprehensive review of the existing literature by experts in the field. 
Given the poor recognition of delirium, they recommend that patients at risk should 
undergo daily screening for the emergence of delirium, with full formal assessment 
by a trained, experienced clinician in those who screen positive. Patients considered 
at high risk included patients with any one of the following characteristics: being of 
65 years and over; having cognitive impairment or dementia; having a current hip 
fracture; or having a severe illness at risk of decompensation. This broad 
categorisation includes the vast majority of hospital inpatients, reflective of the 
pervasiveness of delirium across hospital settings, however as a risk-stratification 
tool, it does not help to target delirium detection programmes towards the most 
vulnerable and hence does not assist in making screening more feasible and 
acceptable to busy clinical staff. In order to achieve this, it is necessary to identify 
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more specifically which of these patients are at sufficiently high risk to warrant more 
intense (e.g. daily or more frequent) screening. 
 
Several clinical prediction tools have been developed (214) in order to assist with risk 
stratification, however these can include elements which are not easily assessed at 
presentation (215) or involve complex calculations that are poorly suited to the 
demands of busy real-world everyday practice (216). In this study, we aimed to focus 
the NICE criteria in order to tailor screening to the most vulnerable groups based on 
information that would be readily available and easily recordable at the point of 
hospital admission.  
 
5.2. METHODS 
5.2.1. SETTING AND PARTICIPANTS 
This was a prospective observational cohort study conducted in two hospitals in Cork 
city, Ireland (Cork University Hospital and the Mercy University Hospital) between 
October 2011 and August 2013. Patients of ≥70 years of age admitted medically 
through the emergency department were screened for study eligibility within 36 
hours of admission (and usually within 24 hours). Patients who refused, who were 
gravely ill or dying, or who were admitted to the intensive care unit (ICU) were 
excluded from screening assessment. Following initial assessment, patients with 
prevalent delirium on admission; and those in whom formal delirium assessment 
was impossible due to severe communication difficulties (e.g. severe dysphasia, 
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severe non-communicative dementia) or coma were excluded from longitudinal 
assessment. Patients who were eligible for inclusion were then invited to participate 
in the prospective study and informed consent was sought. Consenting participants 
underwent daily assessment for the development of delirium for at least seven days 
or until discharged. Patients who were discharged early without delirium (within 3 
days of admission) were excluded from the study due to inability to confidently 
outrule incident delirium post-discharge.  
 
5.2.2. ASSESSMENTS USED 
5.2.2.1. Delirium 
A trained delirium assessor (NO’R) performed all delirium assessments using the 
Revised Delirium Rating Scale (DRS-R98). This diagnostically precise scale comprises 
16-items; 13 of which grade severity of individual features (rated from 0 to 3) and 3 
contextual items (rated from 0 to 2 or 3). The scores from each severity item are 
added to give a severity score and the scores from the diagnostic items are then 
added to the severity score to give a cumulative or total score (range 0 to 46). It is 
validated for discriminating delirium from other neuropsychiatric diagnoses, with 
high inter-rater reliability, sensitivity and specificity (90, 205). It can also be used to 
assess symptom severity over the previous 24-hour period and hence can be used to 
evaluate delirium phenomenology. In this study, delirium was diagnosed using a cut-
off of ≥15 on the severity scale and / or ≥18 using the total score, in keeping with the 




5.2.2.2. Potential delirium predictors 
Potential predisposing and precipitating factors in medical inpatients were identified 
by reviewing the existing literature, including the NICE guidelines published in 2010 
(5). We included only baseline factors which can be easily identified and are typically 
recorded routinely in hospital admission notes. We did not include vital signs or 
laboratory values. Demographic data and social history factors were recorded 
including age, sex, marital status, place of residence, social support, level of 
educational attainment and alcohol and smoking history. Excess alcohol intake was 
defined as drinking more than 14 units per week for females and more than 21 units 
per week for males (217). Comorbidity burden was calculated using the Modified 
Cumulative Illness Rating Scale for Geriatrics (M-CIRS) and medication use was 
recorded (see below). Prior history of depression was obtained from the medical 
chart and ascertainment of prior history of dementia is also described below. The 
Modified Barthel Index (BI) was used to assess functional status on admission and 
the Mini-Nutritional Assessment – Short Form (MNA-SF) graded nutritional status. 
Simple screening assessments of hearing and sight were performed at the bedside. A 
modified version of the Geriatric Depression Scale, the ABCDS (AB Clinician 
Depression Screen), was used to screen for current depression. See appendix A for 
copies of the instruments used. 
 
5.2.2.3. Medications and Polypharmacy 
A list of admission medications was compiled, including those taken regularly or on a 
PRN (as required) basis. This included those prescribed by a patient’s general 
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practitioner or another doctor for recent illness. The term polypharmacy refers to 
the use of multiple medications by a patient, however there is no international 
consensus as to what the cut-off should be (5). Hence, in this study we considered 
the two cut-offs cited in the NICE guidance: three or more; and five or more 
medications. Additionally we collated a list of potentially deliriogenic medications 
(see table 9) based on the existing literature (218) and on the NICE guidelines (5) and 
identified patients who were in receipt of any one or more of those culprit 
medications.  
 
5.2.2.4. Assessment of previous cognitive status 
The Informant Questionnaire on Cognitive Decline in the Elderly Short-Form 
(IQCODE-SF) was used to assess for pre-admission cognitive impairment and decline. 
This is a 16-item scale scored by a caregiver or close relative. In this study, a mean 
item cut-off score of ≥3.5 was used to diagnose dementia in keeping with similar 
study cohorts (193). In borderline cases, diagnosis was reached by consensus 
discussion (with ST and DM). The medical case notes of each patient were also 
reviewed and in patients with no available collateral history / IQCODE-SF, a patient 
with documentation of pre-morbid dementia made by an appropriately trained 
physician was considered to have dementia. In the absence of an IQCODE-SF / 
collateral history / previous diagnosis, ascertaining dementia status was challenging. 
Those patients who scored ≥27 /30 on the SMMSE were considered not to have 
dementia, due to findings from another hospital-based study in which dementia 
prevalence was 2% in older patients with MMSE scores ≥27 /30 (192). Premorbid 
 
 127 
cognition was recorded as “unknown” in participants with SMMSE scores < 27 / 30 
without collateral history / IQCODE-SF (n=2). 
 
5.2.3. ETHICAL PROCEDURES 
The nature and purpose of the study was discussed in detail with participants and 
written information was supplied. However, it was anticipated that many 
participants would not be capable of giving informed written consent due to 
cognitive impairment at study entry. Therefore, in keeping with former studies, 
informed consent was obtained from patients capable of providing it, and assent to 
participation was sought from those who were incompetent to consent (based on 
informal assessment during the consent process), as well as support from a nearest 
relative or carer. Formal ethical approval was granted by the Clinical Research Ethics 
Committee of the Cork Teaching Hospitals. Due to the non-invasive nature of the 
study, ethics committee approval was granted to augment patient assent with proxy 
consent from next of kin where possible, or a responsible caregiver, in accordance 
with the Helsinki Guidelines for Medical Research involving human subjects (207).  
 
5.2.4. STATISTICAL ANALYSES 
Demographic data were expressed as means ± SD or medians and IQR, depending on 
the distribution of the data. Comparisons of groups (delirium, no delirium) were 
made using a χ2 or Fisher Exact test for differences in proportions, a t-test for 
differences in means or Mann Whitney U non-parametric tests for differences in 
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mean ranks. Univariate logistic regression was used to assess if various baseline 
predictor variables were associated with incident delirium. Variables with p<0.05 
were included in a multivariable logistic regression model, using a simple “enter” 
method, where all significant variables were entered in the model together, as well 
as age and sex. The final model was assessed using the Hosmer-Lemeshow (CHL) test 
for goodness of fit, and fitted the data well (p>0.05). Multicollinearity with the 
independent variables was investigated using the variance inflation factor (VIF) and 
tolerance statistic and where there was collinearity between variables, the most 
clinically relevant variable was included in the model, so that all the remaining 
variables had a VIF less than 10 and a tolerance statistic more than 0.1. Analyses 
were conducted using SPSS version 20. 
 
5.3. RESULTS 
A total of 191 patients were included in the final analysis (see figure 9 for a detailed 
explanation of flow of patients through the study). The median age of the included 
patients was 80 (IQR 10), 52.9% (n=101) were male and 16.9% (n=32) had premorbid 
dementia (see table 10 for a full report of the baseline characteristics of the cohort). 
We identified a priori, from the existing literature and using clinical judgement, 
factors which had the potential to increase delirium risk. Table 11 reports the odds 
ratios of important variables in relation to incident delirium development. Those 
who developed delirium were slightly older and more likely to have pre-morbid 
dementia, depression and hearing impairment. They also had higher comorbidity 
and functional dependence and were more likely to be undernourished. Patients 
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with incident delirium were also more likely to have either family support or formal 
social support. This was felt to be a surrogate marker for functional dependence, and 
not in itself likely to be a delirium risk factor so we did not include this factor in 
multivariable analysis. Using multivariable logistic regression (table 12), we identified 
variables that were independently predictive of incident delirium in this cohort and 
found that M-CIRS, BI and premorbid dementia with adjusted Odds Ratios (OR) of 
1.15 (95% CI 1.06-1.25, per 1 unit M-CIRS increase); 1.13 (95% CI 1.06-1.25, per 1 
unit BI decrease); and 2.54 (95% CI 1.01-6.43) respectively predicted delirium 
development independent of confounders. 
 
5.4. DISCUSSION 
The NICE guidelines recognise the importance of regular delirium screening in 
vulnerable inpatients. They propose a risk stratification method which appears 
overly inclusive and which lacks routine applicability in many real world settings. 
Tailoring the approach more specifically to focus upon those most at risk would be 
more manageable in the busy hospital setting. Delirium is known to be a 
multifactorial condition, with more than one causative factor evident in most 
episodes (219). Multiple risk factor studies have shown a diverse range of 
predisposing and precipitating factors, however many studies do not differentiate 
between incident and prevalent delirium, which is crucial in order to ascertain which 
factors predated delirium development. Additionally, many risk factor studies report 
factors that involve excessive complexity in delirium risk stratification, for example 
delirium predictors which require laboratory sample analysis, such as serum urea 
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(81, 220, 221) and serum albumin (222, 223), or predictive models which involve a 
mathematical calculation (216). Our aim was to identify clinically relevant risk factors 
for delirium which could be easily established on the patient’s arrival to the 
emergency department and which may target those who are at significantly higher 
risk of incident delirium during their hospital stay. In this prospective study, having 
examined multiple baseline factors, we identified three independent risk factors for 
incident delirium: high comorbidity; pre-morbid dementia; high functional 
dependence on admission. These risk factors have been identified in other studies, 
pre-existing cognitive impairment being one of the most consistently recognised 
delirium risk factors across clinical settings (224-226).  
 
Co-morbid illness has also been shown in several studies to be independently 
predictive of delirium development. A study of 667 older hospitalised patients in 
Mexico, using the Cumulative Illness Rating Scale (CIRS) to evaluate comorbidity 
burden, found an adjusted OR for delirium development of 1.16 for each unit CIRS 
increase (95% CI 1.04-1.3, p=0.006), independent of other factors, findings very 
similar to ours (223). Inouye and colleagues found that high comorbidity indicated by 
a Charlson Comorbidity Index (CCI) score of >4 was independently predictive of 
delirium diagnosis at discharge from hospital (OR 1.7; 95% CI 1.1-2.6) in older 
medical patients. This effect of comorbidity has also been shown in surgical patients, 




Functional dependence has also been found in previous studies to be an 
independent risk factor for delirium development. Martinez and colleagues 
identified high level of dependency as one of three predictive factors in a model 
developed to classify delirium risk in patients on internal medicine wards (229). 
Another study conducted by Carrasco and co-workers found that older patients with 
good functional status who are not dehydrated on admission are highly unlikely to 
develop incident delirium, independent of increasing age (216). This predictive 
model requires laboratory measurement of serum urea and creatinine, along with BI 
measurement of function, with a subsequent calculation to infer delirium risk. 
Markers of dehydration, for example increased urea, or urea / creatinine ratio have 
been shown to be a risk factor in other studies (81, 220), however we did not include 
laboratory values in our analysis, given that our aim was to investigate risk factors 
that can be ascertained either by the referring doctor or immediately on 
presentation to the ED. 
 
As well as functional dependency, the predictive model developed by Martinez and 
colleagues included two other risk factors: age >85 years old and being on centrally 
acting drugs, including antipsychotics (229). We chose to assess medication burden 
in a variety of ways. We assessed polypharmacy using cut-offs of both ≥3 or ≥5 
medications (as outlined in the NICE guidance). We created a list of potential 
deliriogenic medications on admission (see table 9) and analysed this variable in two 
ways. Firstly, using a binary approach we identified if a patient was or was not on 
one or more potentially deliriogenic medication, and secondly we calculated the 
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number of potentially culprit medications each patient was in receipt of and entered 
this variable as a scale. We compiled this list to include medications identified in a 
recent systematic review by Clegg et al (218) as associated with higher risk of 
incident delirium, as well as those for which there is uncertainty regarding the risk of 
delirium. We also included additional medications outlined in the NICE guidance as 
being potentially deliriogenic (5). Martinez and colleagues included antipsychotics as 
a culprit medication, however the evidence regarding this drug class is mixed, with 
one high quality RCT in hip fracture patients showing that haloperidol was not 
associated with increased delirium risk (230) and other studies finding an 
independent association between antipsychotic use and delirium development (224, 
231). Additionally, it appears that using antipsychotics prophylactically peri-
operatively may reduce post-operative delirium incidence (232). Nonetheless, we 
repeated the analysis including antipsychotics as a culprit medication and our results 
did not differ. Non-steroidal anti-inflammatory drugs (NSAIDs) are another 
medication group in which there remains uncertainty in relation to delirium risk 
(218), however given that cyclo-oxygenase inhibition may have a protective effect in 
mouse models (233), we excluded NSAIDs from our list of potentially culprit 
medications. We did also repeat the analysis including NSAIDs and there remained 
no significant association with incident delirium. It is unclear why medication burden 
was not predictive of delirium development in this cohort, when the literature 
suggests increased risk with many medications. It is possible that our study was 
underpowered to detect a significant effect of medications. We did not examine 
medication doses, and although we were careful to exclude inhaled and topically 
administered preparations given the low likelihood of systemic absorption, all 
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patients on either low or high doses of a potentially culprit medication were treated 
the same. Although we only recorded admission medications, given that the majority 
of cases developed delirium on the second day of assessment, it is probable that the 
effect of post-admission prescriptions is negligible. 
 
Older age was not an independent predictor of incident delirium in our cohort, 
despite being one of the most consistent risk factors throughout the literature (5), 
however like in Inouye’s study in 1993 (220), using an age cut-off of >70 years for 
study inclusion may mean that we had a priori adjusted for age. A recent systematic 
review of risk factors for incident delirium in older medical inpatients found on 
pooled analysis that dementia, illness severity, visual impairment, polypharmacy, 
urinary catheterisation, low albumin, and length of hospital stay were statistically 
significantly associated with delirium (226). In general, only the first four of these 
factors are readily identifiable at presentation. Our study similarly identified 
dementia, comorbidity burden, as well as functional dependence. We also assessed 
for the effect of visual impairment, polypharmacy and malnutrition (using the MNA-
SF), however found no significant independent association. 
 
A study limitation is that we only considered older medical inpatients, and hence our 
findings cannot be generalised to surgical or intensive care patients, or to younger 
patients. The small sample size is another important limitation of our study. We did 
not investigate any of the in-hospital risk factors, as we were focusing on variables 
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which are readily available at presentation to the emergency department, however 
we appreciate that these additional factors play an important role in precipitating 
delirium. Our view is that those who are stratified as high risk at the hospital front 
door, should all then be commenced on a delirium care pathway aiming to minimise 
the in-hospital precipitants. 
 
Despite these limitations, our study has many strengths, including the prospective 
design, the performance of daily assessments throughout the first week of 
hospitalisation, as well as the use of a highly sensitive and standardised delirium 
diagnostic instrument performed by a trained and experienced assessor. There were 
few exclusion criteria and hence our cohort is likely to be representative of real 
world older medical inpatient populations. The patients were carefully assessed for 
pre-morbid dementia; functional dependence; comorbidity; medication burden; and 
for other risk factors, focusing on clinically relevant and easily identifiable risk 
factors. We found that functional and cognitive impairment as well as comorbidity 
burden were independently predictive of delirium development within the first week 
of admission, highlighting that delirium occurrence is a marker of general 
vulnerability, sharing risk factors with other geriatric syndromes, such as falls.  
 
The NICE guidance risk stratification approach incorporates cognitive impairment, 
older age, illness severity and current hip fracture. Our study was conducted in older 
medical inpatients and did not include hip fracture patients. We agree that all hip 
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fracture patients and all dementia patients should undergo frequent delirium 
screening as these groups are especially delirium-prone with incidence rates of up to 
62% in the former and up to 89% in the latter (234). Additionally, all severely unwell 
patients should be monitored regularly for complications, including delirium. 
However, our study has shown that older patients can be further risk stratified, 
based on their burden of comorbidity and their functional level on admission. Hence, 
we propose a modification of the NICE criteria regarding older patients, so that only 
those with higher comorbidity and lower functional status on admission should 
undergo intense (e.g. daily or more frequent) delirium screening, once assessed to 
be delirium free on admission. In busy, and often under-resourced health services, 
risk stratifying older patients in this way may assist in targeting delirium screening 
and preventative strategies to those who are most vulnerable, making this important 



















184 prevalent delirium 
23 communication / coma 
88 early discharge 
36 withdrew 
5 went for surgery 
2 became gravely unwell 
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Table 9: List of medications included as potentially deliriogenic 
*I also repeated the analysis including antipsychotic medications, however there remained no 
significant association on multivariable analysis.  Similarly, I repeated the analysis including NSAIDs as 
potentially culprit medications. Given that both antipsychotics and NSAIDs may have a protective 
effect in relation to delirium development, the analysis reported includes neither of these 





Anticholinergics (excluding inhaled / topical)  
Steroids (excluding inhaled / topical) 
H2-receptor antagonists 
Antihistamines (H1 receptor antagonists) 
Drugs for Parkinson’s disease 









Table 10: Baseline characteristics of the cohort separated into groups based on incident delirium status 
*t-test for continuous data and Chi-squared test for categorical data unless otherwise specified.  
+
Social support= any level of formal support (home help / home care package) or practical support from a relative. 
Variables  Delirium  
(n=61) 
Means (SD)  
n (%) 
No Delirium  
(n=130) 













            Single 
            Married 
            Widow 
 
Residence on admission 
1. Home alone 
2. Home with spouse/partner 
3. Home with relatives, others, sheltered 
4. Nursing home 
 






































                 55 (44) 
(missing=4) 
 
.088          .012                                                 0.03 
.124          .021                                                 0.03 











Fishers exact test: 0.008 











Variables  Delirium  
(n=61) 
Means (SD)  
n (%) 
No Delirium  
(n=130) 





Del         NoDel 
Alcohol excess 
1. No history  
2. Previous history of excess 




















































1. Current screen positive for depression  
(ABCDS and / or GDS) 










Fisher’s exact test: 0.188 
1 cell with expected count <5 
0.028 
Sensory Impairment: 
1. Hearing impairment 


















Variables  Delirium  
(n=61) 
Means (SD)  
n (%) 
No Delirium  
(n=130) 





Barthel Index (median, IQR) 
 
11 (6) 16 (6) <0.001 (Mann-Whitney U-test) 
 
MNA-SF category  
1. Malnourished 0-7 
2. At Risk 8-11 
















Admission culprit medication 
 
 On at least 1 deliriogenic medication on admission 
 




















 ≥3 medications on admission 
 


























Table 11: Odds Ratios for clinically relevant variables in relation to incident delirium development 
β= coefficient, OR = odds ratio, CI = confidence interval; BI = Modified Barthel Index; M-CIRS = Modified Cumulative Illness Rating Scale;  
MNA-SF = Mini Nutritional Assessment – Short Form.  
Residence was recoded as the binary variable ‘nursing home resident yes / no’; Alcohol excess was recoded as ‘current alcohol excess yes / no. 
Variables β OR 95% CI (OR) sig. 
Female sex -0.121 0.886 (0.48-1.63) 0.696 
Age (per 1 unit increase) 0.06 1.06 (1.01-1.12) 0.027 
Premorbid dementia 1.259 3.52 (1.61-7.7) 0.002 
BI (per 1 unit decrease) 0.200 1.22 (1.13-1.32) <0.001 
M-CIRS (per 1 unit increase) 0.150 1.16 (1.09-1.24) <0.001 
MNA-SF score (per 1 unit decrease) 0.179 1.2 (1.04-1.37) 0.012 
≥1 Deliriogenic medication on admission 0.279 1.32 (0.69-2.53) 0.4 
Number of deliriogenic medications on admission 0.210 1.23 (0.83-1.83) 0.298 
Polypharmacy (≥3 medications) 1.299 3.67 (0.8-16.71) 0.093 
Polypharmacy (≥5 medications) 0.777 2.17 (0.83-5.67) 0.112 
Nursing home resident 1.330 3.78 (0.87-16.37) 0.075 
Hearing impairment 0.687 1.99 (1.07-3.71) 0.03 
Visual Impairment 0.097 1.1 (0.5-2.45) 0.812 
Previous history of depression 0.768 2.15 (1.08-4.31) 0.03 
Current alcohol excess -0.336 0.71 (0.19-2.74) 0.624 








Table 12: Association (multivariable logistic regression) between independent variables and incident delirium. 
History of depression was excluded due to collinearity with premorbid dementia (-2 log likelihood 174.164; Hosmer-Lemeshow test p=0.75, β= 
coefficient, OR = odds ratio, CI = confidence interval) 
Variables β OR 95% CI (OR) sig. 
Female sex -0.215 0.81 (0.37-1.75) 0.586 
Age (1 unit increase) 0.01 1.01 (0.95-1.08) 0.756 
Premorbid dementia 0.934 2.54 (1.01-6.43) 0.048 
BI (1 unit decrease) 0.142 1.15 (1.06-1.25) 0.001 
M-CIRS (1 unit increase) 0.124 1.13 (1.05-1.22) 0.001 
Hearing impairment 0.41 1.5 (0.69-3.27) 0.303 




6. THE NICE SCREENING RECOMMENDATIONS: CLINICAL 
EFFICACY AND RELATIONSHIP TO DELIRIUM PHENOMENOLOGY 
 
Authors: N. O'Regan1, M. Davis2, D. Adamis3, M. Buckley4, A. Hannon4, T. Jayaraman4, J. 
Fitzgerald5, D. Meagher,6, S. Timmons1 
Affiliations:
 1
Centre for Gerontology and Rehabilitation, School of Medicine, University College Cork; 
2
Department of Psychiatry, Mercy University Hospital; 
3
Sligo Mental Health Services, Sligo; 
4
Department of Geriatric Medicine, Cork University Hospital, Cork, Ireland; 
5
Graduate Entry Medical 
School, University of Limerick;
4
Cognitive Impairment Research Group, Centre for Interventions in 
Infection, Inflammation & Immunity (4i), Graduate Entry Medical School, University of Limerick. 
 
6.1. INTRODUCTION 
Delirium is a common, serious neuropsychiatric condition occurring in one-fifth of  
acute hospital inpatients with higher rates in older patients and those with pre-
existing cognitive impairment (1). Delirium independently predicts poor outcomes 
including increased mortality, institutionalisation and cognitive decline (3, 17). 
Despite this, delirium remains widely under-diagnosed across clinical settings, even 
though studies indicate an understanding of its importance among physicians (235, 
236). Early recognition can improve outcomes (201) and, conversely, delayed 
diagnosis compounds their severity, most starkly highlighted in one study which 
found that each 48-hour delay in diagnosis resulted in an 11% increase in mortality 
(18). The causes of under-detection are myriad, not least due to its characteristically 
fluctuating nature and varying symptomatology. It is commonly missed or mistaken 
for other neuropsychiatric diagnosis (202) by those without expert training and 
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experience, particularly when it occurs in older patients (2), those with comorbid 
dementia (20) or psychiatric diagnoses (25) and in those with a hypoactive motor 
profile (21, 22).  
 
Given its prevalence and prognostic implications, all patients at risk of developing 
delirium should be frequently and routinely assessed using systematically 
implemented sensitive tools. This is challenging as formal diagnosis is time-
consuming and requires expert assessment using validated delirium assessment 
instruments. The Confusion Assessment Method (CAM) (83) is the most widely used 
diagnostic tool, having been designed initially for non-psychiatrists. It has been 
validated in multiple languages and clinical settings (84), but notwithstanding its 
broad scope and appeal, without appropriate training it lacks sensitivity, missing up 
to 50% of cases (87). It takes approximately 5 minutes to administer, but can take 
longer. More comprehensive assessment tools are more time-consuming and 
require an even greater level of expertise but are more diagnostically precise (89, 
90). Other instruments based on patient observation have been developed, in order 
to address issues with patient fatigability and potential learning effect (92, 102), as 
well as to improve acceptability with nursing staff on the ground. Although these 
instruments show great promise, further studies are required to verify results.  
 
In 2010, the UK National Institute for Health and Clinical Excellence (NICE) launched 
guidelines on the diagnosis, assessment and management of delirium, its key focus 
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being to improve delirium detection and management by promoting the adoption of 
a “THINK DELIRIUM” approach by all healthcare professionals in their day-to-day 
work (5). The guidelines highlighted the importance of identifying particularly 
vulnerable patients and advocated a two-stage screening and diagnostic approach in 
the at-risk population. A two-stage approach (incorporating a highly sensitive, brief 
and usable “rule-out” screening test followed by more detailed “rule-in” assessment 
in those who screen positive) is now widely recognised as the most feasible method 
of improving detection (88, 212), and multiple approaches have been suggested (88, 
91, 105). The NICE guidelines, developed by a panel of experts, make 
recommendations as to how to monitor for emerging delirium on a daily basis as 
unfortunately there was (and still is) no consensus on the best detection method for 
routine ward use by staff untrained or minimally trained in delirium. The 
recommendations prompt staff to observe for changes or fluctuations in a series of 
delirium indicator symptoms divided into four domains: cognitive function; 
perception; physical function; and social behaviour (see table 13). There is no doubt 
that these indicators reflect aspects of the core features of delirium and, hence have 
face validity, however a specific method of application is lacking in the guidelines. 
Given the nuances of delirium presentation, it is likely that success in following these 
recommendations would require a level of clinical skill in delirium detection which is 
only gleaned from experience and training. Whether or not this is the case remains 





Given the protean nature of delirium features, another interesting question 
pertaining to these guidelines is to which aspects of delirium phenomenology do the 
individual indicators relate? We now know that certain delirium features are central 
to diagnosis (for example inattention), and some features occur consistently but not 
universally (such as psychomotor disturbance), whereas other symptoms occur more 
sporadically (for example, perceptual abnormalities, delusions and affective lability) 
(40). The inter-relationship of these delirium features has been analysed in various 
studies by either examining correlations between individual symptoms or their 
relationship through factor analysis (41). Cross-sectional and longitudinal studies 
have identified that delirium comprises a three-factor structure (42, 43), divided into 
attention / other cognitive; circadian (psychomotor and sleep-wake cycle 
disturbances); and higher level thinking (disorders of language, thought process and 
executive function). This work helps to illuminate the inter-relationship between 
certain features and should facilitate improved understanding of delirium 
neuropathogenesis, amongst other areas (41).  
 
As aforementioned, certain patient groups are more prone to under-detection than 
others, but interestingly, there is also evidence to support the notion that different 
healthcare disciplines are more attuned to differing symptomatology as it presents. 
For example, work from our research group shows that doctors tend to identify 
delirium in the presence of inattention and short-term memory, whereas delirium 
visibility to nursing staff was increased in the setting of delusions and affective 
lability, as well as inattention and long-term memory impairment (1). Consequently, 
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the aims of this study were firstly to assess the clinical utility of an operationalised 
approach to the NICE screening recommendations in a routine ward setting 
(compared to two gold-standard tests, namely CAM and DRS-R98), and secondly to 
examine the relationship between the NICE indicators and the various components 
of delirium phenomenology (using the DRS-R98). 
 
6.2. METHODS  
6.2.1. SETTING AND PARTICIPANTS 
This study was nested within a larger prospective observational cohort study of 
delirium prodrome which was conducted in two hospitals in Cork city, Ireland (Cork 
University Hospital and the Mercy University Hospital) between October 2011 and 
August 2013. Patients of ≥70 years of age admitted medically were eligible for 
inclusion. Patients who refused or who were gravely ill or dying were excluded, as 
were those with severe communication difficulties (e.g. severe dysphasia, severe 
non-communicative dementia) or coma.  
 
6.2.2. ASSESSMENTS  
6.2.2.1. Delirium Rating Scale-Revised ’98 (DRS-R98) 
This is a 16-item scale which includes 13 severity items (rated from 0 to 3) and 3 
diagnostic items (rated from 0 to 2 or 3), with a total possible score range of 0 to 46. 
It is a diagnostic tool and is also used to assess symptom severity over the previous 
24-hour period. It has high inter-rater reliability, validity, sensitivity and specificity 
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for distinguishing delirium from other neuropsychiatric disorders including dementia 
and depression (90, 204, 205). In this study, in keeping with guidelines for its use 
(173), DRS-R98 defined delirium was considered if the total score was ≥18.  
 
6.2.2.2. Confusion Assessment Method 
The Confusion Assessment Method (CAM), as stated above, is most broadly used 
delirium instrument (83, 84). It was based on DSM-IIIR (Diagnostic and Statistical 
Manual of Mental Disorders, 3rd edition) criteria. The sensitive short-form and most 
commonly used version of this tool consists of five items: 1A) Acute onset; 1B) 
Fluctuating course; 2) Inattention; 3) Disorganised thinking; and 4) Altered level of 
consciousness, where the presence of 1A or B and item 2 and either item 3 or 4 gives 
a diagnosis of delirium.  
 
6.2.2.3. NICE-based questionnaire 
The NICE guidelines recommend screening for delirium on a daily basis, by assessing 
patients for changes in four domains: cognitive function; perception; physical 
function; and social behaviour. I developed a novel questionnaire based on these 
recommendations incorporating seventeen questions which reflected the key areas 
described in the guidelines (see table 13). These questions were divided into the four 
domains outlined in the guidelines. The first question in each domain is designed to 
introduce the major area under observation in that domain (e.g. Has there been a 
recent change or any fluctuations in the patient’s cognition?) and the following 
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questions are more specific, focusing on a particular aspect of that domain. Each 
question is designed to be as close as possible in wording to that of the guidelines, 
and where possible the exact wording is used. The questionnaire was developed and 
revised in consultation with my supervisors (ST, DM). 
 
A trained experienced delirium researcher (NO’R) conducted the delirium 
assessments, while a group of other researchers questioned the nursing staff 
independently using the NICE-based questionnaire. These researchers underwent a 
training session in which I instructed them to ask the questions in the order shown in 
table 13 (see appendix A for the relevant excerpt from the NICE guidance together 
with a copy of the questionnaire used). The researchers were blinded to the results 
of the delirium assessments and I was blinded to the results of the questionnaire.  
 
6.2.3. ETHICAL PROCEDURES 
This study was approved by the Clinical Research Ethics Committee of the Cork 
Teaching Hospitals. The nature and purpose of the study was thoroughly discussed 
with participants and written information was supplied. Informed consent was then 
obtained from capable participants. Due to the nature of the study, it was 
anticipated that many subjects would not have capacity to give written consent and 
hence, consistent with former studies, ethical approval was granted in these cases to 
bolster patient assent with approval from a nearest relative or next-of-kin in 
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accordance with the Helsinki Guidelines for Medical Research involving human 
subjects (207).   
 
6.2.4. STATISTICAL ANALYSES 
Statistical analyses were conducted using SPSS version 20 and Stata version 11 
software packages. Descriptive statistics were reported as means ± SD for 
continuous variables and as proportions and percentages for categorical variables. In 
order to evaluate the components of the NICE-based questionnaire in terms of 
differentiating delirium from no delirium, a stepwise discriminant analysis was 
performed, using the data from assessment day two as this was the day with most 
delirium cases. The CAM and the DRS-R98 were respectively used to define delirium 
in two separate models, entered as the dependent variable with the individual 
components / domains of the NICE-based questionnaire entered respectively as the 
independent variables. The CAM and DRS-R98 were considered as binary variables 
(CAM positive / negative; DRS-R98 total score ≥ 18 /<18). A p-value of less than 0.05 
was considered significant. The psychometrics of the final models were assessed by 
calculating sensitivity; specificity; positive and negative likelihood ratios, Positive 
Predictive Value (PPV), and Negative Predictive Value (NPV). Confidence intervals of 
95% were utilised and are reported in the results. Cronbach’s alpha was used to 
evaluate the consistency of questionnaire. Because the components of each 
assessment tool were categorical / binary, Spearman’s Rho was used to assess the 
correlations between the elements of the NICE-based questionnaire and the 




The highest number of dual assessments were conducted on assessment day two (n 
= 70), and hence we included only data collected on the second day of assessment 
for each patient. The mean age of this cohort was 79.7 (± 5.5) years, 61.4% (n= 43) 
were male and ten patients (14.3%) had pre-morbid dementia (see Chapter 3 for 
details on how pre-morbid dementia was identified). Nine patients (12.9%) had 
delirium on day two using the DRS-R98 for assessment; and fourteen (20%) using 
CAM. Twenty-nine patients (41.4%) screened positive using the NICE-based 
questionnaire (i.e. at least one of the 17 questions was answered positively by 
nursing staff). Twenty screened positively for physical changes, ten for changes in 
cognition, ten for changes in social behaviour and two for perceptual change. There 
was low agreement using Kappa statistic between a delirium diagnosis using the 
NICE-based questionnaire and either CAM (κ=0.247) or DRS-R98 (κ=0.149). 
Cronbach’s alpha for the 17-item questionnaire was 0.740. 
 
Discriminant analysis was then used to identify which of the questions from the 
NICE-based questionnaire would discriminate between those who had delirium and 
those who did not. Only fifteen of the seventeen questions were included in our 
initial model, as the three questions pertaining to perceptual change were collinear  
(see table 13). The analysis was performed using firstly the CAM and subsequently 
the DRS-R98 as the dependent variable, these two analyses producing differing 
results (see table 14), likely reflecting the known discordance in diagnosis between 
these two tools (as evidenced again here by almost twice the diagnosis rate with 
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CAM than DRS-R98, 12.9% v.s 20%) . We then repeated the analysis, this time 
entering into the model the four domains of change as described by the NICE 
guidelines: cognitive change; perceptual change; changes in physical function; and 
changes in social behaviour (see table 13). If any question(s) in an individual domain 
was positive, change in that domain was considered present. The only domain in 
which changes significantly predicted delirium / not delirium classification, using 
either the CAM or the DRS-R98 as the dependent variable, was cognitive change (see 
table 15, p=0.001; p=0.031 respectively). Using the CAM as the dependent variable, 
82.9% of participants were correctly classified, and 77.1% were correctly classified 
when the DRS-R98 was used. The diagnostic accuracy of this approach was 
calculated, such that any positive response on the cognitive domain section was 
considered a positive screen. Sensitivity; specificity; Likelihood Ratios (positive LR+ 
and LR-) both conventional as well as weighted by prevalence (wLR); and positive 
and negative predictive values (PPV; NPV) are shown in table 16. Despite the high 
percentage of correct classification on discriminant analysis, the sensitivity of the 
NICE-based domains for delirium identification was low, particularly for DRS-R98 
defined delirium at 33% (95% CI 9-69.1), see table 16. Sensitivity for CAM-defined 
delirium was slightly higher at 41.7% (95% CI 0.16.5-71.4), whereas specificity was 
high using both diagnostic methods for diagnosis (CAM 92.9%, 95% CI 81.9-97.7; 
DRS-R98 88.5%, 95% CI 77.2-94.9). 
 
This approach is not how the guidelines were meant to be utilised however. The 
NICE guidelines state that evidence of any of the delirium indicators outlined should 
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alert staff to the possibility of delirium. In relation to our questionnaire, this means 
that a positive response to at least one question in any of the four domains should 
indicate a positive screen. Table 16 also outlines the psychometrics of the NICE-
based questionnaire using each respective delirium diagnostic method as the 
dependent variable. With this approach, sensitivity is improved using either the CAM 
or the DRS-R98 as the reference standard, however at 64.3% (CAM, 95% CI 35.6-
86.0) to 66.7% (DRS-R98, 95% CI 30.9-91.0), it is still too low for the questionnaire to 
be considered a useful screening test. It is important to stress that these results must 
be interpreted with great caution due to the low agreement between the NICE-
based questionnaire and each of the diagnostic methods, as outlined above.  
 
Spearman’s Rho was used to examine the correlations between the individual 
questions from the NICE-based questionnaire and the components for the CAM and 
the DRS-R98. The significant correlations are shown in tables 17 and 18. Some items 
on the NICE-based questionnaire correlate well with corresponding similar items on 
the CAM / DRS-R98, for example NICE-based question 1a (“Has there been a recent 
change or any fluctuations in the patient’s cognition?”) correlates highly with CAM 
item 1B (fluctuating course) and DRS-R98 item 15 (severity of fluctuations); question 
2a (“Has the patient had any perceptual disturbances?”) correlates highly with DRS-
R98 item 2 (perceptual disturbances and hallucinations); and question 3d (“Has there 
been any change in their sleep pattern?”) correlates somewhat with item 1 on the 
DRS-R98 (sleep-wake cycle abnormalities). Other items from the NICE-based 
questionnaire which would be expected to map onto related items from the CAM 
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and / or DRS-R98, do not show any significant correlation with these items. For 
example, question 1b “Does it seem harder for them to focus on what you’re saying 
or on a task?” is a question commonly used to identify from an informant whether or 
not a subject has informally demonstrated inattention over the time period. This 
question would hence be expected to correlate with CAM item 2 and DRS-R98 item 
10 which evaluates for inattention, however it did not. In fact it did not correlate 
with any cognitive item on the DRS-R98. Inattention on the CAM and DRS-R98 
instead correlated with other questions from the cognitive domain of the NICE-
based questionnaire, for instance, question 1b (“Has the patient been more confused 
than usual in the last 24 hours?”), indicating that nursing staff recognise “confusion” 
but not inattention per se. No other cognitive item from the DRS-R98 correlated with 
any of the cognitive domain questions from the NICE-based questionnaire.  
 
Questions directed towards the identification of hyperactivity and hypoactivity did 
not correlate with their counterparts on the DRS-R98, yet DRS-R98 item 7 (motor 
agitation) correlated well with questions pertaining to cognitive function, social 
behavior and changes in sleep pattern. The only question from the NICE-based 
questionnaire which did not correlate with any CAM / DRS-R98 item was the 
question “Have they become less active or have they slowed down in general?”, 
which is unremarkable, given that it is well-documented that hypoactive delirium is 
the most unrecognised form. Instead, motor retardation correlated somewhat with 
questions related to perception and social behavior. DRS-R98 item 14 (temporal 
onset of symptoms) somewhat correlated with question 1a (“Has there been a 
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recent change or any fluctuations in the patient’s cognition?”); question 1b (“Has the 
patient been more confused than usual in the last 24 hours?”); and question 4a 
(“Has there been any changes in their social behaviour?”), whereas its counterpart 
on the CAM (item 1A, acuity of onset) correlated with question 3d (“Has there been 
any change in their sleep pattern?”), indicating that meaningful changes in cognition, 
sleep pattern and social behaviour may be identified by nursing staff.  
 
6.4. DISCUSSION 
Our results indicate that the sensitivity of a questionnaire based on the NICE 
indicators of delirium is too low for the tool to be safely used as a screening test. 
When the questionnaire is used such that any positive answer reflects a positive 
screen, sensitivity is approximately 65%. On discriminant analysis, changes in the 
cognitive domain significantly predicted whether or not a patient was delirious, 
correctly classifying up to 82.9% of patients, whereas changes in other domains did 
not. Using the cognitive domain, a high proportion of patients were labelled falsely 
negative, however, and thus sensitivity was even lower at 33.3-41.7%. Neither 
approach would hence be suitable as the first step in a two-stage delirium screening 
process, where the initial phase requires high sensitivity to minimise the occurrence 
of missed cases. The concept of a two-stage screening method has gained traction in 
recent years as more insights are gained into barriers to delirium detection on the 
ground. Such a concept is utilised successfully in many other clinical scenarios, for 
example the use of D-Dimers to help ascertain which patients require further 
investigation for venous thromboembolism (VTE). Importantly, in this example, a 
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patient presents with a clinical feature suggestive of the diagnosis of concern, thus 
prompting a diagnostic algorithm. When a patient develops delirium, it most 
commonly does not announce its arrival. Affected patients, by its very nature, are 
unaware of unfolding cognitive and neuropsychiatric change, and relatives and 
healthcare professionals alike often normalise ‘confusion’ in the setting of an older 
person with acute underlying illness. Hence when it comes to delirium screening, we 
need a ‘track and trigger’ approach (not unlike the concept of the National Early 
Warning Score for physical illness (237)), where a ‘cognitive vital sign’ is recorded as 
routinely as physical observations, and further assessment is indicated in the setting 
of results outside an accepted range.  
 
By examining the correlations between the NICE indicator features with the 
individual constituents of the CAM and DRS-R98, we explored which formal tool-
identified delirium features were detected by nurses in the routine ward setting 
(tables 17 and 18). Questions on the NICE-based questionnaire which correlated well 
with corresponding items on the formal tests include those pertaining to perceptual 
abnormalities and sleep-wake cycle disturbance, indicating that these features are 
likely to be highly visible to untrained nursing staff. Caution must be exercised when 
interpreting this, however, as only two patients screened positive in this study for 
perceptual change. In any case, psychotic symptoms only occur in approximately half 
of delirium presentations (42) and hence reliance on detecting perceptual 
abnormalities in screening for delirium would miss too many cases. Although the 
sleep-wake cycle is consistently affected in delirium, studies indicate that mild 
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changes occur very frequently in non-delirious patients, with more moderate to 
severe disruption being associated with subsyndromal and full-syndromal delirium 
(76). Thus, depending on recognising changes in sleep pattern is likely to be overly 
non-specific. As aforementioned, inattention is a cardinal feature of delirium, 
however, to those less schooled in delirium presentation, inattention on the CAM or 
DRS-R98 did not correlate with the NICE-based question designed for this purpose 
(question 1b “Does it seem harder for them to focus on what you’re saying or on a 
task?”). Other cognitive questions did however correlate with formally diagnosed 
inattention, which perhaps suggests that the concept of inattention, although 
recognised as a component of cognition, is poorly understood. Questions on the 
NICE-based questionnaire pertaining to physical function would have been expected 
to be associated with motor items on the DRS-R98, but this was not the case. Instead 
both psychomotor agitation and retardation correlated highly with indicators of 
change in social behaviour. Motor agitation correlated also with questions pertaining 
to sleep pattern and cognition. The former finding may reflect a tendency for nursing 
staff to be particularly alert to nocturnal agitation due to the ensuing care issues as 
well as the effect on neighbouring patients. The overly broad use of the umbrella 
term ‘confusion’, which can refer to the presence of any one of various different 
phenomena from disorientation to disorganised thinking to delusions, including 
agitation, may account for this correlation. Unsurprisingly psychomotor retardation 
correlated with fewer questions on the NICE-based questionnaire and indeed the 
only question not to correlate with any of the CAM / DRS-R98 formally diagnosed 
features was the one designed to detect hypoactivity (question 3b, “Have they 
become less active or have they slowed down in general?”). This reflects the subtle 
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presentation of hypoactive delirium and corresponds with previous work reporting 
poor detection rates in this group (21, 22).  
 
In another study, aiming to shorten the duration of CAM assessment, Yang and 
colleagues (238) used item response theory to identify the most efficient set of items 
to determine the presence or absence of each of the CAM features in 4,598 patients 
enrolled in a randomised controlled trial of a Delirium Abatement Program (611 with 
delirium) (239). Although the methodology of this large study contrasts greatly with 
ours, it examines a similar concept and some of their results are mirrored in our 
findings. Investigators report the top five delirium indicators for each CAM feature 
positive subgroup, both on direct interview and by observation, so that each CAM 
feature was related to ten indicators. Features indicating CAM item 1 positivity 
included a subjective feeling of confusion over the past day; and evidence of sleep 
disturbance. In our much smaller study, the NICE-based questions directed at these 
features (“Has there been a recent change or any fluctuations in the patient’s 
cognition?”; “Has the patient been more confused than usual in the last 24 hours?”; 
and “Has there been any change in their sleep pattern?”) also correlated with item 1 
A or B on the CAM. Yang and colleagues identified that formal and informal 
assessment of orientation and attention corresponded to CAM item 2 on the CAM. 
Our work found that the only cognitive items to correlate with this item were 
questions relating to general cognitive change rather than inattention per se, as 
described above. In contrast to the work by Yang and colleagues, in our study none 
of the NICE-based questions correlated with CAM items 3 or 4, however none of 
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them targeted these aspects definitively and only two questions could be considered 
related in some way to these features: respectively “Has there been any changes in 
their level of communication with you?”; and “Has there been any change in their 
sleep pattern?”. The reasons for any discrepancies between the two studies are 
clear. The two studies methodologies are vastly different, our study purely 
identifying correlations between various features of delirium using different 
methods of assessment in a small cohort of older medical inpatients. In the study by 
Yang and co-workers, there was significant a priori conceptualisation by a panel of 
delirium experts as to which symptom dimensions and features would likely be 
related to each CAM item. The data was drawn from a multicentre interventional 
study of delirium with 611 cases of CAM-defined delirium. Additionally, it is likely 
that assessments in this study were made by clinicians trained in delirium 
assessment, whereas the staff nurses who participated in our work were for the 
most part without any delirium training. Nevertheless, there are some interesting 
parallel findings between the two studies. 
 
Despite our small numbers, our study has many strengths. Firstly, to our knowledge, 
it is the first attempt to investigate the clinical utility of these guidelines as 
recommended by NICE and we developed a novel questionnaire based on the 
guidelines for this purpose. Furthermore, we utilised this questionnaire as an 
innovative method to ascertain which delirium features are recognised by staff with 
minimal or no training and which features are not detected. Secondly, formal 
delirium assessment was conducted by a trained and experienced delirium assessor 
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using two well-validated delirium assessment tools. The researchers utilising the 
NICE-based questionnaire were blinded to the delirium status of the patients and 
operated completely independently of the delirium assessor. The cognitive domain 
was the most significantly predictive of delirium / no delirium group membership 
using both DRS-R98 and CAM as the dependent variable indicating validity of the 
results. Limitations of our study include the small number of delirium cases included 
and as this was a study in older medical inpatients only, this may affect the 
generalisability of the results. Also our novel questionnaire was based on our 
interpretation of the guidelines only, and hence we cannot be certain that our 
results definitively answer the question as to the clinical utility of the guidelines.  
 
Approaches to delirium screening must take into account the type of clinical setting 
for implementation, the time available and expertise of staff who will conduct the 
screening, as well as the availability of experts in the area. In general hospitals, 
particularly with increasing demands and staff shortages, it is imperative that a 
screening instrument be brief and easy to apply with minimal training. Approaches 
that require significant training are costly, particularly considering the additional 
opportunity cost of removing staff from duty. Given the prevalence of delirium 
across the general hospital with associated increased healthcare costs and other 
poor outcomes, the initial screening test must be sensitive in order to reduce the risk 
of missing cases. The best, most efficient initial screening method has yet to be 
confirmed, although many approaches have been suggested and initial results are 
encouraging. The NICE guidelines give recommendations to healthcare staff to 
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observe for indicators of delirium in at-risk patients. Similar screening approaches 
designed for nursing staff use and based on monitoring for observed changes include 
two instruments developed in Canada: the NuDESC (92) and the RADAR (102). The 
NuDesc (Nursing Delirium Rating Scale) is a five-item observational test which 
assesses for disorientation; inappropriate behaviour; inappropriate communication; 
perceptual abnormalities and psychomotor retardation. It takes less than one 
minute to perform and takes into account reduced activity which occurs with illness. 
Preliminary studies show a sensitivity of 85.7% and a specificity of 86.8%, using DSM-
IV as the reference standard (92). Designed to be administered during medication 
rounds, the RADAR (102) prompts nursing staff to observe patients for evidence of 
drowsiness, poor concentration / comprehension, and psychomotor retardation. It 
has at best acceptable sensitivity and specificity (at 73% and 67% respectively) 
against DSM-IV-TR (and also DSM5) criteria for delirium when administered four 
times daily, but its major strengths are its brevity and simplicity. Taking only seven 
seconds to administer, the authors assert that it detects 73 times more cases of 
delirium per minute than the CAM. Other advantages include its acceptability to 
nursing staff and a concise training programme. Given the difficulty in picking up 
subtle but highly prevalent hypoactive delirium, it is likely that a formal test of 
attention and / or cognition is also required to buttress these observational methods 
and improve sensitivity.  
 
In conclusion, screening for delirium across clinical settings is important, yet greater 
clarity is required as to the best approach for each environment. The NICE guidelines 
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recommend screening for changes in four domains which can be affected in 
delirium, however our study highlights that minimally trained staff have at best 
modest accuracy in delirium detection by applying a questionnaire based on these 
guidelines. It is likely that a simpler approach is warranted in the acute hospital 
setting. Further studies are required to elucidate which approach is most effective 







Table 13: NICE guidelines with the questionnaire embedded 
These two questions were excluded from the discriminant analysis, as they were considered collinear with question 2a. 
Excerpt from NICE guidelines on screening Questionnaire based on these guidelines 
At presentation, assess people at risk for recent (within hours or days) 
changes or fluctuations in behaviour. These may be reported by the 
person at risk, or a carer or relative. Be particularly vigilant for behavior 
indicating hypoactive delirium (marked*). These behavior changes may 
affect:    
Cognitive function for example: 1.a Has there been a recent change or any fluctuations in the patient’s cognition? 
 confusion  1.b Has the patient been more confused than usual in the last 24 hours? 
 worsened concentration* 1.c Does it seem harder for them to focus on what you’re saying or on a task? 
 slow responses* 1.d Are their responses to you slower than before? 
    
Perception for example: 2.a Has the patient had any perceptual disturbances? 
 visual or auditory hallucinations 2.b Have they complained of any hallucinations?
 
  2.c Does it seem that they are responding to things that are not there?
 
    
Physical function for example: 3.a Has there been any changes in the patient’s physical function? 
 reduced mobility*, reduced movement* 3.b Have they become less active or have they slowed down in general?  
 restlessness, agitation 3.c Have they been restless or agitated at all?  
 sleep disturbance 3.d Has there been any change in their sleep pattern? 
 changes in appetite* 3.e Have they lost their appetite? 
    
Social behaviour for example: 4.a Has there been any changes in their social behaviour? 
 withdrawal* 4.b Have they become withdrawn or disinterested? 
 lack of cooperation with reasonable requests 4.c Have they become less cooperative / need more prompting than usual? 
 alterations mood and/or attitude 4.d Have there been any changes in their mood / attitude towards you? 
 alterations in communication 4.e Has there been any changes in their level of communication with you? 








Table 14: Results from discriminant analysis of 15 NICE-based questions using a) the CAM and then b) the DRS-R98 as the dependent variable 
Significant findings shown  
a) CAM as dependent variable 
NICE-based question Wilks’ Lambda F df1 df2 sig. 
1.b. Has the patient been more confused than usual in the last 24 hours? .933 4.574 1 64 .036 
3.d. Has there been any change in their sleep pattern? .850 11.260 1 64 .001 
3.e. Have they lost their appetite .888 8.095 1 64 .006 
4.a. Has there been any changes in their social behaviour? .933 4.574 1 64 .036 
4.c. Have they become less cooperative / need more prompting than usual? .928 4.998 1 64 .029 
4.e. Has there been any changes in their level of communication with you? .928 4.998 1 64 .029 
 
b) DRS-R98 as dependent variable 
NICE-based question Wilks’ Lambda F df1 df2 sig. 
3.d. Has there been any change in their sleep pattern? 0.868 9.423 1 62 0.003 










Table 15: Results from discriminant analysis of 4 NICE-based domains of change using a) the CAM and b) the DRS-R98 as the dependent 
variable 
(✚Could not be computed as it was a constant in the analysis) 
a) CAM as dependent variable 
NICE-based domain Wilk’s Lamda F df1 df2 sig. 
cognitive change  .849 11.724 1 66 .001 
perceptual change 
 
    
changes in physical function .984 1.039 1 66 .312 
changes in social behaviour .982 1.217 1 66 .274 
82.9% of cross-validated grouped cases correctly classified 
 
b) DRS-R98 as dependent variable 
NICE-based domain Wilk’s Lamda F df1 df2 sig. 
cognitive change .932 4.843 1 66 .031 
perceptual change 
 
    
changes in physical function .973 1.847 1 66 .179 
changes in social behaviour .945 3.858 1 66 .054 










Table 16: Sensitivity, specificity, likelihood ratios and positive and negative predictive values for delirium (CAM / DRS-R98 defined) using the 
NICE-based questionnaire. 
Firstly, results pertaining to the NICE-based questionnaire in totality as a screening approach (any question answered positive = positive test are 
shown and secondly, the NICE-based cognitive domain of change (any cognitive domain question answered positive = positive test).  
In brackets [95% confidence intervals]. LR+= Positive Likelihood Ratio, LR-= Negative Likelihood Ratio, wLR+= Positive Likelihood Ratio weighted by prevalence, 











        








































        













































Table 17: Significant correlations between the NICE-based questionnaire and the CAM using Spearman's Rho (sig.) 
Each CAM item is scored as present or absent. Dis. Thinking = Disorganised Thinking; LOC= Level of consciousness. Correlations between related items shaded. Items which are somewhat related but do not correlate in 
lined shading; *p<0.05; **p<0.005, ***p<0.001 










Cognitive function    No correlations No correlations 
1.a. Has there been a recent change or any 






1.b. Has the patient been more confused than 






1.c. Does it seem harder for them to focus on 
what you’re saying or on a task? 
     




   
Physical function      






   




   
Social behaviour      







4.b. Have they become withdrawn or 
disinterested? 
  0.291 
** 
  
4.c. Have they become less cooperative / need 
more prompting than usual? 
  0.291 
** 
  
4.e. Has there been any changes in their level 
of communication with you? 









Table 18: Significant correlations between the NICE-based questionnaire and the DRS-R98 using Spearman's Rho (sig.) 
Each DRS-R98 item is graded from 0-3 (items 1-14) or 0-2 (items 15 & 16), higher scores indicating greater severity / intensity. Item 1 sleep: Sleep-wake cycle disturbance; Item 2 perc: Perceptual disturbances and 
hallucinations; Item 3 del: Delusions; Item 4 affect: Lability of affect; Item 5 lang: Language; Item 6 thoug: Thought process abnormalities; Item 7 agit: Motor agitation; Item 8 retar: Motor retardation; Item 9 orient: 
Orientation; Item 10 attent: Attention; Item 11 stm: Short-term memory; Item 12 ltm: Long-term memory; Item 13 visuo: Visuospatial ability; Item 14 onset: Temporal onset of symptoms; Item 15 fluct: Fluctuation of 
symptom severity; Item 16 phys: Physical disorder  

















































































Cognitive function                 
1.a. Has there been a recent 
change or any fluctuations in 
the patient’s cognition? 






   
0.321 
** 









1.b. Has the patient been more 
confused than usual in the last 
24 hours? 
       
0.412 
*** 
   
0.314 
** 









1.c. Does it seem harder for 
them to focus on what you’re 
saying or on a task? 
       
0.335 
** 




1.d. Are their responses to you 
slower than before? 











Perception                 






      
0.251 
** 
        
Physical function                 
3.a. Has there been any 






























































































3.b. Have they become less 
active or slowed down? 
                
3.c. Have they been restless or 











     
0.226 
* 
   
0.219 
* 
    
3.d. Has there been any change 




































































Social behaviour                 
4.a. Has there been any 



























4.b. Have they become 




      
0.241 
* 
   
0.242 
* 








4.c. Have they become less 
cooperative / need more 



















   
0.247 
* 
4.d. Have there been any 
changes in their mood / 












       
4.e. Has there been any 
changes in their level of 










   
0.306 
** 
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7.1. INTRODUCTION 
Delirium is a complex neuropsychiatric syndrome caused by a variety of factors 
including acute illness, medication toxicity or injury. It is associated with adverse 
outcomes, such as mortality, loss of independence and cognitive decline (3), which 
relate not only to  the underlying aetiology but also to the severity and duration of 
active delirium itself. It is highly prevalent across treatment settings, occurring in 
one-fifth of hospitalised patients (1) and in up to half of older inpatients (2). Despite 
its significance, case identification remains poor with approximately two-thirds of 
cases in inpatients missed or misdiagnosed as depression, dementia and other 
neuropsychiatric syndromes (202). Underdetection intensifies the poor prognosis 
associated with delirium, such that patients who are detected late have higher 
mortality rates (18, 19, 77), whereas early intervention and prevention can attenuate 
these outcomes and lessen the long-term burden of delirium (6, 7).  
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A characteristic feature of delirium is acuity of onset, with symptoms frequently 
appearing over hours to days. Indeed, this contextual feature is a core criterion for 
diagnosis and emphasised in prevailing diagnostic systems. An additional 
consideration to this paradigm is the concept of a prodromal phase, in which some 
patients can experience a variety of symptoms prior to full delirium onset. Although 
this concept has been mooted for decades, there remains a lack of clarity about the 
exact nature, incidence and course of these early features. This is because few 
studies investigating the delirium prodrome have been conducted, and many of 
these reports have not had the prodrome as a primary focus and hence vary greatly 
in methodology, populations studied and assessments used.  
 
Lipowski provided some of the most comprehensive descriptions of delirium upon 
which many modern concepts of the syndrome are founded (44, 154). This work 
posited that delirium is frequently preceded by a myriad of features including 
reduced clarity of thought processes, emotional lability, sleep-wake cycle 
disturbance and a spectrum of perceptual abnormalities. Moreover, it was further  
asserted that this prodrome tended to occur when delirium was primarily caused by 
an underlying medical illness, whereas delirium due to trauma or surgery, being 
more acute in onset, lacked a prodromal phase. The concept that the prodromal 
phase can consist of delirium features, both cognitive and non-cognitive, as well as 
somatic emotional symptoms, is echoed in some of the subsequent literature in 
various study populations (155-161, 165, 167), see table 1 and 2 (Chapter 2). Sirois 
described headaches and general uneasiness as delirium approached in a study of 
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100 consecutive liaison psychiatry referrals (167). Matsushima and coworkers found 
prodromal changes of background slowing on EEG (theta/alpha ratio), sleep-wake 
cycle disturbance, anxiety and hyperactivity in a small sample (n= 6) of coronary care 
unit patients developing DSM-III-R delirium compared to controls (165). Osse and 
colleagues demonstrated that early changes in activity levels (measured using an 
actigraphic device) are associated with development of delirium in older post-
operative cardiotomy patients (166). Levkoff and colleagues found that almost 70% 
of older inpatients studied experienced a prodromal phase, consisting of varied 
cognitive and non-cognitive features of delirium (159), and studies in bone marrow 
transplant patients have shown cognitive decline in patients with imminent delirium 
(157, 158). Hip surgery patients are the most frequently studied group, although the 
three studies in this population have methodological differences (155, 156, 161). 
Duppils and Wikblad observed patients for behavioural changes and found that 
although some post-operative changes, particularly anxiety, were common in 
patients with and without delirium, urgent calls for assistance, disorientation, 
psychomotor restlessness and inattention were more prevalent in those with 
impending delirium, compared to controls (161). Using the Revised Delirium Rating 
Scale (DRS-R98), De Jonghe and co-workers identifed that memory impairment, 
disorientation and formal thought disorder independently predicted delirium in a 
similar hip fracture cohort and that as delirium approached, DRS-R98 scores 
increased (155). This latter finding was replicated recently using the Korean version 
of the DRS-R98, in which pre-delirious post-operative hip surgery patients were 
found to have significant increases in an array of delirium features in the days before 
delirium developed, compared to those without impending delirium (156).  
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Using delirium specific instruments to detect a prodromal state can help to ascertain 
the relevance of subsyndromal delirium as a precursor to full-blown delirium. 
Subsyndromal delirium (SSD) is a state in which a patient expresses certain features 
of delirium without meeting the threshold for full formal diagnosis. It can occur 
either as a transitional state from no delirium to delirium and vice versa (70) or it can 
occur in isolation (240). It is phenotypically more related to delirium than no delirium 
(75) and has prognostic significance such that those with SSD have been found to 
experience adverse outcomes at rates intermediate between delirium and no 
delirium, independent of confounders (241). Interestingly, one study in post-
cardiotomy patients has found that progression from SSD to full-syndromal delirium 
(FSD) was reduced with low-dose risperidone (73) suggesting that not only can SSD 
occur as a prodromal state but that intervention at this early stage may have huge 
benefits for delirium prevention. Although SSD presentation may contribute to the 
prodromal phase in some patients, the exact nature of the delirium prodrome is not 
yet fully understood and is postulated to include a constellation of other non-
delirium specific symptoms which vary greatly in nature and range from cognitive 
disturbances to affective, behavioural and somatic symptoms. Providing clarity as to 
the characteristics and course of this prodrome may promote strategies to prevent 
progression to a full-blown episode by facilitating appropriate and prompt 
intervention during a clinically identifiable stage of delirium vulnerability. The aim of 
this study was to identify features that indicate imminent delirium in older medical 





7.2.1. SETTING AND PARTICIPANTS 
A prospective observational cohort study was conducted in Cork University Hospital 
and the Mercy University Hospital (Cork city, Ireland) from October 2011 to August 
2013. Medical patients of ≥70 years of age admitted through the emergency 
department were screened for study eligibility within a maximum of 36 hours from 
admission. Patients who refused, who were gravely ill or dying, or who were 
admitted directly to the intensive care unit (ICU) were excluded from screening 
assessment. Following this assessment, patients with prevalent delirium on 
admission; and those in whom formal delirium assessment was unfeasible due to 
severe communication difficulties (e.g. severe dysphasia, advanced non-
communicative dementia) or coma were excluded from further study. Demographic 
data pertaining to all those approached was collected. Eligible patients were then 
invited to participate in the prospective study and informed consent was sought. 
Consenting participants underwent daily assessment for at least seven days or until 
discharged. Patients without delirium who were discharged within three days of 
admission were excluded from the study. This was because in those discharged 
early, we considered it impossible to confidently outrule incident delirium in the 





7.2.2. ASSESSMENTS  
7.2.2.1. Delirium 
Delirium assessments were performed by a trained delirium assessor (NO’R) using 
the Revised Delirium Rating Scale, a 16-item scale including 13 severity items (rated 
from 0 to 3) and 3 diagnostic items (rated from 0 to 2 or 3), giving a total possible 
score range of 0 to 46. This diagnostically precise instrument evaluates symptom 
severity over the previous 24-hour period and hence can be used to characterise 
delirium phenomenology. Additionally, it has high inter-rater reliability, validity, 
sensitivity and specificity for differentiating delirium from other neuropsychiatric 
conditions including dementia and depression (90, 205). In this study, in keeping 
with guidelines for its use (173), delirium was diagnosed if the DRS-R98 severity 
score was ≥15 and / or if the total score was ≥18.  
 
7.2.2.2. Prodromal Checklist 
In order to characterise the behavioural aspects of the delirium prodrome, a novel 
checklist of potential prodromal features was created based on suggested features 
from the existing literature. This prodromal checklist included 34 features, 
categorised into five separate domains (see figure 10 and appendix A). Each item 
was scored from 0 to 2 (0 = not present; 1 = possibly or somewhat present; 2 = 
definitely present). This checklist was used to examine for the emergence of possible 
prodromal features on a daily basis. At admission, a close relative / carer was also 
interviewed using the Prodromal Checklist to ascertain if any features were present 
in the days leading up to admission. It was completed using all available information: 
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interview with the relevant nursing staff (and with family member / carer on day 1), 
direct observation of the patient during assessment, as well as information taken 
from the nursing notes.  
 
7.2.2.3.Baseline assessments 
Demographic data (age, sex) and information relating to social history (including 
marital status; place of residence; alcohol and smoking history; and educational 
attainment) was collected. Comorbidity burden was measured using the Modified 
Cumulative Illness Rating Scale (M-CIRS) and pre-admission regular and ‘as required’ 
(PRN, pro re nata) medication history was documented for the week prior to 
admission. A list of deliriogenic medications (see table 9, Chapter 5) was derived 
from the existing literature and the NICE guidance (5, 218) and used to identify if a 
patient was on an at-risk medication prior to admission. Functional status was 
evaluated using the Modified Barthel Index (BI), nutritional status was measured 
using the Mini-Nutritional Assessment – Short Form (MNA-SF) and screening for 
sensory impairment was performed using simple bedside assessments of hearing 
and sight. Patients were also screened for depression using the ABCDS (AB Clinician 
Depression Screen), a modified version of the Geriatric Depression Scale (see 





7.2.2.4. Assessment of previous cognitive status 
For all patients, the medical case notes were reviewed for a diagnosis of pre-existing 
cognitive impairment or dementia made by a suitably trained physician. This was 
confirmed by the use of the Informant Questionnaire on Cognitive Decline in the 
Elderly Short-Form (IQCODE-SF) to assess pre-admission cognitive impairment and 
decline. This 16 item scale was scored by a caregiver or close relative and a mean 
item cut-off score of ≥3.5 was used to diagnose dementia (193). Consensus 
discussion (with ST and DM) was used to apply diagnosis in borderline cases. In the 
absence of an IQCODE-SF / collateral history / previous diagnosis, patients were 
considered not to have dementia if they scored ≥ 27 / 30 on the SMMSE, as a 
previous study (192) has shown that only 2% of hospitalised older people with an 
MMSE ≥27/30 have dementia.  In those with lower SMMSE scores without collateral 
history, premorbid cognition was determined as “unknown” (n = 2).  
 
7.2.3. ETHICAL PROCEDURES 
The nature and purpose of the study was discussed in detail with participants and 
written information was supplied. However it was anticipated that many participants 
would not be capable of giving informed written consent due to cognitive 
impairment at study entry. Therefore, in keeping with former studies, informed 
consent was obtained from patients capable of providing it, and assent to 
participation was sought from those who were incompetent to consent (based on 
informal assessment during the consent process), as well as support from a nearest 
relative or carer. Formal ethical approval was granted by the Clinical Research Ethics 
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Committee of the Cork Teaching Hospitals. Due to the non-invasive nature of the 
study, ethics committee approval was granted to augment patient assent with proxy 
consent from next of kin where possible, or a responsible caregiver, in accordance 
with the Helsinki Guidelines for Medical Research involving human subjects (207).  
 
7.2.4. STATISTICAL ANALYSES 
Demographic data were expressed as means ± SD or medians and IQR, depending on 
the distribution of the data. Comparisons of groups (delirium, no delirium) were 
made using a χ2 or Fisher Exact test for differences in proportions, a t-test for 
differences in means or Mann Whitney U non-parametric tests for differences in 
mean ranks. Associations between prodromal features and incident delirium were 
assessed using a Cox proportional hazards model. Incident delirium was defined as a 
DRS-R98 severity score of ≥15 and / or total score of ≥18. Models were adjusted for 
age, sex, comorbidity, functional status and cognitive status (see Chapter 5 for 
univariate and multivariable logistic regression models) and log likelihood was used 
to assess model fit. Confidence intervals of 95% were utilised and are reported in the 
results. The proportional hazards assumptions were checked using an extended Cox 
model with time-dependent covariates. Basic descriptives were performed using 





A total of 555 patients were approached over the study period and 529 were 
assessed (figure 9, Chapter 5). Prevalent delirium on admission was detected in 184 
patients (34.8%), while 23 patients were not amenable to full delirium assessment 
on day 1 due to factors such as coma, stupor, or other communication problems. 
Thus, 322 patients were included in the prospective study, however many were 
discharged within 3 days (n=88), 36 withdrew, five underwent surgical procedures 
and two became too unwell to participate and hence were excluded from the 
analysis, leaving 191 patients with at least four consecutive days of assessment 
included in the final analysis. The median age of the included patients was 80 (IQR 
10), 52.9% (n=101) were male and only eight patients (4.2%) were admitted from 
nursing homes (see table 10, Chapter 5) for a report of the baseline characteristics of 
the cohort, separated into groups based on incident delirium status). Multivariable 
logistic regression (see Chapter 5, table 12) identified M-CIRS, BI and pre-morbid 
dementia as  independent predictors of incident delirium in this cohort.  
 
Cox proportional hazards models were used to identify prodromal features that 
predicted delirium onset. Initially we investigated the prodromal items as a three-
point scale as illustrated earlier (0 = not present; 1 = possibly or somewhat present; 2 
= definitely present), however no features emerged as significantly predictive. 
Hence, the scale was collapsed into a two-point scale: 0=not present; 1= possibly or 
definitely present. The first model included all 34 prodromal items along with the 
independent baseline predictors from the multivariable logistic regression (M-CIRS, 
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BI and pre-morbid dementia), as well as age and sex. A step-wise approach was used 
to identify the most parsimonious model (table 19), removing non-significant 
variables at each step and monitoring for changes in model fit using the likelihood 
ratio. The variables did not vary significantly across time and hence proportional 
hazards assumptions were not violated. The features which were most predictive of 
impending delirium up to a week before delirium development were increasing 
confusion or ‘fogginess’ (HR 2.28, 95% CI 1.4-3.72); being easily distractible or going 
‘off-track’ (HR 1.89, 95% CI 1.11-3.21); needing prompting for usual tasks (HR 1.86, 
95% CI 1.1-3.14); seeming tired in the morning (HR 1.77, 95% CI 1.12-2.81); 
drowsiness during the day (HR 1.74, 95%CI 1.12-2.71); being ‘fidgety’, restless or 
wandering (HR 1.72, 95%CI 1.08-2.75); and irritability (HR 1.72, 95% CI 1.06-2.78).  
 
7.4. DISCUSSION 
This is the first study designed primarily to characterise prodromal features in older 
medical inpatients with imminent delirium. Our novel prodromal checklist was 
developed by identifying all possible prodromal behavioural features from the 
existing literature on the subject and by concentrating these features into five 
specific domains. Our data shows that incident delirium in older medical inpatients is 
preceded by a behavioural prodrome characterised by seven features from this 
checklist (irritability; being easily distractible or going ‘off-track; increasing confusion 
or ‘fogginess’; needing prompting for usual tasks; seeming tired in the morning; 
drowsiness during the day; being ‘fidgety’, restless or wandering). Hence, our 
findings depict a prodromal state which closely resembles that which Lipowski 
 
 181 
described anecdotally based on observations made throughout his career: “one may 
often distinguish a prodromal stage during which the patient tends to have some 
difficulty in concentrating and thinking clearly; feels restless and anxious; and may 
complain of irritability, fatigue, malaise, hypersensitivity to lights and sounds, 
drowsiness, insomnia, vivid dreams and nightmares, and even transient illusions and 
hallucinations.”(154)  
 
Moreover, our findings resonate well with those of other prodromal studies. Firstly, 
we found irritability to be predictive of imminent delirium. Duppils and colleagues 
found that signs of irritation / aggression / suspiciousness was slightly more common 
in patients with impending delirium (24%) compared with controls (12%) (161). In a 
study of Bone Marrow Transplant (BMT) patients, Fann and co-workers found using 
the 30-item Profile of Mood States that negative emotions such as tension-anxiety, 
depression-dejection, anger-hostility, fatigue-inertia and confusion-bewilderment 
subscale scores began an upward trajectory from approximately five days prior to 
onset of a delirium episode, peaking at day three to five post-delirium onset (157). 
Secondly, we found that patients with impending delirium were significantly more 
likely to be considered easily distractable or to be going ‘off-track’, an informal 
description of inattention. This characteristic has emerged as a prodromal feature in 
many studies and case studies. De Jonghe and colleagues found that poor 
concentration measured by the digit span was common in the prodromal phase, 
occurring in 67.3% of delirious patients two days before delirium onset and in 81.8% 
of patients on the day before delirium occurred (155). In Levkoff and colleagues’ 
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cohort of older hospitalised patients, 25.4% had either inattention or distractability 
in the delirium prodrome (159), and in two studies of BMT patients, decreasing 
attention span was demonstrated in the prodromal period before delirium onset 
compared to controls (157, 158). Crammer, in his self-report of a delirium 
experience, recounts an apparent decline in his awareness of the environment at 
least 24 hours prior to delirium onset (162). Disruption in the sleep-wake cycle has 
been identified as a feature of the delirium prodrome. In Levkoff’s cohort of older 
medical inpatients, approximately one-quarter of prodromal patients experienced 
circadian disruption, including difficulty getting to sleep at night, being awake at 
night and sleepy during the day, similar to our findings (159). Again, our findings of 
hyperactive features in the prodromal phase compares well to the findings of Levkoff 
and co-workers, where 54% of patients who went on to develop delirium had 
notable psychomotor change, predominantly hyperactivity, in the preceding days. 
Increased psychomotor activity has also been described in prodromal hip fracture 
(156, 161) and in coronary care patients (165). 
 
By including ‘increasing confusion or fogginess’, we were attempting to capture not 
just an obvious change in cognitive state but also the vagueness or disengagement 
that is commonly perceived but difficult to specify in patients with delirium or 
impending delirium. Carers or other untrained observers sometimes remark that the 
patient is ‘not themselves’, which may refer to this vague state. Although other 
studies have objectively demonstrated cognitive decline in various domains prior to 
delirium onset (156-158), no other study has alluded to this subtle manifestation of 
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brain dysfunction as a potential component of the prodromal phase. The item 
‘needing prompting for usual tasks’ was intended to detect the poor motivation 
particularly associated with hypoactive delirium but also sometimes evident in 
hyperactive presentations, however again, this item has not previously been 
specifically investigated. None of the somatic features or general complaints in 
domain A of the prodromal checklist were significantly associated with delirium 
emergence in this cohort. This may be explained in part by the high comorbidity of 
the cohort overall (mean M-CIRS 20.56 ± 6.025), such that patients with and without 
delirium experienced these features or it may be that the items were too non-
specific to rate on a daily basis. Interestingly, none of the items from domain E 
(speech / talk disturbance) were endorsed as significantly predictive of impending 
delirium, although previous studies have demonstrated disruptions in this domain 
during the delirium prodrome (155, 156), using versions of the DRS-R98 to detect 
these changes. Of note, Duppils and Wikblad, using similar observational methods to 
us, did not find an increase in incoherent speech in the pre-delirium stage (161).  
 
Hence, our results indicate a specific prodromal profile in older medical inpatients, 
however it remains unclear as to how these pre-delirium features relate to the 
phenomenology of the ensuing delirium episode. It is possible that the features we 
have outlined are attenuated delirium symptoms which increase in expression as 
delirium unfolds. Being ‘fidgety’, restless or wandering may be a precursor to motor 
agitation, as may irritability which could equally signal the onset of affective lability. 
Increasing confusion or ‘fogginess’ may relate to any of the cognitive features or 
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indeed abnormalities of language, thought process, perception or delusions. Being 
easily distractible or going ‘off-track’ as well as needing prompting for usual tasks 
may indicate a descent into more severe levels of inattention, whereas morning 
tiredness and daytime drowsiness may herald the onset of significant disturbances in 
sleep-wake cycle. Conversely, it may be that the prodromal symptoms evolve in a 
distinct way to those that eventually appear when delirium emerges. Another 
consideration is whether prodromal features differ depending on the underlying 
aetiology or treatment setting. If this were the case, delirium and prodromal 
screening may need to be tailored to specific patient groups. Future studies of 
delirium prodrome should explore these issues further.  
 
The strengths of this study include the prospective study design incorporating robust 
daily assessments for delirium by a trained and experienced delirium assessor. This 
together with daily documentation of individual symptoms from all available sources 
of information allowed us to carefully characterise the prodromal features of 
impending delirium in this large sample of older hospitalised medical patients. 
Another strength was the relatively large sample of patients with incident delirium 
and a comparison group of non-delirious patients. Most previous studies of 
prodromal features included less than 50 cases of delirium, and as low as ten cases 
in Matsushima’s study of coronary care patients. The exceptions include Levkoff and 
colleagues who reported on 91 cases of delirium in 325 older general medical and 
surgical inpatients and de Jonghe and co-workers who studied 101 hip fracture 
patients, of which 66 became delirious and were included in the analysis. Other 
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studies of hip fracture patients included fewer delirium cases: in Duppils and 
Wikblad’s study, 32 of 103 patients developed delirium and in Lee and co-workers’ 
Korean cohort, 18 of 65 became delirious. In Fann and colleagues’ study of BMT 
patients, 45 of 90 participants developed delirium, while Beglinger and coworkers 
reported delirium in 19 of 54 patients. We studied 61 cases of delirium and 130 
controls which compares well with previous studies of this phenomenon. Analyses 
were adjusted for the significant baseline predictors of delirium in this cohort (i.e. 
pre-morbid dementia, comorbidity and functional status), thus allowing us to deduce 
that the identified features were aspects of the prodrome rather than reflective of 
other impairments.  
 
Despite the methodological strengths, this study does have some important 
limitations. Firstly, the sample was non-consecutive, as with a single delirium 
assessor, it would have been unfeasible to assess consecutive patients in the 
longitudinal fashion required for the study’s robustness. Secondly, although the 
prodromal checklist has face validity given its broad coverage of potential prodromal 
symptoms, the validity or reliability of the caregiver and nursing reports used to 
score the items has not been estimated. Of the 191 patients included in the analysis, 
61 (31.9%) developed incident delirium. This is not reflective of a true incidence rate 
however, as many initially included patients were excluded from analysis for various 
reasons, including discharge within 3 days (n=88) and withdrawal (often with up to 
five assessments already performed, n=36). If the denominator includes these 
patients (n=315), the incidence of delirium in this cohort is approximately 19.4%, 
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which concurs with the existing literature on the subject. A systematic review of 
delirium epidemiology in medical inpatients (197) describes incidence rates varying 
between 3% and 29%, depending on the frequency of assessment. In the studies 
which report lower incidence rates (i.e. 3% to 11%), the frequency of assessment is 
either unclear or prompted by clinical need, or in one study, performed every 48 
hours, whereas the majority of studies reporting higher incidence rates (12%-29%), 
utilised at least daily delirium assessment.  
 
Delirium is challenging to detect, and diagnosis not only depends on face-to-face 
interview and observation, but also on the detail and accuracy of the collateral 
history made available to the assessor. It is thus possible that in some cases the 
prodromal phase was actually representative of a missed early diagnosis of delirium. 
Equally, more frequent delirium assessments may have perhaps identified symptoms 
and fluctuations more accurately. However, given the withdrawal rate of 11.2% (36 / 
322), most commonly due to the duration and cognitive content of the assessment, 
performing more frequent assessments is unlikely to have been feasible. 
Furthermore, the delirium assessor was thorough in searching for evidence of 
delirium by interviewing at least one nursing staff member for each patient on a 
daily basis and by frequently checking the medical and nursing notes for 
documentation of delirium or a proxy term (e.g. confusion, agitation, withdrawal). 
Hence, we believe that delirium was diagnosed as early as was clinically possible 
within the confines of the study and that the features described in our results are 
indeed characteristics of the delirium prodrome. 
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Despite the study limitations, our results have illuminated clinically identifiable 
characteristics which herald the onset of delirium. Recognition of such harbingers of 
delirium in older medical inpatients may facilitate earlier detection and prompt 
intervention, and hence being alert to the prodromal features of delirium in this 
vulnerable inpatient group is important. It is well-recognised that in older medical 
patients admitted acutely, a thorough collateral history from a close family member 
or caregiver should be taken, particularly if there is evidence of impaired cognition, 
in order to identify the context of this impairment and establish whether it is due to 
prevalent full- or subsyndromal delirium, or a more chronic progressive decline. We 
propose that this collateral history should also include the seven prodromal features 
identified in this study to progress our efforts at delirium detection towards 
identifying those who are en route to developing the condition over the ensuing 
days. Following admission, monitoring for these features should also be undertaken 
on a daily basis by staff members (see figure 11 for a suggested approach). It is clear 
from the existing evidence that delirium prevention has the most significant impact 
on reducing the burden of delirium in the long-term (7), however it is yet to be 
ascertained if utilising delirium intervention strategies in the prodromal phase can 
actually prevent delirium or improve the prognosis. One study in post-cardiotomy 
patients indicates that antipsychotic prophylaxis in prodromal SSD may reduce the 
incidence of delirium (73), although results from a recent study in medical and 
surgical ICU patients disputes this (242). Furthermore, the effect of intervention in 
this stage on long-term patient outcomes has not yet been studied. Hence, further 
studies of this nature are required to definitively answer if these early changes 
present an opportunity for meaningful pharmaco-prophylaxis.  
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In summary, our study highlights that delirium in older medical inpatients is 
significantly associated with a variety of prodromal features which predict its onset 
and are clinically identifiable. Actively seeking out evidence of these features is likely 
to improve delirium identification rates and may lead to targeted preventive 








Figure 10: Prodromal Checklist 
 (0 = not present; 1 = possibly or somewhat present; 2 = definitely present) 
Prodromal Checklist 
A. General complaints. 
In the last 24 hours, have you noticed any changes in the patient’s 
general wellbeing? 
1. Appetite   
2. Pattern of pain / discomfort    
3. Frequency of requests for analgesia   
4. Frequency of help seeking OR calling for attention 
5. Other non-specific changes (e.g. general malaise,  ‘not themselves’) 
6. Does the patient have nocturnal worsening of symptoms? 
 
B. Affect / emotional changes. 
In the last 24 hours, have you noticed any changes in the patient’s mood? 
1. Tearfulness / sadness 
2. Irritable / grumpy 
3. Fear 
4. Excess anxiety or worry 
5. Inappropriate elation or euphoria   
6. Excess remorse or guilt  
 
C. Demeanour or cognitive changes 
In the last 24 hours, have you noticed any changes in the patient’s ….. 
1. Awareness of surroundings or situation?   
2. Being apathetic or disinterested?   
3. Being easily distractible or going ‘off-track’?  
4. Level of confusion or ‘fogginess’?   
5. Needing prompting / encouragement to do usual tasks? 
 
0/1/2 D. Sleep/ activity changes 
In the last 24 hours, have you noticed any changes in the patient’s sleep / 
activity? 
1. Poor sleep pattern at night (max 2)  
1-3 hours awake   (1)  >3 hours awake   (2)      Nightmares    (1) 
Difficulty getting to sleep (>30 minutes)   (1)   
Seems to be tired in the morning    (1) 
2. Drowsiness during the day  
some of the time   (1)  a lot of the time   (2)  
3. Being ‘fidgety’, restless or wandering    
4. Being combative or resisting care   
5. Being less active than usual / expected   
6. Slower movements     
7. Does the patient SHIFT suddenly from low to high activity or vice versa? 
Over minutes  (2)  Over hours   (1)  
8. Does the patient SHIFT suddenly from wakefulness to drowsiness or vice 
versa  
Over minutes  (2) Over hours   (1) 
 
E. Speech/ Talk disturbance 
In the last 24 hours, have you noticed any changes in the patient’s 
conversation? 
1. Ability to find the right words or name things properly?  
2. Understanding you   
3. Holding a conversation   
4. Saying odd things that don’t make sense  
5. Rambling off the point   









Table 19: Cox Proportional Hazards model. Prodromal features significantly associated with impending delirium 
Most parsimonious model, Log likelihood -425.744., HR = Hazard ratio; SE = Standard error, CI = Confidence interval.  
The final model excluded Modified Cumulative Illness Rating Scale as the best model fit was achieved without it. 
Variable HR 95% CI (HR) SE p value 
Premorbid Dementia 1.96 (1.25-3.07) 0.448 0.003 
Barthel Index Score (inverted) 1.08 (1.04-1.12) 0.023 <0.001 
Increased confusion / ‘fogginess’ 2.28 (1.4-3.72) 0.568 0.001 
Distractibility 1.89 (1.11-3.21) 0.511 0.018 
Needing prompting for usual tasks 1.86 (1.1-3.14) 0.497 0.021 
Tired in the morning 1.77 (1.12-2.81) 0.417 0.015 
Drowsy during the day 1.74 (1.12-2.71) 0.392 0.014 
Restlessness 1.72 (1.08-2.75) 0.412 0.023 




Figure 11: A suggested approach towards monitoring for prodromal features 
+ 
It is important to monitor regularly for evidence of delirium, but here I describe only monitoring for 
prodromal features 
Collateral History on admission:  
1. Has X been more confused lately or do their thoughts seem a bit ‘foggier’? Yes / no 
2. Has X been more easily distracted recently or seem to go ‘off track’ when interacting with 
you? 
Yes / no 
3. Has X needed more prompting or encouragement to do things that he / she would 
usually do? 
Yes / no 
4. Has X seemed more tired than usual in the morning recently? Yes / no 
5. Has X been drowsy at points during the day recently? Yes / no 
6. Has X been more ‘fidgety’, restless or been wandering recently? Yes / no 
7. Has X been more irritable or grumpy than usual recently? Yes / no 
Positive answers to any of the above should alert you to the possibility of prevalent or emerging  
delirium and the patient should be reviewed by an appropriately qualified doctor 
Monitoring on the ward+ 
















1. Thoughts appear ‘foggy’ or ‘confused’         
2. Easily distractable or goes ‘off-track’ when interacting        
3. Needs more prompting or encouragement than usual for 
ADLs / eating / drinking / other tasks 
       
4. More tired in the morning than before        
5. Drowsy at times during the day        
6. Fidgeting, restless or wandering on the ward        
7. Increased irritability or grumpiness        
Positive answers to any of the above should alert you to the possibility of prevalent or emerging  
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Delirium is a serious acute neuropsychiatric syndrome which occurs commonly 
across the hospital setting (1), especially in older inpatients (2). It is independently 
associated with multiple adverse consequences, such as functional and cognitive 
decline, institutionalisation and mortality (3), outcomes which are exacerbated by 
late or missed diagnosis. Gonzalez and colleagues found an 11% increase in mortality 
with every additional 48 hours of delirium in a cohort of acutely unwell older adults, 
(18) and Kakuma and co-workers (19) reported a significant increase in six-month 
mortality in older patients discharged from the ED with undetected delirium, 
compared to those in whom a diagnosis of delirium had been made. Despite this, 
case identification remains low in clinical settings, with as many as 75% of cases 
unrecognised in the emergency department (ED) (23) and up to two-thirds missed or 
misdiagnosed on the wards (202).  
 
 193 
Delirium presents with a constellation of symptoms which vary from patient to 
patient and fluctuate over the course of the day. Hence, making an accurate 
diagnosis requires training, experience, and time as well as a detailed collateral 
history from an informant. In order to improve detection, it is now generally 
recognised that a two-stage process should be employed: routine screening for core 
delirium features using a quick, simple test, with subsequent expert formal 
assessment in those who screen positive. As yet, there is no consensus as to which 
screening method is best, although there is some evidence to suggest that tests of 
attention may be useful (105, 108). Although the benefits of early detection should 
not be underestimated, it is important to highlight that as with most clinical 
conditions, prevention of delirium is prognostically better than cure, with 
multifaceted prevention programmes impacting most successfully on the long-term 
burden of delirium. These programmes, by recognising delirium-proneness, and by 
utilising a systemised approach to risk factor modification, have been shown to 
reduce delirium incidence by over one-third (7, 243, 244) and also to attenuate 
delirium-related mortality (243).  
 
One of the core features for delirium diagnosis using any of the available diagnostic 
systems is acuity of onset, with symptoms typically developing over hours to days. 
There is growing evidence to suggest, however, that delirium can be preceded by a 
prodromal phase, which heralds its onset (10). This area has been under-researched 
to date, the small number of studies varying greatly both in primary study objectives 
and in methodology, including study population, measurements used and frequency 
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of assessment. Nonetheless, results from these studies (described below and in 
Chapter 2) indicate that the prodromal phase may comprise of some features of the 
delirium cluster, both cognitive and non-cognitive, as well as other somatic or 
emotional symptoms. The cognitive aspects of the prodrome vary from one study to 
the next, however the most commonly described features include impairments in 
attention and working memory, orientation, short-term memory and visuospatial 
function. Nonetheless, very few studies have used objective measures to 
characterise emerging cognitive deficits in the prodromal phase.  
 
The most detailed study to date of the cognitive characteristics of the delirium 
prodrome was conducted by Beglinger and colleagues in bone marrow transplant 
(BMT) patients (158). Participants were assessed at a pre-transplantation visit with a 
90-minute screening battery that included the Modified MMSE (3MS); Trail-Making 
Tests Parts A and B (TMT A, TMT B); the Repeatable Battery for the Assessment of 
Neuropsychological Status (RBANS); the Wechsler Abbreviated Scale of Intelligence 
(WASI); and a visual analogue scale of thinking clarity. Subsequently, while 
inpatients, delirium assessments were undertaken twice weekly for up to four weeks 
post-transplant or until discharge. At these points, a shorter cognitive test battery 
was used including TMT A, TMT B, 3MS and the List Learning, Coding, Fluency, List 
Recall, and List Recognition Subsets of the RBANS. The study included 19 BMT 
patients who developed incident delirium, 33 BMT patients who remained delirium-
free, as well as ten healthy control patients. Although there were no group 
differences at baseline, the groups began to diverge in the post-transplant period. In 
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general, the post-transplant patients showed some decline in cognition in 
comparison to healthy controls, but this was most pronounced in those who would 
go on to develop delirium. In these pre-delirious patients, initially a significant 
decline in List Learning and List Recall was noted, followed by a considerable 
deterioration in TMT B, List Recall and Coding from the second-last visit to the last 
visit before delirium diagnosis. All cognitive domains deteriorated further in this 
group once delirium occurred, then varied over the subsequent ten days, yet did not 
return to their normative average during the course of the study. This suggests that 
the delirium prodrome in BMT patients is characterised by acquired deficits in 
attention, memory, visuomotor processing speed and learning. However, given the 
infrequent testing in this study, it is possible that some other prodromal features 
were overlooked. Another study in BMT patients found that prodromal cognitive 
impairments such as disorientation, memory decline and poor performance on the 
digit span, began several days prior to delirium onset and continued on an increasing 
trajectory for 7-10 days before resolving (157). De Jonghe and co-workers used the 
Revised Delirium Rating Scale (DRS-R98), Mini-Mental State Examination (MMSE) 
and the digit span daily to assess hip fracture patients for delirium development and 
found that the frequently observed cognitive symptoms before delirium onset were 
disorientation, difficulty concentrating and short and long-term memory impairment 
(155). Other studies have also explored the delirium prodrome by utilising delirium 
severity scales, however they did not report the results of the specific cognitive tests 
used to score individual items. Levkoff and colleagues, using the Delirium Symptom 
Interview (DSI) on a daily basis, found that disorientation and, to a lesser extent, 
inattention / distractability occurred relatively commonly prior to delirium onset in 
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older hospitalised patients (159). Using the Korean version of the DRS-R98, Lee and 
co-workers found that impairments in orientation, long and short-term memory and 
visuospatial function began to emerge up to four days before delirium diagnosis in a 
cohort of hip fracture patients. Prodromal disorientation was similarly noted in 
Duppils and Wikblad’s cohort of hip fracture patients (161) using subjective ratings 
of behavioural change. 
 
Thus, although it is likely that the delirium prodrome includes new deterioration in 
attention, orientation, memory and visuospatial function as well as other cognitive 
domains, it remains unclear as to how best to measure these prodromal features or 
indeed detect patients who are particularly vulnerable to delirium development over 
the ensuing days. Given that prevention, early identification and prompt, 
appropriate management of delirium is key to minimising the associated 
unfavourable outcomes, it is intuitive that the earlier patients are detected, the 
greater the opportunity for meaningful impact. Understanding how best to identify 
patients during this pre-delirium phase may help to facilitate the development of 
targeted prevention and intervention strategies. Hence, the aim of this study was to 
identify cognitive tests which can be used to detect the prodrome to delirium in 






8.2.1. SETTING AND PARTICIPANTS 
This was a prospective observational cohort study conducted in two hospitals in Cork 
city, Ireland (Cork University Hospital and Mercy University Hospital) between 
October 2011 and August 2013. The study’s procedures are described in detail in 
Chapter 3. In brief, patients ≥70 years of age admitted medically without prevalent 
delirium on initial screening were eligible for inclusion. Patients who refused, who 
were terminally unwell, or admitted to ICU, and those with severe communication 
difficulties or coma were also excluded. Informed consent was sought from eligible 
patients and those who consented underwent daily delirium assessment for at least 
seven days or until discharge. If patients were discharged early without delirium (≤ 3 
days of admission), we were unable to confidently outrule an emerging delirium 
post-discharge, and so these patients were excluded from the analysis. 
 
8.2.2. ASSESSMENTS  
8.2.2.1. Delirium 
A trained delirium assessor (NO’R) performed all delirium assessments using the 
Revised Delirium Rating Scale (DRS-R98). This is a 16-item diagnostically precise scale 
comprising 13 severity items (rated from 0 to 3) and 3 diagnostic items (rated from 0 
to 2 or 3), giving a cumulative score range of 0 to 46. It has been shown to have high 
inter-rater reliability, validity, sensitivity and specificity for discriminating delirium 
from other neuropsychiatric diagnoses (90, 205) It can also be used to evaluate 
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symptom severity over the previous 24-hour period and hence can be used to 
describe delirium phenomenology as it evolves. In this study, delirium was diagnosed 
using a cut-off of ≥15 on the severity scale and / or ≥18 using the total score, in 
keeping with the guidelines for its use (173). 
 
8.2.2.2. Cognitive testing 
Included patients underwent daily cognitive tests in addition to delirium assessment. 
Because previous studies have indicated that the prodrome to delirium includes 
impairments in attention, orientation, short-term memory and visuospatial function, 
we focused on these domains, and employed tests that would be short and quick so 
that they would remain acceptable to the participants on a daily basis.  
 
Six-item Cognitive Impairment Test (6-CIT) 
The 6-CIT was our primary test as it encompasses three of the four target domains: 
orientation (to year, month and time of day), attention (twenty to one; months of 
the year backwards - MOTYB) and short-term recall (a five-item name and address), 
see figure 12 and appendix A. The 6-CIT was originally developed by Katzman and 
colleagues (113) as a screening test for dementia by abridging Blessed’s Mental 
Status Test (114) and is also known as the Six-item Orientation-Memory-
Concentration Test, the Short Orientation-Memory-Concentration Test and the Short 
Blessed Test. It is scored out of twenty-eight with higher scores indicating greater 
degree of impairment. It has a broad spectrum of use, including dementia screening 
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in primary care (115); cognitive screening in the acute setting (116); in Alzheimer’s 
research (117, 118); and in large population-based studies (119). To date, there have 
been no published studies of its diagnostic accuracy in screening for delirium, 
however it is quick, requires minimal training and has been shown to be acceptable 
by nursing staff when used as a cognitive screening test (127). In this study, alternate 
forms of the 5-item name and address were used so that a patient was never given 
the same item to recall twice, see appendix A. 
 
Attention tests 
Inattention is the cardinal feature of delirium and the most prominent cognitive 
feature to emerge from studies of the prodrome, however it is unclear as to how 
attention should best be assessed (245). A recent review by Tieges et al (108) 
concluded that although attention tests show potential in delirium screening, there 
is limited evidence as to which test is most suitable. A previous study published by 
our group showed that MOTYB was sensitive in screening for delirium in older 
inpatients; however in younger cohorts or in those with pre-existing dementia, it 
required supplementation with other tests (105). As aforementioned, the MOTYB is 
a component of the 6-CIT. In the 6-CIT, MOTYB is scored based on the number of 
errors, so that no errors scores 0; 1 error scores 2; and 2 or more errors scores 4. For 
consistency with our previous work (105), we additionally scored MOTYB separately 
using a dichotomous scoring method: patients recited the months of the year 
backwards starting with December, getting back as far as July without error in order 
to pass (MOTYB-July). Counting backwards from twenty to one (20-1) is another 
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element of the 6-CIT which measures attention. It is scored similarly to the 6-CIT 
scoring of MOTYB. It is generally considered less cognitively challenging than MOTYB, 
but has not previously been studied specifically for delirium screening.  
 
In addition to MOTYB and counting backwards from 20 to 1, we assessed attention 
using the Spatial Span Forwards (SSF), which is a visual measure of attention span 
based on the digit span forwards (111). Performance on the SSF has been shown to 
differentiate delirium from dementia (110, 246). The test is performed using an A5-
sized section of white card depicting eight red squares (measuring 1.5cm2 each) 
configured three / two / three over three rows. Pre-set sequences are tapped out for 
the patients to replicate, beginning with a sequence of two squares up to a 
maximum sequence of seven. Generally, subjects who are unable to accurately 
repeat a sequence of five squares are considered to have failed the test.  
 
Visuospatial Function 
Because visuospatial function is not represented in the 6-CIT, we also performed a 
verbal test of visuospatial ability during longitudinal assessments. Patients were 
asked a series of five questions (Environmental Visuospatial Questions, EVSQ) on a 
daily basis (see figure 12 and appendix A) and were then scored according to the 
number of correct answers, with higher scores indicating less impairment. The 
questions were varied from day to day to attempt to allow for learning effect. We 
also included the clock-drawing test (CDT) and interlocking pentagons (IPT) in our 
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assessment, however, many patients were not keen to perform this on a daily basis. 
Approximately one-third of all assessments had missing data for the CDT and / or 
IPT, and hence we do not report these results here.  
 
8.2.2.3. Baseline data 
Information pertaining to demographics and social history (including marital status; 
place of residence; alcohol and smoking history; and educational attainment) was 
gathered; the Modified Cumulative Illness Rating Scale (M-CIRS) was used to 
measure burden of comorbidity; and medication history was recorded. Functional 
status (Modified Barthel Index, BI) and nutritional status (Mini-Nutritional 
Assessment - Short Form, MNA-SF) were assessed and simple bedside screening for 
sensory impairment was performed. The ABCDS (AB Clinician Depression Screen), a 
modified version of the Geriatric Depression Scale, was used to screen for 
depression. 
 
8.2.2.4. Assessment of previous cognitive status 
Although all patients underwent SMMSE (Standardised Mini Mental State 
Examination) testing at baseline, this test was not used to diagnose pre-existing 
dementia. Poor performance on cognitive tests in this setting can be due to delirium, 
sub-syndromal delirium or acute illness, and hence non-specific in the detection of 
premorbid dementia. Instead, each patient’s medical chart was reviewed for 
documentation of prior cognitive impairment or dementia by an appropriately 
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trained clinician. Subsequently, diagnosis was confirmed by using the Informant 
Questionnaire on Cognitive Decline in the Elderly Short-Form (IQCODE-SF), a 16-item 
scale scored by a caregiver or close relative which has been validated as a screening 
test for dementia. We used a mean item cut-off score of ≥3.5 to diagnose dementia 
(193). In borderline cases, consensus discussion (ST, DM) using all available 
information was used to establish dementia status. Where collateral history / 
IQCODE-SF / previous diagnosis were unavailable, patients were deemed not to have 
dementia if they scored ≥27 / 30 on SMMSE as precedented in other studies (192), 
however in those with SMMSE scores < 27 / 30, premorbid cognition was uncertain 
in the absence of collateral history (n=2).  
 
8.2.3. ETHICAL PROCEDURES 
The study objectives and procedures were explained verbally and in writing to all 
patients. However due to cognitive impairment at study entry, it was presumed that 
many subjects were not capable of giving informed written consent. Therefore, as in 
former similar studies, informed consent was taken from competent patients and 
assent to participation was sought from those who were incapacitated, as well as 
approval from a nearest relative or carer. Formal ethical approval was granted by 
Cork Research Ethics Committee and due to the non-invasive nature of the study, 
ethics committee approval was granted to supplement patient assent with proxy 
consent from next of kin (where possible) or a responsible caregiver, as above, in 
accordance with the Helsinki Guidelines for Medical Research involving human 
subjects (207).  
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8.2.4. STATISTICAL ANALYSES 
A Cox proportional hazards model was used to assess the associations between 
prodromal cognitive features and the development of incident delirium, defined as 
above. From previous analysis (Chapter 5, table 12), we know that in this cohort 
significant independent baseline predictors of incident delirium were comorbidity, 
functional status and pre-existing dementia and hence, all models were adjusted for 
these predictor variables, as well as age and sex. Log likelihood was used to assess 
model fit.  Confidence intervals of 95% were employed and are reported in the 
results. All longitudinal analyses were performed using Stata version 11.  
 
8.3. RESULTS 
A total of 191 patients were included in the analysis. The median age of the cohort 
was 80 (IQR 10), just over half (52.9%, n=101) were male and eight patients (4.2%) 
were admitted from nursing homes (see Chapter 5, figure 9 for a detailed description 
of flow of patients through the study and Chapter 5, table 10 for a report of baseline 
characteristics). Longitudinal analyses were performed using Stata version 11. We 
used Cox proportional hazards models (using Breslow method for ties), firstly to 
ascertain which cognitive tests predicted emergent delirium, and then to further 





8.3.1. PREDICTION OF IMPENDING DELIRIUM BY COGNITIVE TESTS 
Our initial model included the 6-CIT, MOTYB-July, SSF and EVSQ as well as sex, age, 
and the independent clinical predictors of incident delirium in the cohort, namely 
dementia status, Barthel Index (BI) and Modified Cumulative Illness Rating Scale (M-
CIRS). The latter three were included in the initial model as potential confounding 
variables. On evaluating the proportional hazards assumption using time dependent 
covariates, we found that MOTYB-July, SSF and 6-CIT varied with time and hence we 
proceeded with our analysis using an extended Cox model. Of note, during our 
assumptions evaluation, we also found that M-CIRS varied with time. As this is a 
baseline feature and was only measured once, we opted to exclude it from the 
model. Subsequently, a step-wise approach was used to achieve the most 
parsimonious model, removing the most non-significant variable at each step and 
monitoring for changes in model fit using the AIC (Akaike Information Criterion). The 
final model is illustrated in table 20. Significant cognitive predictors of impending 
delirium within a week of admission were impairments on the 6-CIT, (Hazard Ratio, 
HR 1.03 per one unit increase (= disimprovement) in score, 95% CI 1.01-1.05, 
p=0.002); MOTYB-July, (HR 0.71 for passing the test, 95% CI 0.55-0.90, p= 0.006) and 
EVSQ (HR 0.68 for one unit increase (= improvement) in score, 95% CI 0.48-0.97, 





8.3.2. PREDICTION OF IMPENDING DELIRIUM BY COGNITIVE IMPAIRMENT AT DOMAIN 
LEVEL 
In the second analysis, we looked at the respective domains of the 6-CIT, as well as 
the other individual tests to investigate which cognitive domains in particular 
became impaired in the delirium prodrome. Our initial model included all items on 
the 6-CIT, SSF score and EVSQ score. Of note, because in previous studies we have 
used the MOTYB-July method of scoring MOTYB (i.e. ability to get to July without 
error) we included this method, rather than the method employed in the 6-CIT 
(number of errors). Additionally, as before, we included the other important 
variables (sex, age, dementia, functional status and comorbidity), see table 21. An 
extended Cox model was used as some of the covariates violated the Cox 
assumption of proportionality. We used robust estimation to allow for 
autocorrelations between assessments, and a similar approach as in our first analysis 
to arrive at the most parsimonious model, see table 22. This shows that the items 
from our assessments which predicted the onset of incident delirium within a week 
of admission were:  
 Orientation to month (HR 0.78 for a correct answer, 95% CI 0.63-0.97, p=0.024);  
 SSF score (HR 0.93 for each unit increase (= improvement) in score, 95% CI 0.87-
0.98, p=0.015);  
 MOTYB-July (HR 0.68 for a correct answer, 95% CI 0.54-0.86, p=0.001);  
 20-1 (HR 1.14 for each unit increase (= disimprovement) in score, 95% CI 1.05-
1.24, p= 0.002);  
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 Recall of 5-item address (HR 1.08 for each unit increase (= disimprovement) in 
score, 95% CI 1.01-1.16, p=0.017);  
 EVSQ score (HR 0.65 for each unit increase (= improvement) in score, 95% CI 0.48-
0.9, p=0.009). 
To summarise, orientation, attention, short-term memory and visuospatial function 
are disturbed in the prodrome to delirium.  
 
8.4. DISCUSSION 
This study of 191 older medical inpatients aimed to characterise the cognitive 
aspects of the delirium prodrome. We performed daily assessments for delirium, as 
well as a battery of carefully selected short cognitive tests to investigate for evidence 
of a cognitive prodrome to delirium. These tests assessed cognitive domains that 
were a priori hypothesised to be disrupted during the delirium prodrome, based on 
the existing literature, i.e. attention, orientation, short-term memory and 
visuospatial function. Our data is consistent with this hypothesis, in that 
impairments in these domains predicted onset of delirium in our cohort.  
 
Our findings compare well with those of previous studies of the delirium prodrome. 
Beglinger and colleagues found that patients with impending delirium began to 
perform more poorly on almost all assessments up to two visits before delirium 
onset, namely TMT A and B, List Recall, and Coding, highlighting that there was 
evidence of impairments in attention, working memory, psychomotor speed and 
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scanning in the prodromal phase (158). Our study highlighted that deficits in 
attention tests such as MOTYB, 20-1 and SSF were notable during the prodrome. The 
SSF, a visual version of the digit span forwards, assesses attention span but also 
requires intact working memory for visual material. The results of Beglinger and 
colleagues are reflective of the view that, although attention is the most markedly 
disturbed domain in delirium, multifactorial cognitive dysfunction is also central to 
presentation. Interestingly, the authors noted a practice effect on all tests for the 
healthy controls. Although the delirium patients did not reach their pre-study 
normative average values during the study time, all BMT patients, delirious and non-
delirious, had improving performance of immediate and delayed recall over time, 
suggesting that this was the most recoverable domain in this cohort. Fann and co-
workers also found that several prodromal features started to emerge prior to 
delirium onset in BMT patients, namely attention; perceptual disturbance; cognition; 
and evidence of fluctuations (157). The authors suggested that clinicians should not 
rely on more easily recognisable delirium features symptoms, such as agitation, 
psychosis or disorientation as it is the more subtle features, for example impaired 
attention and working memory, which occur first and more often and may be more 
useful in screening. De Jonghe and colleagues reported very similar findings to ours 
in their cohort of hip fracture patients (155). They found that cognitive features 
occurred significantly more frequently in the prodromal phase than in control 
patients. Disorientation and long-term memory impairment occurred as early as 
three days prior to full delirium onset, with short-term memory and inattention 
occurring two days pre-delirium. Other features which occurred in this prodrome in 
older hip fracture patients included incoherence of speech and an underlying 
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somatic illness. Franco and co-workers found in a cohort of older medical inpatients 
that MMSE score on admission predicted risk for delirium development by showing 
that for each unit decline on the MMSE on admission, the odds for delirium 
increased by 0.164 (247). There are well-recognised issues in using a cognitive test in 
the acute setting to ascertain pre-morbid dementia status, due to the potential for 
confounding by delirium, subsyndromal delirium and acute illness. Nonetheless, this 
MMSE score was considered by the authors to be reflective of pre-existing cognitive 
impairment for two reasons. Firstly, prevalent delirium on admission was outruled 
using the Columbian version of the CAM, although given the highly variable 
diagnostic accuracy of the CAM (105), it is possible that some prevalent cases and 
some subsyndromal patients were missed using this method. Secondly, the features 
of the baseline MMSE which subsequently most significantly distinguished the 
delirium vulnerable from the control group were orientation, delayed recall, 
comprehension, writing and visuoconstructional ability. Mean score on attention / 
calculation did not differ significantly between the two groups. Given the 
predominance of attentional disturbance in delirium and most likely its prodrome, 
these results support their view that the impairments on the baseline MMSE were 
less likely to be reflective of prevalent delirium. 
 
In our study, we used assessments which were chosen based on findings from 
previous studies of the delirium prodrome, and hence concentrated on measuring 
attention, orientation, short-term memory and visuospatial ability. These domains 
are four of the most frequently affected domains in delirium (42) and so it makes 
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sense that they would also be impaired in the prodromal phase. We chose the 6-CIT 
because it encompasses three of our four proposed prodromal features. It has been 
found to correlate well with the MMSE (r2=- 0.82to -0.926) (115, 116, 120-123), but 
is shorter in duration, taking only 2 to 3 minutes to perform. It is less culturally 
biased (124), and less affected by level of education than the MMSE (122). The 6-CIT 
has other advantages over other tests in that it doesn’t require any equipment and it 
lacks the potential for interpretive error that other tests such as interlocking 
pentagons and clock-drawing may have (122). As it is a completely verbal test, it can 
also be used in the visually impaired (125). Studies have shown high acceptability 
among nursing staff (127), and that scoring accuracy is higher than for the MMSE 
(126). It is easily translatable into other languages (122) and importantly, where 
serial testing is required, no significant learning effect has been demonstrated (123). 
As is the case with other cognitive tests, such as the MMSE (129), scores on the 6-CIT 
are influenced by a patient’s age (123), so this must be considered when using the 
test in practice.  
 
Given the predominance of inattention over deficits in other domains during a 
delirium episode, we elected to measure attention using multiple methods. The 6-
CIT incorporates two tests of attention, namely the MOTYB and 20-1, however the 
scoring of the MOTYB as part of the 6-CIT is not consistent with previous work from 
our group. Hence, we also scored it using a second method for consistency (see 
figure 12). Additionally, we included the SSF as a third attention test. This test was 
chosen for two major reasons. Firstly, studies have indicated it to be sensitive in 
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delirium detection, and in distinguishing delirium from dementia (110, 246). 
Secondly, because it is non-verbal it may be used in patients with expressive 
dysphasia or other communication difficulties. Visuospatial function is not assessed 
using the 6-CIT, so we measured this separately using a series of questions designed 
to evaluate a patient’s perception of their immediate surroundings (see figure 12). 
This test was scored out of five and questions were varied on a daily basis, taking 
into account a patient’s visual status (not performed if blind; limited to large items at 
beside if impaired). We also used the clock-drawing test and interlocking pentagons, 
but many patients were unwilling to perform these tests every day, mainly due to 
the effort required to use pen and paper. Hence, although ideally we would have 
included these commonly used and validated tests in our analysis, we could not due 
to the large amount of missing longitudinal data (>one-third of assessments). 
Excluding these tests allowed us to include a greater number of participants in our 
final analysis.  
 
Our first analysis showed that the 6-CIT, together with MOTYB-July and EVSQ were 
significantly predictive of impending delirium. In our second analysis, concentrating 
on the individual cognitive domains from the 6-CIT, as well as the SSF and EVSQ, our 
best model showed that elements of all four tested domains were predictive of 
delirium onset. Orientation to month was a significant predictor of impending 
delirium, whereas orientation to year or time of day were not predictive on 
multivariable analysis. Most studies of delirium or prodrome in which disorientation 
is described do not specify which exact element of time is most affected. One study 
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of cognitive impairment conducted by O’Keeffe and co-workers in 262 hospitalised 
older adults, fifteen of whom had delirium (248), found that all delirious patients 
were disorientated to year and day of the month, fourteen were disorientated to 
time of day, and twelve misidentified the month or day of the week. Although 
disorientation is well-recognised in delirium, it is important to note that it has been 
shown to be the least frequently occurring cognitive feature, absent in almost one-
quarter of patients and of only mild severity in almost one-half (42), and hence 
larger studies would be required to thoroughly explore the nature of disorientation 
in delirium. Additionally, it is also possible that disorientation is an impairment that 
evolves somewhat from prodrome to full-syndromal delirium and hence prodromal 
disorientation may vary slightly from that which is found in the later delirious 
condition. Better descriptions of disorientation in prodromal studies would allow this 
to be assessed further. 
 
This study has many strengths. Firstly, delirium assessments were performed daily by 
an experienced clinician trained in delirium diagnosis. Secondly, most other studies 
of delirium prodrome included less than fifty delirium cases and so the 
comparatively large number of delirium cases (n=61) in our study is another strength 
of this work. Only 36 patients withdrew out of the 322 initially included, which 
shows that the cognitive tests used were largely acceptable to the patient cohort. 
Were we more strict about including objective pen-and-paper tests of visuospatial 
ability, we are likely to have had a much higher withdrawal rate. Dementia is one of 
the top differential diagnoses when assessing for delirium, and patients with 
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dementia are likely to have impairments on all of the cognitive tests we used to 
identify the delirium prodrome. However, we identified pre-morbid dementia using 
very robust methods and adjusted for its presence in the analysis. Thus, we are 
confident that our results are reflective of the delirium prodrome and not premorbid 
dementia.  
 
One of our study’s limitations is that for feasibility, given that delirium assessments 
were performed by a sole researcher, the sample was non-consecutive. Secondly, 
only a short battery of tests were performed daily. Again this was in order to ensure 
that the daily assessments were acceptable to participants. Additionally, we aimed 
to use tests that could be translated easily into clinical practice and so simplicity and 
short duration were important test characteristics. In studies such as this, capturing 
the onset and fluctuations of delirium is challenging unless assessments are 
performed very frequently. Once again, this must be balanced against study 
feasibility and what will be considered acceptable by the study cohort. We felt that 
the best balance would be achieved by daily assessment. Although our methodology 
and analysis attempted to capture a delirium prodrome occurring during the first 
week of admission, the majority of delirium cases transitioned into delirium on day 2 
(n=30), and so for these cases we were only able to capture a very short prodrome, 
highlighting the importance of prompt assessment. In this study, the vast majority of 
patients were assessed within 24 hours of presentation to the emergency 
department, and the rest assessed well within 36 hours. Early review is vital in future 
studies of delirium prodrome as delay may lead to either missed prodromal features 
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or potentially a missed case of incident delirium having transitioned from a 
prodromal state.  
 
This exploratory study illustrates that delirium onset can be predicted by 
impairments in attention, orientation, short-term memory and visuospatial function 
independent of underlying dementia, and indicates that the 6-CIT may be a useful 
test to identify those who are particularly vulnerable to developing delirium over the 
ensuing days. Although we cannot propose a 6-CIT cut-off that heralds the 
prodromal state, our results suggest that monitoring patients daily for a decline in 
performance on the 6-CIT, or one of the other short domain-specific tests, may 
facilitate very early detection of the pre-delirious patient. Whether or not 
intervention in this prodromal period can impact on delirium incidence has yet to be 
studied, however given that earlier detection and prompt intervention can improve 
outcomes, being alert to changes in the prodromal period may impact greatly on 





Figure 12: The Six-item Cognitive Impairment Test and other tests used in the study 
of cognitive prodrome 




 1. What year is it? Score 4 if incorrect 
 2. What month is it? Score 3 if incorrect 
 Repeat after me:  
“John / Smith / 42 / High Street / Bedford.” 
I want you to try to remember that name 
and address. I will ask you about it later. 
(not scored) 
 3. About what time is it? Score 3 if more than 1 hour wrong 
 4. Count backwards from 20 down to 1 Score 2 if one error 
Score 4 if two or more errors 
 5. Say the months of the year in reverse 
order, starting with December 
Score 2 if one error 
Score 4 if two or more errors 
 6. What was that name and address you 
repeated after me earlier? 
Score 2 for each error  
Maximum score 10 for 5 errors 
 Total score = ____/ 28 
 
 
B. The Months of the Year Backwards  
(MOTYB-July) 
 
Subject must get back as far as 
July without error in order to pass 
the test. 
 
C. Spatial Span Forwards 
(SSF, see appendix A) 
 
Subject must repeat sequences of 
squares of increasing difficulty 
tapped out by the examiner. 
Correctly repeating a sequence of 
5 squares is generally considered 
the criteria to pass the test.  
 
 
D. Environmental Visuospatial Questions 
(EVSQ) 
 
 1. Where is the toilet? 
2. Where is the nurses’ station? 
3. Where is the way out? 
4. Which is bigger, ……* or …….*? 
5. Which is closer to you, the window or 
the door? 
6. Which of my hands is closer to you? 
7. Which is taller, ….. *or ……*? 
8. Which is closer to you, ……* or …….*? 
 
Five of these questions were 
asked daily and the subject was 
given a mark for each correct 




*Objects in room or on bedside 





Table 20: Extended Cox model showing the cognitive tests which predicted incident 
delirium in the cohort 
Most parsimonious model showing hazard estimations, n=191. Breslow method for ties. Log 
pseudolikelihood= -175.58. AIC 359.16 
Cognitive Test  HR 95% CI (HR) sig. 
EVSQ score (per unit increase) 0.68 (0.48-0.97) 0.035 
6-CIT total score (per unit increase) 1.03 (1.01-1.05) 0.002 
MOTYB-July (passing the test) 0.71 (0.55-0.90) 0.006 
SSF score (per unit increase) 
 
0.94 (0.87-1.01) 0.076 
EVSQ = Environmental Visuospatial Questions Test (higher score means better cognition); 6-CIT = Six-
item Cognitive Impairment Test (higher score means worse cognition); MOTYB-July = Months of the 
Year Backwards scored so that a pass is getting back as far as July without error; SSF = Spatial Span 




Table 21: Covariates included in the initial Cox model investigating the individual 
cognitive items which predicted delirium onset in the cohort 
Domain Test item 
 
Orientation 1. What year is it? 
2. What month is it? 
3. What time of day is it (to nearest hour?) 
 
Short-term Recall The patient is given a 5-item name and address and 
asked to recall it after approximately 1-2 minutes 
 




Visuospatial Environmental Visuospatial Questions score  
(marked out of 5) 
 
 




Premorbid dementia status IQCODE-SF ± SMMSE ± Expert opinion:  combined 
into final Yes/No status 
 
Functional status on admission Barthel Index 
 
Comorbidity burden Modified Cumulative Illness Rating Scale 
 
MOTYB-July = Months of the Year Backwards scored so that a pass is getting back as far as July 
without error. 20-1 = counting backwards from twenty down to one, scored such that one error 
scores two points; two or more errors scores four points; SSF = Spatial Span Forwards; IQCODE-SF = 
Informant Questionnaire on Cognitive Decline in the Elderly – Short Form; SMMSE = Standardised 




Table 22: Extended Cox model showing the cognitive items which predicted 
incident delirium in the cohort 
Most parsimonious model showing hazard estimations, n=191. AIC 365.88. Breslow method for ties. 
Log pseudolikelihood= -176.94 
Test HR 95% CI (HR) sig. 
Orientation to month 0.78 (0.63-0.97) 0.024 
SSF score  0.93 (0.87-0.98) 0.015 
MOTYB-July  0.68 (0.54-0.86) 0.001 
20-1  1.14 (1.05-1.24) 0.002 
5-item address recall  1.08 (1.01-1.16) 0.017 
EVSQ score 0.65 (0.48-0.9) 0.009 
Orientation to month: Answers the question ‘What month is it?’ correctly. HR is for correct answer. 
SSF = Spatial Span Forwards, HR per unit increase. Higher score means better cognition, maximum =7. 
MOTYB-July = Months of the Year Backwards scored so that a pass is getting back as far as July 
without error. HR is for passing the test. 
20-1. HR per unit increase in errors (0= no errors; 1 = only one error; 2 = at least two errors)*  
5-item address recall. HR per unit increase in errors, maximum = 5 for greatest number of errors* 
EVSQ = Environmental Visuospatial Questions Test, HR per unit increase. Higher score means better 
cognition, maximum = 5. 
HR = Hazard Ratio; CI= Confidence Interval 
* For this analysis both 20-1 and 5-item recall was scored slightly differently than the scoring method 
used in the 6-CIT. In the 6-CIT each level of error scores 2 marks, whereas in this analysis each level of 
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9.1. INTRODUCTION 
Delirium is a complex neuropsychiatric syndrome which occurs in the setting of 
acute illness or injury. It is highly prevalent across treatment settings, occurring in 
one-fifth of hospitalised patients (1) and with higher frequency in older inpatients (2) 
and other vulnerable groups (12, 13). Delirium independently impacts adversely 
upon patient outcomes (3), yet it remains widely undetected or mistakenly labelled 
as dementia or depression (202). Unfortunately, although preventative strategies 
and early intervention can mitigate against the short- and long-term burden of 
delirium (6, 7), under-recognition exacerbates poor prognosis such that those who 
remain undiagnosed or are detected late have higher risk of mortality (18, 19, 77). 
One study found that for each additional 48 hours that delirium went undiagnosed, 
patient mortality rose by 11% (18). Hence, strategies that facilitate earlier delirium 




Although delirium is characteristically acute in onset, often occurring over hours or 
days, it is now well-recognised that some patients experience a prodromal phase 
(41). One of the earliest mentions of this pre-delirium stage can be found in 
Lipowski’s 1990 seminal work entitled ‘Delirium: Acute Confusional States’ (154), in 
which it is postulated that delirium is commonly preceded by a multitude of features 
including diminished clarity of thought processes, emotional lability, sleep-wake 
cycle disruption and a range of perceptual abnormalities. Latterly, there have been 
few studies exploring the features of the delirium prodrome and these have differed 
in methodology, populations studied and assessments used (see tables 1 and 2 in 
Chapter 2). Thus, the symptom profile and course of these prodromal features has 
yet to be fully appreciated, and like delirium itself, the prodrome can manifest a 
variety of phenomenological features. Some are recognised as part of the delirium 
spectrum, both cognitive and non-cognitive features (155), leading many to consider 
the prodromal phase to be conceptually akin to that of sub-syndromal delirium 
(155). The fact that many non-delirium elements occur in the pre-delirium phase 
also, for example somatic (167), behavioural (161) or emotional (157) features, 
disputes this categorisation. Nonetheless, identifying and defining the non-delirium 
elements of the prodromal phase is challenging, as these features are often less 
concrete than delirium features and are not defined in any related diagnostic 
classification systems. Examples of these features include general uneasiness (167); 
urgent calls for assistance (161); anxiety (164); dysphoria (169) and pain at varying 
sites (157, 165), but again, they vary from study to study for the reasons outlined 
above. Because delirium features have strongly anchored definitions and those 
trained in delirium assessment are confident and experienced in identifying these 
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features, the study of delirium symptoms in the prodromal phase is considered more 
accessible, and hence many prodromal studies have used delirium 
phenomenological instruments to explore the features of the prodromal phase. 
 
The first such report from Levkoff and colleagues (159) used the Delirium Symptom 
Interview (DSI), a structured interview based on DSM-III, to evaluate delirium 
features in 325 older medical and surgical patients, including those with dementia. A 
prodromal phase was identified in almost 70% of patients with imminent delirium, 
the mean duration being 2.7 days. Multiple DSI symptoms occurred in the prodrome, 
the most frequent being disorientation; speech abnormalities; sleep pattern 
disruption; changes in psychomotor activity; perceptual disturbances; difficulties 
with concentration; and fluctuating behaviour. Although the comparative 
frequencies of these symptoms in non-delirious patients were not reported, both 
disorientation and fluctuating behaviour at baseline significantly increased the odds 
of delirium development. In a prospective study of 90 bone marrow transplant 
(BMT) patients, Fann and colleagues performed factor analysis of delirium symptoms 
by combining items from the Delirium Rating Scale (DRS) and the Memorial Delirium 
Assessment Scale (MDAS) (157) and somewhat similar to other phenomenological 
work (43), a three-factor structure to delirium episodes was identified: psychosis-
behaviour; cognition; and mood-consciousness. Features from the former two 
factors preceded delirium onset by up to nine days, and in particular changes in 
attention, perception, cognition and fluctuations rose precipitously from about four 
days before delirium diagnosis. Assessments were conducted thrice weekly and, 
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again in this study, the presence or absence of features in non-delirious patients is 
not discussed. In another study of BMT patients, Beglinger and co-workers 
characterised the neuropsychological performance of 19 delirium patients before, 
during and after the episode compared to controls (33 post-transplant and 10 
healthy normal patients) (158). In the pre-delirium phase, performance in measures 
of attention; learning; psychomotor speed; and scanning began to decline up to one 
week prior to delirium onset indicating prodromal cognitive impairment. 
Additionally, investigators found that MDAS scores and Revised delirium Rating Scale 
(DRS-R98) severity and total scores were trending upwards in the visits before 
delirium was diagnosed. De Jonghe and colleagues studied the onset of DRS-R98 
features in older hip fracture patients at risk of delirium (155). The presence of 
incoherence; disorientation; poor concentration; and short- and long-term memory 
impairments significantly predicted impending delirium on logistic regression. There 
was also an increase in prevalence of perceptual abnormalities, fluctuations and 
acute onset of symptoms in the pre-delirious patients. Because this study was nested 
within a study of the treatment effect of haloperidol versus placebo, it is possible 
that results may have been confounded. However, in the trial no effect was found 
for treatment condition on delirium incidence nor on total DRS-R98 scores prior to 
delirium development. The most recent study to use a phenomenological tool to 
identify prodromal features was conducted by Lee and colleagues (156). This study 
of 65 hip surgery patients, 18 of whom developed delirium post-operatively, used 
the Korean version of the DRS-R98 (K-DRS-R98) to identify features which predict 
delirium onset and found that in the days prior to delirium development those with 
impending delirium scored significantly higher on several K-DRS-R98 items than 
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those who remained delirium-free. From three to four days prior to delirium 
emergence, abnormalities in sleep-wake cycle; thought process; orientation; long-
term memory; and lability of affect were observed and in the two days immediately 
before diagnosis, patients had more notable perceptual abnormalities; visuospatial 
dysfunction; delusions; motor agitation; and short-term memory impairment. They 
also noted that the K-DRS-R98 scores increased incrementally as delirium 
approached, whereas in controls K-DRS-R98 scores remained the same.  
 
Other studies have sought to identify delirium features in the prodromal period by 
utilising different methods. Duppils and Wikblad used a subjective observational 
approach to identify if behavioural changes were more prevalent in those developing 
delirium than those who were not and found that as well as an increase in attention-
seeking behaviour, there was a suggestion (although no formal evaluation was 
made), that certain delirium features occurred more frequently in the delirium 
destined group prior to diagnosis, namely increased psychomotor activity; reduced 
attention; and perceptual disturbances. In a study of long-term care patients, Voyer 
and co-workers used the Confusion Assessment Method (CAM) and an abridged 
version of the Mini-Mental State Examination (MMSE) on a weekly basis to identify 
that evidence of perceptual disturbances; disorganised thinking; and worsening 
registration was significantly associated with progression to delirium (160). Providing 
clarity as to the characteristics and course of this prodrome, both delirium and 
associated elements, may suggest strategies to prevent progression to full delirium, 
by facilitating appropriate and prompt intervention during a clinically identifiable 
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stage of delirium vulnerability. In previous chapters, we have discussed the 
behavioural and cognitive features of the delirium prodrome, many of which are not 
defined elements of the delirium syndrome. In this report, we aim to characterise 
the delirium-specific features that herald delirium onset.  
 
9.2. METHODS 
9.2.1. SETTING AND PARTICIPANTS 
This was a prospective observational cohort study conducted in two acute general 
hospitals in Cork city, Ireland (Cork University Hospital and the Mercy University 
Hospital) between October 2011 and August 2013. The study protocol and 
procedures are described in Chapter 3. In brief, patients of ≥70 years of age admitted 
medically through the emergency department were screened for study eligibility 
within 36 hours of admission (and usually within 24 hours). Patients with prevalent 
delirium on admission; those with severe communication problems limiting 
assessment, those who refused; and those who were comatose, gravely ill or dying 
were excluded. Eligible and consenting participants were assessed daily for delirium 
development for the next seven days or until discharged. Those discharged without 
delirium within three days of admission were excluded due to inability to confidently 
outrule incident delirium development post-discharge. Information relating to 
medical history, social history and previous history of depression was collected and 
patients were assessed for functional status, nutrition and sensory impairment (see 
Chapters 3 and 5 for details).  
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9.2.2. ASSESSMENTS  
9.2.2.1. Delirium 
Delirium assessments were performed on a daily basis by a trained delirium assessor 
(NO’R) using the Revised Delirium Rating Scale. This is a 16-item scale including 13 
severity items (rated from 0 to 3) and 3 diagnostic items (rated from 0 to 2 or 3), 
which together give a total possible score range of 0 to 46. This diagnostically precise 
instrument can be used to describe delirium phenomenology by evaluating breadth 
and severity of symptoms over the previous 24-hour period. It has high inter-rater 
reliability, validity, sensitivity and specificity for the diagnosis of delirium and in 
distinguishing it from other neuropsychiatric conditions including dementia and 
depression (90, 204, 205). In accordance with guidelines for its use (173), in this 
study delirium was diagnosed if the DRS-R98 severity score was ≥15 and / or if the 
total score was ≥18.  
 
9.2.2.2. Assessment of previous cognitive status 
A close relative or caregiver was interviewed using the Informant Questionnaire on 
Cognitive Decline in the Elderly Short-Form (IQCODE-SF), and a mean cut-off score of  
≥3.5 was used to diagnose dementia (193). Additionally, the medical notes were 
reviewed for documentation of a prior diagnosis of dementia by a suitably trained 
physician. Borderline cases were discussed and consensus opinion was used to apply 
diagnosis. In those with no available collateral history and no documented dementia 
diagnosis, a score of ≥ 27 / 30 on the SMMSE was considered normal. We were 
unable to definitively ascertain premorbid cognitive status in those with lower 
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SMMSE scores and no informant history, and hence in these patients premorbid 
cognition was determined as “unknown” (n=2).  
 
9.2.3. ETHICAL PROCEDURES 
Formal ethical approval was granted by the Clinical Research Ethics Committee of 
the Cork Teaching Hospitals. The details of ethical procedures are discussed in 
Chapter 3. In summary, informed consent was sought from those capable, however 
it was expected that many would not be competent to give informed consent and, 
hence, due to the non-invasive nature of the study, approval was granted to 
augment patient assent with proxy consent from next of kin or a responsible 
caregiver, in accordance with the Helsinki Guidelines for Medical Research involving 
human subjects (207).  
 
9.2.4. STATISTICAL ANALYSES 
Demographic data were expressed as means ± SD or medians and IQR, depending on 
the distribution of the data. Comparisons of groups (delirium, no delirium) were 
made using a χ2 or Fisher Exact test for differences in proportions, a t-test for 
differences in means or Mann Whitney U non-parametric tests for differences in 
mean ranks. Associations between prodromal DRS-R98 items and incident delirium 
were analysed using Cox proportional hazards models. The proportional hazards 
assumptions were tested using an extended Cox model with time-dependent 
covariates. Delirium was defined as a DRS-R98 severity score of ≥15 or a total score 
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of ≥18. Models were adjusted for comorbidity, functional status and cognitive status, 
as these were found to be independent predictors of incident delirium on 
multivariable logistic regression (Chapter 5). Sex and age were also included in the 
survival models. The AIC (Akaike Information Criterion) and log likelihood were used 
to assess model fit. Confidence intervals of 95% were utilised and are reported in the 
results. Recurrent event survival analyses were performed using Stata version 11.  
 
9.3. RESULTS 
A total of 555 patients were approached over the study period, and following 
exclusions according to the study protocol, 191 patients were included in the 
analysis (see Chapter 5, figure 9 for flow of patients through the study). The median 
age of the cohort was 80 (IQR 10), 52.9% (n=101) were male and 32 patients had 
pre-morbid dementia (see Chapter 5, table 10 for more detail on baseline 
characteristics). Cox proportional hazards models (using Breslow method for ties) 
were used to identify DRS-R98 features that predicted delirium onset. The first 
model included DRS-R98 items 1 to 15, as well as the independent baseline 
predictors of incident delirium from multivariable logistic regression analysis, namely 
M-CIRS (Modified Cumulative Illness Rating Scale), BI (Barthel Index) and pre-morbid 
dementia. We excluded DRS-R98 item 16 (physical disorder) from the analysis, as it 
simply scores the extent to which a physical condition is considered to account for 
symptoms and hence this item does not relate to delirium phenomenology. A step-
wise approach was used to arrive at the final model (see table 23). At each step, non-
significant variables were removed and changes in model fit were assessed by 
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monitoring the log pseudolikelihood and the AIC (Akaike Information Criterion). On 
assessing the proportional hazards assumption using time dependent covariates, we 
found that DRS-R98 items 2 (perceptual disturbances and hallucinations); 4 (lability 
of affect); 10 (attention); 14 (temporal onset of symptoms); and 15 (fluctuation of 
symptom severity) varied with time and, hence, we proceeded using an extended 
Cox model. Features which were most predictive of emerging delirium in the first 
week of admission were DRS-R98 items 1 (sleep-wake cycle disturbance, HR 1.48, 
95% CI 1.08-2.04, p=0.016); 2 (perceptual disturbances and hallucinations, HR 1.1, 
95% CI 1.03-1.17, p=0.006); 4 (lability of affect, HR 1.14, 95% CI 1.05-1.24, p=0.002); 
10 (attention, HR 1.32, 95% CI 1.23-1.42, p<0.001); 11 (short-term memory, HR 1.45, 
95% CI 1.18-1.78, p<0.001); 14 (temporal onset of symptoms, HR 1.34, 95% CI 1.22-




This study aimed to identify the delirium-specific features which predict the 
development of incident delirium in older medical inpatients, by assessing 
participants on a daily basis using the DRS-R98, a tool which is diagnostically precise 
and also characterises delirium phenomenology in detail. We found using recurrent 
event survival analysis, correcting for other factors that predicted delirium (co-
morbidity, function and pre-morbid dementia) that abnormalities in sleep-wake 
cycle; perception; attention; and short-term memory; as well as presence of 
affective lability; acute onset and increasing severity of symptom fluctuations were 
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all significantly predictive of delirium development in this cohort during the first 
week of admission.  
 
Our findings are generally consistent with results from existing studies in this area. 
The most consistent prodromal delirium feature across all the studies is inattention 
or poor concentration, followed by perceptual abnormalities; presence of 
fluctuations; memory impairment; and sleep-wake cycle disruption, all of which 
were identified in our study. Given that inattention is a cardinal feature of delirium, 
it is unsurprising that it should also feature prominently in the prodromal period. 
Another central feature for delirium diagnosis is evidence of fluctuation of symptom 
type and severity, and it is also interesting to note that this undulating clinical course 
predates the diagnosis of delirium in many patients. Abnormalities in sleep-wake 
cycle are also highly prevalent in delirium, occurring in 97% of delirium cases (42), 
however perceptual disturbances are evident in only approximately half, so their 
significance in the delirium prodrome across studies is an interesting observation. It 
may be that delirious patients who have disturbances in perception are more likely 
to have transitioned through a prodromal phase during the onset of delirium, 
however this needs further investigation.  
 
Although our study findings echo much of the existing literature, there are some 
features which have been shown in other studies to be reasonably prevalent in the 
prodromal phase that we did not find to be predictive of delirium development. Our 
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findings portray that lability of affect predicts delirium onset. The only other study to 
significantly identify this feature was the study of Korean hip surgery patients by Lee 
and colleagues (156), although in the report of Fann and co-workers (157), there 
appeared to be a very slight increase in lability up to five days before delirium onset. 
There was no evidence of prodromal affective lability in the study conducted by de 
Jonghe and colleagues (155), and other prodromal studies did not investigate for this 
feature. It is unclear why findings related to this feature are divergent, and cannot 
be explained by study population given that the results from both hip surgery 
cohorts differ. Other studies report on deficits in orientation; long-term memory and 
visuospatial ability in the prodromal period (155-157, 159), whereas this analysis did 
not produce these results. In a previous chapter, we reported more comprehensively 
on the cognitive elements of the delirium prodrome. We used serial bedside 
cognitive assessments (see Chapter 8) to ascertain the domains involved, and found 
that incident delirium could be predicted by impairments in orientation to month; 
attention; short-term memory and visuospatial function, similar to existing studies as 
above. In this analysis of DRS-R98 items, we found that only impairments in 
attention and short-term memory were significantly indicative of imminent delirium. 
It is likely that the bedside cognitive assessment tools were able to detect more 
subtle changes than the scores on the DRS-R98 items.  
 
Given the consistency with which delirium features have been shown in the pre-
delirium phase, despite the sparsity of studies and diversity between methodologies, 
it could be considered that this phase is purely a manifestation of subsyndromal 
 
 230 
delirium (SSD) which then evolves into the full-blown syndrome. Although there is no 
definite consensus as to the exact definition of SSD, it is widely accepted that the 
concept refers to the presence of delirium features in a patient who does not meet 
diagnostic criteria for full-blown delirium. SSD is often considered a natural point on 
the road between no delirium and delirium, however the temporal relationship 
between SSD and full-syndromal delirium is not fully understood and whether or not 
the SSD point can be bypassed during an episode is not clear. It has been postulated 
that SSD may occur as a precursor to delirium in the setting of a subacute delirium 
onset, or that it ensues as a delirium episode resolves gradually, or it may arise 
independently of any full-syndromal event, although it remains unclear if SSD in each 
these situations differs phenomenologically or with respect to other factors, such as 
aetiology. It is apparent that SSD is not simply a phenomenological state, but that it 
has significant clinical impact, in that it independently leads to outcomes 
intermediate between no delirium and delirium and so occupies a continuum both in 
clinical presentation and in long-term prognosis (249). Despite the notion that SSD 
can precede delirium, it is important to remember that the concept of delirium 
prodrome encapsulates many other features than those recognised as part of the 
delirium spectrum, as described in previous chapters, and hence although the 
prodromal period can include SSD, it should not be its sole defining characteristic. 
 
Strengths of this study include the prospective daily measurement of delirium 
phenomenology using a well-validated delirium rating instrument by a trained, 
experienced researcher, as well as the relatively large sample of delirious patients 
 
 231 
with a larger comparative control sample of delirium-vulnerable patients. This study 
was conducted in a cohort of older medically hospitalised patients who are at 
particular at risk for delirium, and so caution should be exercised before generalising 
results to other patient groups. The vast majority of prodromal studies, with the 
exception of those conducted in BMT patients (157, 158) and in coronary care (165), 
also studied patients of older age with median ages in the 80’s across studies, 
undoubtedly in order to ensure sufficient power to detect a significant effect. 
Nonetheless, despite the variety of treatment settings involved in existing studies, 
results are generally consistent, even including those in younger populations, and 
our findings resonate well.  
 
In conclusion, delirium in older hospitalised patients can be predicted by the 
occurrence of less intense delirium phenomenology, particularly the presence of 
inattention; perceptual disturbances; presence of fluctuations; memory impairment; 
and sleep-wake cycle disruption. Being vigilant to the presence of these features in 
older patients not meeting full criteria for diagnosis may supplement other risk 
assessment and screening methods in the early identification of the delirium-
vulnerable, and hence facilitate more timely and appropriate management. Future 
studies investigating the relationship between prodromal features and delirium 
phenomenology and other factors such as aetiology; risk factors; clinical course and 
outcomes are needed to promote further understanding of the clinical significance 
of the delirium prodrome.  
 
 232 
Table 23: Extended Cox model showing the DRS-R98 features which predict 
impending delirium 
Most parsimonious model showing hazard estimations, Breslow method for ties. Log 
pseudolikelihood= -187.57, AIC 393.13; M-CIRS= Modified Cumulative Illness Rating Scales; DRS-R98= 
Revised Delirium Rating Scale; HR = Hazard ratio; CI= Confidence interval; SE = Standard error 
 HR 95% CI (HR) SE sig. 
Premorbid dementia 0.93 0.61-1.42 0.2 0.745 
M-CIRS 1.06 1.02-1.09 0.02 0.001 
DRS-R98 item 1: 
Sleep-wake cycle disturbance 
1.48 1.08-2.04 0.24 0.016 
DRS-R98 item 2: 
Perceptual disturbances and hallucinations 
1.1 1.03-1.17 0.04 0.006 
DRS-R98 item 4: 
Lability of affect 
1.14 1.05-1.24 0.05 0.002 
DRS-R98 item 10: 
Attention 
1.32 1.23-1.42 0.05 <0.001 
DRS-R98 item 11: 
Short-term memory 
1.45 1.18-1.78 0.15 <0.001 
DRS-R98 item 14:  
Temporal onset of symptoms 
1.34 1.22-1.47 0.06 <0.001 
DRS-R98 item 15:  
Fluctuation of symptom severity 
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10.1. INTRODUCTION 
Delirium as a clinical entity has been recognised since ancient times, although up 
until 1980 when its definition became standardised in DSM III (250), acute and 
subacute cognitive disturbances were known by a disparate array of terms reflecting 
differences in aetiology and clinical setting, rather than describing distinct 
syndromes. This unitary concept of delirium has facilitated a greater awareness of its 
significance and has helped to advance research over the past few decades, yet the 
protean nature of delirium lends itself to subclassification (38). The varying symptom 
profile and severity that occurs from patient to patient and within the same 
individual in the form of fluctuations encourages efforts to identify delirium 
subgroups and hence search for differing pathogenesis, aetiology, treatment 




Although multiple characteristics have been utilised to subclassify delirium, motor 
activity profile is the most studied and the most practicable method (38). Because 
motor change occurs with such frequency in delirium, it is considered a core element 
of delirium phenomenology and although some motor features, particularly 
hypoactivity, are subtle to the untrained eye, motor activity disturbance is readily 
observable when it is actively sought out. Furthermore, in recent years the approach 
towards defining and assigning motor subtypes in delirium has advanced. The 
Delirium Motor Subtype Scale (DMSS) is a 13-item instrument derived from analysis 
of features used in previous subtyping methods. Unlike former approaches, it has 
undergone meticulous validation and correlates highly with accelerometry measures 
of motion (48). In addition, the DMSS shows relative specificity for delirium, and has 
predictive validity with respect to delirium prognosis (47). Recently it has been 
further reduced by latent class analysis to a four-item version, the DMSS-4, allowing 
for speedier assessment without losing subtyping accuracy (49), and a study in older 
medical inpatients found that the DMSS-4 has high concordance with the DMSS and 
good inter-rater reliability (50). 
 
The incidence and outcomes of the individual delirium subtypes has varied widely 
across studies, likely due to inconsistent methodologies and referral bias within 
study samples (38). Furthermore, most studies have been cross-sectional in 
methodology, which is inherently limited in its capacity to capture the dynamic and 
fluctuating nature of delirium. Longitudinal work in the palliative care setting has 
found that subtypes are most commonly stable across time with the most prevalent 
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subtype being hypoactive (11, 51). Conversely, in a longitudinal study of hip fracture 
patients, approximately 87% of patients had a variable motor profile throughout the 
delirium episode (52). It is possible that hip fracture patients follow a different 
course to other patient cohorts. For example, it is now generally accepted that in 
most settings hypoactive delirium carries the worst prognosis, whereas Marcantonio 
and colleagues found that amongst hip fracture patients with delirium, it was those 
with hypoactive motor profile (albeit using categories based on the Memorial 
Delirium Assessment Scale, MDAS) who experienced the best outcomes, 
independent of delirium severity and other confounders (53). 
 
Longitudinal studies in palliative care patients have found that motor activity profile 
is more closely related to delirium phenomenology than to aetiology or medication 
exposure (54). The subtypes can differ with respect to the non-cognitive features of 
delirium, but they do not differ in relation to the spectrum and severity of cognitive 
impairment (38, 54), except that in patients without a motor subtype, cognitive 
impairment is less pronounced than in those presenting with a motoric subtype. This 
former ‘no subtype’ group have less phenomenologically intense delirium than the 
other subtypes and often have rating scores in the subsyndromal range on the DRS-
R98 (54). Although there are few studies investigating how motor subtypes relate to 
various risk factors for delirium, some work suggests that increasing age and 
premorbid cognitive impairment may be more common in those with hypoactive 




To date, studies in older medical inpatients with delirium have all been cross-
sectional in nature and results have been widely conflicting. Liptzin and Levkoff 
(1992) found that 52% of 125 older medical inpatients with incident delirium had a 
mixed profile, whereas only 19% were hypoactive, and that motor subtype did not 
relate to sex, age, place of residence or presence of comorbid dementia (57). 
Subsequently, O’Keeffe and Lavan found that mixed subtype predominated in 94 
acute geriatric medicine patients with delirium, but that those with hypoactive 
profile had higher illness severity and longer length of stay (58). A more recent cross-
sectional study of older medical inpatients primarily designed to identify MMSE 
(Mini-Mental State Examination) items on admission that predict the occurrence of 
incident delirium, used DRS-R98 motor items to apply motor profile and found that 
the most common subtype in patients with incident delirium was hypoactive (38%) 
(59). Furthermore, a study investigating the occurrence of delirium in older patients 
in the emergency department found that 92% of cases were hypoactive, based on 
the Richmond Agitation Sedation Scale, and worryingly more than three quarters of 
cases were missed by emergency physicians (23). It is difficult to draw any 
conclusions about the discordant results of these studies, due to their cross-sectional 
nature and also because of the very different subtyping methods employed. 
Longitudinal data, using a validated instrument, is required to more accurately 
investigate the motor profile in this patient group. 
 
Hence, the aim of this study is (i) to explore the course and stability of motor 
subtypes in older medical inpatients, (ii) to identify how motor subtypes relate to 
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baseline risk factors such as demographics, functional ability, presence of pre-morbid 
dementia and comorbidity, and (iii) to identify how motor profile relates 
longitudinally to cognitive performance in this cohort. 
 
10.2. METHODS 
10.2.1. SETTING AND PARTICIPANTS 
This study was part of a larger prospective observational cohort study of incident 
delirium conducted in two acute general hospitals in Cork city, Ireland (Cork 
University Hospital and the Mercy University Hospital). Details of the study protocol 
and procedures are outlined in chapter 3. In summary, over a two-year period from 
2011 to 2013, patients of ≥70 years of age without prevalent delirium on admission 
and who were admitted medically through the Emergency Department (ED) were 
eligible for study inclusion. Delirium status on admission was ascertained by the 
study’s principal investigator (NO’R). Those eligible for study inclusion were then 
assessed daily for delirium development for the next seven days or until discharged. 
Participants who had not developed delirium and were discharged within three days 
of admission were excluded because delirium development post-discharge could not 
confidently be ruled out in these patients. Patients who developed incident delirium 
(cases) and who remained admitted continued to undergo daily assessment as 
tolerated until assessment day fourteen, followed by weekly assessment for up to six 
weeks. Patients who did not develop delirium in the first week (controls) and who 
remained inpatients beyond this, continued to undergo weekly assessments for 
delirium after the first seven days of participation. Hence there were up to 18 
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potential assessment points for delirium cases (days 1 to 14 and weeks 3 to 6), and 
up to 12 potential assessment points for non-delirious controls (days 1 to 7 and 
weeks 2 to 6). 
 
10.2.2. ASSESSMENTS 
10.2.2.1. Delirium Rating Scale- Revised ‘98 
Delirium assessments were performed on a daily basis by a trained delirium rater 
(NO’R) using the Revised Delirium Rating Scale (DRS-R98). This is a 16-item scale 
comprising 13 severity items (rated from 0 to 3) and 3 diagnostic items (rated from 0 
to 2 or 3), which collectively give a total possible score range of 0 to 46. It is a 
diagnostically precise instrument which can differentiate delirium from other 
neuropsychiatric conditions, such as dementia and depression (90, 204, 205). It can 
be used to rate symptoms over the previous 24-hour period. In this study, in keeping 
with recommendations for its use, delirium was diagnosed if the severity score was 
≥15 and / or if the total score was ≥18 (173). The DRS-R98 has been used to identify 
a three factor structure to delirium phenomenology: cognitive; circadian; and higher 
order thinking (42, 43). Because we were interested in exploring the longitudinal 
relationship between motor profile and cognition, a cognitive subscale of the DRS-
R98 was calculated for each assessment by adding the scores of each of the cognitive 
items of the scale, i.e. items 9 to 13 (item 9- orientation; item 10- attention; item 11- 




10.2.2.2. Delirium Motor Subtyping Scale – 4 (DMSS-4) 
The DMSS-4 (see appendix A) can be used by any healthcare professional with an 
understanding of delirium presentation, and is used to assign one of four motor 
classifications. Hypoactive subtype requires at least one hypoactive feature present 
and no hyperactive features. Conversely, hyperactive subtype requires that the 
patient has at least one hyperactive feature and no hypoactive features. Patients 
with one or more features from each group are classed as mixed subtype, while 
those with no feature from either group are deemed no subtype. In this study, the 
DMSS-4 was rated by questioning the nursing staff along with observations made (by 
NO’R) during patient interview. The DMSS-4 was applied to all patients on a daily 
basis irrespective of their delirium status. 
 
10.2.2.3. Application of longitudinal motor subtypes for delirium cases 
In patients who developed delirium, a longitudinal motor profile was applied to each 
patient by examining motor subtype expression primarily for each day with delirium. 
In some cases, motor profile during days of no delirium was taken into account if we 
considered the score in question to reflect a fluctuation within a delirium episode. 
Over the course of a delirium episode, participants were classified as having either a 
relatively stable, consistent motor profile throughout, or a variable pattern to motor 
subtype classification. Hence there were five possible longitudinal subtypes, four 
stable and one variable: hypoactive subtype throughout; hyperactive subtype 
throughout; mixed subtype thoughout; no subtype throughout; and variable profile. 
Borderline cases were decided by consensus discussion with DM. 
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10.2.2.4. Assessment of previous cognitive status 
Prior cognitive status was determined primarily using the Informant Questionnaire 
on Cognitive Decline in the Elderly Short-Form (IQCODE-SF), an instrument which 
uses structured informant history to detect dementia. It is particularly useful in the 
acute setting where cognitive tests are less specific for dementia (191). In this study, 
as in similar populations, a mean score of ≥3.5 was considered consistent with 
premorbid dementia (193). In addition to the IQCODE-SF, the medical notes were 
examined for a prior diagnosis of dementia made by a suitably trained physician. 
Borderline cases were discussed with ST and DM and, in these cases, diagnosis was 
reached by consensus opinion. In those with no available informant report and no 
documented dementia diagnosis, the baseline SMMSE (Standardised Mini Mental 
State Examination) was examined and a score of ≥27 /30 was considered normal, in 
keeping with similar studies (181). In those with lower SMMSE scores, in the absence 
of collateral history, we were unable to apply dementia diagnosis and, thus, prior 
cognitive status was deemed “unknown” in these patients (n=2). 
 
10.2.2.5. Baseline data 
Other baseline variables were collected including demographic data (age, sex); 
medical history; and functional status. Comorbidity burden was measured using the 
Modified Cumulative Illness Rating Scale (M-CIRS) and baseline functional status was 





Data pertaining to in-hospital mortality and discharge destination were collected 
using the hospital electronic system. Patients and General Practitioners were 
contacted at six months post study entry to ascertain six-month outcomes 
(mortality; place of residence). 
 
10.2.4. ETHICAL PROCEDURES 
Ethical approval was granted by the Clinical Research Ethics Committee of the Cork 
Teaching Hospitals. The principles and procedures of the study were discussed with 
all patients but it was anticipated that many participants would have cognitive 
impairment at study entry and hence would not be capable of giving informed 
written consent. Thus, although informed written consent was sought from those 
who were competent to give it, due to the non-invasive nature of the study, ethical 
approval was also granted to enhance patient assent with proxy consent from next 
of kin or a responsible caregiver in those cases where capacity was questioned. 
These methods are in keeping with the Helsinki Guidelines for Medical Research 
involving human subjects (207). 
 
10.2.5. STATISTICAL ANALYSIS 
Statistical analyses were conducted using the SPSS-20.0 package. Demographic data 
were expressed as means ± SD or medians and IQR, depending on the distribution of 
the data. Comparisons of groups (1. stable vs. variable profile; 2. comparisons 
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between all five longitudinal patterns) were made using a χ2 test for differences in 
proportions and a t-test, Mann Whitney U-test or ANOVA for differences in means. 
Logistic regression analysis was used to ascertain if motor subtypes were predictive 
of composite adverse outcomes of (i) death during hospitalisation or new admission 
to nursing home following the index admission, and (ii) death or institutionalisation 
at six months.  
 
The Generalised Estimating Equation (GEE) method was utilised to analyse 
longitudinal data for the relationship over time between the four individual motor 
subtypes and independent variables (delirium event; DRS-R98 severity score; 
cognitive subscale of the DRS-R98; baseline functional status; premorbid cognitive 
status; comorbidity burden; sex; and age). Four separate binary comparisons were 
conducted, contrasting each motor category against the others: 1) no subtype vs. 
any subtype; 2) hypoactive vs. the other three profiles; 3) hyperactive vs. the other 
three profiles; and 4) mixed vs. the other three profiles. The GEE method allows for 
the fact that within subject observations are correlated and estimates the population 
average across time (expressed as coefficients). The estimated coefficients depict 
the relationship between the independent predictors and motor subtype status at 
each time point, rather than comparing motor profile groups based on longitudinal 
course. This allowed each available score for every included patient to be 
incorporated in the analysis, taking into account the correlation between scores for 





In total, 555 patients were approached and, following study protocol exclusions, 191 
participants were included in the longitudinal analysis, 61 of whom developed 
incident delirium (see Chapter 5, figure 9 for flow of patients through the study). The 
median age of the cohort was 80 (IQR 10), just over half (n=101) were male and 32 
(16.9%) had pre-morbid dementia. Table 24 illustrates clinical and demographic 
information for the overall group, as well as for subgroups based on delirium status 
and on longitudinal motor subtype. The median number of assessments per patient 
was seven for both control patients and for those with incident delirium (range = 2 
to 14 for cases; 2 to 9 for controls). In total, there were 1,219 contemporaneous 
DRS-R98 and DMSS-4 assessments conducted, and in 61 cases of delirium there were 
113 delirium days with motor profile ascertained. Stability of motor subtype was 
significantly more predominant than variability (stable subtype n=45, 73.8%; variable 
subtype n=16, 26.2%; p<0.001). Sex, age, dementia status, BI, M-CIRS, and length of 
stay in days were entered into a GEE model to explore for independent predictors of 
stability of motor subtype (table 26). The only significant predictor of stability was BI 
(β =0.166; 95% CI 0.082-0.25; Wald Chi-Square 15.086; QIC 464.91; p<0.001). The 
most common subtype per delirium day was hypoactive subtype (66.4%, n= 75 / 
113) and this subtype was also more common when longitudinal subtypes were 
applied (62.3%, n= 38 / 61), see table 25. 
 
Including all 191 patients (1,219 assessments), GEE was used to identify variables 
related to DMSS motor subtype. The independent variables included in the initial 
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model were sex; age; dementia status; delirium status; BI; M-CIRS; and the cognitive 
subscale of DRS-R98. The latter variable was introduced to assess how the motor 
subtypes related to cognitive state over time. Because DRS-R98 severity score was 
not significant in any of the preliminary models, we did not include it in the analysis 
nor consider modifying the score to exclude motor items as has been done in 
previous studies (54). Four analyses are presented in table 26, highlighting the 
factors which differentiate each subtype from the other three. Neither age nor 
dementia were related to any of the subtypes. Both hyperactive and hypoactive 
subtypes were significantly associated with higher degrees of baseline functional 
dependence (BI) and comorbidity (M-CIRS), whereas mixed subtype and no subtype 
related to lower degree of impairment on these scales. Both hyperactive and 
hypoactive subtypes were significantly associated with greater levels of impairment 
on the cognitive subscale of the DRS-R98. There was no association on logistic 
regression analysis between the five different longitudinal subtypes and adverse 
outcomes during the index admission or at six months, nor was there an association 




This is the first longitudinal study of motor activity profile in older medical inpatients, 
with results indicating that the majority of incident delirium cases maintain a stable 
motor course throughout the episode, and are primarily hypoactive in presentation. 
Although results from cross-sectional studies in older patients are divergent, the 
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preponderance of hypoactive subtype found in our data resonates with the findings 
of other recent work conducted in the emergency department, where over 90% of 
delirious older patients presented with hypoactive profile (23). We found that the 
only predictor of motor profile stability was level of functional independence on 
admission, with lower levels of independence predicting a stable course over a 
variable one. Importantly, table 24 illustrates that this finding is not simply due to an 
association between hypoactivity and poor function. A previous report from this 
study indicates that one of the most significant independent predictors of incident 
delirium in this cohort was functional impairment on admission. In addition, this 
work highlights that this baseline feature also predicts the stability of delirium 
throughout the episode, compounding the significance of functional impairment as a 
baseline measure for delirium risk stratification.  
 
Despite the dynamic nature of delirium and its multifactorial aetiology, the vast 
majority of research investigating the prevalence of and differences between 
delirium motor subtypes with respect to, for example, phenomenology, aetiology, 
detection rates and outcomes have used cross-sectional methodology. In order to 
better understand how factors interplay with the various motor subtypes, 
longitudinal observational studies are required. To date, longitudinal studies have 
only been conducted in two clinical settings, palliative care and in hip fracture 
patients (11, 52, 54). Findings from these studies have been conflicting in relation to 
stability of motor profile, predominant subtype, as well as the differences between 
the subtypes with respect to outcomes. The only common finding between all 
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longitudinal studies (including ours) is that motor subtypes were not distinguished by 
age or presence of pre-morbid dementia. Other than this, our results resonate with 
different findings from these previous studies, and also contrast in certain ways. 
Firstly, the study of palliative care patients found that they adhered to a principally 
stable course, the primary motor subtype being hypoactive (11), comparable to our 
findings, whereas Slor and colleagues found that hip fracture patients followed a 
more variable pattern with hyperactive subtype being the most prevalent of the 
stable profiles (52). This disparity between our study and that of Slor and colleagues 
is interesting given that these studies were similar with respect to median age (>80 
years) and the use of daily delirium and motor assessment. In the study of palliative 
care patients, the median age was slightly younger at 70 years and assessments were 
conducted twice weekly. In relation to motor subtyping methods, we employed a 
version of the DMSS, similar to the study in palliative care patients, and in contrast 
to that in hip fracture patients in which the motor items from the DRS-R98 were 
utilised for this purpose. Of note, a separate report from the same Dutch study 
found high correlation between the DRS-R98 method and the more rigorously 
validated DMSS in delirious patients, with the correlation between DRS-R98 
categories and their corresponding subgroups on the DMSS ranging from 69-100% 
(251). 
 
Hence, our study is somewhat closer in methodology to that of Slor and colleagues, 
which indicates different delirium trajectories between hip fracture patients and 
older medical inpatients. It is conceivable, yet not proven, that delirium due to hip 
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fracture and other trauma follows a contrasting course to that caused by medical 
illness, substance intoxication or withdrawal. In 1990, Lipowski postulated that these 
respective deliria differ in relation to the occurrence of prodromal features (154), 
and so if this were true, it supports the theory that post-delirium trajectories in 
these distinct groups may also diverge. Studies of delirium prodrome have not 
investigated differences in prevalence of prodromal features between these groups, 
however one study in hip fracture patients identified a prodromal period in over 80% 
of patients, disputing Lipowski’s proposal. Nonetheless, in terms of outcomes, our 
findings are similar to that of Slor and colleagues. Our study of older medical 
inpatients found no difference in a combined adverse outcome of death or 
institutionalisation on discharge and at six months between the motor subtypes, 
whereas in palliative care patients, Meagher and co-workers found that hypoactivity 
was independently associated with increased mortality at 30 days. 
 
Our results also suggest that there may be important clinical differences between 
the subtypes in this population, particularly in relation to cognitive impairment. This 
depicts another very important difference between our findings and that of Meagher 
and colleagues in palliative care patients. In our cohort, the motor subtypes differed 
with respect to the cognitive subscale of the DRS-R98, such that purely hyperactive 
and hypoactive profiles were more impaired than mixed subtype and no subtype. In 
contrast, Meagher and colleagues found that cognitive subscale remained 
comparative across motor subtypes (54). Antecedent cross-sectional studies herald 
similar findings, indicating that motor subtypes do not differ with respect to the 
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degree of cognitive impairment nor the domains involved, although as these studies 
involved mainly patients referred to a psychiatry consultation-liaison team, referral 
bias may have impacted upon results (252-254). This difference in findings may 
signify that cognitive features of delirium occurring in different treatment settings or 
patient groups can vary and have a different relationship to motor activity profile. 
 
This study has many strengths. Firstly, delirium diagnosis was ascertained by a 
trained experienced researcher using a well-validated diagnostically precise 
instrument. Secondly, participants were assessed on a daily basis, the instruments 
employed being used to rate features over the previous 24 hours, giving a richness of 
detail to the data, which may be lost when the interval between assessments is 
greater than one day. Furthermore, motor profile was determined using the 
intensively evaluated DMSS-4, which is now the most widely accepted method for 
motor subtyping in delirium. A limitation of our study is that because it was part of a 
larger study of delirium prodrome, patients with prevalent delirium were excluded 
and, hence, these data only reflect the longitudinal motor subtype characteristics in 
patients with incident delirium. It is possible that delirium occurring in older patients 
on admission may follow a different course to that which emerges during 
hospitalisation. On cross-sectional analysis of the prevalent delirium patients in this 
study, hypoactive subtype predominated with 67.4% of patients meeting hypoactive 
criteria on the DMSS-4, and the study by Han and co-workers also indicates that 
hypoactivity prevails as the dominant motor subtype in this group (23). However, we 
do not know if the course remains stable or varies throughout the episode. Another 
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limitation is that given the low representation of any subtype other than hypoactive, 
either from day-to-day assessment or as a longitudinal profile, it is possible that the 
study is underpowered to detect differences between the subtypes with respect to 
baseline variables and the cognitive subscale of the DRS-R98. Larger studies with 
greater numbers of patients, specifically with stable mixed and hyperactive motor 
profiles, are required to further examine the relationship between the subtypes and 
other factors. In particular, we must confirm how subtypes relate to impaired 
cognition in this clinical setting. If this relationship does indeed differ between 
patient groups, it may provide very important information to guide future work 
linking aetiology and neuropathophysiology. 
 
In conclusion, we found that older medical inpatients with incident delirium follow a 
stable and predominantly hypoactive course during admission. This underlines the 
importance of fostering a greater awareness and understanding of the features and 
significance of hypoactivity in our hospitals, where hyperactivity and its associated 
challenges gain the most attention. Functional impairment on admission is not only a 
harbinger of delirium in this population, but also influences its course and thus 
should act as a prompt for us to urgently employ delirium prevention strategies at 









Table 24: Demographics and clinical characteristics of the overall group and as subgroups based on incident delirium status and longitudinal 
motor subtype 
M-CIRS= Modified Cumulative Illness Rating Scale; ns = non-significant; sd = standard deviation. * comparisons between the five longitudinal categories (Chi-square for 
proportions; ANOVA with Bonferroni correction for continuous variables). comparisons between stable and variable profiles (Chi-square for proportions; independent 













































































































































Table 25: Frequency of motor subtypes in patients with delirium 
*Comparison between stable and variable profiles using chi-square statistic 
Longitudinal profile 
n=61 
n (%) sig.  
Stable subtype 45 (73.8) p<0.001* 
 Hypoactive throughout 38 (62.3)  
 Hyperactive throughout 2 (3.3)  
 Mixed Subtype throughout 2 (3.3)  
 No subtype throughout 3 (4.9)  
Variable subtype 16 (26.2)  





Table 26: Four GEE models exploring the relationship between motor subtype and 
other variables. 
GEE = Generalised Estimating Equation. Variables include demographics (sex, age); presence of pre-
morbid dementia; baseline functional ability (BI, Modified Barthel Index, inverted so that higher 
scores indicate greater degrees of impairment); comorbidity burden (M-CIRS, Modified Cumulative 
Illness Rating Scale); delirium event; DRS-R98 (Revised Delirium Rating Scale) severity score; score on 
the cognitive subscale of the DRS-R98. All 191 patients included. Only significant variables are shown. 
Parameter β S.E. 95% C.I. Wald χ2 d.f. sig. 
No subtype vs. the other 3 categories 
Inverted BI score -0.1 0.02 -0.13 to -0.07 41.17 1 <0.001 
M-CIRS total score -0.04 0.01 -0.06 to -0.01 7.1 1 0.008 
Male sex 0.34 0.16 0.03 to 0.65 4.63 1 0.031 
















Cognitive subscale score -0.1 0.03 -0.16 to -0.03 8.27 1 0.004 
       
Hyperactive subtype vs. the other three categories 
Inverted BI score 0.1 0.02 0.07 to 0.13 40.15 1 <0.001 
M-CIRS total score 0.04 0.01 0.01 to 0.06 7.76 1 0.005 
Male sex -0.34 0.15 -0.63 to -0.04 4.99 1 0.026 

















Cognitive subscale score 0.1 0.03 0.03 to 0.16 9.17 1 0.002 
       
Mixed subtype vs. the other three categories 
Inverted BI score -0.09 0.02 -0.13 to -0.04 14.45 1 <0.001 
M-CIRS total score -0.05 0.02 -0.09 to -0.02 10.21 1 0.001 
















Cognitive subscale score -0.22 0.05 -0.33 to -0.12 17.9 1 <0.001 
       
Hypoactive subtype vs. the other three categories 
Inverted BI score 0.12 0.02 0.09 to 0.16 42.66 1 <0.001 
M-CIRS total score 0.04 0.01 0.01 to 0.07 8.88 1 0.003 
Cognitive subscale score 0.1 0.04 0.03 to 0.17 7.66 1 0.006 
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11.1. INTRODUCTION 
Delirium is a serious neuropsychiatric condition which is ubiquitous across 
healthcare settings and independently linked to a variety of adverse events including 
prolonged length of hospital stay, loss of independence, and mortality (3). Full-
syndromal delirium (FSD) is present when a patient meets pre-defined criteria using 
a robust diagnostic classification system, however in addition to FSD, a delirium 
spectrum exists such that subsyndromal delirium (SSD) describes a state 
characterised by the presence of certain delirium features without fully meeting FSD 
thresholds. The context in which SSD develops is not fully understood, however it is 
posited that SSD can exist as a transitional state between no delirium and FSD or vice 
versa, and some work has indicated that antipsychotic prophylaxis during SSD can 
reduce progression to FSD in the post-operative period (73). It is also recognised that 
SSD may occur in isolation without ever traversing full-syndromal thresholds (75). 
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Although SSD is a more moderate presentation than FSD, it has prognostic 
significance in that outcomes have repeatedly been shown to be intermediate 
between those of patients with no delirium and those with FSD (53, 62, 65, 69, 74).  
 
As well as FSD, SSD is prevalent across the acute hospital, occurring in 7-50% of 
inpatients, depending on the ward setting and the diagnostic criteria used (76). 
Clarity in relation to SSD definition and diagnosis has in general been lacking, with 
methods varying greatly from study to study. Some authors have used categorical 
definitions based on the presence of core delirium or CAM features and others have 
applied pre-defined cut-offs on dimensional diagnostic instruments (76). Recently, a 
phenotype of SSD has been conceptualised using analysis of pooled multi-cultural 
data. This study found that SSD is closer in phenotype to delirium than non-delirium 
and that some core delirium phenomenological features occur in SSD, however with 
milder severity than in FSD (75). Laterally, results from our research group has found 
that certain core diagnostic features (including impairments in higher order thinking 
and cognition, particularly attention) were the key differentiating features between 
SSD and FSD, and SSD and no delirium (76). Furthermore, in this cross-sectional 
study, SSD patients with inattention had higher ratings on the DRS-R98 severity and 
total scales than those without, and also scored higher on items related to higher 
order thinking; cognition (including attention); motor agitation; and contextual items 
such as acuity of onset and severity of fluctuations. These findings support a more 
anchored definition of the concept and presentation of SSD to facilitate diagnosis in 
the clinical and research setting. This definition recognises that although other 
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delirium features can vary between patients with SSD (as they do in FSD), certain 
core criteria are necessary for SSD diagnosis to be made, namely impaired attention 
span; and an acute or subacute onset of symptoms. These important features are 
central to the diagnosis and philosophy of full-syndromal delirium and so their being 
fundamental to the definition of a milder delirium spectrum disorder is intuitive (76).  
 
Hence, SSD is conceptually akin to FSD, albeit less phenomenologically intense, 
presenting with milder manifestations of core delirium features that do not reach 
FSD diagnostic criteria. Despite this, to date there has been no study exploring the 
relationship between SSD and motor disturbance. Abnormal motor behaviour is now 
recognised as core to delirium presentation (38), with subgroups based on motor 
profile being used as the primary method for delirium subclassification. One 
longitudinal study of the stability of motor subtypes in delirious palliative care 
patients identified that those presenting with no motor subtype were likely to have 
lower DRS-R98 scores more consistent with SSD than FSD, even when motor items 
on the DRS-R98 were excluded from the analysis (11). Franco and colleagues found 
in a large pooled sample that any abnormal motor behaviour was significantly more 
prevalent in patients with SSD or FSD than those without either, however did not 
differentiate between SSD and FSD nor specifically examine the prevalence of motor 
subtypes in the sample (255). Given that motor features are often the most visible 
and observable features of delirium, understanding their relevance in SSD may help 
to facilitate the development of feasible methods for detecting SSD. Hence, the aim 
of this study was to examine the prevalence of motor disturbance in SSD compared 
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to FSD, measured using validated motor subtyping methods, and which motor 
subtypes predominate. We were also interested in examining if the motor profile of 
SSD remains stable across episodes or whether the profile varies from day to day. 
Additionally, we aimed to identify non-motor phenomenological differences 
between SSD and FSD or no delirium in older medical inpatients.  
 
11.2. METHODS 
11.2.1. SETTING AND PARTICIPANTS 
This prospective observational cohort study of incident delirium was conducted in 
Cork University Hospital and the Mercy University Hospital, two acute general 
hospitals in Cork city, Ireland, between October 2011 and August 2013. Patients of 
seventy years and older who were admitted medically through the Emergency 
Department (ED) were eligible for inclusion. Further details of the study protocol and 
exclusion criteria are detailed in Chapter 3.  
 
Older medical patients underwent assessment for prevalent delirium by the principal 
investigator (NO’R), within a maximum of 36 hours of presentation to the ED. Those 
without delirium on admission were then considered for inclusion in a prospective 
study of incident delirium, in which delirium assessment was conducted daily for the 
next seven days or until discharged. Those discharged free of delirium within three 
days of admission were ultimately excluded as in these patients delirium 
development post-discharge could not be outruled with certainty. Participants who 
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developed incident delirium (cases) continued to undergo daily assessment as 
tolerated until assessment day fourteen or until discharge or death. Thereafter, 
cases underwent weekly assessment for up to six weeks. Those who did not develop 
delirium during the first seven days of assessment (controls), continued to undergo 
weekly delirium assessment for a maximum of six weeks or until discharge or death. 
 
11.2.2. ASSESSMENTS 
11.2.2.1. Delirium Rating Scale- Revised ‘98 
Daily delirium assessments were conducted by a trained rater (NO’R) using the 
Revised Delirium Rating Scale (DRS-R98), a widely used, well-validated, specific and 
sensitive tool for diagnosing delirium. It comprises 16 items which rate 13 severity 
features (from 0 to 3) and three diagnostic features (from 0 to 2 or 3), using 
phenomenological descriptive anchors for scoring each item. It is used to measure 
symptoms over the previous 24 hours, with the total possible score ranging from 0 
to 46, higher scores indicating greater breadth and intensity of symptoms. The DRS-
R98 is a precise diagnostic instrument which can distinguish delirium from other 
neuropsychiatric conditions, for example dementia and depression (90, 204, 205), 
making it an ideal tool for assessing phenomenology. In this study, consistent with 
guidelines for its use, FSD was diagnosed if the DRS-R98 severity score was ≥15 and / 
or if the total score was ≥18 (173). The DRS-R98 can also be used to identify 
subsyndromal delirium (SSD), although definitions differ from study to study. In this 
study, in keeping with methods previously proposed by our research group (249), we 
considered SSD present if the DRS-R98 total score was between 6 and 17 (inclusive); 
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and a score of at least 1 was reached on each of items 10 (attention) and 14 
(temporal onset of symptoms).  
 
11.2.2.2. Delirium Motor Subtyping Scale – 4 (DMSS-4) 
The Delirium Motor Subtype Scale (DMSS) is a data-derived scale (47) which shows 
good specificity for delirium and correlates well with objective measures of motion 
(48). The 13-item scale was condensed to four items by latent class analysis, in order 
to facilitate use in busy treatment settings. This more concise version, the DMSS-4, 
has good concordance with the DMSS and similarly classifies patients into one of 
four motor subgroups based on the presence or absence of four key features: 
hypoactive; hyperactive; mixed and no subtype (see appendix A) (49). The DMSS-4 
can be used by any healthcare professional with an understanding of delirium and in 
this study it was scored by questioning relevant nursing staff, supplemented by 
observations made (by NO’R) during patient interview. Each patient was assessed 
daily using the DMSS-4 regardless of delirium status.  
 
11.2.2.3. Application of longitudinal motor subtypes for FSD and SSD patients 
A longitudinal motor profile was applied to each patient who developed FSD or SSD 
by studying the motor subtype expression for each relevant day. In FSD patients, this 
was based primarily on presentation during days with delirium, however days with 
SSD were sometimes considered if they were felt to reflect a fluctuation within a 
delirium episode. Similarly, in SSD patients, longitudinal subtype was assigned based 
 
 259 
on motor presentation during days with SSD. Using this method, participants were 
classified as having either a relatively stable motor profile throughout, or a variable 
motor pattern, giving five potential longitudinal subtypes, four stable and one 
variable: hypoactive subtype throughout; hyperactive subtype throughout; mixed 
subtype thoughout; no subtype throughout; and variable profile. Borderline cases 
were assigned longitudinal subtype following consensus discussion with DM. 
 
11.2.2.4. Assessment of previous cognitive status 
Premorbid cognitive status was established primarily using the Informant 
Questionnaire on Cognitive Decline in the Elderly Short-Form (IQCODE-SF), which 
utilises structured care-giver interview to detect cognitive change over the preceding 
ten years. It is especially useful in the acute setting, when cognitive baseline is often 
unknown and where cognitive tests are poorly specific for dementia (191). In this 
study, as in comparable populations, we used a mean score of ≥3.5 to detect 
premorbid dementia (193). The medical charts were also examined for a prior 
diagnosis of dementia made by a suitably trained physician. Borderline cases were 
decided by consensus discussion with ST and DM. In those without an available 
informant for the IQCODE-SF and no documented dementia diagnosis, a score of ≥27 
/30 on baseline SMMSE (Standardised Mini Mental State Examination) was 
considered normal, consistent with similar studies (181). In patients with lower 
SMMSE scores, without formal diagnosis or IQCODE-SF, prior cognitive status was 




11.2.2.5. Baseline data 
Baseline data were also recorded including demographics (age, sex); comorbidity; 
and functional status, see Chapter 3 for more detail. The Modified Cumulative Illness 
Rating Scale (M-CIRS) was used to evaluate burden of comorbidity, and baseline 
functional status was measured using the Modified Barthel Index (BI) on admission. 
 
11.2.3. ETHICAL PROCEDURES 
Formal ethical approval was granted by the Clinical Research Ethics Committee of 
the Cork Teaching Hospitals. Study aims and procedures were explained to each 
patient, however due to the nature of the study it was anticipated that many 
participants would be incapable of giving informed consent. Hence, in these cases, 
ethical approval was granted to augment patient assent with proxy consent from 
next-of-kin or responsible caregiver, consistent with the Helsinki Guidelines for 
Medical Research involving human subjects (207). 
 
11.2.4. STATISTICAL ANALYSIS 
Data were analysed using SPSS version 20. Demographic data and rating scale data 
are listed as means ± SD, for the whole group and for subgroups based on delirium 
status: FSD; SSD; No Delirium (ND). Differences in proportions were estimated using 
a χ2 test. Continuous variables including age; M-CIRS; BI and DRS-R98 scores (total 
scores; severity scores; and individual item scores) were compared between the 
groups using one-way ANOVA, followed by pairwise comparisons. DRS-R98 item 16 
was not included in this analysis as in all cases of FSD this was scored as 2 and so 
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became a constant. All other items on the DRS-R98 were used to make comparisons 
between the groups, although there was a pre-defined difference between SSD and 
ND for items 10 (attention) and 14 (temporal onset of symptoms) as scoring at least 
1 on each of these items was a pre-requisite for membership of the SSD category.  
 
11.3. RESULTS 
Following exclusions according to the study protocol, 191 patients were included in 
the analysis. Sixty-one participants developed incident full-syndromal delirium, 41 
experienced a defined period of subsyndromal delirium but never developed full 
syndromal delirium and 89 patients remained completely free of either 
subsyndromal or full-syndromal delirium throughout the study period (see figure 13 
for flow of patients through the study). The median age of participants was 80 years 
(IQR 10) and 52.9% (n=101) were male (see table 27 for clinical and demographic 
information relating to the overall group and for subgroups based on delirium 
status).  
 
There were 1,219 delirium assessments conducted with corresponding assessments 
of motor profile. Hypoactive subtype was the most common subtype overall and was 
particularly prevalent when delirium or SSD was present, whereas in patients with 
no delirium, no subtype predominated, see table 28 for details. Classifying SSD 
patients according to longitudinal subtype, we found that the majority of SSD 
patients demonstrated a stable course (n= 32, 78%, p<0.001), and the predominant 
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stable profile was hypoactivity (n = 19 / 41, 46.3%). No SSD patients were found to 
have a stable hyperactive or mixed course throughout.  
 
Given our methods for applying delirium status, mean scores on the DRS-R98 were 
inevitably lower in patients with no delirium than SSD and in SSD than in FSD. 
However, the applied (dimensional) definition of delirium did not emphasise any 
particular items and as such we examined for differences between the groups in 
mean scores for individual items on the DRS-R98 using ANOVA with Bonferroni 
correction. Results are shown in table 29 and illustrated graphically in figure 14. 
Every DRS-R98 item from 1 to 15 was significantly higher in FSD than in ND, p<0.001. 
FSD was significantly different to SSD for all items except items 1 (sleep-wake cycle 
abnormalities); 3 (delusions); 4 (lability of affect); and 8 (motor retardation); 
whereas SSD was significantly different from no delirium for items 3 (delusions); 6 
(thought process abnormalities); 8 (motor retardation); 10 (attention); 11 (short-
term memory) and the contextual items.  
 
11.4. DISCUSSION 
The results of our study highlight the predominance of hypoactive full-syndromal 
delirium relative to other motoric presentations. In addition, for the first time we 
report that hypoactive subtype is the primary motor profile in SSD. Existing studies 
have found that SSD is phenomenologically more similar to FSD than to ND, 
manifesting with milder expression of core delirium features. Although no studies 
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have specifically explored the relevance of motor profile to SSD presentation, one 
large study identified that motor retardation measured on the DRS-R98 was one of 
the factors differentiating SSD from ND (75) and another study found that any 
abnormal motor behaviour was significantly more common in those with FSD or SSD 
than ND (255). Now we find, using validated motor profiling methods, that almost 
two-thirds of SSD assessments meet motor subtype criteria (predominantly 
hypoactive) and although the prevalence of motor subtype presentations in SSD is 
less than that in FSD, it remains significantly higher than that in no delirium, which 
presents most commonly with no subtype. This finding, given how central motor 
disturbance is to FSD presentation, further consolidates the association between SSD 
and FSD, and differentiates them from those without a delirium spectrum disorder. 
The only other study to refer to motor subtypes in relation to SSD found that DSM-IV 
diagnosed delirium patients presenting with no motor subtype were more likely to 
have DRS-R98 scores in the SSD range, however this study was aimed at describing 
the frequency and stability of motor subtypes in patients with delirium and hence 
did not a priori include patients without FSD (i.e. those with either no delirium or 
pre-defined SSD), the observation in relation to SSD being made post-hoc. In this 
study when longitudinal subtypes were applied, stable patterns of motor expression 
were more common in FSD than variable patterns. Our findings suggest that this is 
also the case in SSD, the most common stable motor pattern being hypoactive. 
Interestingly, none of our cohort with SSD presented with either stable hyperactive 
or stable mixed profiles, and those who manifested either of these motor 
presentations during the SSD course followed a variable profile. It is important to 
note that some experts consider the DRS-R98 to be somewhat biased towards 
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diagnosing delirium in the setting of hyperactive presentations and hence it is 
possible that those presenting with hyperactivity or mixed profiles were more likely 
to reach full-syndromal thresholds than remain in the SSD range. Nonetheless, 
because of the predominance of hypoactivity in this cohort, this potential bias 
towards hyperactivity is unlikely to have had significant impact on the results. 
 
We also explored phenomenological differences between FSD, SSD and ND using 
mean scores on various items of the DRS-R98. We found that older medical FSD 
patients scored significantly higher on many DRS-R98 items than SSD patients, 
namely perceptual abnormalities; language; thought process abnormalities; motor 
agitation (but not retardation); all cognitive items (including attention) and all 
contextual items, although the pattern of symptoms is almost parallel (see figure 14) 
between the two conditions. These results are comparable to those from a point 
prevalence study conducted by our group, in which FSD was differentiated from SSD 
by language and thinking; all cognitive items; and diagnostic items (76). In a much 
larger analysis of pooled multicultural data, features which distinguished FSD from 
SSD similarly included perceptual disturbance and acuity of onset, however 
additionally, delusions and affective lability delineated the groups. In this study, 
again the pattern of symptoms appeared very similar in FSD and SSD participants 




What is more important clinically given the prognostic implications of having any 
delirium spectrum disorder is the ability to differentiate those with SSD from those 
with ND. In our study, we found that these groups diverged in relation to delusions; 
thought process abnormalities; motor retardation; attention; short-term memory; 
acuity of onset; and severity of fluctuations (although scoring at least one on each of 
attention and acuity of onset items was a pre-requisite for SSD diagnosis). Once 
again, these results resonate well with our previous work in which disorganised 
thinking; inattention; and both short- and long-term memory differentiated the two 
groups (76). Furthermore, for the comparison between SSD and ND, Trzepacz and 
colleagues similarly identified that delusions; motor retardation; temporal onset; as 
well as all cognitive items differentiated SSD from ND, however this analysis found 
that sleep-wake cycle abnormalities; perceptual disturbance; and affective lability 
were additionally discriminating. Importantly, this study found that sleep-wake cycle 
disruption; motor retardation; and all cognitive items differentiated SSD from ND but 
not from FSD. In our study, the only features to significantly delineate SSD from ND 
(and not FSD) were delusions and motor retardation, the latter of which echoes our 
findings in relation to motor subtyping. Hence, our results suggest that although 
hypoactivity is common to SSD and FSD and distinguishes them from ND, motor 
agitation may be one of the factors that separates the two delirium spectrum 
disorders, bearing in mind the hypothesis mentioned above in relation to DRS-R98 




This is the first study exploring the presentation of motor subtypes in SSD and its 
strengths include the relatively high numbers of patients with SSD, the prospective 
nature of the study incorporating daily assessments, as well as the use of a 
standardised and well-validated delirium assessment instrument by a trained and 
experienced delirium researcher. Furthermore, motor profile was applied using the 
most intensively evaluated and widely used motor subtyping method, the DMSS-4. 
We defined SSD using a method developed following detailed review of the existing 
literature supplemented by data gathered by our research group, and hence it is the 
most up-to-date and accurate method currently available (76). Although this study 
was conducted only in older medical inpatients, thus limiting its generalisability, 
there are significant elements which resonate well with the existing SSD literature. 
Firstly, our results highlight the fact that SSD is an intermediate state between ND 
and FSD. In table 27 we can see that mean age; prevalence of comorbid dementia; 
and levels of functional impairment and comorbidity are lowest in patients with no 
delirium, and highest in those with FSD, with levels in SSD being between these 
levels, although not all of these comparisons reach statistical significance. In 
particular, escalating rates of comorbid dementia with increasing delirium syndromal 
status (from ND to SSD to FSD) has been demonstrated in a previous study, using 
both categorical and dimensional approaches to SSD definition (76). Secondly, as 
described above, our findings in relation to the phenomenological differences 
between SSD, FSD and ND are largely consistent with prior work and any 




In summary, this study has identified that SSD in older medical inpatients presents 
primarily with a stable hypoactive motor subtype, whereas those patients without 
any delirium spectrum disorder most commonly express no motor subtype. This 
characteristic is one of a series of core elements that not only differentiates SSD 
from ND, but further aligns SSD conceptually with FSD. The fact that hypoactivity as 
defined by the DMSS-4 can delineate SSD and FSD from ND is an important clinical 
finding which may help us to more accurately detect patients on the delirium 

















184 prevalent delirium 
23 communication / coma 
88 early discharge 
36 withdrew 
5 went for surgery 









Table 27: Demographics and clinical characteristics of the overall group and as subgroups based on delirium status 
a. Using ANOVA with Bonferroni correction, mean age of FSD > ND at p= 0.02, other comparisons ns 
b. Using ANOVA with Bonferroni correction, mean iBI of i) FSD > SSD at p= 0.008; ii) FSD > ND at p<0.001; iii) SSD > ND at 0.012 
c. Using ANOVA with Bonferroni correction, mean M-CIRS of i) FSD > SSD at p= 0.004; ii) FSD > ND at p<0.001; iii) SSD>ND ns 
ND = no delirium; SSD= Subsyndromal delirium; FSD= full-syndromal delirium; iBI = Inverted Barthel Index; M-CIRS= Modified Cumulative Illness 
Rating Scale; ns = non-significant; sd  standard deviation; * = Chi-square tests 

















































































Table 28: Prevalence of motor subtype by assessment: no delirium, subsyndromal delirium and full-syndromal delirium 
Chi-square p <0.001 


























































Table 29: DRS-R98 items and scale scores (means +/- SD) for each assessment, ANOVA with pairwise comparisons using Bonferroni correction. 
a) FSD > ND significant; b) FSD > SSD significant; c) SSD > ND significant (* p < 0.05; ** p < 0.005; *** p < 0.001; 
+
not applicable). ND = No delirium; SSD = subsyndromal  
delirium; FSD = full syndromal delirium 
DRS-R98 item No delirium Subsyndromal delirium Full-syndromal delirium sig. 
 
1. Sleep-wake cycle disturbance 1.01 ± 0.63 1.26 ± 0.67 1.67 ± 0.62 a*** 
2. Perceptual disturbances and hallucinations 0.04 ± 0.26 0.9 ± 0.44 0.51 ± 0.97 a***; b* 
3. Delusions 0.05 ± 0.21 0.14 ± 0.36 0.44 ± 0.73 a***; c* 
4. Lability of affect 0.26 ± 0.49 0.46 ± 0.57 0.89 ± 0.75 a*** 
5. Language 0.16 ± 0.37 0.3 ± 0.48 0.68 ± 0.54 a***; b** 
6. Thought process abnormalities 0.75 ± 0.48 0.91 ± 0.42 1.42 ± 0.55 a***; b***; c* 
7. Motor agitation 0.15 ± 0.37 0.22 ± 0.44 0.78 ± 0.89 a***; b*** 
8. Motor retardation 0.81 ± 0.64 1.3 ± 0.67 1.56 ± 0.82 a***; c*** 
9. Orientation 0.14 ± 0.39 0.36 ± 0.56 0.96 ± 0.84 a***; b*** 
10. Attention 0.38 ± 0.61 1.29 ± 0.53 1.74 ± 0.85 a***; b***; c+ 
11. Short-term memory 1.24 ± 0.88 1.63 ± 0.87 2.14 ± 0.86 a***; b*; c** 
12. Long-term memory 0.21 ± 0.47 0.4 ± 0.61 0.82 ± 0.85 a***; b** 
13. Visuospatial ability 1.03 ± 0.69 1.28 ± 0.7 1.82 ± 0.73 a***; b*** 
14. Temporal onset of symptoms 0.34 ± 0.82 1.9 ± 0.77 2.5 ± 0.52 a***; b***; c+ 
15. Fluctuation in symptom severity 0.07 ± 0.27 0.28 ± 0.45 0.95 ± 0.51 a***; b***; c*** 
DRS-R98 Severity score 6.25 ± 2.65 9.63 ± 2.1 15.42 ± 2.76 a***; b***; c*** 





Figure 14: Radar graph illustrating the key phenomenological differences between 






























This thesis aimed to contribute to the current evidence by characterising delirium 
and its prodrome in older medical inpatients and by identifying methods to detect 
delirium early. This chapter firstly highlights the main findings of this thesis. 
Secondly, the strengths and limitations of this work are outlined. Thirdly, the 
potential clinical impact of this thesis is discussed and suggestions in relation to 
delirium screening and early detection are made. Fourthly, areas for future research 
are proposed and lastly, I conclude this thesis with a brief summary. 
 
12.1 MAIN STUDY FINDINGS 
12.1.1. THE PRODROMAL FEATURES OF DELIRIUM 
This thesis is the first work designed primarily to characterise the delirium prodrome 
in older medical inpatients, and explored this concept in relation to behavioural 
features, cognitive features and delirium phenomenological features. Behavioural 
features were longitudinally assessed using a newly developed Prodromal Checklist, 
based on the existing literature (Chapter 7). I found that seven behavioural features 
were significantly predictive of delirium development independent of confounding 
variables (premorbid dementia; comorbidity burden; and functional impairment). 
These features were: irritability; being easily distractible or going ‘off-track; 
increasing confusion or ‘fogginess’; needing prompting for usual tasks; seeming tired 
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in the morning; drowsiness during the day; and being ‘fidgety’, restless or 
wandering. Many of these features have been identified by other studies (see 
Chapter 7) as occurring in the delirium prodrome, however it remains unclear as to 
how they relate to delirium phenomenology as it unfolds. Chapter 8 reports findings 
relating to the study of cognitive prodrome. I assessed participants on a daily basis 
using a series of cognitive tests and found that impairments in attention, orientation, 
short-term memory and visuospatial function were significantly indicative of 
impending delirium, independent of dementia and other confounders (Chapter 8). 
Again these features resonate well with other studies of the cognitive aspect of the 
delirium prodrome in other populations. In order to examine the delirium 
phenomenological features (including cognitive features) which occur in the 
prodromal phase, I used the Revised Delirium Rating Scale (DRS-R98) to assess 
patients daily and found that sleep-wake cycle abnormalities; perceptual 
disturbances; affective lability; inattention; short-term memory impairment; acuity 
of onset; and increasing severity of symptom fluctuations were all significantly 
predictive of delirium development in this cohort (Chapter 9). The findings outlined 
in these three chapters indicate that older medical inpatients with delirium may 
present with a variety of prodromal features including behavioural features; 
cognitive features; non-cognitive neuropsychiatric features; and emotional / 






12.1.2. EARLY IDENTIFICATION OF DELIRIUM AND THOSE AT RISK OF DELIRIUM 
This thesis explored the utility of several screening approaches in the detection of 
delirium. Firstly, a selection of cognitive tests were assessed in relation to their 
diagnostic accuracy in identifying prevalent delirium in older medical inpatients 
within 36 hours of admission (Chapter 4). I found that the 6-CIT was the most robust 
test in detecting delirium in this acutely unwell cohort with an AUC of 0.876 (95% CI 
0.84-0.91) and, in particular, I found using discriminant analysis that the 6-CIT has 
the potential to differentiate between patients with cognitive impairment due to 
delirium from those with cognitive impairment caused by dementia without 
delirium, correctly classifying 78.1% of the original grouped cases (Wilk’s Lambda = 
0.748, F=62.15, df1:1, df2:1, df3:184, p<0.001). This finding is especially important 
due to the challenges of distinguishing between these two diagnoses in clinical 
practice, a process which requires detailed collateral history, often unavailable in the 
acute setting. Promoting the use of the 6-CIT as a delirium screening approach may, 
hence, facilitate speedier identification of those with delirium, a medical emergency, 
and distinguish them from those with dementia (without delirium) early on in 
admission.  
 
Secondly, I assessed if the screening approach recommended by the NICE guidance 
was useful in detecting delirium (Chapter 6). This approach advises monitoring for 
delirium indicators in four major domains, namely changes in cognitive function; 
perception; physical function; and social behavior. I developed a questionnaire based 
on the wording of the guidance and a blinded and independent group of researchers 
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then used this questionnaire to survey relevant nursing staff. Although the 
questionnaire had low Kappa agreement with the delirium diagnostic methods used 
(CAM and DRS-R98), I proceeded to assess the diagnostic accuracy of the 
questionnaire in detecting delirium (according to NICE guidance that any positive 
response indicates a positive screen) and unfortunately the sensitivity was too low 
for the questionnaire to be considered a useful screening test (64.3-66.7%). When I 
explored if the individual domains were able to discriminate those with delirium 
from no delirium, the only domain in this questionnaire to have any utility for this 
purpose was the cognitive domain (correctly classifying 77.1-82.9% of participants). 
Although this approach was highly delirium specific (85-93%), sensitivity was far too 
low (25-42%) for clinical use.  
 
Thirdly, I evaluated which baseline factors were associated with the development of 
incident delirium. The NICE guidance recommends that daily delirium screening is 
undertaken in those at risk of delirium, namely those of 65 years and older; those 
with cognitive impairment; those with a current hip fracture; and those with severe 
illness at risk of decompensation. However, in a busy acute hospital implementation 
of this highly inclusive risk stratification method would be challenging. I collected 
data pertaining to known delirium risk factors (from the NICE guidance and the 
existing literature) and using multivariable analysis, found that premorbid dementia; 
higher comorbidity burden and greater functional impairment were all 
independently associated with incident delirium development. This information may 
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help to streamline risk stratification, prevention and detection strategies to those 
who are most vulnerable to delirium development.  
 
12.1.3. MOTOR PROFILE AND PHENOMENOLOGY 
To date, the motor subtype of delirium in older medical inpatients has only been 
described in cross-sectional samples, the results of which have been inconsistent. 
Given the dynamic nature of delirium, a longitudinal assessment of motor subtypes 
is necessary to accurately define how they relate to other factors, such as aetiology, 
risk factors and non-motor phenomenology. I examined longitudinal motor subtypes 
in patients with delirium in this cohort and found that they were predominantly 
stable, the most prevalent subtype being hypoactive subtype (62.3%). As well as 
being independently associated with incident delirium, functional impairment was 
also independently associated with having a stable motor profile, whereas neither 
age nor premorbid cognitive status had a significant relationship with stability or 
motor subtype. Unlike work in the palliative care population (54), this study found 
that in older medical patients, motor subtypes differed in relation to cognitive 
phenomenology (measured by the cognitive subscale of the DRS-R98), such that 
hypoactive and hyperactive subtypes had more cognitive impairment than those 
with mixed subtype or no subtype.   
 
In addition to finding that hypoactive motor profile is the primary subtype in FSD, 
when subtypes were applied to those with SSD (Chapter 11) for the first time in this 
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thesis, I found that almost two-thirds of SSD patients fitted criteria for hypoactive 
subtype, whereas those with no delirium most commonly had no motor subtype. 
This finding consolidates that of other studies which found that SSD is 
phenomenologically closer to FSD than to no delirium, providing further evidence for 
delirium as a spectrum disorder. Additionally, in Chapter 11, I identified features 
which distinguished SSD from FSD and from no delirium, the latter comparison being 
clinically most important given the prognostic implications of having any delirium 
spectrum disorder. In this cohort of patients, the delirium features which were 
significantly more severe in SSD than in no delirium were delusions; thought process 
abnormalities; motor retardation; attention; short-term memory; acuity of onset; 
and severity of fluctuations, which compares well with the existing literature on this 
subject.  
 
12.2 STRENGTHS AND LIMITATIONS 
12.2.1. PROSPECTIVE STUDY 
Strengths of the primary longitudinal study include the prospective study design 
(Chapters 5; 7; 8; 9; 10; and 11), allowing the features of prodromal delirium and 
incident delirium to be characterised; and the early inclusion into the study, daily 
assessment of subjects, the use of a well-validated sensitive instrument for the 
detection of delirium, such that incident delirium is unlikely to have been missed, 
and the use of the DMSS-4, now the most well-validated and widely used motor 
subtyping method, to apply motor subtypes. Furthermore, the fact that I have 
undergone intensive training in delirium assessment and had significant delirium 
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experience in both research and in a clinical capacity prior to commencement of this 
study is another study strength. Daily assessments for delirium phenomenology, 
prodromal features, cognition, and motor subtyping allowed me to carefully 
characterise FSD, SSD and the delirium prodrome in this cohort of older medical 
inpatients. This study was conducted in a cohort of older medically hospitalised 
patients who are at particular risk for delirium, and so caution should be exercised 
before generalising results to other patient groups, especially as the study sample 
was not consecutive. Even so, the prevalence and incidence rates found are broadly 
similar to those previously reported (197) and the low number of exclusion criteria 
meant that our cohort is likely to be representative of a “real life” inpatient 
population. Furthermore, my findings in relation to prodromal features are generally 
consistent with those of previous studies, including those in younger populations. 
Only 36 patients of the 322 initially included withdrew from the prospective study, 
highlighting the acceptability of the testing processes we used, particularly salient 
when considering repeated cognitive testing (Chapter 8) which patients often find 
tiring and cumbersome. Another study strength is the relatively large sample of 
patients with incident delirium (n=61), in comparison to other studies of delirium 
prodrome (see table 1). Chapter 11 reports on the motor subtype and 
phenomenology of participants with SSD, and again, the high number of subjects 
with SSD compares well to other similar studies. Another strength of this thesis is 
that I used the most up-to-date and accurate method to define SSD, an approach 




I collected data pertaining to easily identifiable and clinically relevant baseline risk 
factors and using multivariable logistic regression, I identified the baseline predictors 
of delirium in this cohort (i.e. pre-morbid dementia, comorbidity and functional 
status). Dementia is one of the top differential diagnoses when assessing for 
delirium, and patients with dementia are likely to have impairments on all of the 
cognitive tests we used to identify the delirium prodrome. However, we identified 
pre-morbid dementia using very robust methods (see Chapter 3, section 3.3.5.1.) 
and adjusted for its presence in the analysis. Thus, we are confident that our results 
are reflective of the delirium prodrome and not premorbid dementia. 
 
Importantly, concerning the prospective assessment of prodromal features, both the 
Prodromal Checklist (completed by nursing staff) and the DRS-R98 assessments were 
conducted contemporaneously, and although the information acquired from the 
nursing staff to complete the Prodromal Checklist was not used to inform DRS-R98 
scoring, there is a potential for bias. Furthermore, this novel checklist has not been 
tested for validity or reliability in the assessment of prodromal features. In relation 
to the study of cognitive prodrome, some of the cognitive tests used contributed to 
the scoring of the cognitive items on the DRS-R98 (see appendix B), so it is 
unsurprising that some of the results from Chapters 8 and 9 are similar. Both 
chapters indicate that changes in attention and short-term memory occur in the 
delirium prodrome, however prodromal changes in orientation and visuospatial 
function too subtle to be detected using the DRS-R98 were identified using the 6-CIT 
and the novel EVSQ test (developed in order to make assessment of visuospatial 
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function more palatable in ill older adults). Interestingly, the findings in Chapter 9 
also reflect some of the findings in Chapter 7, specifically ‘tiredness in the morning’ 
and ‘drowsiness during the day’, identified using the prodromal checklist, mirrors 
prodromal sleep-wake cycle abnormalities detected using the DRS-R98. The 
symptom of ‘irritability’ recognised using the prodromal checklist may be a 
component of the affective lability identified in the prodrome using the DRS-R98. A 
limitation in the study of cognitive prodrome (Chapter 8) is that although we 
collected data on the CDT and IPT, due to reluctance on the part of participants to 
perform these tests on a daily basis, there were too much missing data (>1/3 of 
assessments), to include these tests in the longitudinal analysis.  
 
A limitation in the studies of motor subtyping (Chapters 10 and 11) is that because 
the prospective study excluded patients with prevalent delirium on admission, I only 
have longitudinal data pertaining to the subtypes of patients with incident delirium. 
Cross-sectional analysis of motor subtypes in the study participants with prevalent 
delirium also shows a preponderance of hypoactive subtype (67.4%), however we do 
not know if prevalent delirium in older medical inpatients follows a stable course so 
we cannot make assumptions about the longitudinal subtype in this group. Another 
potential limitation is that so few participants had any stable subtype other than 
hypoactivity which may mean that the study was underpowered to differentiate the 




12.2.2. CROSS-SECTIONAL STUDIES 
12.2.2.1. Screening for prevalent delirium 
In relation to the study of screening instruments in the detection of prevalent 
delirium (Chapter 4), strengths again include the diagnosis of delirium by a trained 
rater using a well-validated tool, and additionally, the evaluation of six cognitive 
tests for diagnostic accuracy. Furthermore, the high number of participants (470 in 
total, 184 with delirium) is a study strength, but because the sample was not 
consecutive, the diagnostic accuracy calculations conducted in this analysis must be 
interpreted with caution, despite the fact that prevalence rates resonate with the 
existing literature on the subject (197). Also, I as a sole researcher conducted all 
cognitive tests and delirium tests contemporaneously and delirium diagnosis was 
applied afterwards. Ideally, the cognitive assessments would be conducted by an 
independent and blinded researcher to minimise bias. Premorbid dementia was 
diagnosed using highly acceptable methods for studies such as this, however data 
pertaining to premorbid cognitive ability was not available for all included patients, 
which meant that on discriminant analysis of separate neurocognitive groups, we 
could not attempt to differentiate between those with comorbid delirium and 
dementia and those with delirium without dementia.  
 
12.2.2.2. Utility of the NICE-based questionnaire 
One strength of this study is that it is, as far as I am aware, the first attempt to 
investigate the clinical utility of the NICE recommendations in relation to delirium 
screening.  A novel questionnaire was developed and trained researchers used this 
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questionnaire to survey relevant nursing staff, independent of my delirium 
assessments. A study limitation is the small convenience sample of delirium cases 
included, which may affect the study’s validity and generalisability.  
 
12.3. CLINICAL IMPLICATIONS AND SUGGESTIONS FOR CLINICAL PRACTICE 
12.3.1. DELIRIUM SCREENING 
As is discussed at multiple points throughout this thesis, delirium is highly prevalent 
but is underdetected at alarming rates. Formal diagnosis is challenging and requires 
experience and expertise. It is now recognised and advocated by the NICE guidelines 
that delirium diagnosis should be undertaken in two steps: firstly, a quick, sensitive 
rule-out screening method should be used; and secondly, formal assessment by an 
expert should then be performed in those who screen positive at stage one. 
Although multiple screening methods have been proposed, there is no consensus as 
to which is most suitable. The NICE guidance recommends monitoring for a series of 
delirium indicators in those at risk of delirium, but in Chapter 6 the clinical utility of 
an operationalised version of these guidelines is tested and found not to be sensitive 
enough for clinical use in this capacity. In Chapter 4, I report the findings of a cross-
sectional study which assessed the diagnostic accuracy of a number of different 
cognitive screening methods in a cohort of older medical inpatients and found that 
for the most robust test was the 6-CIT. Using a cut-off of 8 / 9, the sensitivity was 
89.9% (95% CI 83.8-93.9) and NPV was 91.2% (95% CI 85.8-94.7), indicating that this 
test may be useful at step one in screening. The 6-CIT has many other qualities which 
make it suitable as a screening test (see Chapter 2, section 2.5.3.3.2. and Chapter 8, 
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section 8.4), including its brevity, high acceptability among staff and patients, and 
minimal training requirements. Additionally, results reported in Chapter 4 suggest 
that this using this instrument may facilitate differentiation between different 
neurocognitive groups on admission. Hence, I suggest considering this tool as a first-
line screening approach for delirium in the clinical setting.  
 
12.3.2. MONITORING FOR PRODROMAL FEATURES 
The main aim of this thesis was to characterise the delirium prodrome in older 
medical inpatients, and three chapters (Chapters 7, 8, and 9) report the findings in 
relation to this aim. In this study, multiple behavioural, cognitive and delirium 
features were found to occur in the delirium prodrome (outlined above) and I 
suggest that monitoring for prodromal features in those at risk of delirium may 
facilitate early detection of those with imminent delirium. Firstly, when an older 
patient is admitted, it is good practice that a thorough collateral history should be 
taken, especially if there is any question of cognitive impairment, in order to 
establish the context of this impairment and to confirm other important medical 
details. At this point, I propose that this collateral history should also include the 
seven behavioural features identified in Chapter 7 in order to help ascertain if the 
patient may have impending delirium. This may help to focus our delirium 
prevention and intervention strategies to those who are most at risk. Following 
admission, staff members should also consider monitoring for these features on a 




In the above section (12.3.1.), I suggested the use of the 6-CIT as a screening method 
for delirium. Additionally, Chapter 8 reports that this tool may be useful in detecting 
the cognitive decline that occurs in the delirium prodrome. Hence, I suggest using 
the 6-CIT as a daily monitoring tool for delirium and its prodrome. Any increase 
(worsening) in a patient’s score should prompt further assessment. Following this, if 
the patient does not meet full criteria for delirium in the setting of cognitive decline, 
it could well be that the patient is either in the prodromal phase of delirium or they 
may meet criteria for SSD. If the patient is in the prodromal phase, this should alert 
staff to engage even more actively with delirium prevention techniques and 
hopefully attenuate the duration and severity of the episode when it occurs. If the 
patient has SSD, this may too be prodromal in nature and herald the onset of FSD in 
the ensuing days. Even if SSD does not traverse into FSD, this is still important to 
identify as SSD has prognostic implications of its own which must be taken seriously.  
 
12.3.3. FOSTER A GREATER AWARENESS OF HYPOACTIVITY 
Chapters 10 and 11 discuss in detail the motor subtypes of FSD and SSD in this 
cohort of older medical inpatients. By far the most prevalent subtype in both FSD 
and SSD was hypoactive subtype, and when we individually examined FSD, SSD and 
‘no delirium’ assessments, we found that hypoactive subtype occurred about half as 
frequently in no delirium (35.2%) than in FSD (66.4%) or SSD (61.7%), p<0.001. This 
indicates that hypoactivity measured using the DMSS-4 is significantly more common 
in delirium spectrum diagnoses than no delirium. Unfortunately, the misperception 
that delirium presents primarily with hyperactivity still prevails across clinical 
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settings and the hypoactive subtype remains the least detected form of delirium, 
despite the fact that it incurs the most severe adverse outcomes. Therefore, I 
consider it important that delirium education programmes with particular focus on 
the identification of hypoactivity and its significance are developed for all clinical 
staff disciplines. Improved awareness and understanding of the hypoactivity 
associated with delirium may further facilitate delirium detection in the clinical 
setting.  
 
12.4. FUTURE RESEARCH 
The most clinically important question in relation to the concept of the delirium 
prodrome is whether or not intervening swiftly in the prodromal period can reduce 
delirium incidence and hence the associated adverse sequelae. In order to answer 
this question, we must first be able to confidently diagnose the delirium prodrome. 
We must also understand which patients are more likely to traverse through a 
prodromal period en route to delirium diagnosis. For example, is the prodrome and 
its duration related to delirium aetiology, risk factors, phenomenology and course? 
Following on from this, we then must design and conduct randomised trials to assess 
the impact of an intervention in the prodromal period. This study is the first study 
designed specifically to capture the delirium prodrome in an older medical inpatient 
cohort and the findings are important. However, further studies are required to 
validate these findings both in a similar population and in other patient groups and 
clinical settings and subsequently, diagnostic criteria for the prodromal period must 
be developed and validated, before we progress to interventional trials.  
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This study identified for the first time that SSD in older medical inpatients has a 
motor profile, which is predominantly hypoactive. Further research is required to 
investigate if this is the case in other patient cohorts. We also identified features 
which differentiate SSD from FSD and ‘no delirium’, the latter comparison being 
most clinically important, as outlined in Chapter 11. SSD occurs in many settings. It 
can occur as part of the prodromal phase or in the recovery period after delirium 
and it can also occur in isolation, without ever reaching diagnostic thresholds for 
FSD. Future work should investigate if SSD differs phenomenologically in each of 
these settings and if other factors, such as aetiology, relate to these individual 
settings.  
 
Another finding from this work is that the 6-CIT may be a useful screening 
instrument in the detection of prevalent delirium on admission. More importantly, 
our results suggest that the 6-CIT may be able to differentiate between those with 
delirium and those with dementia without delirium on admission. This finding needs 
further investigation with larger populations, more defined neurocognitive groups 
and a greater number of researchers to ensure that the 6-CIT is conducted 
independently of the delirium assessments and reduce the potential for bias.  
 
12.5. CONCLUSION 
Delirium is highly prevalent and serious, being associated with poor outcomes. 
Despite the fact that prompt diagnosis may improve these outcomes, delirium 
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remains underdetected. This thesis describes factors which may assist with early 
detection of delirium in older medical inpatients, including screening approaches for 
prevalent delirium; the identification of baseline predictors of incident delirium; the 
description of prodromal features in three domains; and the predominance of 
hypoactive motor subtype in both SSD and FSD. These findings should inform future 
efforts in developing delirium detection and prevention strategies, as well as staff 
education programmes. Future research is required particularly to ascertain if 
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A. ASSESSMENT TOOLS USED  
 
 Confusion Assessment Method 
 Revised Delirium Rating Scale 
 Delirium Motor Subtype Scale – 4 
 Six-item Cognitive Impairment Test 
 Spatial Span Forwards Card 
 Spatial Span Forwards Instructions for Use 
 Clock Drawing Test 
 Clock Drawing Test Scoring Template 
 Interlocking Pentagons Test 
 Environmental Visuospatial Questions Test 
 Standardised Mini Mental State Examination 
 Barthel Index 
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 Prodromal Checklist 
 The Informant Questionnaire on Cognitive Decline in The Elderly- Short Form 
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CAM SCORING SHEET 
Positive ☐ Negative ☐ 























(a) Acute onset   Y О  N О       [acute on chronic О] ____________________________                              
(b) Fluctuation  Y О  N О  
 
Item 2 
Inattention  Y О  N О     _____________________________________________________ 
Months Forwards 
J F MH A MY JE JY A S O N D 
_________________________________________________________________________________ 
Months Backwards 




Disorganised Thinking  Y О  N О   ____________________________________________________ 
Proverb (cloud / meat / stitch / blood / vessels / actions / book / chickens / leopard / cat) 





Alert    Y О  N О                                   Other _____________________________ 
(hyperalert or vigilant/ lethargic but readily rousable/ stuporose or comatose) 
309 
 
REVISED DELIRIUM RATING SCALE (DRS-R-98) 
 
The following is an excerpt from the DRS-R98 Administration Manual. A copy of this was 
used as a scoring sheet for each DRS-R98 assessment.  
Trzepacz PT MJ, Kean J, Abell M, Meagher DJ. . The Delirium Rating Scale- Revised- 98 (DRS-R98) Administration Manual. A 
guide to increase understanding of how to solicit delirium symptoms to administer the DRS-R98. Indianapolis, IN, USA: Paula 
Trzepacz ®; 2009. 
 
This is a revision of the Delirium Rating Scale (Trzepacz et al. 1988). It is used for initial 
assessment and repeated measurements of delirium symptom severity. The sum of the 13 item 
scores provides a severity score. All available sources of information are used to rate the 
items (nurses, family, chart) in addition to examination of the patient. For serial repeated 
ratings of delirium severity, reasonable time frames should be chosen between ratings to 
document meaningful changes because delirium symptom severity can fluctuate without 
interventions. 
DRS-R-98 SEVERITY SCALE 
1. Sleep-wake cycle disturbance 
Rate sleep-wake pattern using all sources of information, including from family, caregivers, 
nurses’ reports, and patient. Try to distinguish sleep from resting with eyes closed. 
0. Not present 
1. Mild sleep continuity disturbance at night or occasional drowsiness during the day 
2. Moderate disorganization of sleep-wake cycle (e.g., falling asleep during conversations, 
napping during the day or several brief awakenings during the night with 
confusion/behavioral changes or very little nighttime sleep) 
3. Severe disruption of sleep-wake cycle (e.g., day-night reversal of sleep-wake cycle or 
severe circadian fragmentation with multiple periods of sleep and wakefulness or severe 
sleeplessness.) 
 
2. Perceptual disturbances and hallucinations 
Illusions and hallucinations can be of any sensory modality. Misperceptions are “simple” if 
they are uncomplicated, such as a sound, noise, color, spot, or flashes and ‘‘complex’’ if they 
are multidimensional, such as voices, music, people, animals, or scenes. Rate if reported by 
patient or caregiver, or inferred by observation. 
0. Not present 
1. Mild perceptual disturbances (e.g., feelings of derealization or depersonalization; or patient 
may not be able to discriminate dreams from reality) 
2. Illusions present 
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3. Hallucinations present 
 
3. Delusions 
Delusions can be of any type, but are most often persecutory. Rate if reported by patient, 
family or caregiver. Rate as delusional if ideas are unlikely to be true yet are believed by the 
patient who cannot be dissuaded by logic. Delusional ideas cannot be explained otherwise by 
the patient’s usual cultural or religious background. 
0. Not present 
1. Mildly suspicious, hypervigilant, or preoccupied 




4. Lability of affect 
Rate the patient’s affect as the outward presentation of emotions and not as a description of 
what the patient feels. 
0. Not present 
1. Affect somewhat altered or incongruent to situation; changes over the course of hours; 
emotions are mostly under self-control 
2. Affect is often inappropriate to the situation and intermittently changes over the course of 
minutes; emotions are not consistently under self-control, though they respond to redirection 
by others 
3. Severe and consistent disinhibition of emotions; affect changes rapidly, is inappropriate to 
context, and does not respond to redirection by others 
 
5. Language 
Rate abnormalities of spoken, written or sign language that cannot be otherwise attributed to 
dialect or stuttering. Assess fluency, grammar, comprehension, semantic content and naming. 
Test comprehension and naming nonverbally if necessary by having patient follow commands 
or point. 
0. Normal language 
1. Mild impairment including word-finding difficulty or problems with naming or fluency 
2. Moderate impairment including comprehension difficulties or deficits in meaningful 
communication (semantic content) 
3. Severe impairment including nonsensical semantic content, word salad, muteness, or 




6. Thought process abnormalities 
Rate abnormalities of thinking processes based on verbal or written output. If a patient does 
not speak or write, do not rate this item. 
0. Normal thought processes 
1. Tangential or circumstantial 
2. Associations loosely connected occasionally, but largely comprehensible 
3. Associations loosely connected most of the time 
 
7. Motor agitation 
Rate by observation, including from other sources of observation such as by visitors, family 
and clinical staff. Do not include dyskinesia, tics, or chorea. 
0. No restlessness or agitation 
1. Mild restlessness of gross motor movements or mild fidgetiness 
2. Moderate motor agitation including dramatic movements of the extremities, pacing, 
fidgeting, removing intravenous lines, etc. 
3. Severe motor agitation, such as combativeness or a need for restraints or seclusion 
 
8. Motor retardation 
Rate movements by direct observation or from other sources of observation such as family, 
visitors, or clinical staff. Do not rate components of retardation that are caused by 
parkinsonian symptoms. Do not rate drowsiness or sleep. 
0. No slowness of voluntary movements 
1. Mildly reduced frequency, spontaneity or speed of motor movements, to the degree that 
may interfere somewhat with the assessment. 
2. Moderately reduced frequency, spontaneity or speed of motor movements to the degree that 
it interferes with participation in activities or self-care 
3. Severe motor retardation with few spontaneous movements. 
 
9. Orientation 
Patients who cannot speak can be given a visual or auditory presentation of multiple choice 
answers. Allow patient to be wrong by up to 7 days instead of 2 days for patients hospitalized 
more than 3 weeks. Disorientation to person means not recognizing familiar persons and may 
be intact even if the person has naming difficulty but recognizes the person. Disorientation to 
person is most severe when one doesn’t know one’s own identity and is rare. Disorientation to 
person usually occurs after disorientation to time and/or place. 
0. Oriented to person, place and time 
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1. Disoriented to time (e.g., by more than 2 days or wrong month or wrong year) or to place 
(e.g., name of building, city, state), but not both 
2. Disoriented to time and place 
3. Disoriented to person 
 
10. Attention 
Patients with sensory deficits or who are intubated or whose hand movements are constrained 
should be tested using an alternate modality besides writing. Attention can be assessed during 
the interview (e.g., verbal perseverations, distractibility, and difficulty with set shifting) 
and/or through use of specific tests, e.g., digit span. 
0. Alert and attentive 
1. Mildly distractible or mild difficulty sustaining attention, but able to refocus with cueing. 
On formal testing makes only minor errors and is not significantly slow in responses 
2. Moderate inattention with difficulty focusing and sustaining attention. On formal testing, 
makes numerous errors and either requires prodding to focus or finish the task 
3. Severe difficulty focusing and/or sustaining attention, with many incorrect or incomplete 
responses or inability to follow instructions. Distractible by other noises or events in the 
environment 
 
11. Short-term memory 
Defined as recall of information (e.g., 3 items presented either verbally or visually) after a 
delay of about 2 to 3 minutes. When formally tested, information must be registered 
adequately before recall is tested. The number of trials to register as well as effect of cueing 
can be noted on scoresheet. Patient should not be allowed to rehearse during the delay period 
and should be distracted during that time. Patient may speak or nonverbally communicate to 
the examiner the identity of the correct items. Short-term deficits noticed during the course of 
the interview can be used also. 
0. Short-term memory intact 
1. Recalls 2/3 items; may be able to recall third item after category cueing 
2. Recalls 1/3 items; may be able to recall other items after category cueing 
3. Recalls 0/3 items 
 
12. Long-term memory 
Can be assessed formally or through interviewing for recall of past personal (e.g., past 
medical history or information or experiences that can be corroborated from another source) 
or general information that is culturally relevant. When formally tested, use a verbal and/or 
visual modality for 3 items that are adequately registered and recalled after at least 5 minutes. 
The patient should not be allowed to rehearse during the delay period during formal testing. 
Make allowances for patients with less than 8 years of education or who are mentally retarded 
regarding general information questions. Rating of the severity of deficits may involve a 
313 
 
judgment about all the ways long-term memory is assessed, including recent and/or remote 
long-term memory ability informally tested during the interview as well as any formal testing 
of recent long-term memory using 3 items. 
0. No significant long-term memory deficits 
1. Recalls 2/3 items and/or has minor difficulty recalling details of other long-term 
information 
2. Recalls 1/3 items and/or has moderate difficulty recalling other long-term information 
3. Recalls 0/3 items and/or has severe difficulty recalling other long-term information 
 
13. Visuospatial ability 
Assess informally and formally. Consider patient’s difficulty navigating one’s way around 
living areas or environment (e.g., getting lost). Test formally by drawing or copying a design, 
by arranging puzzle pieces, or by drawing a map and identifying major cities, etc. Take into 
account any visual impairments that may affect performance. 
0. No impairment 
1. Mild impairment such that overall design and most details or pieces are correct; and/or 
little difficulty navigating in his/her surroundings 
2. Moderate impairment with distorted appreciation of overall design and/or several errors of 
details or pieces; and/or needing repeated redirection to keep from getting lost in a newer 
environment despite, trouble locating familiar objects in immediate environment 
3. Severe impairment on formal testing; and/or repeated wandering or getting lost in 
environment 
 
DRS-R-98 OPTIONAL DIAGNOSTIC ITEMS 
These three items can be used to assist in the differentiation of delirium from other disorders 
for diagnostic and research purposes. They are added to the severity score for the total scale 
score, but are NOT included in the severity score. 
14. Temporal onset of symptoms 
Rate the acuteness of onset of the initial symptoms of the disorder or episode being currently 
assessed, not their total duration. Distinguish the onset of symptoms attributable to delirium 
when it occurs concurrently with a different preexisting psychiatric disorder. For example, if a 
patient with major depression is rated during a delirium episode due to an overdose, then rate 
the onset of the delirium symptoms. 
0. No significant change from usual or longstanding baseline behavior 
1. Gradual onset of symptoms, occurring over a period of several weeks to a month 
2. Acute change in behavior or personality occurring over days to a week 




15. Fluctuation of symptom severity 
Rate the waxing and waning of an individual or cluster of symptom(s) over the time frame 
being rated. Usually applies to cognition, affect, intensity of hallucinations, thought disorder, 
language disturbance. Take into consideration that perceptual disturbances usually occur 
intermittently, but might cluster in period of greater intensity when other symptoms fluctuate 
in severity. 
0. No symptom fluctuation 
1. Symptom intensity fluctuates in severity over hours 
2. Symptom intensity fluctuates in severity over minutes 
 
16. Physical disorder 
Rate the degree to which a physiological, medical or pharmacological problem can be 
specifically attributed to have caused the symptoms being assessed. Many patients have such 
problems but they may or may not have causal relationship to the symptoms being rated. 
0. None present or active 
1. Presence of any physical disorder that might affect mental state 
2. Drug, infection, metabolic disorder, CNS lesion or other medical problem that specifically 





DELIRIUM MOTOR SUBTYPE SCALE-4 (DMSS-4) 
 
(a) Hyperactive subtype defined by the presence of either (i) or (ii) 
 
(i) Increased activity levels evidenced by a positive response to either: 
 Is (s)he more active than before? 
 Does (s)he seem overactive? 
 
(ii) Loss of control of activity evidenced by a positive response to either: 
 Are his / her movements unproductive or lacking in purpose 
 Has (s)he lost a sense of control over their actions? 
 
(b) Hypoactive subtype defined by the presence of either (iii) or (iv): 
 
(iii) Decreased speed of actions evidenced by a positive response to either: 
 Is (s)he moving more slowly than before? 
 Does it take longer than previously to perform simple tasks? 
 
(iv) Decreased amount of speech evidenced by a positive response to either: 
 Does (s)he speak less than before? 
 Is (s)he lacking in spontaneous speech? E.g. only speaks when spoken to. 
 
(c) Mixed subtype defined by the presence of both hyperactive and hypoactive 
criteria as outlined in (a) and (b) above. 
 







SIX-ITEM COGNITIVE IMPAIRMENT TEST (6-CIT) 
Instruction 
 
Date        
1. What year is it? Score 0 if correct 
Score 4 if incorrect 
       
Patient’s answer        
2. What month is it? Score 0 if correct 
Score 3 if incorrect 
       
 Patient’s answer        
3. Repeat this address (choose one)*: 
 
a. Mary /O’Brien/      b. John/ Daly/         c. William/ Murphy/       d. Tom/ O’Shea/          e. Anne/ Hurley/ 
42/ High Street/        77/ Lake View/       53/ College Road/        38/ Station Road/          29/ Church Street/ 
Waterford                 Killarney                 Galway                         Kilkenny                        Limerick 
*(I used a variety of different addresses to minimise learning effect) 
Try to remember this address. I’ll ask you to recall it at the end of the test 
       
4. About what time is it (without looking at watch or clock)? Score 0 if patient is correct to within 1 hour 
Score 3 if patient is incorrect 
       
 Patient’s answer        
5. Count backwards 20 down to 1 
20 19 18 17 16 15 14 13 12 11 10 9 8 7 6 5 4 3 2 1  
Score 0 if no mistakes 
Score 2 if 1 mistake 
Score 4 if 2 or more mistakes 
       
6. Say the months of the year in reverse order 
 
Dec Nov Oct Sept Aug July June May April Mar Feb Jan 
Score 0 if no mistakes 
Score 2 if 1 mistake 
Score 4 if 2 or more mistakes 
       
7. Repeat the address I asked you to remember earlier Score 2 for each error 
0, 2, 4, 6, 8, 10 




























SPATIAL SPAN FORWARDS INSTRUCTIONS FOR USE 
 
1. Show the A5 sized card to the patient and introduce the test by saying; “ I would like 
to do a short test of your concentration. Can you see the squares on the piece of 
card? I am going to point to a sequence of squares with my finger and I would like 
you to repeat what I do by pointing with your finger to the same sequence of 
squares in the same order as me. For example: (point to the second square for one 
second and then slowly move your finger to the sixth square for one second saying) 
“I  would like you to copy this” (point to the same two squares again as if you are the 
patient) 
 
2. “Does that make sense?” Explain again if any uncertainty 
 
3. “Are you comfortable and ready to start? The test starts with just 2 squares but I will 
keep making the sequence longer until you get stuck- don’t worry when that 
happens as that is normal” 
 
4. Point to the sequences in this order, lingering on each square for 1 second: 
2-6;  2-7-5;  3-2-8-4; 5-3-4-6-1 ; 1-7-2-8-5-4 
 
5. Keep going until the patient makes an error; note this and then try the second test 
of this trial (in column B below) i.e. if the patient fails the sequence of 4 (3-2-8-4), 
you should then perform the sequence of 4 from column B (2-6-1-5). If the patient 
fails the second attempt, stop and mark them as the last correctly repeated 
sequence, in this case the patient scores 3. If the patient succeeds at the second 
attempt, proceed to the sequence of 5 in column A. Hence, the patient is allowed 2 
trials if necessary at every stage in order to proceed to the next stage. 
 











CLOCK DRAWING TEST 
 
Please put numbers in the circle so it looks like 






CLOCK DRAWING TEST SCORING TEMPLATE  
Molloy DW. The Quick Mild Cognitive Impairment Screen (Qmci ) Administration and Scoring Manual.21st September 2011. 
 
Scoring 
Place this scoring template over the completed clock with the template’s “12 o’clock” line 
placed over the subject’s 12.  Adjust the template to maximize the score for the numbers 
and hands. The total score is 15. Record scores on the score sheet as follows: 
 
Numbers 
 For the numbers 12, 3, 6, and 9 score one (1) point if they touch their respective 
lines, zero (0) point if missed, and zero (0) if the number is omitted.  
 For the numbers 1, 2, 4, 5, 7, 8, 10, and 11 score one (1) point for each number in 
the correct quadrant, zero (0) point if the number is outside the quadrant, and zero 
(0) if the number is omitted. 
 Subtract one point for each number repeated or more than 12. 
 
Hands 
Score the placement of the entire hand. If the hands are drawn within range, score one (1) 
point for each hand; if the hands are drawn outside the hatched line or are omitted score 











 9  3 
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OVERLAPPING PENTAGONS TEST  
 






ENVIRONMENTAL VISUOSPATIAL QUESTIONS TEST 
 
Five of the following questions were asked daily and the subject was given a mark for each correct 
answer. The test was scored out of five. 
 
1. Where is the toilet? 
2. Where is the nurses’ station? 
3. Where is the way out? 
4. Which is bigger, ……* or …….*? 
5. Which is closer to you, the window or the door? 
6. Which of my hands is closer to you? 
7. Which is taller, ….. *or ……*? 
8. Which is closer to you, ……* or …….*? 
 




STANDARDISED MINI MENTAL STATE EXAMINATION (SMMSE) 
 
Time allowed for each question is given in brackets 
Section 1- Orientation (10 seconds allowed for each question) 
 
1.a. What year is this?  ☐/1  2.a. What country are we in?      ☐/1 
 
b. Which season is this?  ☐/1  b. What county are we in?      ☐/1 
 
c. What month is this?  ☐/1  c. What city / town are we in?      ☐/1 
 
d. What is today’s date?  ☐/1  d. What is the name of this place?  ☐/1 
 
e. What day of the week is this? ☐/1  e. What floor are we on?      ☐/1 
 
 
Section 2- Cognition 
 
3.  SAY: “I am going to name three objects. When I am finished, I want you to repeat 
them. Remember what they are because I am going to ask you to name them again in a few 
minutes.” Say the following words slowly at 1 second intervals: ball / car / man. (20 seconds) 
 
Word 1 _____________ ☐/1   
  
 Word 2 _____________ ☐/1   
 
 Word 3 _____________ ☐/1   
 
4.  Spell the word ‘WORLD’. Now spell it backwards. (30 seconds) 
 
DLROW _____________ ☐/5   
 
5.  Now what were the three objects I asked you to remember? (10 seconds) 
 
Word 1 _____________ ☐/1   
 
 Word 2 _____________ ☐/1   
 
 Word 3 _____________ ☐/1   
 
6. SHOW wristwatch. Now ASK: “What is this called?” (10 seconds)  ☐/1  
 
7. SHOW pencil. Now ASK: “What is this called?” (10 seconds)   ☐/1  
 
8. SAY “I would like you to repeat this phrase after me:  




9. SAY “Read the words on the page and then do what it says.” Then hand the person the 
sheet with CLOSE YOUR EYES on it. If the subject reads but does not close their eyes, repeat 
up to three times. Score only if subject closes eyes. (10 seconds) 
 
Subject closes eyes  ☐/1 
 
10. HAND the person a pencil and paper. SAY: “Write any complete sentence on that piece 
of paper.” Note: the sentence must make sense. Ignore spelling errors. (30 seconds) 
 
 Sentence   ☐/1 
 
11. Place design, eraser and pencil in front of the person. SAY: “Copy this design please.” 
Allow multiple tries. Wait until the person is finished and hands it back. Score only for 
correctly copied diagram with a 4-sided figure between 2 5-sided figures. 
(1 minute) 
 
 Copies design  ☐/1 
 
12. ASK the person if he / she is right or left-handed. Take a piece of paper and hold it up in 
front of the person. SAY: “Take this paper in your right / left hand (whichever is non-
dominant), fold the paper in half once with both hands and put the paper down on the 
floor.” Score 1 point for each instruction executed correctly. (30 seconds) 
 


















Copy this diagram 
  
 






 Date Date Date Date Date Date Date 
Bowels 0= incontinent, 1= 
occasional accident (1 per 
week), 2= continent 
       
Bladder 0= incontinent or 
catheterized & unable to 
manage, 1= occasional 
accident (max 1 per 24 
hours), 2= continent for over 
7 days 
       
Grooming 0= needs help, 1= 
independent (face, hair, 
teeth, shaving) 
       
Toilet use 0= dependent, 1= needs 
some help but can do 
something, 2= independent 
(on & off, dressing, wiping) 
       
Feeding 0= unable, 1= needs help 
cutting, spreading butter, 
etc, 2= independent 
       
Transfer 0= unable, 1= major help (1-
2 people, physical), 2= minor 
help (verbal or physical), 3= 
independent 
       
Mobility 0= immobile, 1= wheelchair 
independent including 
corners etc, 2= walks with 
help of 1 person (verbal/ 
physical), 3= independent 
(but may use aid, e.g. stick) 
       
Dressing 0= dependent, 1= needs 
help but can do half 
unaided, 2= independent 
       
Stairs 0= unable, 1= needs help 
(verbal, physical, carrying 
aid), 2= independent up & 
down 
       
Bathing 0= dependent, 1= 
independent 
       
Score (__/20)        
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MINI NUTRITIONAL ASSESSMENT- SHORT FORM 
 
A. Have you been eating less than normal over the past 3 months? Is it much less or 
only a little less? 
  Severe decrease  0 
  Moderate decrease  1 
  No decrease   2 
 
 
B. Have you lost weight recently without trying? How much?  
Was that in the last few months or over the last year? 
 
 Weight loss >3kg  0 
 Does not know   1 
 Weight loss 1 to 3kg  2 
 No weight loss   3 
 
 
C. Mobility  Bed / chair bound   0 
   Able to get up but not out  1 
   Goes out    2 
 
D. Psychological stress/ acute disease  
(e.g. bereavement / moved house / recent illness) 
        Yes 0 
         No 1 
 
E. Neuropsychological problems (medical notes / collateral history) 
 
Severe dementia / depression  0 
Mild dementia    1 
Nil     2 
 
F1. Body Mass Index _________  OR  F2. Calf Circumference (cm) 
  
 Weight (kg)  ______    _____________ 
Height (m)  ______ 
 Demispan (cm)  ______ 
          
 BMI <19   0   <31 cm  0 
 BMI 19-21   1     
 BMI 21-23   2 
 BMI ≥23   3   ≥31 cm  3 
 
 




AB CLINICIAN DEPRESSION SCREEN (ABCDS) 
 
 
 1. Do you often feel downhearted and blue?  
 
   No ☐ Depression ruled out with 95% certainty 
 
   Yes ☐  Ask the following questions: 
 
 
 2. Do you often feel helpless?   Yes ☐ No ☐ 
 
 3. Do you feel that your life is empty?  Yes ☐ No ☐ 
 
 4. Do you feel happy most of the time?  Yes ☐ No ☐ 
 
 5. Are you basically satisfied with your life? Yes ☐ No ☐ 
  
  
Score 1 or 2 / total of 5 questions: Not depressed 
Score 4 or 5 / total of 5 questions: Depressed.   




GERIATRIC DEPRESSION SCALE: SHORT FORM  
 
Choose the best answer for how you have felt over the past week:  
 
1. Are you basically satisfied with your life? YES / NO  
2. Have you dropped many of your activities and interests? YES / NO  
3. Do you feel that your life is empty? YES / NO  
4. Do you often get bored? YES / NO  
5. Are you in good spirits most of the time? YES / NO  
6. Are you afraid that something bad is going to happen to you? YES / NO  
7. Do you feel happy most of the time? YES / NO  
8. Do you often feel helpless? YES / NO  
9. Do you prefer to stay at home, rather than going out and doing new things? YES / NO  
10. Do you feel you have more problems with memory than most? YES / NO  
11. Do you think it is wonderful to be alive now? YES / NO  
12. Do you feel pretty worthless the way you are now? YES / NO 
13. Do you feel full of energy? YES / NO  
14. Do you feel that your situation is hopeless? YES / NO  
15. Do you think that most people are better off than you are? YES / NO  
 
Answers in bold indicate depression. Score 1 point for each bolded answer.  
 
A score > 5 points is suggestive of depression.  
A score ≥ 10 points is almost always indicative of depression.  





THE MODIFIED CUMULATIVE ILLNESS RATING SCALE (M-CIRS). 
Body system Score 
1. Cardiac (heart only) 0 1 2 3 4 
2. Hypertension (rating is based on severity; organ damage is rated separately) 0 1 2 3 4 
3. Vascular (blood, blood vessels and cells, bone marrow, spleen, lymphatics) 0 1 2 3 4 
4. Respiratory (lungs, bronchi, trachea below the larynx) 0 1 2 3 4 
5. EENT (eye, ear, nose, throat, larynx) 0 1 2 3 4 
6. Upper GI (esophagus, stomach, and duodenum; pancreas; do not include diabetes) 0 1 2 3 4 
7. Lower GI (intestines, hernias) 0 1 2 3 4 
8. Hepatic (liver and biliary tree) 0 1 2 3 4 
9. Renal (kidneys only) 0 1 2 3 4 
10. Other GU (ureters, bladder, urethra, prostate, genitals) 0 1 2 3 4 
11. Muscolo-skeletal-integumentary (muscle, bone, skin) 0 1 2 3 4 
12. Neurological (brain, spinal cord, nerves, do not include dementia) 0 1 2 3 4 
13. Endocrine-Metabolic (includes diabetes, thyroid; breast; systemic infections; toxicity) 0 1 2 3 4 








 (0 = not present; 1 = possibly or somewhat present; 2 = definitely present) 
A. General complaints. 
In the last 24 hours, have you noticed any changes in the patient’s 
general wellbeing? 
1. Appetite   
2. Pattern of pain / discomfort    
3. Frequency of requests for analgesia   
4. Frequency of help seeking OR calling for attention 
5. Other non-specific changes (e.g. general malaise,  ‘not themselves’) 
6. Does the patient have nocturnal worsening of symptoms? 
 
B. Affect / emotional changes. 
In the last 24 hours, have you noticed any changes in the patient’s mood? 
1. Tearfulness / sadness 
2. Irritable / grumpy 
3. Fear 
4. Excess anxiety or worry 
5. Inappropriate elation or euphoria   
6. Excess remorse or guilt  
 
C. Demeanour or cognitive changes 
In the last 24 hours, have you noticed any changes in the patient’s ….. 
1. Awareness of surroundings or situation?   
2. Being apathetic or disinterested?   
3. Being easily distractible or going ‘off-track’?  
4. Level of confusion or ‘fogginess’?   
5. Needing prompting / encouragement to do usual tasks? 
 
0/1/2 D. Sleep/ activity changes 
In the last 24 hours, have you noticed any changes in the patient’s sleep / 
activity? 
1. Poor sleep pattern at night (max 2)  
1-3 hours awake   (1)  >3 hours awake    (2)      Nightmares    (1) 
Difficulty getting to sleep (>30 minutes)   (1)   
Seems to be tired in the morning    (1) 
2. Drowsiness during the day  
some of the time    (1)  a lot of the time   (2)  
3. Being ‘fidgety’, restless or wandering    
4. Being combative or resisting care   
5. Being less active than usual / expected   
6. Slower movements     
7. Does the patient SHIFT suddenly from low to high activity or vice versa? 
Over minutes  (2)  Over hours   (1)  
8. Does the patient SHIFT suddenly from wakefulness to drowsiness or vice 
versa?  
Over minutes (2) Over hours   (1) 
 
E. Speech/ Talk disturbance 
In the last 24 hours, have you noticed any changes in the patient’s 
conversation? 
1. Ability to find the right words or name things properly?  
2. Understanding you   
3. Holding a conversation   
4. Saying odd things that don’t make sense  
5. Rambling off the point   










INFORMANT QUESTIONNAIRE FOR COGNITIVE DECLINE IN THE ELDERLY – SHORT FORM 
(IQCODE-SF) 
Source: http://www.alz.org/documents_custom/shortiqcode_english.pdf 
Now we want you to remember what your friend or relative was like 10 years ago 
and to compare it with what he/she is like now. 10 years ago was in 19__. Below 
are situations where this person has to use his/her memory or intelligence and we 
want you to indicate  whether  this has improved,  stayed  the same  or got worse  
in that situation over the past 10 years. Note the importance of comparing his/her 
present performance with 10 years ago. So if 10 years ago this person always forgot 
where he/she had left things, and he/she still does, then this would be considered 
"Hasn't changed much". Please indicate the changes you have observed by circling 
the appropriate answer. 
 
Compared with 10 years ago how is this person at: 
 
1                   2                     3                 4                   5 
1. Remembering things about 





































4. Remembering his/her address 
and telephone number 
Much 
improved 








5. Remembering what day and 
month it is 
Much 
improved 








6. Remembering where things 
are usually kept 
Much 
improved 








7. Remembering where to find 
things which have been put in 
a different place from usual 
Much 
improved 










8. Knowing how to work 












9. Learning to use a new gadget 
or machine around the house 
Much 
improved 




















11. Following a story in a book 
or on TV 
Much 
improved 
































15. Handling other everyday 
arithmetic problems e.g. 
knowing how much food to 
buy, knowing how long 












16. Using his / her intelligence 
to understand what's going on 
and to reason things through 
Much 
improved 










DELIRIUM ETIOLOGY CHECKLIST  
Trzepacz P, Meagher D. Neuropsychiatric aspects of delirium. In: Eds Yudofsky S, Hales R, editors. American Psychiatric 
Association Manual of Neuropsychiatry. 1st ed. Washington DC: American Psychiatric Publishing Press; 2012. 
 
This checklist accounts for the multifactorial etiologies in causing delirium by allowing 
a weighted approach for documenting the range of potential inputs in any single 
case.  Therefore, raters may indicate multiple categories as contributing toward 
reaching the threshold for delirium.  The relative importance of history, examination, 
and tests in supporting the significance of any particular causative factor will vary 
among cases so that the certainty of causation will depend on the judgement of the 
clinician involved based on all available information.  Specific disorders assigned to 
categories are noted on the reverse side of this page. 
 






























    
Traumatic Brain Injury 
 
 




































    
 
See other side for a more detailed list of conditions grouped under each of the above 
categories and please check each one you considered as a contributory (definite, 














6 Prescribed drug ___________________ 
7 Other ___________________________ 






3 Prescribed drug ________________________ 
4 Other drug ____________________________ 
Metabolic/Endocrine Disturbance 
1 Volume depletion 









6 Uremia  
7 Anemia 
8 Avitaminosis ________________ 























28 Cushing’s Syndrome 
29 Addison’s Disease 
 

































3 Meningeal Carcinomatosis 
Extracranial Neoplasm 
Site of primary lesion _________________________ 
 
 Paraneoplastic Syndrome 
 
Cerebrovascular Disorder 
1 Transient Ischemic Attack 
2 Subarachnoid Hemorrhage 
 
3 Stroke 
4 Subdural Hemorrhage 
5 Cerebral Edema 
 
5 Intraparenchymal hemorrhage 
6 Cerebral Vasculitis 










6 Other _______________________________ 
 
Other CNS 
1 Parkinson’s Disease 
2 Huntington’s Disease 
 
3 Multiple Sclerosis 
4 Wilson’s Disease 
 
5 Hydrocephalus 
6 Other _______________________________ 
 
Other Systemic 




4 Post-operative state 
 
5 Immunosuppressed                    7 Fractures 




EXCERPT FROM NICE GUIDELINES: CG103 
Delirium: Diagnosis, prevention and management. London: National Institute for Health and Clinical 
Excellence, 2010 CG103 Contract No.: CG103. 
 
Risk factor assessment  [Recommendation 1.1.1.] 
When people first present to hospital or long-term care, assess them for the following  
risk factors. If any of these risk factors is present, the person is at risk of delirium.  
• Age 65 years or older.  
• Cognitive impairment (past or present) and/or dementia. If cognitive impairment is 
suspected, confirm it using a standardised and validated cognitive impairment measure. 
• Current hip fracture.  
• Severe illness (a clinical condition that is deteriorating or is at risk of deterioration). 
 
Indicators of delirium: at presentation [Recommendation 1.2.1] 
At presentation, assess people at risk for recent (within hours or days) changes or 
fluctuations in behaviour. These may be reported by the person at risk, or a carer or relative. 
Be particularly vigilant for behavior indicating hypoactive delirium (marked*). These 
behavior changes may affect:    
• Cognitive function: for example, worsened concentration*, slow responses*, confusion.  
• Perception: for example, visual or auditory hallucinations.  
• Physical function: for example, reduced mobility*, reduced movement*, restlessness, 
agitation, changes in appetite*, sleep disturbance.  
• Social behaviour: for example, lack of cooperation with reasonable requests, withdrawal*, 
or alterations in communication, mood and/or attitude.  
 
If any of these behavior changes are present, a healthcare professional who is trained and 
competent in diagnosing delirium should carry out a clinical assessment to confirm the 
diagnosis  
 
Indicators of delirium: daily observations  
Observe at least daily, all people in hospital or long-term care for recent (within hours or 
days) changes or fluctuations in usual behaviour (see recommendation 1.2.1). These may be 
reported by the person at risk, or a carer or relative. If any of these behaviour changes is 
present, a healthcare professional who is trained and competent in the diagnosis of delirium 





NICE: Questions to nursing staff  Study number____________________ 
First use open questions and document response. Then ask more specific questions.  
 
1. Has there been a recent change or any fluctuations in the patient’s cognition? 
 
Describe_________________________________________________________________________________________________ 
a. Has the patient been more confused than usual in the last 24 hours?  Y / N 
b. Does it seem harder for them to focus on what you’re saying or on a task? Y / N 
c. Are their responses to you slower than before?     Y / N 
 




a. Have they complained of any hallucinations?      Y / N 
b.  Does it seem that they are responding to things that are not there?  Y / N 
 




a. Have they become less active or have they slowed down in general?  Y / N 
b. Have they been restless or agitated at all?      Y / N 
c. Has there been any change in their sleep pattern?     Y / N 
d. Have they lost their appetite?        Y / N 
 




a. Have they become withdrawn or disinterested?     Y / N 
b. Have they become less cooperative / need more prompting than usual?  Y / N 
c. Have there been any changes in their mood / attitude towards you?  Y / N 




B. DETAILS ON HOW DELIRIUM INSTRUMENTS WERE SCORED IN 
THIS STUDY 
 
 CAM Scoring 







To score the attention component of the CAM, I used only the ‘Months of the Year 
Backwards (MOTYB)’ supplemented by observations of level attentiveness / distractability 
during the assessment. MOTYB was considered incorrect if the patient failed to get back as 
far as July without error or major hesitation. Questions requiring abstract answers based 
largely on the CAM-ICU (The Confusion Assessment Method for the ICU) training manual1 
were used to discern if there was disorganised thinking present. This item was scored 
positively if any of these questions were answered incorrectly or if there was clear evidence 
of disorganised thought processes during the assessment. Level of alertness was considered 
abnormal if there was either evidence of drowsiness or hyperalertness or if collateral history 
suggested evidence of this over the previous 24-hour period. Patients were not considered 
drowsy if they had one nap after a meal and were easily roused during this nap. Acuity of 








1Ely EW. Confusion Assessment Method for the ICU (CAM-ICU). The Complete Training Manual. 2001 [updated October 2010; 






DRS-R98 SCORING  
 
In this study, in keeping with guidelines for its use, each DRS-R98 item was scored according 
to the training manual1. Items 1 (sleep-wake cycle disturbance); 2 (perceptual disturbances 
and hallucinations); 3 (delusions); 4 (lability of affect); 7 (motor agitation); 8 (motor 
retardation); 14 (temporal onset of symptoms); 15 (severity of fluctuations); and 16 (physical 
disorder) were scored using the anchored descriptions and suggested questions in the 
manual. Other items are scored using formal testing coupled with observations made during 
the interview: items 5 (language); 6 (thought process abnormalities); and the cognitive items 
(9 to 13). The following is a description of how each of these latter items were scored. 
 
Item 5 (Language) 
The patient was asked to firstly name two items shown to them (e.g. pen; watch; glass; jug; 
or other items found at the bedside) and secondly to follow a three-stage command (e.g. 
‘Close your eyes, stick out your tongue and raise your right hand in the air’; or ‘Take this 
piece of paper, fold it in half and leave it on the bed’). Correct responses to these 
assessments were scored 0. Mild impairments were scored 1, e.g. mild word finding 
difficulty or hesitancy in following the command. A score of 2 was given if both items were 
named incorrectly or the three-stage command was incorrectly followed. A score of three 
was rarely given and was reserved for those with severe dysphasia (in which case they were 
generally excluded from the longitudinal study).  
Item 6 (Thought Process Abnormalities) 
Item 6 was scored by asking the patient to interpret a proverb or saying and to answer two 
questions requiring an abstract answer. Examples of the proverbs or sayings used included 
‘Every cloud has a silver lining’; ‘Don’t judge a book by its cover’; ‘A stitch in time saves nine’; 
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‘Actions speak louder than words’; ‘Blood is thicker than water’; ‘The grass is always greener 
on the other side’. Some of the questions I used were based on the CAM-ICU training 
manual2 and included ‘Would a stone float on water?’; ‘Would two pounds of flour weigh 
more than one pound?’; ‘Can you use a hammer to pound a nail?’; ‘Would you find fish in 
the sea?’. Other questions I used included ‘Would a good pair of wellies (wellington boots) 
let water in?’ and ‘Is a cat bigger than a rat?’; ‘Would you use a spoon to eat soup?’; ‘Would 
you use a fork to eat soup?’; and ‘Would you find sand on a beach?’. A score of 0 was given 
when thought process was normal, the proverb was interpreted correctly and the two 
questions answered correctly. A score of 1 was given if the patient was either circumstantial 
or tangential in their output or if they didn’t entirely interpret the proverb correctly but got 
both abstract questions correct. A score of two was given if they got one or both of the 
abstract questions incorrect and / or the proverb was completely incorrect and / or there 
was demonstrable thought disorder (e.g. loosening of associations) at times during the 
conversation. Patients were rarely scored 3 and only if they had severe thought disorder 
such that full formal delirium assessment was challenging.  
Item 9 (Orientation) 
Scoring item 9 (orientation), was based on questions relating to the day, month, year and 
place as per the scoring manual. A patient scored 0 if he / she was fully orientated to time, 
place and person. A score of 1 was given if he / she was  disoriented to time (e.g. by more 
than 2 days or wrong month or wrong year) or to place (e.g. name of building, city, county), 
but not both, whereas a score of 2 was given if the patient was disoriented to both time and 
place. A score of 3 was reserved only for those who could not identify who they themselves 




Item 10 (Attention) 
In this study, I incorporated multiple tests of attention (see later), however to score 
attention on the DRS-R98 I used only the ‘days of the weeks backwards (DOTWB)’ (in which 
a patient is asked to recite the days of the week in reverse order starting with Sunday); and 
‘20 to 1’ (in which a patient is requested to count backwards from 20 down to one), as well 
as a clinical assessment of their attention / distractability during the interview. Patients 
scored 0 if they were able to perform both tests without any error or hesitation and there 
was no evidence of distractability during the interview. A score of 1 was given if they made 
one error on one or both of the tests and / or there was mild distractability during the 
assessment. A score of 2 was given if the patient managed to finish the tests with more than 
one error, with or without prompting or if there was evidence of distractability requiring 
refocusing, during the interview. A score of three was given to those who were unable to 
finish the tests even with prompting or those who were so distractable that they were 
unable to engage with the tests.   
Item 11 (short-term memory) 
Item 11 was scored using the patient’s ability to remember a five-point address (from the 6-
CIT). If the five points were recalled correctly, the patient scored 0. If three or four items 
were recalled, a score of 1 was given, whereas a score of 2 was given to those who recalled 
only one to two items from the address. A score of 3 was given to those who could not 
remember any of the address.  
Item 12 (long-term memory)  
Item 12 was scored by asking the patient three questions pertaining to long-term memory, 
including ‘What date is St. Patrick’s Day?’; ‘What year was the Easter Rising?’; ‘What’s the 
name of the Taoiseach / President?’. Sometimes these were substituted with questions 
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pertaining to the patient’s personal history (e.g. ‘What are the names of your children?’; 
‘What year did you return to live in Ireland from London?’; ‘What year did you get married?’; 
‘What operations have you had in the past?’), if the patient indicated that they didn’t want 
to answer questions about history or politics, but for the most part the first three questions 
were asked. A score of 0 was achieved if all three questions were answered correctly. If two 
questions were answered correctly, a score of 1 was given; if one question was answered 
correctly a score of 2 was given and if all questions were answered incorrectly a score of 3 
was given.  
Item 13 (Visuospatial Ability) 
Item 13 was scored by considering the patients performance on each of 3 tests, the Clock-
Drawing Test (CDT); the overlapping pentagons test (OPT) and a set of questions designed to 
verbally assess visuospatial function. An overall impression of the severity of impairment 
was decided upon and a score given accordingly.  
1Trzepacz PT MJ, Kean J, Abell M, Meagher DJ. . The Delirium Rating Scale- Revised- 98 (DRS-R98) Administration Manual. A 
guide to increase understanding of how to solicit delirium symptoms to administer the DRS-R98. Indianapolis, IN, USA: Paula 
Trzepacz ®; 2009. 
2Ely EW. Confusion Assessment Method for the ICU (CAM-ICU). The Complete Training Manual. 2001 [updated October 2010; 






C. DATA RECORDING FILES 
 
 
All data collection forms are included in the following pages: 
 Baseline data collection form 
 Longitudinal assessment forms 
 Screening assessment forms 
 Daily assessment forms 






BASELINE DATA COLLECTION FORM 
“A Prospective Study of the Incidence, Prodrome, 
Characterisation, Risk Factors and Outcomes of 




A two-centre, prospective cohort study of 










Study ID:  
 
Consent Form    
Note for chart   
Patient Info leaflet 
346 
 
Study number ___________ 
Baseline 
 Nursing notes 
 Social/ 
 educational hx 
 Medical History  
  M-CIRS 
 DEC   
  MNA   
 weight  & 
 demispan /calf 
  Waterlow / 
 Braden 
  Frailty  
  Dynamometer  
  Standing  
  Depression  
 sMMSE  
  QOL  
 
Collateral 
 Delirium  
  IQCODE-SF 
 Barthel / iADL 
 Dysf. Behaviour 
  Burden 
 MNA 
 Prodrome 
 Other info 
patient  unable 






Assessment  Date         
ABDS (Depression)        
Possible interval delirium        
Barthel Score (discharge)        
347 
 
Study number ___________ 
Overall Clinician assessment... 
The patient: 
☐1. Never develops delirium     
☐2. Develops Subsyndromal Delirium    
☐3. Develops Full-blown delirium 
 
If the patient develops full-blown or subsyndromal delirium: 
1. Fill the Delirium Etiology Checklist (full-blown mainly) 
2. What day / date does he / she become delirious?____________________ 
3. Which day of assessments is that?  ______________________________ 























Study number ___________ 
C.2 Barthel Index (Baseline is day of admission) 
  
  
 Date Date Date Date Date Date Date 
Bowels 0= incontinent, 1= 
occasional accident (1 per 
week), 2= continent 
       
Bladder 0= incontinent or 
catheterized & unable to 
manage, 1= occasional 
accident (max 1 per 24 
hours), 2= continent for 
over 7 days 
       
Grooming 0= needs help, 1= 
independent (face, hair, 
teeth, shaving) 
       
Toilet use 0= dependent, 1= needs 
some help but can do 
something, 2= independent 
(on & off, dressing, wiping) 
       
Feeding 0= unable, 1= needs help 
cutting, spreading butter, 
etc, 2= independent 
       
Transfer 0= unable, 1= major help (1-
2 people, physical), 2= 
minor help (verbal or 
physical), 3= independent 
       
Mobility 0= immobile, 1= wheelchair 
independent including 
corners etc, 2= walks with 
help of 1 person (verbal/ 
physical), 3= independent 
(but may use aid, e.g. stick) 
       
Dressing 0= dependent, 1= needs 
help but can do half 
unaided, 2= independent 
       
Stairs 0= unable, 1= needs help 
(verbal, physical, carrying 
aid), 2= independent up & 
down 
       
Bathing 0= dependent, 1= 
independent 
       





Study number ___________ 
1.0 Baseline Assessment 
A. Demographics/ Medical History 
 
a)  Gender: Male  Female  b) married / widowed / single 
 
c)   Age :_______ years  DOB (dd/mm/yy):  ____/_____/____ 
 
d) Date of Admission ___/___/ ___  
 
e) Arrived to A/E    _____________  Arrived to ward _____________ 
 LOS in A&E _______ hrs       
 
f) Reason for Admission ______________________________________ 
________________________________________________________________ 
  
g) Working Diagnosis______________________________________________ 
________________________________________________________________ 
 
h) Medical diagnoses  
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 





Study number ___________ 
m) Modified Cumulative Illness Rating Scale 
 
 (include presenting complaints and past medical history). If not sure how to score, write in 
details. 
 
Body system Score 
1. Cardiac (heart only) 0 1 2 3 4 
2. Hypertension (rating is based on severity; organ damage is 
rated separately) 
0 1 2 3 4 
3. Vascular (blood, blood vessels and cells, bone marrow, spleen, 
lymphatics) 
0 1 2 3 4 
4. Respiratory (lungs, bronchi, trachea below the larynx) 0 1 2 3 4 
5. EENT (eye, ear, nose, throat, larynx) 0 1 2 3 4 
6. Upper GI (esophagus, stomach, and duodenum; pancreas; do 
not include diabetes) 
0 1 2 3 4 
7. Lower GI (intestines, hernias) 0 1 2 3 4 
8. Hepatic (liver and biliary tree) 0 1 2 3 4 
9. Renal (kidneys only) 0 1 2 3 4 
10. Other GU (ureters, bladder, urethra, prostate, genitals) 0 1 2 3 4 
11. Muscolo-skeletal-integumentary (muscle, bone, skin) 0 1 2 3 4 
12. Neurological (brain, spinal cord, nerves, do not include 
dementia) 
0 1 2 3 4 
13. Endocrine-Metabolic (includes diabetes, thyroid; breast; 
systemic infections; toxicity) 
0 1 2 3 4 
14. Psychiatric/Behavioral (includes dementia, depression, 
anxiety, agitation/delirium, psychosis) 












Study number ___________ 
i) Medications  
 




 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
______________________________ ___________________________ 
______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 
Changes since admission (Before recruitment): 
 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 
 ______________________________ ___________________________ 





Study number ___________ 
j)  Place of residence  
 
 home alone   ☐ home with _______________ ☐
 sheltered accommodation ☐ nursing home     ☐ 
 
 
k) Social supports (if known)  
None   ☐ PHN  ☐ how often ________ 
Home help   ☐ amount  ________ 
MOW   ☐ Private carer  ☐   
Family support ☐ 
Details  __________________________________________________ 
 
l) Education level 
Age left school ______________ 
Primary school  ☐  Inter Cert   ☐
 Leaving Cert   ☐  3rd level   ☐ 
 
m) Smoking history  
Current  ☐ how many /day _______how many years_________ 
Ex   ☐ When started?________When stopped?_________ 
   How many? _____________ 
Never  ☐ 
 
n) Alcohol History 
Teetotaller ☐ Currently drinks ☐ (amount)_________ 






Study number ___________ 
B) Baseline Patient Assessment 
 
B.1 Sensory screening 
 
 
 1. Hearing 
 
 Can you understand me/ Can you hear me?  ☐ 
 
 No hearing impairment    ☐ 
  
 Known hearing impairment    ☐ 
 




2.  Vision 
 
 No visual impairment  ☐   Can you see these objects? 
 
 Known visual impairment ☐   Pen  ☐ 
  
Blind or near-blind  ☐    Watch  ☐ 
 
 Wears glasses   ☐ 
 
 
 Can you read this?   ☐ 
 




The quick brown fox jumps over 





Study number ___________ 
B.5. AB Clinician Depression Screen (ABCDS) 
 
 
1. Do you often feel downhearted and blue?  
 
  No ☐ Depression ruled out with 95% certainty 
 
  Yes ☐  Ask the following questions: 
 
 
2. Do you often feel helpless?   Yes ☐ No ☐ 
 
3. Do you feel that your life is empty?  Yes ☐ No ☐ 
 
4. Do you feel happy most of the time?  Yes ☐ No ☐ 
 
5. Are you basically satisfied with your life? Yes ☐ No ☐ 
  
  
Score 1 or 2 / total of 5 questions: Not depressed 
Score 4 or 5 / total of 5 questions: Depressed.   
Score of 3/5: proceed to Geriatric Depression Scale 
 
 
Date __________  Result ___________ 
 
Date __________  Result ___________ 
 





Study number ___________ 
B.2 Nutrition: Mini- Nutrional Assessment- Short form 
 
A. Have you been eating less than normal over the past 3 months? 
  Is it much less or only a little less? 
  
Severe decrease  0 
  Moderate decrease  1 
  No decrease   2 
 
 
B. Have you lost weight recently without trying? How much?  
Was that in the last few months or over the last year? 
 
 Weight loss >3kg  0 
 Does not know  1 
 Weight loss 1 to 3kg  2 
 No weight loss  3 
 
 
C. Mobility  Bed / chair bound   0 
   Able to get up but not out  1 
   Goes out    2 
 
D. Psychological stress/ acute disease  (e.g. bereavement / moved house / 
recent illness)      Yes 0 
       No 1 
 
E. Neuropsychological problems (medical notes / collateral history) 
Severe dementia / depression 0 
Mild dementia   1 
Nil     2 
 
F1. Body Mass Index _________  OR  F2. Calf Circumference (cm) 
  
 Weight (kg)  ______   _____________ 
Height (m)  ______ 
 Demispan (cm) ______ 
          
 BMI <19   0   <31 cm 0 
 BMI 19-21   1     
 BMI 21-23   2 
 BMI ≥23   3   ≥31 cm 3 
 
 





B.5 Standardised Mini-Mental State Examination (SMMSE)  
 
Study number _______________  DATE_______ 
 
Time allowed for each question is given in brackets 
Section 1- Orientation (10 seconds allowed for each question) 
 
1.a. What year is this?  ☐/1  2.a. What country are we in?      ☐/1 
 
b. Which season is this?  ☐/1  b. What county are we in?      ☐/1 
 
c. What month is this?  ☐/1  c. What city / town are we in?      ☐/1 
 
d. What is today’s date?  ☐/1  d. What is the name of this place?  ☐/1 
 
e. What day of the week is this? ☐/1  e. What floor are we on?      ☐/1 
 
 
Section 2- Cognition 
 
3.  SAY: “I am going to name three objects. When I am finished, I want you to repeat 
them. Remember what they are because I am going to ask you to name them again in a few 
minutes.” Say the following words slowly at 1 second intervals: ball / car / man. (20 seconds) 
 
Word 1 _____________ ☐/1   
  
 Word 2 _____________ ☐/1   
 
 Word 3 _____________ ☐/1   
 
4.  Spell the word ‘WORLD’. Now spell it backwards. (30 seconds) 
 
DLROW _____________ ☐/5   
 
5.  Now what were the three objects I asked you to remember? (10 seconds) 
 
Word 1 _____________ ☐/1   
 
 Word 2 _____________ ☐/1   
 
 Word 3 _____________ ☐/1   
 
6. SHOW wristwatch. Now ASK: “What is this called?” (10 seconds)  ☐/1  
 






8. SAY “I would like you to repeat this phrase after me:  
No ifs, ands, or buts” (10 seconds)     ☐/1 
 
9. SAY “Read the words on the page and then do what it says.” Then hand the person the 
sheet with CLOSE YOUR EYES on it. If the subject reads but does not close their eyes, repeat 
up to three times. Score only if subject closes eyes. (10 seconds) 
 
Subject closes eyes  ☐/1 
 
10. HAND the person a pencil and paper. SAY: “Write any complete sentence on that piece 
of paper.” Note: the sentence must make sense. Ignore spelling errors. (30 seconds) 
 
 Sentence   ☐/1 
 
11. Place design, eraser and pencil in front of the person. SAY: “Copy this design please.” 
Allow multiple tries. Wait until the person is finished and hands it back. Score only for 
correctly copied diagram with a 4-sided figure between 2 5-sided figures. 
(1 minute) 
 
 Copies design  ☐/1 
 
12. ASK the person if he / she is right or left-handed. Take a piece of paper and hold it up in 
front of the person. SAY: “Take this paper in your right / left hand (whichever is non-
dominant), fold the paper in half once with both hands and put the paper down on the 
floor.” Score 1 point for each instruction executed correctly. (30 seconds) 
 



















Copy this diagram 
  
 





Study number ___________ 




Score = ____________ 
Mean score = __________ 
 Much 
Improved 




A bit worse Much 
worse 
1 2 3 4 5 
Remembering things about family      
Remembering recent events      
Recalling conversations a few days later      
Remembering own address/ phone number      
Knowing day/ month      
Remembering where things are usually kept      
Remembering where to find things that are 
in a different place than usual 
     
Knowing how to work familiar machines 
around the house 
     
Learning how to use a new gadget around 
the house 
     
Learning new things in general      
Following a story in a book or on TV      
Making decisions on everyday matters      
Handling money for shopping      
Handling financial matters, eg: pension      
Handling other everyday arithmetic       




LONGITUDINAL ASSESSMENTS  
 Study number ________________  DATE / DAY Sample questions        
Sleep Did you sleep well? 
 
Were you awake during the night? 
 
Did you feel well-rested this morning? 
 
Do you have trouble staying awake during the day? 
       
Del/ Hall Do you feel alright in yourself? 
 
Has anything strange happened that you think might 
not be real? 
 
Any nightmares / vivid dreams?  
 
Do you feel safe here? 
 
Have you been treated well here? 
       
Mood Has anything upset you? 
 
Are you annoyed about anything? 
 
Do you feel in control of your emotions? 
       
MA Have you felt agitated / restless / fidgety? 
 
Do you feel the need to keep moving?        
MR Have you slowed down?  
 
Are you moving around less than usual?        
Speech Has your speech changed in anyway? 
       
Thought Have you noticed any changes in your ability to think 










 Study number ________________     DATE /DAY        
Observation Bed location (1= window, 2= middle, 3= door, 4= 2-
bedded, 5= single room)        
 
Bed move 
       
 
Clock / watch (1= yes, 0= no) 
       
 
IV line (number, 4= central) 
       
 
Restraint: 0 =none; 1=tray; 2=bedrail; 3=both; 4=other 
       
 
Feeding: 0=oral; 1= fast; 2=NGT; 3=PEG; 4=TPN; 5= 
unable to eat (e.g. nausea)        
 
Catheter (0= none; 1 = urethral; 2 = s-pub) 
       
 
O2 (0= none; 1=continuous; 2 = intermittent) 




       
 
Month 
       
         
 
Place 








       
 
Months Backwards 
       
6-item CIT 
Orientation 
Time of day 














































Nurse Study number ________________     DATE /DAY        
CAM1 Any changes in last 24 hours- confusion, drowsiness, 
behaviour? 
 
       
 
Any fluctuations / waxing & waning? 
       
Sleep Sleeping well? 
 
Any confusion during the night? 
 
Any drowsiness or hyperalertness during the day? 
 
       
Del/ Hall Any hallucinations or delusions? 
 
Do they seem preoccupied with / upset about anything? 
 
       
Mood Any tearfulness / inappropriate emotions? 
       
Language Any difficulty in conversing? 
       
MA Any agitation / restlessness? 
 
Are they constantly trying / asking to get out of the 
chair / bed? 
 
       
MR Initiate any activity (scratching / eye contact / personal 
needs)? 
 
Does poor spontaneous movement interfere with care? 
 
       
Attention Is the patient easily distracted by things going on in the 
room? 
 










(0 = not present; 1 = possibly or somewhat present; 2 = definitely present) 
A. General Complaints Date  
Baseline        
1. Appetite 
        
2. Pain / discomfort 
Describe         
3. Frequency of requests for analgesia 
How often?         
4. Frequency of help seeking 
How often?         
5. Other changes 
Describe         
6. Nocturnal worsening of symptoms 
        
B. Affect / emotions 
        
1. Sadness / tearfulness 
        
2. Irritability / grumpiness 
        
3. Fear 
        
4. Excess anxiety / worry 
        
5. Inappropriate elation / euphoria 
        
6. Excess remorse or guilt 
        
C. Demeanour / Cognition 
        
1. Awareness of surroundings, etc 
         
2. Apathy / disinterest 
         
3. Distractability / going ‘off-track’ 
         
4. Confusion / ‘fogginess’ 
         
5. Needing prompting / encouragement 









D. Sleep / activity Date  
Baseline        
1. Poor sleep pattern 
(1= 1-3 hours awake, 2= >3 hours awake, 
nightmare-1, difficulty falling asleep [>30 
mins]-1, seems tired in the morning) 
[Any 2 of the above =2] 
        
2. Drowsy during the day 
(1= some of the time, 2= a lot of the time)         
3. Fidgety or restless or wandering 
        
4. Combative / resisting care 
        
5. Less active than usual / expected 
        
6. Slower movements 
 
        
7. Shifts in wakefulness / drowsiness (1= over 
hours, 2= over minutes) 
 
        
8. Low activity / high activity (1= over hours, 
2= over minutes) 
 
        
F. Speech / talk 
        
1. Finding the right word / naming 
        
2. Understanding you 
        
3. Holding a conversation 
        
4. Saying odd things that don’t make sense 
        
5. Rambling off the point 
        
6. Saying less than usual, lack of spontaneous 
speech 
 










STUDY NUMBER ______ 
 
DMSS-4   Date 
 
 
          
Day 
 
          
Hypoactive 
 
          
Decreased speed of actions  
Moving around slowly, as if in slow motion 
A simple task takes a long time to do due to 
slow body movements 
 
 
          
Decreased amount of speech  
Speaks less than before 
Lacks spontaneous speech 
Speaks only when spoken to, doesn’t initiate 
a chat 
Speaks only in monosyllables or short 
sentences (not due to aphasia) 
 
          
Hyperactive 
 
          
Increased activity levels   
More active than before 
Seems overactive 
Moves around a lot 
Seems to be “on the go” a lot of the time 
 
          
Loss of control of activity   
Movements are unproductive / lacking in 
purpose 
Impulsive body movements (perhaps in an 
unsafe manner) 
Seems to have lost control over his / her own 
body movements 
 





SCREENING ASSESSMENT  
Date ________________  
Collateral from family member 
Acute changes? 
Increased confusion (forgetfulness / disorientation / recognise)? 
Fluctuations? 
Hallucinations/ delusions? 
Change in activity levels (high / low)? 
Changes in speech? 
Change in sleep pattern? 










Plans for discharge? 
 
Patient 
Sleeping ok?     Drowsy during the day? 
Upset / emotions?     Del / Hall? 
Any confusion / difficulty thinking clearly? 
Naming 1. _____________________    Thinking:   Proverb _____________________ 
 2. _____________________     1. _____________________ 
Command  _____________________     2. _____________________ 
STM 1. _____________________ 2. _______________________  3. _____________________  
LTM 1. _____________________ 2. _______________________  3. _____________________  
Day   Month   Year   Place 
Days backwards 
Months backwards 
Way out?     Bigger?    Closer? 
SSF Score _______________ Attempt ________







Please copy this diagram 
   
 
 
Please put numbers in the circle so it looks like the face 
















CAM Scoring sheet 
Positive ☐ Negative ☐ 






















(c) Acute onset   Y О  N О       [acute on chronic О] ____________________________                              
(d) Fluctuation  Y О  N О  
 
Item 2 
Inattention  Y О  N О     _____________________________________________________ 
Months Forwards 
J F MH A MY JE JY A S O N D 
_________________________________________________________________________________ 
Months Backwards 




Disorganised Thinking  Y О  N О   ____________________________________________________ 
Proverb (cloud / meat / stitch / blood / vessels / actions / book / chickens / leopard / cat) 




Consciousness  Alert    Y О  N О                                   Other _________________________ 
(hyperalert or vigilant/ lethargic but readily rousable/ stuporose or comatose) 





Please copy this diagram Please put numbers in the circle so it looks like the face of a 
clock 
 














Increased confusion (forgetfulness / disorientation / recognise)? 
Fluctuations? 
Hallucinations/ delusions? 
Change in activity levels (high / low)? 
Changes in speech? 
Change in sleep pattern? 




Plans for discharge? 
Barthel Index ☐  Burden  ☐  Behaviour  ☐ 
 
Patient 
Sleeping ok?     Drowsy during the day? 
Upset / emotions?     Del / Hall? 
Any confusion / difficulty thinking clearly? 
Naming 1. _____________________    Thinking:   Proverb _____________________ 
 2. _____________________     1. _____________________ 
Command  _____________________     2. _____________________ 
 
STM 1. _____________________ 2. _______________________  3. _____________________  
LTM 1. _____________________ 2. _______________________  3. _____________________ 
  




Way out?     Bigger?    Closer? 
SSF Score _______________ Attempt _________ 
 
Depression ☐   QOL ☐





Please copy this diagram Please put numbers in the circle so it looks like the face of a 
clock 
 










D. ETHICAL CONSIDERATIONS 
 
 
 Patient Information Leaflet 
 Consent Form 
 Note for Medical Chart 







PATIENT INFORMATION SHEET:  
A Prospective Study of the Incidence, Prodrome, Characterisation, Risk Factors 
and Outcomes of Delirium in Older People in an Acute Hospital Setting  
(Dr. Niamh O’Regan) 
What is delirium? 
Delirium is a sudden, temporary reduced memory and awareness of surroundings during an 
illness. There are many different symptoms such as confusion, agitation, hallucinations (seeing 
things that are not there) and poor sleeping and it can vary in severity from day to day. 
Common causes of delirium include infection, some medications and a change in a person’s 
surroundings. 
Why are we doing this study? 
Delirium is common in hospital, particularly in older people, and can be very distressing for 
patients and families. It leads to higher risk of death, dementia and need for nursing home care 
which can be reduced by early diagnosis and treatment. However it is often difficult to 
diagnose correctly. Little research has been done in delirium in Ireland to date. In our study we 
hope to identify early signs of delirium, assess the impact of delirium on patients and carers, 
and examine ways to improve its detection. We hope that this will lead to better detection and 
treatment of delirium in Ireland.   
Why am I being considered for this study? 
Any patient of 70 years of age and older who is admitted to this ward is being asked to take 
part in the study. To fully understand delirium, we need to study a large number of patients, so 
every participant is very important to us. 
What do I need to do if I’m interested? 
Simply agree to take part in our study. This involves a series of interviews during your hospital 
stay. The first interview should be less than 30 minutes and the other interviews, sometimes 
daily, should last only 10 minutes. We may also need to interview your next-of-kin/ carer.  
After you are discharged, we will ask you to come to a special clinic to be reviewed twice (at 6 
months and 1 year after discharge). We will arrange for the clinic to be as close as possible to 
where you live and transport will be arranged for you and a carer on each occasion. 
Will all details be confidential? 
Yes. The recorded interview details will not include your name or hospital number. 
Is there any risk? 
The study only involves being interviewed. There will be no procedure and no risk to you. We 
will stop the interview at any time if you wish to stop.   
Thank you for reading this leaflet.  






Clinical Research Ethics Committee of The Cork Teaching Hospitals 
-----------------------------------------------------------------------------------------
This is a Consent Form 
 
Participant’s Name: ……………………………… 
 
Study Title:  A Prospective Study of the Incidence, Prodrome, 
Characterisation, Risk Factors and Outcomes of Delirium in Older People 
in an Acute Hospital Setting 
 
Chief  Investigators: Dr. Suzanne Timmons  Tel No: 021 4205976 
Dr. ………………………. has given me a full explanation of the nature, 
purpose and duration of this study. I have also received and read the patient 
information leaflet. I was able to ask him/ her questions regarding all 
aspects of the study. 
I consent to the study investigators interviewing me on several occasions 
during my hospital stay, as well as discussing my case with the nursing 
staff caring for me. I also consent to the investigators speaking to my 
family about my health and functional abilities before I was admitted. 
I accept that data recorded during this study may be processed on a 
computer by the investigators. My identity will never be disclosed and the 
data collected will remain confidential. I agree that I will not seek to 
restrict the use to which results of the study may be put. 
After due consideration, I agree to participate in this study and co-operate 
with the testing required. I understand that at any time I may withdraw 
from this study without giving a reason. 
 
_______________________ 













NOTE FOR MEDICAL CHART 
 
 “A Prospective Study of the Incidence, Prodrome, Characterisation, Risk Factors 
and Outcomes of Delirium in Older People in an Acute Hospital Setting” 
Dear Doctor, 
Your patient _________________________  has been included in the above study, with their 
consent / a relative’s assent.  
The aim of the study is to identify incident delirium in hospital and involves daily cognitive and delirium 
assessments of each recruited patient for at least the first week of their admission. Collateral history will also be 
sought from a close relative. This study has been approved by the Cork Research Ethics Committee and the EMB 
of the Mercy University Hospital.  
Any clinically pertinent results / scores from my assessments will be entered on this page. Should you have any 
questions, please don’t hesitate to contact me at 087 9736620.  
Yours sincerely, 
Dr. Niamh O’Regan (IMCN 189937), Geriatric Medicine Research Fellow, University College Cork 
___________________________________________________________________________ 
IQCODE-SF _________ (≥3.5 indicates pre-existing dementia)  SMMSE __________ 
Depression screen positive Yes / no 





















Early Detection of Delirium: 
Prodromal Features 
 
Published In: Alonso R, editor. Delirium Diagnosis, Management and 
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Delirium is a serious neuropsychiatric condition, with a point 
prevalence of 20% in the general inpatient population, rising to almost 
50% in older patients. It is independently associated with a range of 
adverse outcomes, including prolonged length of hospital stay, increased 
dependency and increased mortality. Despite its significance, delirium is 
often underrecognised in the hospital setting, with up to two thirds missed 
or misdiagnosed across treatment settings. This underdetection 
contributes significantly to poorer outcomes. Early identification and 
multifaceted intervention can reduce the degree and duration of delirium, 
but once a patient develops established delirium, even the best quality 
medical and nursing care can only modestly impact on long-term 
sequelae. Multicomponent systemised strategies to identify those at risk 
and minimise modifiable risk factors have been shown to halve delirium 
incidence, and hence improve outcomes. Hence, delirium prevention is 
key to attentuating its long-term impact.  
 
One of the most typical features of delirium is its acute onset, 
however, there is growing evidence to suggest that delirium is preceded 
by a prodrome of varying duration. The proposed symptoms have differed 
from one report to the next, some being part of the delirium cluster, both 
cognitive and non-cognitive, and others more somatic in nature. Lipowski 
described a prodromal period characterised by poor concentration, 
restlessness, irritability, fatigue, malaise, hypersensitivity to stimuli, 
sleep-wake cycle abnormalities and perceptual phenomena and suggested 
that a longer prodrome heralded a delirium secondary to systemic illness 
or metabolic abnormalities, rather than that caused by more mechanical 
or surgical aetiology. Over the last thirty years or so, studies in differing 
patient populations, and designed for other purposes, have described a 
variety of other potential prodromal features including headaches and 
general uneasiness; inattention and other cognitive features; changes in 
activity levels; frequent calls for assistance; perceptual disturbances; 
mood changes; language and thought disorder and disruption in sleep-





patients who go on to develop delirium tend to have subsyndromal 
features in the days or weeks before full diagnostic criteria are met. 
 
Greater recognition of the symptoms that characterise emerging 
delirium can facilitate proactive detection and prompt intervention; so 
that, in effect, we may be able to treat delirium pre-emptively. Further 
work is required to accurately define these early indicators and to 
ascertain whether intervening at this prodromal stage can lead to a 







Delirium, a complex neuropsychiatric syndrome caused by acute illness or 
injury, is one of few conditions to permeate across all treatment settings, 
occurring in one-fifth of all hospital inpatients (1), in up to half of the 
hospitalised elderly (2) and at higher rates in the critically ill (3). It is 
independently associated with adverse sequelae including increased 
mortality, institutionalisation and cognitive decline (4). Despite this, case 
identification remains poor, with up to two-thirds being missed or 
misattributed to dementia, depression and other neuropsychiatric 
diagnoses (5).  
 
One of the major barriers to delirium detection is that, to the untrained 
eye, it is difficult to recognise and can present in many guises. The more 
subtle hypoactive form, although most prevalent and most prognostically 
significant, is commonly mistaken for depression. Symptoms undulate in 
severity over the course of the day which can be deceptive to clinicians, 
as the delirium symptoms which so often present more floridly at night, 
can appear almost fully resolved during a morning ward round. Another 
obstacle to improved detection is that delirium in itself is not often 
acknowledged as causing serious healthcare, economic and personal 
burden. It is commonly seen purely as a manifestation of underlying 
illness, and not as a medical emergency in it own right. Unfortunately, 
confusion in ill older people can be viewed as the norm due to its high 
prevalence, and, hence, is often passively overlooked during medical 
review. 
 
The under-detection of delirium is one of the major challenges facing 
delirium care today for several reasons. Firstly, non-detection is 
associated with particularly poor outcomes, including mortality (6). 
Secondly, it is well-recognised that delirium duration has a direct 
relationship with poor outcomes, such that the longer a patient goes 





starkly illustrated in a study by Gonzalez et al, which found that for each 
additional forty-eight hours of delirium, mortality was increased by 11% 
(7). Kiely et al found that patients with persistent delirium were almost 
three times more likely to die within one year than those whose delirium 
resolved early, independent of other confounders.(8)  
 
Additionally, early and more optimal intervention in delirium has been 
shown to improve short-term outcomes, for example delirium duration 
and severity (9). However, in order to impact significantly on long-term 
outcomes, delirium prevention is the key, but for the most part this 
involves the implementation of systematic and widespread delirium 
prevention programmes(10), which in turn requires that delirium as a 
serious healthcare concern is recognised by clinical leaders and senior 
hospital management, as well as on the ground.  
 
The development of strategies for prevention and early intervention of 
delirium has been informed by multiple studies of factors which increase 
delirium risk. Hence, strategies are targeted at patients and populations 
most predisposed to delirium development. Although a wide range of risk 
factors have been identified, differing slightly across treatment settings 
and patient groups, the most consistent independent predisposing factors 
for delirium development are advancing age and premorbid cognitive 
decline(11). Our ageing population means that the proportion of 
hospitalised patients over the age of seventy years is steadily rising, 
leading to higher proportions of at risk patients. Hence, efforts at delirium 
prevention are commonly spread thinly. Fine-tuning the ability to identify 
delirium-prone patients could facilitate a more streamlined and efficient 
approach towards delirium prevention and identification. 
 
One of the most characteristic features of delirium is that its onset is 
typically acute, with symptoms occurring over hours to days and, indeed, 





using any of the available diagnostic systems. Somewhat converse to this 
construct is the concept of a delirium prodrome, where in some patients 
full-syndromal delirium is preceded by a range of cognitive and other 
varied symptoms. This concept has appeared in the literature for decades, 
however it has yet to be fully characterised. Improved understanding of 
the features, context and duration of this prodrome may lead to advances 





Subsyndromal delirium (SSD) is described broadly as evidence of delirium 
features without full diagnostic criteria for delirium diagnosis. Accurate 
definition remains challenging as it is unclear as to the number, type and 
severity of symptoms required to warrant a label of SSD. Some features 
of delirium can occur in isolation, for instance in the setting of illness (e.g. 
drowsiness, hypoactivity) and other symptoms can occur either alone or in 
clusters as components of non-delirium diagnoses (e.g. hypomania, acute 
psychosis). Hence, in order to accurately identify SSD, we must be able to 
tease out what it is that distinguishes it from delirium and other 
diagnoses. Previous studies have used a variety of different approaches to 
define and measure SSD, including categorical and dimensional methods. 
Categorical methods are underpinned according to the presence of core or 
key diagnostic features (12-18) whereas dimensional approaches are 
based on symptom severity scores on a spectrum from absence of 
delirium to presence of the full-syndromal state (19-25). Studies have 
shown that SSD differs from full-blown delirium, and also from no 
delirium, in symptom profile and severity (26, 27). Although it remains 
unclear as to which mechanism for diagnosis is most appropriate, one 
study suggests that the features are relatively consistent regardless of the 






The clinical relevance of SSD is illustrated in multiple studies outlining its 
prognostic significance, with SSD patients experiencing adverse outcomes 
intermediate between those with delirium and normal controls (14, 17, 
21, 28, 29). The relationship of SSD to delirium is not yet fully understood 
as some patients with SSD symptoms resolve fully without progression to 
delirium, and others experience subsyndromal features in the prodromal 
and post-dromal (or recovery period)(19) phases of delirium. Recently, a 
randomised controlled trial of risperidone versus placebo in SSD post 
cardiac surgery showed significantly reduced transition to full delirium in 
the intervention group (25). This landmark study indicates that improving 
understanding and recognition of SSD may increase opportunities to 
prevent delirium and hence help to mitigate its accompanying cognitive, 
functional and social burden.  
 
 
Current concepts in early diagnosis 
 
Given its high prevalence and clinical significance, all at-risk patients 
should be routinely and frequently assessed for delirium. Unfortunately, 
definitive diagnosis is challenging due to its nuanced and commonly 
complex presentation. There are two standard diagnostic systems for the 
diagnosis of delirium, the Diagnostic and Statistical Manual of Mental 
Disorders criteria(30) and the International Classification of Diseases 
(ICD)-10(31), neither of which are easily applicable in day-to-day 
practice, and require specific training and experience in their use. In order 
to make delirium identification more feasible in a practical setting, a two-
phase approach to detection is now recommended by experts. A 
preliminary step where all patients at high risk for delirium are screened 
for key features using a short easily applicable test, would then be 
succeeded by full formal assessment in those who screen positive. The 
recent NICE (National Institute for Clinical Excellence, UK)(32) guidelines 





have been developed, consensus remains lacking as to which screening 
method should be used.  These seminal guidelines proposed a screening 
approach based on daily observation of all at-risk patients for specific 
delirium indicators. Although the theory behind this approach, developed 
by a panel of experts, is rooted in common sense and highlights a number 
of important delirium features, it has yet to be validated and 
operationalized for practical use.  
 
Whichever method is employed, a crucial property is high sensitivity in 
order to curtail the risk of missing cases, as with any screening process 
for a serious condition. There are multiple bedside screening tests for 
delirium, the most widely used screening test being the Confusion 
Assessment Method (CAM)(33, 34), which has been validated in several 
languages and a wide range of settings, for example, intensive care (35), 
emergency department(36, 37) and long-term care settings (14). 
Designed originally for diagnostic use, and based on DSM-IIIR  (Diagnostic 
and Statistical Manual of Mental Disorders, third edition) criteria, its 
application requires semi-structured patient interview and accurate 
collateral history for accurate application. Hence, it lacks the brevity 
required for routine ward use. Importantly, its accuracy is also closely 
related to the training level of those using it, such that sensitivities drop 
to 50% in the minimally trained (38). Recently, a systematic review of its 
diagnostic accuracy reported a high specificity (99%, 95% CI 87-100%) 
and only moderate to high sensitivity (82%, 95% CI 69-91%), advising 
against reliance on the CAM in isolation and concluding that its use should 
not replace clinical judgement. The ‘SQiD’ or ‘Single Question in Delirium’ 
is a useful screening question for family members or carers. It is simple 
and does not require training, and although its diagnostic accuracy has 
only been reported in one study, sensitivity was as high as 80%(39).  
Some screening tools have been developed for use by nursing staff, which 
is intuitive given that nurses have most exposure to patients round the 
clock and have more opportunity to notice a significant change in 
behaviour or cognition than medical staff. The Nu-DESC (The Nursing 





designed to be completed quickly by nursing staff(40). It measures 
symptoms of disorientation, inappropriate behaviour and communication, 
illusions / hallucinations and psychomotor retardation. A strength of this 
tool is its recognition of the significance of hypoactivity, which can be 
difficult to detect and linked to poorer outcomes (41). Additionally, its 
sensitivity of up to 96%, associated specificity of 79% and easy 
applicability makes it very practical for general use. The NEECHAM is 
another nursing based tool used mainly in post-operative patients(42). It 
incorporates the measurement of physiological markers of illness severity 
and hence can take longer to perform.  
 
Recently attempts to simplify screening approaches in order to improve 
penetration across healthcare settings on the ground are showing 
promising results. Tests of attention are quick, easy to perform and 
require minimal training in their use and because inattention is a cardinal 
compulsory feature of delirium, these tests seem an obvious choice for 
investigation.  Recent and on-going studies have been aimed at examining 
the predictive validity of simple attention tests in the diagnosis of 
delirium. One such study suggests that simply asking a patient to recite 
the months of the year in reverse order has a sensitivity of 83.3% and a 
specificity of 90.8% in detecting full syndromal delirium in general 
hospital patients (43). Examples of useful attention tests are shown in 
Table 1.   
 
The Role of Biological Markers in Early Diagnosis of Delirium 
 
 Although there are many hypotheses as to the pathophysiology of 
delirium, the exact process has not yet been clearly defined. Theories 
include imbalances in the neurotransmitter system; altered brain 
responses to peripheral inflammatory processes;  dysregulation of the 
hypothalamic pituitary adrenal axis; and direct cerebral insults such as 





degrees to delirium development and that initial triggering mechanisms 
ultimately culminate in a final common pathway of neurotransmitter 
imbalance. Multiple studies of biomarkers and genetic polymorphisms 
have been conducted, indicating relationships with delirium incidence, 
course and severity (44, 45). Studies of peripheral inflammatory 
mediators have shown some promise in relation to heralding emerging 
delirium. Studies in hip fracture patients illustrated higher levels of IL-8 
and cortisol in patients with delirium, with peak levels occurring prior to 
delirium onset (46, 47). A study in older medical patients found that 
elevated C-reactive protein (C-RP) independently predicted the onset of 
delirium, however numbers of incident cases were very small(48). More 
recently, Zhang et al found that changes in the C-RP of >8.1 in the first 
24 hours of admission to intensive care were independently associated 
with an increased risk of developing delirium, however predictive ability of 
C-RP was poor (AUC 0.68) (49). Studies of the cytoprotectant peptide 
Insulin-like growth factor I (IGF-I) have shown that low baseline levels 
are associated with a greater delirium risk (50) and that patients with 
delirium have lower levels that controls (51), however a study in intensive 
care patients found that IGF-I levels were not predictive of delirium onset 
(52). It is clear that further studies are necessary to fully understand the 
neurobiological processes underpinning delirium and to examine the role 
of biological markers in delirium detection, before we can assess the utility 
of these markers in predicting delirium onset. 
 
Concept of a prodromal state 
 
As aforementioned, although coupling delirium screening with 
appropriate early intervention policies is important in reducing adverse 
outcomes, in order to truly harness the short- and long-term effects of 
delirium, prevention strategies are key. Identifying the features of the 
delirium prodrome may help to refine these preventative strategies to 
those most at risk, however as yet, these warning symptoms have not 





prodromal phase have been studied or referenced in only a small number 
of works. Most studies alluding to this prodrome were principally designed 
for other purposes and other works have given anecdotal descriptions 
based on clinical experience. Lipowski referred to a prodromal period 
characterised by difficulties with concentation, restlessness, irritability, 
fatigue and sleep-wake cycle disruption, perceptual abnormalities, 
malaise, and hypersensitivity to light and sound (53). Other authors have 
described a variety of other features. Broadly, the various proposed 
symptoms can be divided into four major domains: cognitive features, 
non-cognitive delirium features, somatic features and non-specific 
emotional features. Some features are recognised delirium symptoms, 
however when present during this prodromal phase, occur in the absence 
of full delirium diagnostic criteria. Depending on the type and severity of 
these features during the prodromal period, they may be considered part 
of a subsyndromal delirium presentation. Other prodromal features are 
less related to the delirium cluster and are more somatic or non-specific in 
nature. Hence, the prodrome is even more polymorphic than the delirium 
itself increasing the challenge of detection. Below, the various potential 
prodromal features, based on existing literature, are outlined and 
considered conceptually as components of four respective symptom 





Attentional deficit / clouding of consciousness 
 
Considering the significance of impaired attention span in the diagnosis of 
delirium, it is unsurprising that it is also the most commonly referenced 
feature of the delirium prodrome, either distinctly, or as an element of the 
phenomenon known as ‘clouding of consciousness’. In his 1990 textbook, 
Lipowski discusses the history of how delirium came to be viewed as a 
disorder of consciousness in the latter nineteenth century, and describes 
how the term ‘clouding of consciousness’ evolved to mean a disturbance 





happenings in the environment(53). His report of the prodromal state 
includes a wide spectrum of features including poor concentration. 
Similarly, Crammer, a retired emminent psychiatrist, in describing his 
subjective experience of a delirious state, refers to a ‘declining awareness 
of the environment’ as delirium approached(54). Mermelstein’s case series 
of clarithromycin-induced delirium describes a prodrome in one patient 
who had ‘difficulty focusing’ the day prior to delirium onset(55).  
 
Duppils et al showed that although clouding of consciousness did not 
feature prominantly in older hip surgery patients, when it did occur it was 
only in those about to develop delirium.   Conversely, in two other studies 
of delirious hip fracture patients, inattention was found to be one of the 
dominant features of the prodromal period. Firstly, de Jonghe et al found 
that poor concentration, measured using the digit span, was common in 
the prodromal phase, occurring in 53% of delirious patients two days 
before delirium onset (OR 3.9, CI: 1.6-9.8) and in 81.8% of patients on 
the day before delirium (OR 13.0, CI 4.9-34.7) (56). In a more recent 
study, conducted by Lee et al, almost all DRS-R98 (Korean version) 
features were present during the delirium prodrome, with inattention, 
accompanied by some other cognitive and non-cognitive features, 
occurring as early as four days prior to delirium onset(57). In a more 
general older study population of 91 delirious medical and surgical 
patients, 15.9% experienced a prodrome which included inattentiveness 
(58).  
 
Studies in bone marrow transplant (BMT) patients have also illustrated 
attentional deficits to be a central feature of the delirium prodrome. Fann 
et al used a multifaceted approach, including assessments of mood, pain 
and delirium features, to identify prodromal features in a cohort of 90 BMT 
patients, half of whom went on to have a delirium episode(59). 
Decreasing attention span and cognitive decline was noted in the days 
before delirium onset in the delirium group. In 2010, Beglinger et al 
conducted a prospective case-control study of delirium in 54 BMT patients 
aiming to describe the cognitive performance of patients during the 





controls(60). A comprehensive battery of neuropsychological tests were 
administered at baseline pre-transplantation, including Modified Mini 
Mental State Examination (3MS); Trail-making tests (TMT) A and B; The 
Repeatable Battery for the Assessment of Neuropsychological Status 
(RBANS); The Wechsler Abbreviated Scale of Intelligence (WASI); as well 
as a visual analog scale of thinking clarity. Subsequently subjects were 
assessed twice weekly for up to four weeks post transplantation, using an 
abbreviated version of the baseline assessment (TMT; 3MS; RBANS list 
learning, Coding, Fluency, List Recall and List Recognition subsets). 
Patients who developed delirium showed a consistent drop in scores on all 
measures throughout the post-transplant period. TMT B, list recall and 
coding scores decreased significantly in these patients from the second 
visit to the visit just before delirium. At baseline, there was no significant 
difference between groups for age, education level and WASI IQ, 
however, those patients who went on to develop delirium performed 
significantly more poorly than non-delirious BMT patients on list learning 
and list recall. This indicates that acquired deficits in attention domains 
(particularly divided attention, complex scanning and visual tracking), 
along with impairments in psychomotor speed, learning and memory 




Another frequently observed cognitive feature of impending delirium is 
disorientation. Eden and Foreman recorded in detail a case of tardily 
diagnosed delirium in the intensive care setting, aiming to highlight 
barriers to early recognition(61). The 69-year old elective renal 
endartectomy patient began to exhibit prodromal delirium symptoms on 
the first post-operative night, having been documented as being 
“confused at times, but reoriented easily”. Although, the first  mention of 
delirium in his case-notes was on the fourth post-operative day, and no 
formal neuro-cognitive assessment took place, it appears from the report 
that delirium began on post-operative day two, hence, his early 
disorientation was likely to be part of a prodrome. Disorientation was also 





325 older general medical and surgical patients(58). Of 91 cases of 
delirium, 69.2% experienced a prodrome based on daily longitudinal 
assessment using the Delirium Symptom Interview. Almost half of these 
prodromal patients had evidence of disorientation, most commonly to 
place, just prior to delirium onset. In delirious hip surgery patients, 
disorientation has been a consistent and significant feature of the delirium 
prodrome. In an observational study recording behavioural changes 
before and during the course of delirium in hip surgery patients, 
disorientation was significantly more represented in the delirium group in 
the 48 hours preceding diagnosis, and additionally was one the the most 
dominant features of the prodromal period in these patients(62). 
Subsequently, de Jonghe et al assessed older hip fracture patients on a 
daily basis for incident delirium using the DRS-R98, MMSE and digit 
span(56). In this study, disorientation preceded delirium by as early as 
four days and became more prevalent as delirium approached, occuring in 
over eighty per cent of delirium prodrome patients the day before full 
diagnosis. This finding of early onset disorientation in the prodromal phase 




Registration and Memory impairment 
 
Deficits in registration and memory have been indicated as features of the 
delirium prodrome in some of the aforementioned articles. Crammer’s 
account of his subjective experience refers to the onset of retrograde 
amnesia and impaired registration before delirium emerged(54). Both 
short- and long-term memory impairments feature substantially in the 
prodrome to delirium in de Jonghe et al’s hip fracture cohort(56). In Lee 
et al’s Korean cohort, long-term memory deficits appeared first and 
persisted throughout the prodromal phase, while short-term memory 
declined just before delirium onset(57). In Beglinger et al’s detailed 
investigation of neurocognitive performance in BMT patients, significant 
declines in immediate recall and verbal long-term memory functions 





diagnosis(60). Additionally, in a recent study of long-term care patients, 
using serial CAM assessments to detect delirium, worsening of registration 
(measured by requesting immediate recall of three words) was 





Visuospatial impairments appear to be less prevalent and less prominent 
than other features in the delirium prodrome. A decline in TMT B in 
prodromal BMT patients reflects poor visuomotor processing speed but not 
necessarily visuospatial impairment(60). Mild deficits in visuospatial ability 
have been reported in prodromal hip surgery patients however the 
magnitude of clinical change was less than that of declines in other 




The ‘non-cognitive’ domain is made up of neuropsychiatric symptoms 
which are key components of delirium phenomenology but, as expected, 
are not relating to deficits in cognition. Amost all non-cognitive delirium 
symptoms have been reported in the prodromal phase, though some 
feature more prominently than others. Perceptual abnormalities; 
psychomotor disturbances; and disruption in the sleep-wake cycle are the 
most prevalent non-cognitive prodromal features, whereas delusons; 
speech problems; thought disorder; affective lability; and evidence of 





Psychomotor disturbance in delirium has long been recognised as central 
to clinical presentation. The ancient Greeks coined the phrases 
‘lethargicus’ and ‘phrenitus’ to indicate decreased and increased motor 





symptoms have been proposed and studied, however, most work has 
focused on subtyping based on motor activity profile. Not only are motor 
features more visible than other signs, delirium subtypes based on motor 
profile differ distinctly in relation to many important clinical parameters 
including aetiology, duration and outcomes. Hence, if delirium 
phenomenology is also heavily represented in its prodrome, it is intuitive 
that psychomotor symptoms would predominate. 
 
A few studies have suggested a prodrome characterised by hypoactivity, 
however, restlessness or hyperactivity has most frequently appeared in 
the prodromal literature. It is important to note that although the 
hypoactive subtype of delirium is now known to be more prevalent, 
especially in older populations, it remains the least detected. Hypoactivity 
presents less of a challenge to staff and is often incorrectly not considered 
pathological. Understanding of the subtle signs of delirium is rare, 
withdrawal and poor mobility often attributed solely to concommitant 
illness. Hence, although hyperactivity has been described more frequently, 
it is possible that hypoactivity has simply gone largely unnoticed in the 
prodromal literature. 
 
In a study of older general hospital patients, changes in psychomotor 
activity occurred in 54% of patients who went on to develop delirium(58). 
Hyperactive features predominated slightly and, in particular, 
restlessness. Restlessness has featured significantly in case studies or 
accounts of the prodromal phase. Lipowski included it in his 1990 
characterisation of the delirium prodrome(53) and in Eden and Foreman’s 
case study, restlessness was one of first features of impending delirium, 
increasing in severity as delirium approached(61). In Miller’s case series 
of three delirium tremen patients, restlessness was a chief feature of the 
prelude to delirium(64). Increased psychomotor activity has also been 
described in the prodromal phase in hip fracture patients (57, 62) and in 
Matsushima’s small study of 20 coronary care unit patients, almost all in 
the delirium group had evidence of hyperactivity during the prodromal 
phase(65). Conversely, Osse at al showed using wrist actigraphy in 





activity levels and reduced restlessness in the first post-operative day and 
night(66). In was unclear from this report, however, whether the these 
changes were, in fact, recorded in early delirium or just preceding it.  
 
Sleep-wake cycle disturbance 
 
Disruptions in the sleep-wake cycle are also common during the delirium 
prodrome and have been illustrated in orthopaedic, cardiology and general 
hospital patients. In Levkoff et al’s cohort, 25.4% of prodromal patients 
experienced problems in this domain, in particular describing difficulties 
getting to sleep and staying asleep during the night (58). Nocturnal 





Perceptual disturbance is the most prevalent psychiatric feature of the 
delirium prodrome and can vary in severity from fleeting illusions to 
disturbing hallucinations. Although other cognitive and non-cognitive 
features occur with more consistency in this phase, the presence of 
perceptual abnormalities is the most convincing evidence for the existence 
of a delirium prodrome and that the features of this phase are not simply 
due to illness behaviour. Lipowski described prodromal symptoms 
including vivid dreams and nightmares and difficulty differentiating 
between dreaming and waking imagery or true perceptions. He asserts 
that the fleeting illusions and hallucinations that may occur during this 
phase contribute to a decline in an individual’s sense of control over both 
cognitive processes and the ability to make sense of the environment. 
Perceptual abnormalities of varying severity have been found in the 
prodromal phase in many patient groups, including hip surgery patients 
(57, 62); bone-marrow transplant patients (59); long-term care patients 
(63) and older general hospital patients (58). The reports in delirium 
tremens patients are most dramatic, for example one case report 





while another report depicts recurrent frightening visual hallucinations 
involving large black rocks hurtling towards the patient’s head(64).  
 
Other non-cognitive symptoms 
 
Other delirium symptoms have been observed in the prodromal phase but 
with less consistency. Incoherent speech and tangentiality were common 
in Levkoff et al’s cohort occurring in 49.2% and 22% of prodromal 
patients respectively(58). Mermelstein reported a prodrome including 
‘confused speech’ in one of his cases of clarithromycin-induced 
delirium(55) and incoherence was also recognised in one study of hip 
fracture patients(56). A second study of hip surgery patients found 
disorganised thinking, delusions and lability of affect in the prodromal 
phase(57). Prodromal suspiciousness was recorded in one of Miller’s cases 
of delirium tremens(64) and new-onset disorganised thinking was a 
feature in Voyer et al’s long-term care cohort(63), whereas Fann and 




Somatic or physical features 
 
A wide range of somatic features have been reported in the delirium 
prodrome, so much so that they vary disparately from study to study and 
very few features have been documented with any regularity. The most 
consistent report is that of pain. In Sirois’ evaluation of 100 consecutive 
cases of delirium referred to liaison psychiatry, it was observed that 
unexplained headaches preceded delirium onset in a number of 
subjects(67). Lumbar or thoracic back pain as well as discomfort at 
catheter sites was described in prodromal coronary care patients(65). 
Fann et al reported that pain (measured using a ten-point Likert Scale) 
preceded delirium in BMT patients by approximately three days and 
increased in severity as delirium approached(59). Lipowski’s constellation 
of prodromal features include fatigue, malaise and hypersensitivity to light 





limb sensations in the prodromal phase, accompanying the expected  
diaphoresis, nausea and vomiting (64). 
 
 
Non-specific emotional symptoms 
 
One of the reasons the delirium prodrome has not yet been 
characterised, despite being recognised as a concept for decades, is that 
there are elements that difficult to define and quantify. Many clinicians, 
and indeed family members, note that in the days before delirium a 
patient may seem ‘not quite right’ or ‘not quite him / herself’. Usually 
these observations are made retrospectively as the non-specific nature of 
the signs and symptoms do not lend themselves well to measurement or, 
indeed, to detection in a prospective fashion. When these reported non-
specific symptoms are studied and distilled down, the vast majority 
include an element of emotional change. These reported emotional 
changes include irritability (53, 64), fear (64), anxiety (61, 65), and 
dysphoria (68). Anxiety is documented with the most frequency. Reported 
in cardiology patients(65) and also in Eden and Foreman’s case study of 
an ICU patient(61), anxiety, manifesting as urgent calls for attention, was 
also a key feature of the delirium prodrome in one study of hip surgery 
patients (62). Apathy, dysphoria and withdrawal were observed in the 
prodromal phase of delirium in children and adolescents in an urban sub-
Saharan setting(68). Fann described (using the Profile of Mood States) an 
increase in all negative emotional states in BMT patients as delirium 
approached, indicating a marked rise in distress levels in these 
patients(59). The most non-specific symptom was described by Sirois, 
who reported that complaints of ‘general uneasiness’ preceded delirium in 





From the above, we can see that the delirium prodrome is 





challenging efforts to derive a definition. Some features appear 
consistently across the literature, whereas some of the symptoms are 
observed in only one study. Figure 1 illustrates a schematic representation 
of the features of the delirium prodrome based on the literature to date. 
Many of the symptoms also occur in delirium, so conceptually it can be 
difficult to distinguish some prodromal episodes from subsyndromal 
delirium. De Jonghe and colleagues suggest that a differentiating factor is 
the impact of symptom severity on daily functioning, with delirium 
diagnosed when function is impaired(56). Another obstacle to defining the 
delirium prodrome is that many of the described somatic and emotional 
features could be influenced by other patient factors. Illness behaviour 
may explain fatigue and malaise; an unwell patient may experience 
understandable anxiety in relation to prognosis; and low mood may be 
contributed to by reduced function when physically compromised. Hence, 
further studies are required to elucidate the specific features that herald a 
delirium episode. 
Another aspect of this prodrome which remains unclear is its 
duration in relation to the onset of delirium. Lipowski suggested that a 
longer prodrome preceded delirium secondary to systemic illness or 
metabolic abnormalities, and that delirium secondary to mechanical or 
surgical aetiology was likely to be more acute in onset(53).   Studies 
looking at delirium in hip surgery populations dispute this, with prodromal 
symptoms occurring in many cases three to four days before delirium 
diagnosis and varying in type and severity on a daily basis(56, 57). A 
similar duration has been reported in BMT patients (59, 60), whereas in 
general hospital patients, mean duration was 2.7 days (SD 3.3) with a 
range of one to nineteen days (58). Prodromal symptoms occurred 
between a few days to over a week in ill children and adolescents(68) and 
were described between one and two weeks prior to delirium diagnosis in 
long-term care patients (63), so defining duration based on aetiology may 
not be accurate. Noted in many studies and case reports is that prodromal 
features tend to increase in number and severity as delirium proximity 
increases. This is best illustrated by Fann et al(59), whose data show a 
precipitous rise in all prodromal features from four days prior to delirium 





then tail off in the post-dromal period.  In Duppils et al’s study in hip 
fracture patients, although behavioural changes were common in all 
patients, the changes were different and more repeatedly observed in 
those with emerging delirium(62). Additionally, there was increased 
frequency and evidence of behavioural changes in these patients with 





Delirium is a serious highly prevalent condition which has a significant 
impact on medical, social and personal outcomes, as well as on 
increasingly stretched health budgets. Our ageing population is leading to 
increasing age profiles across all medical settings, which in turn will 
generate higher case complexity across the board and increased 
prevalence rates of all age-related co-morbidities. Delirium rates are 
hence likely to increase dramatically, given that advancing age, pre-
existing cognitive impairment and comorbidity are all significant risk 
factors for its development. This makes improving delirium care a key 
factor in delivering enhanced care quality to this growing proportion of 
older patients. Prognosis is linked to delirium duration, underlining the 
importance of early detection and appropriate intervention, yet we are still 
hampered by a lack of awareness and understanding of delirium on the 
ground. Delirium prevention has the potential to yield great long-term 
benefits on both personal and population-based levels, but strategies to 
prevent delirium must be multifactorial and system-wide in order to be 
effective and must include educational initiatives to improve 
comprehension of its significance both at staff level and at institutional 
level.  
 
Understanding early indicators of delirium, specifically the features of the 





initiatives to identify those in the early stages of delirium. Although, the 
studies as described above have outlined the landscape, further work is 
needed to definitively characterise this prodromal period with regard to 
symptom profile and duration and whether or not these characteristics 
differ according to delirium aetiology or other factors. We also must 
investigate why some patients experience a prodrome, yet others do not. 
Is this related to acuity of onset of the underlying precipitant or do all 
patients with delirium traverse through a prodromal period of varied 
duration and symptom profile? Once we understand the nature of the 
prodrome in more depth, we must turn our efforts towards investigating if 
intervening at this pre-delirium phase has meaning in relation to 
improving patient outcomes. Prospective studies of incident delirium 
focussing on the characterisation of the prodromal period are necessary to 







Table 1: Useful attention tests 
 
Cognitive tests Description 
Digit Span forwards (DSF)/ 
backwards (DSB)  
Patient must repeat a sequence of numbers read out 
by examiner (same order for DSF, reverse order for 
DSB) 
Abnormal: DSF <5 or DSB <3 on 2 trials 
Spatial Span forwards (SSF)/ 
backwards (SSB)  
A visual version of the digit span, using a card with 
8 coloured squares. Sequences are tapped out for 
the patient to repeat.  
Useful in patients with communication difficulties.  
Abnormal: SSF <5 or SSB <3 on 2 trials 
Months of the year backwards Recite the months of the year in reverse order 
starting with December. 
Failure to reach July without error is abnormal 
Days of the week backwards Recite the days of the week backwards. 
Any error is abnormal 
20 to 1 Count backwards from 20 to 1. 













Table 2: Studies of delirium prodrome 





Assessments used Frequency of 
Assessments 
Outcomes Prodromal features Prodromal 
duration 







Not specified Not specified Not specified  Headaches  
 General uneasiness 
Not 
specified 













Daily 69.2% of cases experienced a 
prodrome. 
 
 Changes in psychomotor activity  
 Speech and thought disorder 
 Disorientation  
 Sleep disturbance  
 Inattentiveness 















MMSE; EEG and eye 
movement recordings; 
Assessment of clinical 
symptoms 
Daily on days 
1,2,3 and 4 of 
admission to CCU  
and a subsequent 
control recording  
Slowing of background EEG 
activity and Increased R and 
RS group eye movements in 
delirium group.  
 Anxiety (p<0.05) 
 Increased body activity (p<0.05) 
 Sleep disturbance (p<0.05) 
 Slowing of background EEG activity 
1-3 days 













protocol assessing for 
behavioural changes  
3 to 8 times daily BCs were more frequent in 
delirium group. 
 Disorientation (p<0.05) 
 Urgent calls for attention (p<0.05) 
 Increased psychomotor activity (ns) 
 Perceptual disturbance (ns) 
Up to 48 
hours 








DRS  DRS, MDAS, POMS, 








 Impairments in attention 
 Perceptual disturbance 
 Changes in cognition 
 Evidence of variability of symptoms. 
 Pain  
 Distress symptoms 
5 days 
De Jonghe et 
al(56) 
Prospective 








MMSE, DRS-R-98, Digit 
span 
Daily Marked increase in mean 
DSR-R98 scores on the day 
before delirium. 
 Disorientation  
 Difficulty concentrating  







(DSM-III: Diagnostic and Statistical Manual for Mental Disorders (Third Edition); DSM-IIIR: Diagnostic and Statistical Manual for Mental Disorders (Third Edition)- Revised; DSM-IV: Diagnostic and Statistical Manual for 
Mental Disorders (Fourth Edition); CCU: Coronary Care Unit; MMSE: Mini Mental State Examination; EEG: Electroencephalogram; BC(s): Behavioural change(s); HSCT: Haematopoeitic Stem Cell Transplantation; DRS: 
Delirium Rating Scale; DRS-R98: Delirium Rating Scale-Revised ’98; MDAS: Memorial Delirium Assessment Scale; CAM-ICU: Confusion Assessment Method for the Intensive Care Unit; 3MS: Modified MMSE; TMT A and 
B: Trail Making Tests A and B; RBANS: Repeatable Battery for the Assessment of Neuropsychological Status; WAIS: The Wechsler  Abbreviated Intelligence Scale; DRS-R98: Korean version of the Delirium Rating Scale-
Revised ’98; MMSE-K: Korean version of the MMSE: APACHE II: Acute Physiology and Chronic Health Evaluation II; HDS: Hierarchic Dementia Scale; BI: Barthel Index; CAM: Confusion Assessment Method)  
 
  









38 CAM-ICU Actiwatch® actigraphy on 
non-dominant wrist  
Continuous data 
for 1st post-
operative day and 
night 
Number of immobility 
minutes was higher and 
mean activity level was 
lower for the delirious group 
compared to non-delirious 
group 
 Lower nocturnal mean activity levels 
(p<0.05) 
 Reduced restlessness (p<0.05) 
 Higher immobility minutes (ns) 





















3MS, TMT A and B; RBANS; 
WAIS; A visual analog scale 
of thinking clarity‡ 
 
Twice weekly Trails B, List recall, and 
coding z-scores (from 
RBANS) show a significant 
drop from the second visit to 
the visit just before delirium.  
 Deficit in psychomotor speed 
 Learning and memory impairment 
 Attention / working memory impairment 
 
Slight increase in DRS and MDAS scores prior to 
delirium onset 
2-5 days 













operative day 5 
Increasing K-DRS-R98 
symptoms and severity 
scores as delirium 
approached with no change 
in the non-delirious group. 
 Day -4: sleep-wake, thought process, 
orientation, attention, LTM impairment  
 Del -3: lability of affect 
 Del -2: perceptual disturbances, 
hallucinations and visuospatial ability 
 Del -1: delusions, motor agitation, STM 
1-4 days 






85 CAM MMSE; HDS; BI; CAM  
 
Weekly There were more new-onset 
delirium symptoms prior to 
delirium in the delirium 
group, but the prevalence 
was still very low (<15%) 
 Perceptual disturbances (9.4%) 
 Disorganised thinking (8.3%) 






Table 3: Case studies of delirium prodrome 
Case Studies Study design Patient group Number 
of cases 
Outcomes Prodromal features Prodromal duration 
Miller, 1982(64) Case series Delirium tremens patients 3 N/A  Recurrent visual and / or tactile 
hallucinations 
 Motor agitation 
 Fear 
 Suspiciousness / argumentativeness  
 Disturbing sensation in limbs 
 Diaphoresis 
 Nausea and vomiting 
Perceptual abnormalities: 1-6 months  
Other symptoms: 1-2 days 
Eden et al, 1996(61) Case study ICU  1 N/A  Restlessness 
 Anxiety 
 Nocturnal insomnia 
 Intermittent disorientation 
3 days 
Mermelstein, 1998(55) Case series Clarithromycin-induced delirium 
 
3 One patient had an 
apparent prodrome 
 Difficulty focusing 
 Confused speech 
24 hours 
Crammer, 2002(54) Case report ICU (Subjective experience) 1 N/A  Retrograde amnesia 
 Declining awareness of the environment 
 Impaired registration 
 
At least 24 hours 
Hatherill et al, 2010(68) Prospective case 
series 
Paediatric referrals to 
consultation liaison psychiatry 
(Sub-saharan Africa) 
 
23 22% (n=5) patients 
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